Sentence,class,file
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/99/27/ijn-11-543.PMC4745829.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/99/27/ijn-11-543.PMC4745829.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/66/e8/ijn-11-485.PMC4745830.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 485–500International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  485OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9438 4heterogeneous response of different tumor cell  lines to methotrexate-coupled nanoparticles in  presence of hyperthermia Marcus stapf* Nadine Pömpner* Ulf T eichgräber Ingrid hilger Institute of Diagnostic and  Interventional radiology, Department  of experimental radiology, Jena  University hospital, Friedrich-schiller  University, Jena, germany *These authors contributed equally  to this workAbstract:  Today, the therapeutic efficacy of cancer is restricted by the heterogeneity of the  response of tumor cells to chemotherapeutic drugs.",Non-OADS,/arxiv_data1/oa_pdf/66/e8/ijn-11-485.PMC4745830.pdf
"In spite of correspondence: Ingrid hilger Institute of Diagnostic and Interventional  radiology, Jena University hospital,  Forschungszentrum lobeda, erlanger  allee 101, D-07747 Jena, germany Tel +49 3641 932 5921 Fax +49 3641 932 5922 email ingrid.hilger@med.uni-jena.d e Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Stapf et al Running head recto: Cytotoxicity of MTX–MNP after hyperthermia treatment DOI: http://dx.doi.org/10.2147/IJN.S94384",Non-OADS,/arxiv_data1/oa_pdf/66/e8/ijn-11-485.PMC4745830.pdf
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521101 /.,Non-OADS,/arxiv_data1/oa_pdf/66/e8/ijn-11-485.PMC4745830.pdf
http://www.ncbi.nlm.nih.gov/pubmed/1131097 3  27.,Non-OADS,/arxiv_data1/oa_pdf/66/e8/ijn-11-485.PMC4745830.pdf
http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/66/e8/ijn-11-485.PMC4745830.pdf
http://www.biomednet.com/db/medline/9200545 4  34.,Non-OADS,/arxiv_data1/oa_pdf/66/e8/ijn-11-485.PMC4745830.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/66/e8/ijn-11-485.PMC4745830.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/66/e8/ijn-11-485.PMC4745830.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/23/e1/dddt-10-593.PMC4745832.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2016:10 593–607Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  593Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9531 6randomized clinical trial: pharmacokinetics and  safety of multimatrix mesalamine for treatment  of pediatric ulcerative colitis carmen cuffari1 David Pierce2 Bartosz Korczowski3 Krzysztof Fyderek4 heather Van heusen5 stuart hossack6 hong Wan5 alena YZ edwards7 Patrick Martin5 1Department of Pediatrics, Division  of Pediatric gastroenterology  and nutrition, The Johns hopkins  University school of Medicine,   Baltimore, MD, Usa; 2shire,   Basingstoke, UK; 3Medical college,   University of rzeszów, rzeszów,   Poland; 4University children’s hospital  of cracow, cracow, Poland; 5shire,   Wayne, P a, Usa; 6covance clinical  research Unit limited, leeds, UK;   7icOn  early Phase services, Marlow,   Buckinghamshire, UKBackground:  Limited data are available on mesalamine (5-aminosalicylic acid; 5-ASA) use  in pediatric ulcerative colitis (UC).",Non-OADS,/arxiv_data1/oa_pdf/23/e1/dddt-10-593.PMC4745832.pdf
"However, correspondence: carmen cuffari Department of Pediatrics, Division of  Pediatric gastroenterology and nutrition,  The Johns hopkins University school of  Medicine, Brady 320, 600 north Wolfe  street, Baltimore, MD 21287-2631, Usa Tel +1 410 955 8769 Fax +1 410 955 1464 email ccuffari@jhmi.ed u Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Cuffari et al Running head recto: Multimatrix mesalamine PK in pediatric UC DOI: http://dx.doi.org/10.2147/DDDT.S95316",Non-OADS,/arxiv_data1/oa_pdf/23/e1/dddt-10-593.PMC4745832.pdf
Further details are available at https://clinicaltrials.gov/ct2/ show/NCT01130844 .,Non-OADS,/arxiv_data1/oa_pdf/23/e1/dddt-10-593.PMC4745832.pdf
Available from: http://www.accessdata.,OADS,/arxiv_data1/oa_pdf/23/e1/dddt-10-593.PMC4745832.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/23/e1/dddt-10-593.PMC4745832.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/23/e1/dddt-10-593.PMC4745832.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/99/08/copd-11-193.PMC4745834.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 193–205International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  193OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S9505 5The lung function profile of once-daily tiotropium  and olodaterol via respimat® is superior to  that of twice-daily salmeterol and fluticasone  propionate via accuhaler® (energITO® study) Kai-Michael Beeh1 eric Derom2 José Echave-Sustaeta3 lars grönke4 alan hamilton5 Dongmei Zhai6 Leif Bjermer7 1Insaf gmbh Institut für  atemwegsforschung, Wiesbaden,   Germany; 2Department of Internal  Medicine, Ghent University Hospital,   Ghent, Belgium; 3servicio de  Neumología, Hospital Universitario  Quirón, Madrid, Spain; 4Boehringer  Ingelheim Pharma gmbh & Co. K g,   Ingelheim, Germany; 5Boehringer  Ingelheim, Burlington, ON, Canada;   6InVentiv health Clinical, Wilmington,   DE, USA; 7Department of Respiratory  Medicine and Allergology, Lund  University, Lund, SwedenBackground:  Tiotropium + olodaterol has demonstrated improvements beyond lung function  benefits in a large Phase III clinical program as a once-daily maintenance treatment for COPD  and may be a potential option for the initiation of maintenance treatment in COPD.",Non-OADS,/arxiv_data1/oa_pdf/99/08/copd-11-193.PMC4745834.pdf
"Keywords:  COPD, maintenance treatment, lung function, tiotropium, FEV1, inhaled  corticosteroid Introduction In addition to smoking cessation and nonpharmacologic interventions, including pul - monary rehabilitation, maintenance pharmacotherapy is well established for the man - agement of COPD to optimize lung function and improve symptoms.1,2 Tiotropium is a  once-daily COPD maintenance treatment for which there is a broad evidence base that Correspondence: Kai-Michael Beeh Insaf gmbh Institut für  Atemwegsforschung, Biebricher Allee 34,  65187 Wiesbaden, Germany Tel +49 611 985 4410 Fax +49 611 985 4348 email k.beeh@insaf-wi.d e Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Beeh et al Running head recto: Tiotropium + olodaterol 24-hour lung function profile DOI: http://dx.doi.org/10.2147/COPD.S9505 5",Non-OADS,/arxiv_data1/oa_pdf/99/08/copd-11-193.PMC4745834.pdf
"Available from:  http://www.goldcopd.org/uploads/users/files/GOLD_Report_2015_ Feb18.pd f. Accessed September 30, 2015.",OADS,/arxiv_data1/oa_pdf/99/08/copd-11-193.PMC4745834.pdf
"Available from: http://www.goldcopd.org/ uploads/users/files/AsthmaCOPDOverlap.pd f. Accessed July 30,  2015.",OADS,/arxiv_data1/oa_pdf/99/08/copd-11-193.PMC4745834.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/99/08/copd-11-193.PMC4745834.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/99/08/copd-11-193.PMC4745834.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ac/55/tcrm-12-135.PMC4745837.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 135–138Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  135ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S9924 1sudoscan as a noninvasive tool to assess  sudomotor dysfunction in patients with Fabry  disease: results from a case–control study Pauline sahuc1 laurent Chiche2 Bertrand Dussol3 Jean Pouget1 Jérôme Franques1,2,4 1Department of neurology, la  Timone hospital, aPhM, aix- Marseille University, 2Department of  internal Medicine, european hospital,   3Department of n ephrology, la  Conception hospital, aPhM, aix- Marseille University, 4Department of  neurology, la Casamance hospital,   Marseille, FranceAbstract:  Hypohidrosis is a frequent and early symptom in patients with Fabry disease.",Non-OADS,/arxiv_data1/oa_pdf/ac/55/tcrm-12-135.PMC4745837.pdf
"However, assessment of sudomotor dysfunction requires highly  technical and time-consuming procedures, such as the Quantitative Sudomotor Axon  Reflex Test or skin biopsies, which limit their widespread adoption in clinical prac - tice.4 Noninvasive tools assessing skin impedance have been tested but evidence of Correspondence: laurent Chiche service de Médecine interne, hôpital  européen, 6 Rue Désirée Clary,  13003 Marseille, France Tel +33 4 616 834 430 Fax +33 4 413 427 712 email l.chiche@hopital-europeen.f r Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Sahuc et al Running head recto: Noninvasive assessment of sudomotor function in Fabry disease DOI: http://dx.doi.org/10.2147/TCRM.S99241",Non-OADS,/arxiv_data1/oa_pdf/ac/55/tcrm-12-135.PMC4745837.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/ac/55/tcrm-12-135.PMC4745837.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ac/55/tcrm-12-135.PMC4745837.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c2/66/dddt-10-585.PMC4745838.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 585–592Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  585Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9673 0establishment of a novel therapeutic vector  targeting the trigeminal ganglion in rats Kun Xu1,2 shi-Yin Pan1,2 Jin-Xin song1 Xian-n ing liu1,2 na an1,2 Xuan Zheng1,2 1Department of Ophthalmology,   The n o 1 hospital of Xi’an, 2shaanxi  Provincial Key laboratory of  Ophthalmology, Ophthalmological  institute of shaanxi Province, Xi’an,   shaanxi Province, People’s republic  of chinaBackground:  In the pathogenesis of herpes simplex keratitis, herpes simplex virus type 1  (HSV -1) infection begins in corneal epithelium cells and then progresses through the sensory  nerve endings and finally travels up forward to the trigeminal ganglion (TG), where it remains as  latent virus.",Non-OADS,/arxiv_data1/oa_pdf/c2/66/dddt-10-585.PMC4745838.pdf
"However, HSV -1 infection correspondence: Kun Xu; Jin-Xin song Department of Ophthalmology,   The no 1 hospital of Xi’an, Fen rd 30,   The south street, Xi’an, shaanxi  Province, People’s republic of china Tel +86 29 8763 0869 Fax +86 29 8724 1606 email xukun0418@126.co m;  jinxxsong@yeah.ne tJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Xu et al Running head recto: A novel therapeutic vector targeting trigeminal ganglion DOI: http://dx.doi.org/10.2147/DDDT.S96730",Non-OADS,/arxiv_data1/oa_pdf/c2/66/dddt-10-585.PMC4745838.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c2/66/dddt-10-585.PMC4745838.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/66/dddt-10-585.PMC4745838.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bd/bb/cmar-8-011.PMC4745839.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pCancer Management and Research 2016:8 11–20Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  11ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CMAR.S8517 3EGFR testing and clinical management of advanced  nsClC: a galician lung Cancer group study  (ggCP 048-10) sergio Vázquez1 Joaquín Casal2 Francisco Javier afonso afonso3 José luis Fírvida4 lucía santomé5 Francisco Barón6 Martín lázaro7 Carolina Pena7 Margarita amenedo8 ihab abdulkader9 Carmen gonzález-arenas10 laura Fachal11 ana Vega11 On behalf of the galician lung  Cancer group (ggCP) 1Medical Oncology Department, lucus  augusti University hospital, lugo, 2Medical  Oncology Department, University hospital  Complex of Vigo, Pontevedra, 3Medical  Oncology Department, University hospital  Complex of Ferrol, Ferrol, 4Medical  Oncology Department, University hospital  Complex of Ourense, Ourense, 5Medical  Oncology Department Povisa hospital,   Vigo, 6Medical Oncology Department,   University hospital Complex of santiago  de Compostela, santiago de Compostela,   7Medical Oncology Department, hospital  Complex of Pontevedra, Pontevedra,   8Medical Oncology Department, Oncology  Center of galicia, a Coruña, 9anatomical  Pathology Department, University hospital  Complex of santiago de Compostela,   santiago de Compostela, 10astraZeneca,   Madrid, 11galician Public Foundation of  genomic Medicine-seRgas, santiago  de Compostela Clinic hospital, santiago  de Compostela, spain Correspondence: sergio Vázquez   Medical Oncology Department, lucus  augusti University hospital, lugar san  Cibrao, s/n 27004 lugo, spain   Tel +34 982 296 000   Fax +34 982 295 544   email s ergio.vazquez.estevez@sergas.e sPurpose:  This study aimed to assess the incidence of mutations in the epidermal growth factor  receptor ( EGFR ) gene in non-small-cell lung cancer (NSCLC) patients in the Galician region of  Spain and the clinical management and outcome of patients carrying EGFR  mutations.",Non-OADS,/arxiv_data1/oa_pdf/bd/bb/cmar-8-011.PMC4745839.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/bd/bb/cmar-8-011.PMC4745839.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bd/bb/cmar-8-011.PMC4745839.pdf
"Available from: http://avalia-t.sergas.es/ DXerais/289/avalia-t200706Cribado-ca-Pulmon.pd f. Accessed Decem - ber 23, 2015.",Non-OADS,/arxiv_data1/oa_pdf/bd/bb/cmar-8-011.PMC4745839.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/08/f7/dddt-10-465.PMC4745840.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 465–481Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  465Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S7945 8Efficacy and safety of iron-chelation therapy with  deferoxamine, deferiprone, and deferasirox for  the treatment of iron-loaded patients with non- transfusion-dependent thalassemia syndromes Christina N Kontoghiorghe George J Kontoghiorghes Postgraduate Research institute of  Science, Technology, environment and  Medicine, Limassol, CyprusAbstract:  The prevalence rate of thalassemia, which is endemic in Southeast Asia, the Middle  East, and the Mediterranean, exceeds 100,000 live births per year.",Non-OADS,/arxiv_data1/oa_pdf/08/f7/dddt-10-465.PMC4745840.pdf
"Iron plays an important catalytic role in free radi - cal pathology and oxidative stress damage, which is not only observed in iron-overload Correspondence: George J Kontoghiorghes Postgraduate Research institute of  Science, Technology, environment  and Medicine, 3 Ammochostou Street,  Limassol 3021, Cyprus Tel +357 2627 2076 Fax +357 2627 1434 email kontoghiorghes.g.j@pri.ac.c y Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Kontoghiorghe and Kontoghiorghes Running head recto: Iron chelation in non-transfusion-dependent thalassemias DOI: http://dx.doi.org/10.2147/DDDT.S79458",Non-OADS,/arxiv_data1/oa_pdf/08/f7/dddt-10-465.PMC4745840.pdf
"Available from: http://www.fda.gov/ohrms/dockets/ ac/05/briefing/2005-4177B1_02_b.pd f. Accessed December 1, 2015.",OADS,/arxiv_data1/oa_pdf/08/f7/dddt-10-465.PMC4745840.pdf
"Available from: http://www.accessdata.fda.gov/drugsatfda_docs/ label/2010/021882s010lbl.pd f. Accessed December 1, 2015.",Non-OADS,/arxiv_data1/oa_pdf/08/f7/dddt-10-465.PMC4745840.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/08/f7/dddt-10-465.PMC4745840.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/08/f7/dddt-10-465.PMC4745840.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/48/2e/bctt-8-013.PMC4745841.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pBreast Cancer: Targets and Therapy 2016:8 13–27Breast Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  13Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/BCTT .S9241 4interleukin-6 is a potential therapeutic target in  interleukin-6 dependent, estrogen receptor- α- positive breast cancer Tineke Casneuf1 amy e axel2 Peter King2 John D alvarez2 Jillian l Werbeck3 Tinne Verhulst1 Karin Verstraeten1 Brett M hall2 a Kate sasser2 1Janssen research and Development,   Beerse, Belgium; 2Janssen research  and Development, spring house, P a,   3labConnect llC, seattle, W a, Usa Correspondence: a Kate sasser   Janssen research and Development,   1400 McKean road, spring house,   Pa 19477, Usa   Tel +1 215 628 6813   Fax +1 215 986 1019   email ksasse r1@its.jnj.comIntroduction:  Interleukin-6 (IL-6) is an important growth factor for estrogen receptor- α (ERα)- positive breast cancer, and elevated serum IL-6 is associated with poor prognosis.",Non-OADS,/arxiv_data1/oa_pdf/48/2e/bctt-8-013.PMC4745841.pdf
r-project.org/ ; http://bioconductor.org ).,OADS,/arxiv_data1/oa_pdf/48/2e/bctt-8-013.PMC4745841.pdf
org/; http://bioconductor.or g).,OADS,/arxiv_data1/oa_pdf/48/2e/bctt-8-013.PMC4745841.pdf
"Notably, IL-6-induced  phosphorylation of Akt, MEK1/2, or ERK1/2 was not  observed, confirming results of a previous study and showing  that STAT3 phosphorylation is the primary IL-6-responsive  pathway in ER α-positive cell lines.36The IL-6 PAS was determined for each patient and  compared with the serum IL-6 level from the same patient  (Figure  4B); these data have also been deposited in the  NCBI’ s GEO and are accessible through accession number  GSE54330 ( http://www.ncbi.nlm.nih.gov/geo/que ry/acc.",Non-OADS,/arxiv_data1/oa_pdf/48/2e/bctt-8-013.PMC4745841.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/48/2e/bctt-8-013.PMC4745841.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c9/c2/dddt-10-547.PMC4745842.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 547–555Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  547Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9348 7Targeting the D1-n-methyl- d-aspartate receptor  complex reduces l-dopa-induced dyskinesia in  6-hydroxydopamine-lesioned Parkinson’s rats lu song1,* Zhanzhao Zhang2,* rongguo hu1 Jie cheng1 lin li1 Qinyi Fan1 na Wu1 Jing gan1 Mingzhu Zhou1 Zhenguo liu1 1Department of neurology, Xinhua  hospital, 2Department of Plastic and  reconstructive surgery, shanghai  9th People’s hospital, shanghai Jiao  T ong University school of Medicine,   shanghai, People’s republic of china *These authors contributed equally  to this workAbstract:  L-3,4-dihydroxyphenylalanine ( l-dopa) remains the most effective therapy for  Parkinson’s disease (PD), but its long-term administration is associated with the development  of debilitating motor complications known as l-dopa-induced dyskinesia (LID).",Non-OADS,/arxiv_data1/oa_pdf/c9/c2/dddt-10-547.PMC4745842.pdf
"It is believed that the pathological  mechanism of LID involves complex alterations of both dopaminergic and non- dopaminergic (eg, glutamatergic) neurotransmitter systems induced by the pulsatile  stimulation of short-acting dopaminergic agents.5 Denervation-dependent D1 receptor  (D1R) super-sensitivity is widely believed to be an important postsynaptic determinant  of LID in animal models, although the exact mechanisms remain to be elucidated.6  There is an increasing evidence supporting the idea that enhancement of glutamate  N-methyl- d-aspartate receptor (NMDAR) function may also contribute to the devel - opment of LID.7,8correspondence: Zhenguo liu Department of neurology, Xinhua  hospital, shanghai Jiao Tong University  school of Medicine, 1665 Kongjiang  road, shanghai 200092, People’s  republic of china email zhenguoliu2004@aliyun.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Song et al Running head recto: Targeting the D1-NMDA complex reduces dyskinesia DOI: http://dx.doi.org/10.2147/DDDT.S93487",Non-OADS,/arxiv_data1/oa_pdf/c9/c2/dddt-10-547.PMC4745842.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c9/c2/dddt-10-547.PMC4745842.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c9/c2/dddt-10-547.PMC4745842.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b1/7d/cia-11-111.PMC4745843.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2016:11 111–125Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  111RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S6530 4Optimal breast cancer screening strategies for  older women: current perspectives Dejana Braithwaite1 Joshua Demb1 Louise M Henderson2 1Department of epidemiology and  Biostatistics, University of California,   San Francisco, CA, 2Department  of Radiology, University of North  Carolina, Chapel Hill, NC, USAAbstract:  Breast cancer is a major cause of cancer-related deaths among older women, aged  65 years or older.",Non-OADS,/arxiv_data1/oa_pdf/b1/7d/cia-11-111.PMC4745843.pdf
"Diminished life expectancy that occurs with aging decreases the probability of a screen - ing benefit and likely increases the risk of harms.7 Because of large heterogeneity in  comorbidity status and life expectancy among older women, aged 65 years or older,  a continuing controversy exists over screening mammography in this population.8,9 Correspondence: Dejana Braithwaite Department of epidemiology and  Biostatistics, Mission Hall: Global  Health & Clinical Sciences Building,  University of California, 550 16th  Street, 2nd Floor, PO Box No 0560,  San Francisco, CA 94143, USA Tel +1 415 514 8019 email dejana.braithwaite@ucsf.ed u Journal name: Clinical Interventions in Aging Article Designation: Review Y ear: 2016 Volume: 11 Running head verso: Braithwaite et al Running head recto: Breast cancer screening strategies DOI: http://dx.doi.org/10.2147/CIA.S65304",Non-OADS,/arxiv_data1/oa_pdf/b1/7d/cia-11-111.PMC4745843.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/b1/7d/cia-11-111.PMC4745843.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/b1/7d/cia-11-111.PMC4745843.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/38/28/ijn-11-557.PMC4745844.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 557–574International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  557OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9661 4Nanodiamonds coupled with 5,7- dimethoxycoumarin, a plant bioactive metabolite,  interfere with the mitotic process in B16F10 cells  altering the actin organization angelo gismondi1 Valentina Nanni1 giacomo reina2 silvia Orlanducci2 Maria letizia T erranova2 antonella canini1 1Department of Biology, 2Department  of chemical science and T echnology,   University of rome “T or Vergata”,   rome, ItalyAbstract:  For the first time, we coupled reduced detonation nanodiamonds (NDs) with a plant  secondary metabolite, citropten (5,7-dimethoxycoumarin), and demonstrated how this complex  was able to reduce B16F10 tumor cell growth more effectively than treatment with the pure  molecule.",Non-OADS,/arxiv_data1/oa_pdf/38/28/ijn-11-557.PMC4745844.pdf
"The first of them illustrated the antimicro - bial activity of menthol ((1 R,2S,5R)-2-isopropyl-5-methylcyclohexanol)-modified correspondence: angelo gismondi Department of Biology, University of  rome “Tor Vergata”, via della ricerca  Scientifica 1, Rome 00133, Italy Tel +39 6 7259 4333 Fax +39 6 2023 500 email gismondi@scienze.uniroma2.i tJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Gismondi et al Running head recto: Citropten conjugated with nanodiamonds arrests B16F10 mitosis DOI: http://dx.doi.org/10.2147/IJN.S96614",Non-OADS,/arxiv_data1/oa_pdf/38/28/ijn-11-557.PMC4745844.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/38/28/ijn-11-557.PMC4745844.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/38/28/ijn-11-557.PMC4745844.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ea/4e/copd-11-263.PMC4745845.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 263–271International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  263OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S9383 0Functional respiratory imaging to assess   the interaction between systemic roflumilast   and inhaled ICs/laB a/laMa Wim Vos1 Bita hajian2 Jan De Backer1 Cedric Van holsbeke1 samir Vinchurkar1 rita Claes2 annemie hufkens2 Paul M Parizel3 lieven Bedert4 Wilfried De Backer2 1FlUIDD a nv, groeningenlei, Kontich,   2Department of respiratory Medicine,   3Department of radiology, University  hospital antwerp, Wilrijkstraat,   edegem, 4Department of respiratory  Medicine, Zna Middelheim hospital,   antwerp, BelgiumBackground:  Patients with COPD show a significant reduction of the lobar hyperinflation  at the functional residual capacity level in the patients who improved .120 mL in forced  expiratory volume in 1 second (FEV1) after 6 months of treatment with roflumilast in addition  to inhaled corticosteroids (ICSs)/long-acting beta-2 agonists (LABAs)/long-acting muscarinic  antagonists (LAMAs).",Non-OADS,/arxiv_data1/oa_pdf/ea/4e/copd-11-263.PMC4745845.pdf
"While ICS combined  with LABA remains an established standard, several monoclonal antibodies, a new Correspondence: Wim Vos FlUIDDa nv, groeningenlei 132,   2550 Kontich, Belgium Tel +32 3 450 87 20 Fax +32 3 450 87 29 email w im.vos@fluidda.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Vos et al Running head recto: An image of interacting inhaled and systemic drugs DOI: http://dx.doi.org/10.2147/COPD.S93830",Non-OADS,/arxiv_data1/oa_pdf/ea/4e/copd-11-263.PMC4745845.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/ea/4e/copd-11-263.PMC4745845.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/4e/copd-11-263.PMC4745845.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/11/03/amep-7-041.PMC4745846.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/11/03/amep-7-041.PMC4745846.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Advances in Medical Education and Practice 2016:7 41–48Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  41OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S9287 9impact and feasibility of the Allied health  Professional Enhancement Program placements –  experiences from rural and remote Queensland Priya Martin1,2 saravana Kumar2 Melinda stone1 luJuana Abernathy1 Vanessa Burge1 lucylynn lizarondo3 1Allied health Education and  Training, cunningham centre, Darling  Downs hospital and health service,   T oowoomba, QlD, 2international  centre for Allied health Evidence  (icAhE), school of health sciences,   University of south Australia,   3Joanna Briggs institute, University of  Adelaide, Adelaide, sA, Australia correspondence: Priya Martin   PMB2, cunningham centre,  T oowoomba hospital, T oowoomba,  QlD,  4350, Australia   Email preeyamartin99@gmail.co mBackground:  Allied health professionals practicing in rural and remote areas are often faced  with barriers that prevent them from accessing professional development opportunities.",Non-OADS,/arxiv_data1/oa_pdf/11/03/amep-7-041.PMC4745846.pdf
"Available from: http://www.health.qld.gov.au/cunninghamcentre/html/ about-us.as p. Accessed March 01, 2015.",Non-OADS,/arxiv_data1/oa_pdf/11/03/amep-7-041.PMC4745846.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/11/03/amep-7-041.PMC4745846.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/11/03/amep-7-041.PMC4745846.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c4/01/ijn-11-501.PMC4745847.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 501–513International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  501OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9349 6Efficient inhibition of ovarian cancer by degradable  nanoparticle-delivered survivin T34A gene Correspondence: Ke Men; Maling Gou State Key Laboratory of Biotherapy and  Cancer Center, West China Hospital,  Medical School, Sichuan University and  Collaborative Innovation Center for  Biotherapy, No 17, Section 3, South  Renmin Road, Chengdu 610041,   People’s Republic of China Tel +86 028 8516 4061 Fax +86 028 8516 4060 email mendingbob@hotmail.co m;  goumaling@scu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Luo et al Running head recto: Nanoparticle-delivered survivin T34A  gene for ovarian cancer therapy DOI: http://dx.doi.org/10.2147/IJN.S93496 li luo1,* Ting Du1,* Jiumeng Zhang1 Wei Zhao2 Hao Cheng1 Yuping Yang1 Yujiao Wu1 Chunmei Wang1 Ke Men1 Maling Gou1 1State Key Laboratory of Biotherapy  and Cancer Center, West China  Hospital, Sichuan University and  Collaborative Innovation Center  for Biotherapy, 2Department of  Thoracic Oncology, Cancer Center,   West China Hospital, Medical School,   Sichuan University, Chengdu, People’s  Republic of China *These authors contributed equally to  this workAbstract:  Gene therapy has promising applications in ovarian cancer therapy.",Non-OADS,/arxiv_data1/oa_pdf/c4/01/ijn-11-501.PMC4745847.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c4/01/ijn-11-501.PMC4745847.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/01/ijn-11-501.PMC4745847.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f7/ed/ijn-11-515.PMC4745848.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 515–527International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  515OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9808 0Preparation of finasteride capsules-loaded drug  nanoparticles: formulation, optimization, in vitro,  and pharmacokinetic evaluation Tarek a ahmed1,2 1Department of Pharmaceutics  and Industrial Pharmacy, Faculty of  Pharmacy, King Abdulaziz University,   Jeddah, Kingdom of Saudi Arabia;   2Department of Pharmaceutics  and Industrial Pharmacy, Faculty of  Pharmacy, Al-Azhar University, Cairo,   EgyptAbstract:  In this study, optimized freeze-dried finasteride nanoparticles (NPs) were prepared  from drug nanosuspension formulation that was developed using the bottom–up technique.",Non-OADS,/arxiv_data1/oa_pdf/f7/ed/ijn-11-515.PMC4745848.pdf
"This process has found wide applications in the pharmaceutical  industry owing to its capacity to enhance the dissolution rate and bioavailability of many  poorly water-soluble drugs.1,2 Of the new chemical compounds developed by medicinal  drug design programs, more than 40% have limited water solubility.3 Enhancement  of aqueous drug solubility affects the process of drug dissolution, and hence both the  rate and extent to which the administered drug reaches the systemic circulation are  augmented.4 Many techniques have been reported to improve drug aqueous solubility  through salt formation, solubilization by cosolvent approach, complexation, micellar  formation, and particle size reduction.3 Some other techniques that have illustrated  reasonable successes involve enclosing the drug in vesicular nanoparticles (NPs)5 or correspondence: Tarek a ahmed Department of Pharmaceutics and  Industrial Pharmacy, Faculty of Pharmacy,  King Abdulaziz University, Jeddah 21589,  Kingdom of Saudi Arabia Tel +966 2 640 0000 ext 22250 email dr_tarek_nour@yahoo.co mJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Ahmed Running head recto: Preparation of finasteride capsules-loaded drug nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S98080",Non-OADS,/arxiv_data1/oa_pdf/f7/ed/ijn-11-515.PMC4745848.pdf
Available from: http://www.fda.gov/downloads/drugs/   guidancecomplianceregulatoryinformation/guidances/ucm377465.,Non-OADS,/arxiv_data1/oa_pdf/f7/ed/ijn-11-515.PMC4745848.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/f7/ed/ijn-11-515.PMC4745848.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f7/ed/ijn-11-515.PMC4745848.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/24/9f/cia-11-127.PMC4745849.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 127–132Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  127OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S8835 4reasons for elderly patients gP visits: results of a  cross-sectional study Thomas Frese Jarmila Mahlmeister T obias Deutsch hagen sandholzer Department of general Practice,   Medical Faculty, University of leipzig,   leipzig, germanyObjective:  The aim of this study is to describe the frequency of reasons for elderly patients  visits to a general practice (GP) setting.",Non-OADS,/arxiv_data1/oa_pdf/24/9f/cia-11-127.PMC4745849.pdf
"Identifying and describing needs and trends in care could Correspondence: Thomas Frese Department of general Practice, Medical  Faculty, University of leipzig, Philipp- rosenthal-straße 55, 04103 leipzig,  germany Tel +49 341 971 5710 Fax +49 341 971 5719 email mail@thomasfrese.d e Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Frese et al Running head recto: Reasons for elderly visits to GP DOI: http://dx.doi.org/10.2147/CIA.S88354",Non-OADS,/arxiv_data1/oa_pdf/24/9f/cia-11-127.PMC4745849.pdf
"Data from: https://www-genesis.destatis.de/genesis/onlin e.28 Abbreviations:  rFV, reasons for visit; M, male; F, female.",Non-OADS,/arxiv_data1/oa_pdf/24/9f/cia-11-127.PMC4745849.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/24/9f/cia-11-127.PMC4745849.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/24/9f/cia-11-127.PMC4745849.pdf
Available from: http://www.statistik.,OADS,/arxiv_data1/oa_pdf/24/9f/cia-11-127.PMC4745849.pdf
[Population structure of the Free State of Saxony on  31 December 1998 to 2014] Available from: http://www.statistik.,OADS,/arxiv_data1/oa_pdf/24/9f/cia-11-127.PMC4745849.pdf
"Available from:  https://www-genesis.destatis.de/genesis/onlin e. Accessed January 12,  2016.",Non-OADS,/arxiv_data1/oa_pdf/24/9f/cia-11-127.PMC4745849.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/12/23/copd-11-227.PMC4745850.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 227–237International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  227OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S9702 7antioxidant activity of pomegranate juice reduces  emphysematous changes and injury secondary to  cigarette smoke in an animal model and human  alveolar cells ahmad husari1,* Yasmine hashem1 hala Bitar1 ghassan Dbaibo2,3 ghazi Zaatari4 Marwan el sabban5,* 1Division of Pulmonary and Critical  Care Medicine, Department of  Internal Medicine, 2Department  of Pediatrics and adolescent  Medicine, Division of Pediatric  Infectious Diseases, 3Department of  Biochemistry and Molecular genetics,   4Department of Pathology and  laboratory Medicine, 5Department  of anatomy, Cell Biology and  Physiological sciences, Faculty of  Medicine, american University of  Beirut, Beirut, lebanon *These authors contributed equally  to this workBackground:  Cigarette smoke (CS) increases oxidative stress (OS) in the lungs.",Non-OADS,/arxiv_data1/oa_pdf/12/23/copd-11-227.PMC4745850.pdf
"It is estimated that  each puff may contain .1015 free radicals that deplete endogenous antioxidants and  tilt the delicate balance in favor of an OS.4–6 Increased OS is well described in patients Correspondence: ahmad husari Division of Pulmonary and Critical  Care Medicine, Department of Internal  Medicine, Faculty of Medicine, american  University of Beirut, PO Box 11-236,  riad el solh, Beirut 1107 2020, lebanon email ah51@aub.edu.l b  Marwan el sabban Department of anatomy, Cell Biology  and Physiological sciences, Faculty of  Medicine, american University of Beirut,  PO Box 11-236, riad el solh, Beirut 1107  2020, lebanon email me00@aub.edu.l b Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Husari et al Running head recto: Pomegranate juice reduces cigarette induced emphysema and alveolar injury DOI: http://dx.doi.org/10.2147/COPD.S97027",Non-OADS,/arxiv_data1/oa_pdf/12/23/copd-11-227.PMC4745850.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/12/23/copd-11-227.PMC4745850.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/12/23/copd-11-227.PMC4745850.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a7/0e/dddt-10-541.PMC4745851.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2016:10 541–546Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  541Hypo THesisopen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S8303 7Antiviral therapy: a perspective Amir Hashem shahidi  Bonjar Clinician scientist, institute of Applied  Research in Dentistry, Kerman  University of Medical sciences,   Kerman, iranAbstract:  This paper discusses extracorporeal removal of viral particles and their antigens  from the blood as an auxiliary therapy.",Non-OADS,/arxiv_data1/oa_pdf/a7/0e/dddt-10-541.PMC4745851.pdf
"Individuals older than 84 years  have the highest risk of dying from these complications.3 Ebola virus accumulates  specifically in the bloodstream, and patients remain infectious as long as their blood  contains the virus;4 transport of viral antigens and toxins via the blood to the liver,  muscles, spleen, kidneys, lungs, heart, and brain produces hemorrhages that may  lead to death.5,6 Generally, blood titers of viruses and their toxins are proportional Correspondence: Amir Hashem  shahidi Bonjar Clinician scientist, institute of  Applied Research in Dentistry,  Kerman University of Medical sciences,  Kerman 7616913555, iran email shahidiah@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Hypothesis Y ear: 2016 Volume: 10 Running head verso: Shahidi Bonjar Running head recto: Antiviral therapy: a perspective DOI: http://dx.doi.org/10.2147/DDDT.S83037",Non-OADS,/arxiv_data1/oa_pdf/a7/0e/dddt-10-541.PMC4745851.pdf
"Available from: http://www.webmd.com/ cold-and-flu/flu-guide/fact-sheet-elderly-peopl e. Accessed February 18,  2015.",Non-OADS,/arxiv_data1/oa_pdf/a7/0e/dddt-10-541.PMC4745851.pdf
"Available from: http://www.cdc.gov/vhf/ ebola/transmission/human-transmission.htm l. Accessed March 22,  2015.",OADS,/arxiv_data1/oa_pdf/a7/0e/dddt-10-541.PMC4745851.pdf
Available from: https://www.lens.org/lens/ patent/US_6528057_B 1.,Non-OADS,/arxiv_data1/oa_pdf/a7/0e/dddt-10-541.PMC4745851.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/a7/0e/dddt-10-541.PMC4745851.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a7/0e/dddt-10-541.PMC4745851.pdf
"Available from:  http://my.clevelandclinic.org/health/diseases_conditions/hic_Sepsi s.  Accessed March 19, 2015.",Non-OADS,/arxiv_data1/oa_pdf/a7/0e/dddt-10-541.PMC4745851.pdf
"Available from: http://www.nhs.uk/ Conditions/Blood-poisoning/Pages/Introduction.asp x. Accessed March  24, 2015.",Non-OADS,/arxiv_data1/oa_pdf/a7/0e/dddt-10-541.PMC4745851.pdf
Available from: http://www.healthline.,Non-OADS,/arxiv_data1/oa_pdf/a7/0e/dddt-10-541.PMC4745851.pdf
Available from: http://www.davita.com/treatment-options/hemodialy - sis/in-center-hemodialysis/how-does-a-dialysis-machine-work?/t/559 6.,Non-OADS,/arxiv_data1/oa_pdf/a7/0e/dddt-10-541.PMC4745851.pdf
"Available from: http://www.tpims.org/disease-research/aids-a-other- infectious-diseases/persistent-viral-infection s. Accessed February 19,  2015.",Non-OADS,/arxiv_data1/oa_pdf/a7/0e/dddt-10-541.PMC4745851.pdf
Available  from: http://www.mayoclinic.org/tests-procedures/hemodialysis/basics/ risks/prc-2001501 5.,Non-OADS,/arxiv_data1/oa_pdf/a7/0e/dddt-10-541.PMC4745851.pdf
Available from: https://www.kidney.org/news/ekidney/ january12 /top5.,Non-OADS,/arxiv_data1/oa_pdf/a7/0e/dddt-10-541.PMC4745851.pdf
"Available from: http://www.kidneydialysis.org.uk/ risks.ht m. Accessed March 20, 2015.",Non-OADS,/arxiv_data1/oa_pdf/a7/0e/dddt-10-541.PMC4745851.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/96/03/ccid-9-029.PMC4745852.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical, Cosmetic and Investigational Dermatology 2016:9 29–40Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  29RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S6910 6The role of lasers and intense pulsed light  technology in dermatology Zain Husain1 Tina S Alster1,2 1Department of Dermatology,   Georgetown University Hospital,   2washington Institute of  Dermatologic Laser Surgery,   washington, DC, USA Correspondence: Tina S Alster   washington Institute of Dermatologic  Laser Surgery 1430 K Street Nw , Suite  200 washington, DC 20005, USA   Tel +1 202 628 8855   Fax +1 202 628 8850   email talster@skinlaser.co mAbstract:  The role of light-based technologies in dermatology has expanded dramatically in  recent years.",Non-OADS,/arxiv_data1/oa_pdf/96/03/ccid-9-029.PMC4745852.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/96/03/ccid-9-029.PMC4745852.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/96/03/ccid-9-029.PMC4745852.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e6/63/dhps-8-001.PMC4745853.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/e6/63/dhps-8-001.PMC4745853.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug, Healthcare and Patient Safety 2016:8 1–7Drug, Healthcare and Patient Safety Dove press submit your manuscript | www.dovepress.co m Dove press  1Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DHPS.S6264 9Benefit–risk assessment of golimumab in the  treatment of refractory ulcerative colitis Daniela Pugliese Carla Felice Rosario Landi Alfredo Papa Luisa Guidi Alessandro Armuzzi inflammatory Bowel Disease Unit,   Complesso Integrato Columbus,   Catholic University, Rome, italy Correspondence: Alessandro Armuzzi   Inflammatory Bowel Disease Unit,  Complesso Integrato Columbus,   Catholic University, via Giuseppe   Moscati 31, 00168 Rome, italy   Tel +39 06 3503357   email alearmuzzi@yahoo.co mAbstract:  Significant advances in the management of patients with ulcerative colitis (UC) have  been made since the introduction of anti-tumor necrosis factor (TNF)-alpha agents, especially  for those who fail or do not tolerate conventional therapies.",Non-OADS,/arxiv_data1/oa_pdf/e6/63/dhps-8-001.PMC4745853.pdf
"Drug, Healthcare and Patient Safety Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-healthcare-and-patient-safety-journa lDrug, Healthcare and Patient Safety is an international, peer-reviewed  open-access journal exploring patient safety issues in the healthcare  continuum from diagnostic and screening interventions through to treat - ment, drug therapy and surgery.",Non-OADS,/arxiv_data1/oa_pdf/e6/63/dhps-8-001.PMC4745853.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e6/63/dhps-8-001.PMC4745853.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0d/6c/copd-11-251.PMC4745854.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2016:11 251–261International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  251OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S7958 0Determinants of change in physical activity during  moderate-to-severe COPD exacerbation Cristóbal esteban1,2 José M Quintana2,3 susana garcia-gutierrez2,3 ane anton-ladislao3 nerea gonzalez2,3 Marisa Baré2,4 nerea Fernández de  larrea2,5 Francisco rivas-ruiz2,6 For the I rYss-COPD group  1respiratory Department, hospital  galdakao-Usansolo, Bizkaia; 2red de  Investigación en servicios sanitarios y  enfermedades Crónicas (reDIsseC),   galdakao; 3research Unit, hospital  galdakao-Usansolo, Bizkaia; 4Unit of  Clinical epidemiology, Corporacio  Parc Tauli, Barcelona; 5health  Department, Madrid; 6research Unit,   hospital Costa del sol, Mabella,   Málaga, spainBackground:  Data are scarce on patient physical activity (PA) level during exacerbations of  chronic obstructive pulmonary disease (eCOPD).",Non-OADS,/arxiv_data1/oa_pdf/0d/6c/copd-11-251.PMC4745854.pdf
"However, the evidence  base has begun to grow and it has been seen that PA may have an influence on very Correspondence: Cristóbal esteban servicio de neumología, hospital de  galdakao-Usansolo, Barrio labeaga s/n,  48960 galdakao, Bizkaia, spain Tel +34 944 007 002 Fax +34 944 007 002 email cristobal.est@gmail.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Esteban et al Running head recto: Physical activity changes during COPD exacerbations DOI: http://dx.doi.org/10.2147/COPD.S79580",Non-OADS,/arxiv_data1/oa_pdf/0d/6c/copd-11-251.PMC4745854.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/0d/6c/copd-11-251.PMC4745854.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0d/6c/copd-11-251.PMC4745854.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fb/75/copd-11-161.PMC4745855.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 161–166International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  161OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S9680 9association of incidental emphysema with annual  lung function decline and future development  of airflow limitation hyeon-Kyoung Koo1 Kwang n am Jin2 Deog Kyeom Kim3 hee soon Chung3 Chang-hoon lee3,4 1Department of Internal Medicine,   Division of Pulmonary and Critical  Care Medicine, College of Medicine,   Ilsan Paik hospital, Inje University,   goyang-si, gyeonggi-Do, 2Department  of radiology, seoul Metropolitan  government – seoul national  University Boramae Medical Center,   3Department of Internal Medicine,   Division of Pulmonary and Critical  Care Medicine, seoul Metropolitan  government- seoul national  University Boramae Medical Center,   4Department of Internal Medicine,   Division of Pulmonary and Critical  Care Medicine, seoul national  University College of Medicine, seoul  national University hospital, seoul,   republic of KoreaObjectives:  Emphysema is one of the prognostic factors for rapid lung function decline in  patients with COPD, but the impact of incidentally detected emphysema on population with - out spirometric abnormalities has not been evaluated.",Non-OADS,/arxiv_data1/oa_pdf/fb/75/copd-11-161.PMC4745855.pdf
"Correspondence: Chang-hoon lee Department of Internal Medicine,  Division of Pulmonary and Critical  Care Medicine, seoul national  University College of Medicine, seoul  national University hospital, 101  Daehak-ro Jongno-gu, seoul 03080,  republic of Korea Tel +82 2 2072 4743 Fax +82 2 762 9662 email kauri670@empal.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Koo et al Running head recto: Emphysema with normal lung function DOI: http://dx.doi.org/10.2147/COPD.S96809",Non-OADS,/arxiv_data1/oa_pdf/fb/75/copd-11-161.PMC4745855.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/fb/75/copd-11-161.PMC4745855.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fb/75/copd-11-161.PMC4745855.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6e/1d/ijn-11-389.PMC4745856.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2016:11 389–397International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  389OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8880 3Preclinical animal study and human clinical  trial data of co-electrospun poly( l-lactide-co- caprolactone) and fibrinogen mesh for anterior  pelvic floor reconstruction Xujun Wu1,2,* Yuru Wang3,* cancan Zhu2 Xiaowen T ong3 Ming Yang2 Li Yang2 Zhang Liu1,2 Weihong Huang2 Feng Wu2 Honghai Zong2 Huaifang Li3 Hongbing He2,4 1school of Materials science and  Engineering, Shanghai Jiao Tong  University, 2Shanghai Pine & Power  Biotech co. ltd., 3Department of  Obstetrics and Gynecology, Shanghai  T ongji Hospital, T ongji University,   4Section of Tissue Engineering,   Institute of Peripheral Vascular  Surgery, Fudan University, Shanghai,   People’s Republic of China *These authors contributed equally  to this workAbstract:  Synthetic and biological materials are commonly used for pelvic floor reconstruction.",Non-OADS,/arxiv_data1/oa_pdf/6e/1d/ijn-11-389.PMC4745856.pdf
"Compared with the Correspondence: Hongbing He Shanghai Pine & Power Biotech Co. Ltd.,  Shanghai 201108, People’s Republic of  china email hhb@shsongli.co m  Huaifang Li Department of Obstetrics and  Gynecology, Shanghai Tongji Hospital,  Tongji University, Shanghai, People’s  Republic of China email huaifangli@126.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Wu et al Running head recto: PLCL/Fg mesh for anterior pelvic floor reconstruction DOI: http://dx.doi.org/10.2147/IJN.S88803",Non-OADS,/arxiv_data1/oa_pdf/6e/1d/ijn-11-389.PMC4745856.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/6e/1d/ijn-11-389.PMC4745856.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6e/1d/ijn-11-389.PMC4745856.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e4/fd/tacg-9-005.PMC4745857.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).The Application of Clinical Genetics 2016:9 5–13The Application of Clinical Genetics Dove press submit your manuscript | www.dovepress.co m Dove press  5Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TACG.S6199 9Candidate genes of idiopathic pulmonary fibrosis:  current evidence and research wei Zhou1,2 Yaping wang1,2 1Department of Medical Genetics,   2Jiangsu Key Laboratory of Molecular  Medicine, Nanjing University School  of Medicine, Nanjing, People’s  Republic of China Correspondence: Yaping wang  Department of Medical Genetics, Nanjing  University School of Medicine, Nanjing  210093, People’s Republic of China   T el +86 25 8368 6495   Fax +86 25 8368 6451   email wangyap@nju.edu.c nAbstract:  Idiopathic pulmonary fibrosis (IPF) is a group of common and lethal forms of  idiopathic interstitial pulmonary disease.",Non-OADS,/arxiv_data1/oa_pdf/e4/fd/tacg-9-005.PMC4745857.pdf
"The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/the-application-of-clinical-genetics-journa lThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in  the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/e4/fd/tacg-9-005.PMC4745857.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e4/fd/tacg-9-005.PMC4745857.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/98/0d/copd-11-207.PMC4745858.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 207–216International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  207OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S9820 5“Frequent exacerbator” is a phenotype of poor  prognosis in Japanese patients with chronic  obstructive pulmonary disease ryusuke T omioka1,2 T omotaka Kawayama1 Masashi suetomo1,2 Takashi Kinoshita1 Y oshihisa T okunaga1 haruki Imaoka1 Kazuko Matsunaga1 Masaki Okamoto1 T omoaki hoshino1 1Division of respirology, neurology,   and rheumatology, Department of  Medicine, Kurume University school  of Medicine, Kurume, 2respiratory  Medicine, Chikugo City hospital,   Chikugo, JapanBackground:  The prognosis of Japanese patients with COPD who suffer repeated exacerbations  is unclear, although Westerners with such episodes have a poor prognosis.",Non-OADS,/arxiv_data1/oa_pdf/98/0d/copd-11-207.PMC4745858.pdf
kurume-u.ac.j p Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Tomioka et al Running head recto: Frequent exacerbators in Japanese COPD DOI: http://dx.doi.org/10.2147/COPD.S98205,OADS,/arxiv_data1/oa_pdf/98/0d/copd-11-207.PMC4745858.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/98/0d/copd-11-207.PMC4745858.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/98/0d/copd-11-207.PMC4745858.pdf
Available from: http://www.jds.,Non-OADS,/arxiv_data1/oa_pdf/98/0d/copd-11-207.PMC4745858.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5a/34/ijn-11-529.PMC4745859.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 529–542International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  529OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9359 1cytotoxicity of cdT e quantum dots in human  umbilical vein endothelial cells: the involvement  of cellular uptake and induction of pro-apoptotic  endoplasmic reticulum stress correspondence: Ming Yan Department of Biomedical engineering,  college of life Information science and  Instrument engineering, hangzhou Dianzi  University, 2nd avenue 1158, Xiasha  higher education Zone, hangzhou  310018, People’s republic of china Tel +86 571 8687 8667 Fax +86 571 8687 8667 email yanming@hdu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Y an et al Running head recto: Cytotoxicity of CdTe quantum dots in HUVECs DOI: http://dx.doi.org/10.2147/IJN.S93591 Ming Yan1,* Yun Zhang2,* haiyan Qin3 Kezhou liu1 Miao guo1 Yakun ge1 Mingen Xu1 Y onghong sun4 Xiaoxiang Zheng4 1Department of Biomedical  engineering, college of life  Information science and Instrument  engineering, hangzhou Dianzi  University, hangzhou, 2Basic Medical  sciences, college of Medicine,   shaoxing University, shaoxing,   3Department of chemistry, Zhejiang  University, 4Zhejiang Provincial Key  laboratory of cardio- cerebral  Vascular Detection T echnology and  Medicinal effectiveness appraisal,   Department of Biomedical  engineering, Zhejiang University,   hangzhou, People’s republic of china *These authors contributed equally   to this workAbstract:  Cadmium telluride quantum dots (CdTe QDs) have been proposed to induce oxidative  stress, which plays a crucial role in CdTe QDs-mediated mitochondrial-dependent apoptosis  in human umbilical vein endothelial cells (HUVECs).",Non-OADS,/arxiv_data1/oa_pdf/5a/34/ijn-11-529.PMC4745859.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/5a/34/ijn-11-529.PMC4745859.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/34/ijn-11-529.PMC4745859.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/93/01/dddt-10-557.PMC4745860.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 557–570Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  557Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9268 7curcumin enhances the cytogenotoxic effect of  etoposide in leukemia cells through induction of  reactive oxygen species Monika A Papież1 Wirginia Krzyściak2 Krzysztof szade3 Karolina Bukowska- straková3,4 Magdalena Kozakowska3 Karolina hajduk3 Beata Bystrowska5 Jozef Dulak3,6 alicja Jozkowicz3 1Department of cytobiology,  2Department of Medical  Diagnostic, Faculty of Pharmacy,  Jagiellonian University Medical  college, 3Department of Medical  Biotechnology, Faculty of Biochemistry,  Biophysics and Biotechnology,  Jagiellonian University, 4Department  of clinical immunology, institute of  Pediatrics, 5Department of T oxicology,  Faculty of Pharmacy, Jagiellonian  University Medical college,  6Malopolska centre of Biotechnology,  Jagiellonian University, Krakow, PolandAbstract:  Curcumin may exert a more selective cytotoxic effect in tumor cells with elevated  levels of free radicals.",Non-OADS,/arxiv_data1/oa_pdf/93/01/dddt-10-557.PMC4745860.pdf
"Cancer cells have many mutations in proto-oncogenes, which  can contribute to an increase in free radicals.4 Curcumin can exert selective pro- oxidant action in cancer cells with high levels of free radicals and, in this way, induce  apoptosis.5,6 Curcumin may also inhibit the antiapoptotic genes that are often over - expressed in leukemia cells, which may be a cause of resistance to anticancer drugs.7  Correspondence: Monika A Papież Department of cytobiology, Jagiellonian  University Medical college, 9 Medyczna  street, 30-688 Krakow, Poland Tel/fax +48 12 620 5700 email monika.papiez@uj.edu.p l Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Papie ż et al Running head recto: Curcumin enhances etoposide-induced antileukemic effect DOI: http://dx.doi.org/10.2147/DDDT.S92687",Non-OADS,/arxiv_data1/oa_pdf/93/01/dddt-10-557.PMC4745860.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/93/01/dddt-10-557.PMC4745860.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/93/01/dddt-10-557.PMC4745860.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2c/ad/jpr-9-025.PMC4745947.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2016:9 25–36Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  25PeRsPectivesopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/JPR.S9250 2Present-day challenges and future solutions   in postoperative pain management: results   from PainForum 2014 Kristiina Kuusniemi1 Reino Pöyhiä2,3 1Department of Anaesthesiology,   turku University, turku, Finland;   2Department of Anaesthesiology,   University of Helsinki, Helsinki,   Finland; 3Department of Palliative  Medicine and Oncology, University of  turku, turku, Finland correspondence: Kristiina Kuusniemi   Department of Anaesthesiology,  University of turku, Fi-20014 turun  Yliopisto, Finland   email Kristiina.Kuusniemi@terveystalo.",Non-OADS,/arxiv_data1/oa_pdf/2c/ad/jpr-9-025.PMC4745947.pdf
"Available from: http://www.rcoa.ac.uk/clinical-standards- qualit y. Accessed November 30, 2014.",Non-OADS,/arxiv_data1/oa_pdf/2c/ad/jpr-9-025.PMC4745947.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/2c/ad/jpr-9-025.PMC4745947.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/ad/jpr-9-025.PMC4745947.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c0/a8/ppa-10-115.PMC4745948.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 115–121Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  115OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S9644 9Profile of rheumatology patients willing to report  adverse drug reactions: bias from selective  reporting Dragana Protić1 Nada Vujasinović-Stupar2 Zoran Bukumirić3 Slavica Pavlov-Dolijanović4 Snežana Baltić5 Slavica Mutavdžin6 Ljiljana Marković-Denić7 Marija Zdravković8 Zoran T odorović1 1Department of Pharmacology, Clinical  Pharmacology and Toxicology, Faculty  of Medicine, University of Belgrade,   Belgrade, Serbia; 2Department 2,   Institute of Rheumatology, Faculty  of Medicine, University of Belgrade,   Belgrade, Serbia; 3institute for Medical  Statistics and Informatics, Faculty  of Medicine, University of Belgrade,   Belgrade, Serbia; 4Department 5,   Institute of Rheumatology, Faculty  of Medicine, University of Belgrade,   Belgrade, Serbia; 5Department 5,   Institute of Rheumatology, Belgrade,   Serbia; 6Institute of Physiology  “Rihard Burjan”, Faculty of Medicine,   University of Belgrade, Belgrade,   Serbia; 7Institute of Epidemiology,   Faculty of Medicine, University  of Belgrade, Belgrade, Serbia;   8Department of Cardiology, Medical  Center “Bežanijska kosa”, Faculty  of Medicine, University of Belgrade,   Belgrade, SerbiaBackground:  Adverse drug reactions (ADRs) have a significant impact on human health and  health care costs.",Non-OADS,/arxiv_data1/oa_pdf/c0/a8/ppa-10-115.PMC4745948.pdf
"Therefore, ADRs are  among leading causes of death in the USA.2 In addition, 6.5% of admissions to UK  hospitals were due to ADRs; three quarters of those were preventable ADRs, and .2%  of them caused death.3 Patient reporting of potential ADRs has an important role in Correspondence: Zoran Todorović Department of Pharmacology,  Clinical Pharmacology and Toxicology,  Faculty of Medicine, University of  Belgrade, Dr Subotića starijeg 1,   PO Box 38, Belgrade 11129, Serbia Tel +381 11 364 3389 Fax +381 11 364 3397 email zoran.todorovic@mfub.bg.ac.r s Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Proti ć et al Running head recto: Profile of rheumatology patients willing to report adverse drug reactions DOI: http://dx.doi.org/10.2147/PPA.S96449",Non-OADS,/arxiv_data1/oa_pdf/c0/a8/ppa-10-115.PMC4745948.pdf
Patient’s  spontaneous reports are submitted directly to the ALIMS  (http://www.alims.gov.rs/eng/pharmacovigilance /).,Non-OADS,/arxiv_data1/oa_pdf/c0/a8/ppa-10-115.PMC4745948.pdf
The researchers believe that such forums are a rich resource  of information about ADRs and drug–drug interaction  (http://www.meco-project.eu /).,Non-OADS,/arxiv_data1/oa_pdf/c0/a8/ppa-10-115.PMC4745948.pdf
These data are different from the last few ALIMS annual  reports on ADRs (data available at: http://www.alims.gov.rs/ eng/pharmacovigilance /).,OADS,/arxiv_data1/oa_pdf/c0/a8/ppa-10-115.PMC4745948.pdf
"Available from: http://www.alims.gov.rs/eng/files/2012/10/8-Rulee-on- the-method-of-reporting-collecting-and-monitoring-adverse-reactions- to-medicines_64-2011.pd f. Accessed January 3, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c0/a8/ppa-10-115.PMC4745948.pdf
"Available from: http://www.irdes.fr/espaceanglais/publications/ irdespublications /qes156.pd f. Accessed January 3, 2014.",Non-OADS,/arxiv_data1/oa_pdf/c0/a8/ppa-10-115.PMC4745948.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/c0/a8/ppa-10-115.PMC4745948.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8b/47/ndt-12-269.PMC4745949.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 269–274Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  269OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S9788 3Depot-medication compliance for patients with  psychotic disorders: the importance of illness  insight and treatment motivation ernst l Noordraven1,2 andré i Wierdsma2 Peter Blanken3 anthony F T Bloemendaal1 cornelis l Mulder2,4 1Dual Diagnosis centre (cDP),   Parnassia Psychiatric institute, the  hague, 2Department of Psychiatry,   erasmus University Medical center,   rotterdam, 3Parnassia addiction  research centre (P arc), Parnassia  Psychiatric institute, the hague,   4Bavo-europoort Mental health  care, Parnassia Psychiatric institute,   rotterdam, the NetherlandsBackground:  Noncompliance is a major problem for patients with a psychotic disorder.",Non-OADS,/arxiv_data1/oa_pdf/8b/47/ndt-12-269.PMC4745949.pdf
"Of patients with a psychotic disorder, approximately  50% to 75% have only a limited degree of illness insight, which often results in poorer  treatment outcomes.6–8correspondence: ernst l Noordraven erasmus Medical center, Psychiatry  Department, gravendijkwal 230,   3015 ce rotterdam, the Netherlands Tel +31 10 703 3227 email e.noordraven@erasmusmc.n l Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Noordraven et al Running head recto: Depot-medication compliance for patients with psychotic disorders DOI: http://dx.doi.org/10.2147/NDT.S97883",Non-OADS,/arxiv_data1/oa_pdf/8b/47/ndt-12-269.PMC4745949.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/8b/47/ndt-12-269.PMC4745949.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8b/47/ndt-12-269.PMC4745949.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8c/29/ndt-12-275.PMC4745950.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 275–277Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  275Case repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/NDT .S9167 3Chronic organophosphate-induced  neuropsychiatric disorder: a case report shree ram Ghimire1 sarita parajuli2 1Department of psychiatry, National  Medical College, Birgunj, 2Department  of anesthesiology, Kathmandu  National Medical College, anamnagar,   Kathmandu, NepalAbstract:  Chronic organophosphate (OP)-induced neuropsychiatric disorder is a rare condition  following prolonged exposure to OP compounds.",Non-OADS,/arxiv_data1/oa_pdf/8c/29/ndt-12-275.PMC4745950.pdf
"The patients’ record showed that his symptoms included deep coma (Glasgow Coma  Scale E1V1M1), hypotension (80/56 mmHg), tachycardia (128/min), miosis, and Correspondence: shree ram Ghimire Department of psychiatry, National  Medical College, po Box 78, Birgunj,  parsa 44400, Nepal email drsrghimire@gmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Case report Y ear: 2016 Volume: 12 Running head verso: Ghimire and Parajuli Running head recto: Chronic organophosphate induced neuropsychiatric disorder DOI: http://dx.doi.org/10.2147/NDT.S91673",Non-OADS,/arxiv_data1/oa_pdf/8c/29/ndt-12-275.PMC4745950.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/8c/29/ndt-12-275.PMC4745950.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8c/29/ndt-12-275.PMC4745950.pdf
The full terms of this license are available at https://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/5c/ec/imcrj-9-019.PMC4745951.pdf
"com/terms.ph p and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5c/ec/imcrj-9-019.PMC4745951.pdf
"For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Medical Case Reports Journal 2016:9 19–24International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  19Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S9419 4Rheumatoid polyarthritis suspected in an HIV  patient with scleritis, peripheral ulcerative  keratitis, and anterior uveitis Christelle Domngang  Noche1 Madeleine singwé-Ngandeu2 assumpta Lucienne Bella2 1Université des Montagnes, Yaoundé,   Cameroon; 2Université de Yaoundé 1,   Yaoundé, Cameroon Correspondence: Christelle Domngang  Noche   Université des Montagnes,   po Box 12 715 Yaoundé, Cameroon   email dockrystlnoche@gmail.co mIntroduction:  Scleritis and peripheral ulcerative keratitis are ocular manifestations found in  many inflammations and infections.",Non-OADS,/arxiv_data1/oa_pdf/5c/ec/imcrj-9-019.PMC4745951.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/5c/ec/imcrj-9-019.PMC4745951.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5c/ec/imcrj-9-019.PMC4745951.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/be/d8/ndt-12-265.PMC4745952.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 265–268Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  265Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S9957 7Neuroleptic-induced deficit syndrome in bipolar  disorder with psychosis satoshi Ueda1 Takeshi sakayori1 ataru Omori2 Hajime Fukuta3 Takashi Kobayashi3 Kousuke ishizaka1 T omoyuki saijo4 Y oshiro Okubo1 1Department of Neuropsychiatry,   Nippon Medical school, T okyo, Japan;   2Tamachuo Hospital, T okyo, Japan;   3Kurumegaoka Hospital, T okyo, Japan;   4saijo Clinic, T okyo, JapanAbstract:  Neuroleptics can induce not only physical adverse effects but also mental effects  that produce deficit status in thought, affect, cognition, and behavior.",Non-OADS,/arxiv_data1/oa_pdf/be/d8/ndt-12-265.PMC4745952.pdf
"We describe three cases of NIDS in bipolar Correspondence: satoshi Ueda Department of Neuropsychiatry,  Nippon Medical school, 1-1-5 sendagi,  Bunkyo-ku, Tokyo 113-8603, Japan Tel +81 3 3822 2131 Fax +81 3 5814 6287 email sat333@nms.ac.j p Journal name: Neuropsychiatric Disease and Treatment Article Designation: Case Series Y ear: 2016 Volume: 12 Running head verso: Ueda et al Running head recto: NIDS in bipolar disorder with psychosis DOI: http://dx.doi.org/10.2147/NDT.S99577",Non-OADS,/arxiv_data1/oa_pdf/be/d8/ndt-12-265.PMC4745952.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/be/d8/ndt-12-265.PMC4745952.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/be/d8/ndt-12-265.PMC4745952.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/dc/4c/ott-9-635.PMC4745953.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 635–641OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  635Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9270 7radix Tetrastigma hemsleyani  flavone inhibits  proliferation, migration, and invasion of human  lung carcinoma a549 cells liangrui Zhong1 Junxian Zheng2 Qianqian sun3 Kemin Wei2 Yijuan hu2 1Department of Oncology, Tongde  hospital of Zhejiang Province,   affiliated to Zhejiang chinese  Medical University, 2Department of  chinese Medicine, Zhejiang academy  of Traditional chinese Medicine,   3Department of chinese Medicine,   Zhejiang chinese Medical University,   Hangzhou, Zhejiang, People’s Republic  of chinaAbstract:  Radix Tetrastigma hemsleyani  flavone  (RTHF) is widely used as a traditional herb  and has detoxification and anti-inflammatory effects.",Non-OADS,/arxiv_data1/oa_pdf/dc/4c/ott-9-635.PMC4745953.pdf
"The possible antimetastasis mechanisms of RTHF  are demonstrated in this study.correspondence: Yijuan hu Department of chinese Medicine,  Zhejiang academy of Traditional  chinese Medicine, 132 Tianmushan  road, hangzhou 310012, Zhejiang,  People’s Republic of China Tel +86 571 8884 9080 email huyijuan2014@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Zhong et al Running head recto: Effect of RTHF on A549 cell growth DOI: http://dx.doi.org/10.2147/OTT.S92707",Non-OADS,/arxiv_data1/oa_pdf/dc/4c/ott-9-635.PMC4745953.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/dc/4c/ott-9-635.PMC4745953.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/dc/4c/ott-9-635.PMC4745953.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8e/e6/opth-10-257.PMC4745954.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2016:10 257–267Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  257Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S9261 6The emotional and physical impact of wet age- related macular degeneration: findings from the  waMD Patient and Caregiver survey Monica Varano1 nicole eter2 steve Winyard3 Kim U Wittrup-Jensen4 rafael navarro5 Julie heraghty6 On behalf of the w aMD  Patient and Caregiver  survey Committee  members 1Department of Ophthalmology,   Fondazione gB Bietti-irCCs, rome,   italy; 2Department of Ophthalmology,   University of Münster, Münster,   germany; 3Department of Policy  and Campaigns, royal national  institute of Blind People, london, UK;   4Bayer Pharma ag, Berlin, germany;   5instituto de Microcirugia Ocular,   Barcelona, spain; 6Macular Disease  Foundation australia, sydney, nsW,   australiaObjectives:  This was a cross-sectional survey to evaluate the physical and emotional impact  of wet age-related macular degeneration (wAMD) on a global cohort of patients who were  receiving (or had previously received) antivascular endothelial growth factor injections, and  caregivers (paid and unpaid).",Non-OADS,/arxiv_data1/oa_pdf/8e/e6/opth-10-257.PMC4745954.pdf
"Surveys of caregivers of patients with chronic diseases indicate that inadequate income, Correspondence: Monica Varano Department of Ophthalmology,  Fondazione gB Bietti-irCCs,  Via livenza 3, rome 00198, italy Tel +39 06 8535 6727 Fax +39 06 8424 2333 email m.varano@mclink.i tJournal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Varano et al Running head recto: Emotional and physical impact of wAMD DOI: http://dx.doi.org/10.2147/OPTH.S92616",Non-OADS,/arxiv_data1/oa_pdf/8e/e6/opth-10-257.PMC4745954.pdf
"Available from: http://www.who.int/whr/2001/en/whr01_en.pd f.  Accessed October 7, 2014.",OADS,/arxiv_data1/oa_pdf/8e/e6/opth-10-257.PMC4745954.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/8e/e6/opth-10-257.PMC4745954.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8e/e6/opth-10-257.PMC4745954.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/88/d8/tacg-9-015.PMC4745955.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pThe Application of Clinical Genetics 2016:9 15–26The Application of Clinical Genetics Dove press submit your manuscript | www.dovepress.co m Dove press  15Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TACG.S8536 1Non-invasive prenatal testing for fetal chromosome  abnormalities: review of clinical and ethical issues Jean Gekas1,2 Sylvie Langlois3 vardit Ravitsky4 François Audibert5 David Gradus van den Berg6 Hazar Haidar4 François Rousseau2,7 1Prenatal Diagnosis Unit, Department  of Medical Genetics and Pediatrics,   Faculty of Medicine, Université  Laval, Québec City, QC, Canada;   2Department of Medical Biology, CHU  de Québec, Québec City, QC, Canada;   3Department of Medical Genetics,   University of British Columbia,   vancouver, BC, Canada; 4Bioethics  Program, Department of Social  and Preventive Medicine, School of  Public Health, University of Montreal,   Montreal, QC, Canada; 5Department  of Obstetrics and Gynecology,   Hospital Sainte-Justine, Montreal,   QC, Canada; 6Department of Social  and Preventive Medicine, Faculty of  Medicine, Université Laval, Québec  City, QC, Canada; 7Department  of Molecular Biology, Medical  Biochemistry and Pathology, Faculty  of Medicine, Université Laval, Québec  City, QC, Canada Correspondence: Jean Gekas   Centre Hospitalier de l’Université  Laval (CHUL), CHU de Québec, 2705  Boulevard Laurier, Bureau RC-9300,  Sainte-Foy, G1v 4G2, Québec City, QC,  Canada   Tel +1 418 525 4444 ext 48114   Fax +1 418 654 2748   email jean.gekas@mail.chuq.qc.c aAbstract:  Genomics-based non-invasive prenatal screening using cell-free DNA (cfDNA  screening) was proposed to reduce the number of invasive procedures in current prenatal diag - nosis for fetal aneuploidies.",Non-OADS,/arxiv_data1/oa_pdf/88/d8/tacg-9-015.PMC4745955.pdf
Available from: http://www.nchpeg.org/ index.php?option=com_content&view=article&id=384&Itemid=25 5.,Non-OADS,/arxiv_data1/oa_pdf/88/d8/tacg-9-015.PMC4745955.pdf
A vailable from:  http://www.ctaf.org/assessments/fetal-aneuploidy-detection- maternal - plasma-dna-sequencing-part- 2.,Non-OADS,/arxiv_data1/oa_pdf/88/d8/tacg-9-015.PMC4745955.pdf
"Available from: http://www.ccne-ethique.fr/sites/default/ files/ publications/avis-120.pd f. Accessed June 22th, 2015.",Non-OADS,/arxiv_data1/oa_pdf/88/d8/tacg-9-015.PMC4745955.pdf
Available from: http://www.bzga.de/?,Non-OADS,/arxiv_data1/oa_pdf/88/d8/tacg-9-015.PMC4745955.pdf
"The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/the-application-of-clinical-genetics-journa lThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in  the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/88/d8/tacg-9-015.PMC4745955.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/88/d8/tacg-9-015.PMC4745955.pdf
Available from: http://www.wsj.,Non-OADS,/arxiv_data1/oa_pdf/88/d8/tacg-9-015.PMC4745955.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/35/67/ott-9-615.PMC4745956.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2016:9 615OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  615ReTRacTiO nopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10094 1RetractionJournal name: OncoTargets and Therapy Article Designation: Retraction Y ear: 2016 Volume: 9 Running head verso: Dove Medical Press.,Non-OADS,/arxiv_data1/oa_pdf/35/67/ott-9-615.PMC4745956.pdf
"Running head recto: influence of TLR4 agonist lipopolysaccharides DOI: http://dx.doi.org/10.2147/OTT.S100941 Gu J, Sun R, Shen S, Yu Z.",OADS,/arxiv_data1/oa_pdf/35/67/ott-9-615.PMC4745956.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/35/67/ott-9-615.PMC4745956.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.Dove pres s,Non-OADS,/arxiv_data1/oa_pdf/35/67/ott-9-615.PMC4745956.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/64/84/prom-7-013.PMC4745957.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/64/84/prom-7-013.PMC4745957.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Related Outcome Measures 2016:7 13–18Patient Related Outcome Measures Dove press submit your manuscript | www.dovepress.co m Dove press  13ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/PROM.S9695 6Mapping of Multiple sclerosis Walking scale  (MSWS-12) to five-dimension EuroQol (EQ-5D)  health outcomes: an independent validation in a  randomized control cohort Matthew F sidovar1 Brendan l limone2 craig i coleman2 1Clinical Development and Medical  affairs, acorda Therapeutics, ardsley,   nY, 2Department of Pharmacy  Practice, University of connecticut  school of Pharmacy, storrs, cT, Usa correspondence: craig i coleman   evidence-Based Practice center,  University of connecticut/hartford  hospital, 80 seymour street, hartford,  CT 06102-5037, USA   T el +1 860 545 2096   Fax +1 860 545 2277   email ccolema@harthosp.or gBackground:  Mapping of patient-reported outcomes to the five-dimension EuroQol (EQ-5D)  health index is increasingly being used for understanding the relationship of outcomes to health  states and for predicting utilities that have application in economic evaluations.",Non-OADS,/arxiv_data1/oa_pdf/64/84/prom-7-013.PMC4745957.pdf
"Available from: http://www.nicedsu.org.uk/TSD% 2010%20 mapping%20FINAL.pd f. Accessed September 5, 2015.",Non-OADS,/arxiv_data1/oa_pdf/64/84/prom-7-013.PMC4745957.pdf
"Patient Related Outcome Measures Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-related-outcome-measures-journa lPatient Related Outcome Measures is an international, peer-reviewed,  open access journal focusing on treatment outcomes specifically  relevant to patients.",Non-OADS,/arxiv_data1/oa_pdf/64/84/prom-7-013.PMC4745957.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/64/84/prom-7-013.PMC4745957.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/26/91/ott-9-617.PMC4745958.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 617–626OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  617Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9983 9intracellular calcium is a target of modulation of  apoptosis in McF-7 cells in the presence of iga  adsorbed to polyethylene glycol adenilda cristina honorio- França1 gabriel Triches nunes1 Danny laura gomes  Fagundes1 Patrícia gelli Feres de  Marchi1 rubian Trindade da silva  Fernandes1 Juliana luzia França1,2 aline do carmo França- Botelho2 lucélia campelo  albuquerque Moraes1 Fernando de Pilla Varotti3 eduardo luzía França1,3 1institute of Biological and health  science, Federal University of  Mato grosso, Barra do garças,   Mato grosso, Brazil; 2institute of  health sciences, University center  of Planalto de araxá, araxá, Minas  gerais, Brazil; 3campus centro Oeste  Dona lindu – Federal University of  são João Del rei, Divinópolis, Minas  gerais, BrazilPurpose:  Clinical and epidemiological studies have indicated that breastfeeding has a protective  effect on breast cancer risk.",Non-OADS,/arxiv_data1/oa_pdf/26/91/ott-9-617.PMC4745958.pdf
"Some studies have  also indicated that a reduced incidence of breast cancer is the most well-documented  long-term effect of breastfeeding on mothers;4 however, the degree to which some of  these health benefits may be realized depends on the breastfeeding duration, breast - feeding frequency, breastfeeding exclusivity, and other personal factors.3 Efforts have been directed to identify the various immunoreactive substances in  human breast milk that account for the protective effects of breastfeeding against  diseases.5–8 However, additional studies must be conducted to elucidate the mechanisms correspondence: eduardo luzía França institute of Biological and health science,  Federal University of Mato grosso,  rodovia Br070, Km 5 s/n, Barra do  garças-MT, 78600-000, Brazil Tel +55 66 3402 1121 Fax +55 66 3402 1117 email dr.eduardo.franca@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Honorio-França et al Running head recto: IgA induces apoptosis in MCF-7 cells DOI: http://dx.doi.org/10.2147/OTT.S99839",Non-OADS,/arxiv_data1/oa_pdf/26/91/ott-9-617.PMC4745958.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/26/91/ott-9-617.PMC4745958.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/26/91/ott-9-617.PMC4745958.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/19/8c/ott-9-613.PMC4745959.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 613OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/19/8c/ott-9-613.PMC4745959.pdf
"Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.Dove pres s 613ReTRacTiO nopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10516 8Retraction Li J-Z, Zhang Y, Wen B, Li M, and Wang Y-J have failed  to provide any explanation for the unauthorised re-use of  figures and tables from the 2014 publication, Vasiljevic N,  Ahmad AS, Carter PD, Fisher G, Berney DM, Foster CS,  Cuzick J, Lorincz AT.",Non-OADS,/arxiv_data1/oa_pdf/19/8c/ott-9-613.PMC4745959.pdf
"Large sections of text in this paper have been reused, albeit  with minimal re-wording, without citation back to the  source:Journal name: OncoTargets and Therapy Article Designation: Retraction Y ear: 2016 Volume: 9 Running head verso: Dove Medical Press Running head recto: Retraction DOI: http://dx.doi.org/10.2147/OTT.S105168",Non-OADS,/arxiv_data1/oa_pdf/19/8c/ott-9-613.PMC4745959.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b9/b2/opth-10-269.PMC4745960.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2016:10 269–276Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  269Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S9485 0Comparison between the eX-Press P-50 implant  and trabeculectomy in patients with open-angle  glaucoma María elena Mendoza- Mendieta1 ana Paola lópez-Venegas2 gerardo Valdés-Casas3 1Department of anterior segment,   Dr luis sánchez Bulnes hospital,   association to Prevent Blindness,   Mexico City, Mexico; 2institute of  Ophthalmology, Conde de Valenciana,   Mexico City, Mexico; 3Department of  general Ophthalmology, institute of  Ophthalmology, Conde de Valenciana,   Mexico City, MexicoPurpose:  To evaluate the EX-PRESS P-50 implant compared to standard trabeculectomy  (TBC).",Non-OADS,/arxiv_data1/oa_pdf/b9/b2/opth-10-269.PMC4745960.pdf
"Trabeculectomy (TBC) was introduced by Cairns in 1968 as a surgical  procedure for glaucoma, and it is the procedure of choice for surgical open-angle  glaucoma treatment.3 Early postoperative complications associated with this condition include hyphema,  excessive filtration, wound leak, flat chamber, choroidal detachment, hypotony,  suprachoroidal hemorrhage, and cataract.4,5 These complications have motivated the  development of alternative techniques and devices, including the EX-PRESS® glau - coma filtration device.3,6Correspondence: María elena   Mendoza-Mendieta Department of anterior segment,  Dr luis sánchez Bulnes hospital,  association to Prevent Blindness,  Chimalpopoca #14, Colonia Obrera,  Mexico City 06800, Mexico Tel +52 55 5588 4600 Fax +52 55 5442 1700 email maelena_mm@hotmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Mendoza-Mendieta et al Running head recto: Comparison between the EX-PRESS P-50 implant and trabeculectomy DOI: http://dx.doi.org/10.2147/OPTH.S94850",Non-OADS,/arxiv_data1/oa_pdf/b9/b2/opth-10-269.PMC4745960.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/b9/b2/opth-10-269.PMC4745960.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b9/b2/opth-10-269.PMC4745960.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/38/4d/ott-9-627.PMC4745961.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 627–634OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  627Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9732 8Potassium-3-beta-hydroxy-20-oxopregn-5-en- 17-alpha-yl sulfate: a novel inhibitor of 78 kDa  glucose-regulated protein  nizar M Mhaidat1,2 Qosay a al-Balas1 Karem h alzoubi1 rowan F alejielat2 1Department of clinical Pharmacy,  Faculty of Pharmacy, Jordan University  of science and T echnology, irbid,   2Department of clinical Pharmacy,   Faculty of Pharmaceutical sciences,   hashemite University, Zarqa, JordanBackground:  Previous studies have shown the central role of 78 kDa glucose-regulated protein  (GRP78) in colorectal cancer (CRC) survival and chemoresistance.",Non-OADS,/arxiv_data1/oa_pdf/38/4d/ott-9-627.PMC4745961.pdf
"correspondence: nizar M Mhaidat Department of clinical Pharmacy,  Faculty of Pharmacy, Jordan University of  science and Technology, PO Box 3030,  irbid 22110, Jordan Tel +962 2 720 1000 Fax +962 2 720 1075 email nizarm@just.edu.j o Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Mhaidat et al Running head recto: GRP78-targeted therapy DOI: http://dx.doi.org/10.2147/OTT.S97328",Non-OADS,/arxiv_data1/oa_pdf/38/4d/ott-9-627.PMC4745961.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/38/4d/ott-9-627.PMC4745961.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/38/4d/ott-9-627.PMC4745961.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ff/05/ov-4-119.PMC4746000.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncolytic Virotherapy 2015:4 119–132Oncolytic Virotherapy Dove press submit your manuscript | www.dovepress.co m Dove press  119Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OV.S8736 9characterization of an oncolytic adenovirus  vector constructed to target the cMet receptor hany i sakr1–3 David T coleman3,4 James a cardelli3,4 J Michael Mathis2,3,5 1Department of cellular Biology and  anatomy, 2gene Therapy Program,   3Feist-Weiller cancer center,   4Department of Microbiology and  immunology, lsU health shreveport,   shreveport, 5Department of  comparative Biomedical sciences,   school of Veterinary Medicine,   louisiana state University, Baton  rouge, la, Usa correspondence: J Michael Mathis   Department of comparative Biomedical  sciences, school of Veterinary Medicine,  louisiana state University, 1909 skip  Bertman Drive, Baton rouge, la 70803,  Usa  Tel +1 225 578 9888   Fax +1 225 578 9895   email jmathis@lsu.ed uAbstract:  The cMet receptor is a homodimer with tyrosine kinase activity.",Non-OADS,/arxiv_data1/oa_pdf/ff/05/ov-4-119.PMC4746000.pdf
"Oncolytic Virotherapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncolytic-virotherapy-journa lOncolytic Virotherapy is an international, peer-reviewed, open access online journal  publishing original research, study protocols, reviews, editorials and commentaries  on all aspects of oncolytic virology, namely the application of oncolytic viruses for  the treatment of cancer.",Non-OADS,/arxiv_data1/oa_pdf/ff/05/ov-4-119.PMC4746000.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/05/ov-4-119.PMC4746000.pdf
"HCE was the primary author.Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/49/f3/40259_2015_Article_154.PMC4746210.pdf
2011. http://www.rheumatology.org/Practice/ Clinical/Position/Position_Statements .,Non-OADS,/arxiv_data1/oa_pdf/49/f3/40259_2015_Article_154.PMC4746210.pdf
2009. http://www.who.int/ biologicals/areas/biological_therapeutics/BIOTHERAPEUTICS_ FOR_WEB_22APRIL2010.pdf .,Non-OADS,/arxiv_data1/oa_pdf/49/f3/40259_2015_Article_154.PMC4746210.pdf
2014. http://www.hc-sc.gc.ca/dhp-mps/prodpharma/sbd-smd/ drug-med/sbd_smd_2014_inﬂectra_159493-eng.php#sbd .,Non-OADS,/arxiv_data1/oa_pdf/49/f3/40259_2015_Article_154.PMC4746210.pdf
2013. http://www.ema.europa.eu/ema/index.,Non-OADS,/arxiv_data1/oa_pdf/49/f3/40259_2015_Article_154.PMC4746210.pdf
http://www.Exemptia.com .,Non-OADS,/arxiv_data1/oa_pdf/49/f3/40259_2015_Article_154.PMC4746210.pdf
2012. http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/49/f3/40259_2015_Article_154.PMC4746210.pdf
2007. http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/49/f3/40259_2015_Article_154.PMC4746210.pdf
2015. http://www.ema.europa.eu/e ma/index.jsp?curl=pages/ medicines/landing/epar_search.jsp&mid=WC0b01ac058001d124 .,Non-OADS,/arxiv_data1/oa_pdf/49/f3/40259_2015_Article_154.PMC4746210.pdf
2012. http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/49/f3/40259_2015_Article_154.PMC4746210.pdf
2012. http://www.hc-sc.gc.ca/dhp-mps/prodpharma/sbd- smd/drug-med/index-eng.php .,Non-OADS,/arxiv_data1/oa_pdf/49/f3/40259_2015_Article_154.PMC4746210.pdf
2015. https://www.tga.gov.au/book/labels-product-information- pi-and-consumer-medicine-information-cmi-biosimilars .,Non-OADS,/arxiv_data1/oa_pdf/49/f3/40259_2015_Article_154.PMC4746210.pdf
https://www.tga.,Non-OADS,/arxiv_data1/oa_pdf/49/f3/40259_2015_Article_154.PMC4746210.pdf
2015. http://www.ema.europa.eu/ docs/en_GB/document_library/Scientiﬁc_guideline/2015/01/WC500180219.pdf .,Non-OADS,/arxiv_data1/oa_pdf/49/f3/40259_2015_Article_154.PMC4746210.pdf
2014. http://www.fda.gov/downloads/ Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ UCM397017.pdf .,Non-OADS,/arxiv_data1/oa_pdf/49/f3/40259_2015_Article_154.PMC4746210.pdf
2015. http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ UCM291134.pdf .,Non-OADS,/arxiv_data1/oa_pdf/49/f3/40259_2015_Article_154.PMC4746210.pdf
2015. http://www.ema.europa.eu/docs/en_GB/document_ library/Scientiﬁc_guideline/2015/07/WC500190635.pdf .,Non-OADS,/arxiv_data1/oa_pdf/49/f3/40259_2015_Article_154.PMC4746210.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/7a/bb/40259_2015_Article_153.PMC4746214.pdf
http://www.nihs.go.jp/dbcb/ TEXT/yakusyokuhatu-0304004.pdf .,Non-OADS,/arxiv_data1/oa_pdf/7a/bb/40259_2015_Article_153.PMC4746214.pdf
http://www.pmda.go.jp/ﬁles/000157415.pdf .,Non-OADS,/arxiv_data1/oa_pdf/7a/bb/40259_2015_Article_153.PMC4746214.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.References 1.",Non-OADS,/arxiv_data1/oa_pdf/ce/f5/40259_2015_Article_155.PMC4746226.pdf
2010. http://www.ema.europa.eu/docs/en_GB/ document_library/Scientiﬁc_guideline/2010/04/WC500089474.,Non-OADS,/arxiv_data1/oa_pdf/ce/f5/40259_2015_Article_155.PMC4746226.pdf
2014. http://www.amrer.it/download_documenti/ manifesto-farmaci-biosimilari.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ce/f5/40259_2015_Article_155.PMC4746226.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.Dear Editor Recently , several published papers aiming to isolate and  characterize methicillin resistant Staphylococcus aureus   (MRSA) have had major bias.",Non-OADS,/arxiv_data1/oa_pdf/a1/04/jjm-08-12-25973.PMC4746288.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.Corrigendum This corrigendum supplies corrected Figure 1 which had missed the numbers and titles of X axis.",Non-OADS,/arxiv_data1/oa_pdf/21/0f/jjm-08-12-31014.PMC4746291.pdf
"14,15 Subjects and Methods Subjects The pedigrees of familial PDB-affected individuals with GCT and the clinical features of the affected family members are 1Institute of Genetics and Biophysics ‘‘Adriano Buzzati-Traverso,’’ National Research Council of Italy, 80131 Naples, Italy;2Department of Medicine, Surgery and Neurosciences, University of Siena, Siena 53100, Italy;3Laboratory of Experimental Oncology, Rizzoli Orthopaedic Institute, Bologna 40136, Italy; 4Bambino Gesu `Children’s Hospital, Regenerative Medicine Unit, Rome 00146, Italy;5Department of Medicine, Columbia University Medical Centre, New York, NY 10032, USA;6Poˆle Appareil Locomoteur, Service de Rhumatologie B, Ho ˆpital Lariboisie `re, Assistance Publique–Ho ˆpitaux de Paris, Paris 75010, France; 7Division of Rheumatology, Department of Medicine, Universite ´Laval, Que ´bec, QC 42178, Canada;8Department of Medicine and Surgery, Federico II Univer- sity, Naples 80131, Italy;9Department of Biomedical Sciences and Medicine and Centre of Marine Sciences, University of Algarve, Faro 8005-139, Portugal 10These authors contributed equally to this work *Correspondence: fernando.gianfrancesco@igb.cnr.it http://dx.doi.org/10.1016/j.ajhg.2015.12.016 ./C2112016 The Authors This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/c3/55/main.PMC4746367.pdf
Supplemental Data Supplemental Data include ﬁve ﬁgures and ﬁve tables and can be found with this article online at http://dx.doi.org/10.1016/j.ajhg.,OADS,/arxiv_data1/oa_pdf/c3/55/main.PMC4746367.pdf
"Received: September 15, 2015 Accepted: December 17, 2015 Published: February 4, 2016 Web Resources The URLs for data presented herein are as follows: 1000 Genomes, http://browser.1000genomes.org ChIPBase database, http://deepbase.sysu.edu.cn/chipbase/index.",OADS,/arxiv_data1/oa_pdf/c3/55/main.PMC4746367.pdf
"php ExAC Browser, http://exac.broadinstitute.org/ GenBank, http://www.ncbi.nlm.nih.gov/genbank/ NetPhos 2.0, http://www.cbs.dtu.dk/services/NetPhos/ NLStradamus, http://www.moseslab.csb.utoronto.ca/NLStradamus/ OMIM, http://www.omim.org/ UCSC Genome Browser, http://genome.ucsc.eduReferences 1.Ralston, S.H.",OADS,/arxiv_data1/oa_pdf/c3/55/main.PMC4746367.pdf
http://dx.doi.org/10.1016/j.ajhg.2015.12.013 ./C2112016 The Authors This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c3/17/main.PMC4746371.pdf
Supplemental Data Supplemental Data include 11 ﬁgures and 8 tables and can be found with this article online at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c3/17/main.PMC4746371.pdf
"Received: August 22, 2015 Accepted: December 15, 2015Published: January 28, 2016 Web Resources The URLs for data presented herein are as follows: European Genome-phenome Archive (EGA), https://www.ebi.ac.",Non-OADS,/arxiv_data1/oa_pdf/c3/17/main.PMC4746371.pdf
"uk/ega OMIM, http://www.omim.org/ References 1.Inaki, K., and Liu, E.T.",Non-OADS,/arxiv_data1/oa_pdf/c3/17/main.PMC4746371.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/15/fc/kev355.PMC4746431.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/6c/a8/jjm-08-12-26727.PMC4746439.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-009698).,Non-OADS,/arxiv_data1/oa_pdf/ec/49/bmjopen-2015-009698.PMC4746441.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-009804).,Non-OADS,/arxiv_data1/oa_pdf/4a/07/bmjopen-2015-009804.PMC4746443.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/4a/07/bmjopen-2015-009804.PMC4746443.pdf
2014. http://www.who.int/substance_abuse/publications/global_alcohol_report/en/ 4.,Non-OADS,/arxiv_data1/oa_pdf/4a/07/bmjopen-2015-009804.PMC4746443.pdf
"2014. http://www.cdc.gov/mmwr/ preview/mmwrhtml/ss6304a1.htm 5. van der Vorst H, Engels RC, Meeus W, et al.",OADS,/arxiv_data1/oa_pdf/4a/07/bmjopen-2015-009804.PMC4746443.pdf
2012.http://www.nationaldrugstrategy.gov.au/internet/drugstrategy/Publishing.nsf/content/BCBF6B2C638E1202CA257ACD0020E35C/$File/National%20Report_FINAL_ASSAD_7.12.pdf 14.,Non-OADS,/arxiv_data1/oa_pdf/4a/07/bmjopen-2015-009804.PMC4746443.pdf
2013. http://www.hketousa.gov.hk/usa/wine/HKidealplace.html 25.,Non-OADS,/arxiv_data1/oa_pdf/4a/07/bmjopen-2015-009804.PMC4746443.pdf
"2013.https://www.censtatd.gov.hk/hkstat/sub/sp140.jsp?productCode=B1010003 Au WM, et al.BMJ Open 2016; 6:e009804.",Non-OADS,/arxiv_data1/oa_pdf/4a/07/bmjopen-2015-009804.PMC4746443.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010265).,Non-OADS,/arxiv_data1/oa_pdf/a5/b3/bmjopen-2015-010265.PMC4746444.pdf
2015. http://www.aph.gov.au/Parliamentary_Business/Committees/Senate/Community_Affairs/Cancer_Drugs 15.,Non-OADS,/arxiv_data1/oa_pdf/a5/b3/bmjopen-2015-010265.PMC4746444.pdf
2014. http://www.pharmac.,Non-OADS,/arxiv_data1/oa_pdf/a5/b3/bmjopen-2015-010265.PMC4746444.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010149).,Non-OADS,/arxiv_data1/oa_pdf/67/31/bmjopen-2015-010149.PMC4746445.pdf
http://data.un.org/CountryProfile.,Non-OADS,/arxiv_data1/oa_pdf/67/31/bmjopen-2015-010149.PMC4746445.pdf
http://www.who.int/gho/ countries/per.pdf?ua=1 (accessed on 1 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/67/31/bmjopen-2015-010149.PMC4746445.pdf
2010. http://www.who.int/chp/gshs/GSHS_Report_Peru_2010.pdf (accessed on 14 Sep 2015).,Non-OADS,/arxiv_data1/oa_pdf/67/31/bmjopen-2015-010149.PMC4746445.pdf
2013. http://www.who.int/chp/gshs/GSHS_Core_Modules_2013_English.pdf (accessed on14 Sep 2015).,Non-OADS,/arxiv_data1/oa_pdf/67/31/bmjopen-2015-010149.PMC4746445.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010287).,Non-OADS,/arxiv_data1/oa_pdf/71/e2/bmjopen-2015-010287.PMC4746446.pdf
http://www.who.int/features/factfiles/safe_ surgery/en/index.html 2.,Non-OADS,/arxiv_data1/oa_pdf/71/e2/bmjopen-2015-010287.PMC4746446.pdf
Royal Australian & NewZealand College of Obstetricians & Gynaecologists; 2011. https://www.ranzcog.edu.au/college-statements-guidelines.html (accessed20 Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/71/e2/bmjopen-2015-010287.PMC4746446.pdf
"National Statement on Ethical Conduct in Human Research (2007) —Updated May 2015. https://www.nhmrc.gov.au/guidelines-publications/e72 Gillespie BM, et al.BMJ Open 2016; 6:e010287.",Non-OADS,/arxiv_data1/oa_pdf/71/e2/bmjopen-2015-010287.PMC4746446.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010388).,Non-OADS,/arxiv_data1/oa_pdf/df/a9/bmjopen-2015-010388.PMC4746448.pdf
2015. http://apps.who.int/iris/bitstream/10665/179870/1/9789241508926_eng.pdf?ua=1&ua=1 (accessed 23 Jul 2015).,OADS,/arxiv_data1/oa_pdf/df/a9/bmjopen-2015-010388.PMC4746448.pdf
2015. http://www.unaids.org/sites/default/files/country/documents/MEX_narrative_report_2015.pdf(accessed 23 Dec 23 2015).,Non-OADS,/arxiv_data1/oa_pdf/df/a9/bmjopen-2015-010388.PMC4746448.pdf
2011. http://www.inegi.org.mx/inegi/contenidos/espanol/prensa/contenidos/estadisticas/2011/sida11.asp?s=inegi&c=2819&ep=78 (accessed 23Jul 2014).,OADS,/arxiv_data1/oa_pdf/df/a9/bmjopen-2015-010388.PMC4746448.pdf
2001. http://www.glma.org/_data/n_0001/resources/ live/HealthyCompanionDoc3.pdf (accessed 20 July 2015).,Non-OADS,/arxiv_data1/oa_pdf/df/a9/bmjopen-2015-010388.PMC4746448.pdf
"Conclusions and recommendations, 2001. http://www.who.int/inf-pr-2001/en/note2001 –07.html 4.",Non-OADS,/arxiv_data1/oa_pdf/a7/e1/bmjopen-2015-008292.PMC4746449.pdf
2013. http://www.education.vic.gov.au/childhood/professionals/health/Pages/maternalchildhealth.aspx 13.,Non-OADS,/arxiv_data1/oa_pdf/a7/e1/bmjopen-2015-008292.PMC4746449.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010080).,Non-OADS,/arxiv_data1/oa_pdf/a1/4e/bmjopen-2015-010080.PMC4746456.pdf
2013.http://www.meti.go.jp/earthquake/nuclear/pdf/131231a.pdf (accessed5 Nov 2015).,OADS,/arxiv_data1/oa_pdf/a1/4e/bmjopen-2015-010080.PMC4746456.pdf
2015. http://www.meti.go.jp/earthquake/nuclear/kinkyu/hinanshiji/2015/pdf/0905_02gainenzu.pdf (accessed 6 Nov 2015).,OADS,/arxiv_data1/oa_pdf/a1/4e/bmjopen-2015-010080.PMC4746456.pdf
"http://www.city.minamisoma.lg.jp/index.cfm/8,4705,44,html (accessed 20 Sep 2015).",Non-OADS,/arxiv_data1/oa_pdf/a1/4e/bmjopen-2015-010080.PMC4746456.pdf
http://www.city.soma.fukushima.jp/data/new/jinkou/j_jinkou_setai.html (accessed 20 Sep 2015).,OADS,/arxiv_data1/oa_pdf/a1/4e/bmjopen-2015-010080.PMC4746456.pdf
http://radioactivity.nsr.go.jp/ja/ list/362/list-1.html (accessed 22 Jun 2015).,OADS,/arxiv_data1/oa_pdf/a1/4e/bmjopen-2015-010080.PMC4746456.pdf
"https:// http://www.city.minamisoma.lg.jp/index.cfm/10,853,58,html (accessed 20 Sep 2015).",Non-OADS,/arxiv_data1/oa_pdf/a1/4e/bmjopen-2015-010080.PMC4746456.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 009889).,Non-OADS,/arxiv_data1/oa_pdf/d0/1d/bmjopen-2015-009889.PMC4746458.pdf
"”Testimony before the Committee on Oversight and Governmental Reform, UnitedStates House of Representatives, 17 June 2010. http://www.hhs.gov/asl/testify/2010/06/t20100617b.html (accessed 23 Jan 2016).",Non-OADS,/arxiv_data1/oa_pdf/d0/1d/bmjopen-2015-009889.PMC4746458.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/aa/af/bmjopen-2015-007912.PMC4746460.pdf
https://www.gov.uk/government/ uploads/system/uploads/attachment_data/file/447605/fit-note-gps-guidance-jan-15.pdf: Gov.co.uk; [cited 2015].,Non-OADS,/arxiv_data1/oa_pdf/aa/af/bmjopen-2015-007912.PMC4746460.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 009221).,Non-OADS,/arxiv_data1/oa_pdf/4c/b7/bmjopen-2015-009221.PMC4746461.pdf
"Analyses were performed using SAS V.9.3 (SAS Institute, Raleigh, North Carolina, USA) and R V.2.15 (http://www.r-project.org).",OADS,/arxiv_data1/oa_pdf/4c/b7/bmjopen-2015-009221.PMC4746461.pdf
http://www.amazon.com/ Observational-Studies-Springer-Series-Statistics/dp/1441931910 15.,Non-OADS,/arxiv_data1/oa_pdf/4c/b7/bmjopen-2015-009221.PMC4746461.pdf
"New York, NY: 2015. https://cran.r-project.org/web/packages/treatSens/index.html (accessed 17 Jan 2016).",Non-OADS,/arxiv_data1/oa_pdf/4c/b7/bmjopen-2015-009221.PMC4746461.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-009448).,Non-OADS,/arxiv_data1/oa_pdf/66/50/bmjopen-2015-009448.PMC4746462.pdf
http://classics.mit.edu/Hippocrates/ulcers.5.5.html 6.,Non-OADS,/arxiv_data1/oa_pdf/66/50/bmjopen-2015-009448.PMC4746462.pdf
2005. http://www.fda.gov/downloads/drugs/ guidancecomplianceregulatoryinformation/guidances/ucm071292.pdf 10.,Non-OADS,/arxiv_data1/oa_pdf/66/50/bmjopen-2015-009448.PMC4746462.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010008).,Non-OADS,/arxiv_data1/oa_pdf/fe/34/bmjopen-2015-010008.PMC4746463.pdf
Intervention: The pictorial encounter decision aid was derived from an evidence-based table comparingtreatment options for breast cancer (http://www.optiongrid.org).,Non-OADS,/arxiv_data1/oa_pdf/fe/34/bmjopen-2015-010008.PMC4746463.pdf
"The latter is a one-page, evidence-based summary of available options presented in a tabular format, listing the trade-offs or frequently asked questions that patients normally consider when making treatment decisions for early stage breast cancer (http://www.optiongrid.org).",Non-OADS,/arxiv_data1/oa_pdf/fe/34/bmjopen-2015-010008.PMC4746463.pdf
http://www.cancer.org/cancer/ breastcancer/detailedguide/breast-cancer-key-statistics 2.,Non-OADS,/arxiv_data1/oa_pdf/fe/34/bmjopen-2015-010008.PMC4746463.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010035).,Non-OADS,/arxiv_data1/oa_pdf/b4/46/bmjopen-2015-010035.PMC4746464.pdf
Qualitative checklist 14.10.10.http://www.casp-uk.net/wp-content/uploads/2011/11/CASP_ Qualitative_Appraisal_Checklist_14oct10.pdf 38.,Non-OADS,/arxiv_data1/oa_pdf/b4/46/bmjopen-2015-010035.PMC4746464.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-008459).,Non-OADS,/arxiv_data1/oa_pdf/96/6f/bmjopen-2015-008459.PMC4746467.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-008698).,Non-OADS,/arxiv_data1/oa_pdf/08/59/bmjopen-2015-008698.PMC4746469.pdf
"Geneva: World Health Organisation, 2012. http://www.who.",Non-OADS,/arxiv_data1/oa_pdf/08/59/bmjopen-2015-008698.PMC4746469.pdf
2014. http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/4364.0.55.0072011-12?OpenDocument 10.,Non-OADS,/arxiv_data1/oa_pdf/08/59/bmjopen-2015-008698.PMC4746469.pdf
"Department of Health and Ageing, 2006. http://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/n35.pdf(accessed 10 Jan 2015).",Non-OADS,/arxiv_data1/oa_pdf/08/59/bmjopen-2015-008698.PMC4746469.pdf
"Canberra: Commonwealth of Australia, 2013. https://www.nhmrc.gov.au/guidelines-publications/n55(accessed 30 Jan 2015).",Non-OADS,/arxiv_data1/oa_pdf/08/59/bmjopen-2015-008698.PMC4746469.pdf
"Canberra, Australia, 2007. http://www.foodstandards.gov.au/science/monitoringnutrients/ausnut/Pages/ausnut2007.aspx (accessed 10 Jan 2015).",Non-OADS,/arxiv_data1/oa_pdf/08/59/bmjopen-2015-008698.PMC4746469.pdf
"Food Standards Australia New Zealand, 2015. http://www.foodstandards.gov.au/science/monitoringnutrients/ausnut/classificationofsupps/Pages/default.aspx (accessed 10 Jan 2015).",Non-OADS,/arxiv_data1/oa_pdf/08/59/bmjopen-2015-008698.PMC4746469.pdf
"Geneva, Switzerland: World Health Organization, 2006. http://www.who.int/childgrowth/standards/technical_report/en/(accessed 9 Jan 2015) 23.",Non-OADS,/arxiv_data1/oa_pdf/08/59/bmjopen-2015-008698.PMC4746469.pdf
"Australia: Department of Health and Ageing, 2010. http://www.foodhealthdialogue.gov.au/internet/foodandhealth/publishing.nsf/Content/summary_food_categories penDocument (accessed 25 Jan 2015).",Non-OADS,/arxiv_data1/oa_pdf/08/59/bmjopen-2015-008698.PMC4746469.pdf
2014. http://bvsms.saude.gov.br/bvs/publicacoes/ dietary_guidelines_brazilian_population.pdf (accessed 15 Feb 2015).,Non-OADS,/arxiv_data1/oa_pdf/08/59/bmjopen-2015-008698.PMC4746469.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 009610).,Non-OADS,/arxiv_data1/oa_pdf/b8/5d/bmjopen-2015-009610.PMC4746470.pdf
Recruitment was via profes- sional bodies and associations when registers were notavailable.The online questionnaire was administered using SurveyMonkey.com (http://www.SurveyMonkey.com).,OADS,/arxiv_data1/oa_pdf/b8/5d/bmjopen-2015-009610.PMC4746470.pdf
"Statistical analysis Quantitative analyses for the primary outcome were per- formed using MLwiN (http://www.cmm.bristol.ac.uk/MLwiN/) for both, binary and ordered categories.",OADS,/arxiv_data1/oa_pdf/b8/5d/bmjopen-2015-009610.PMC4746470.pdf
The final project report is available here: http://abcproject.eu/img/ABC%20Final.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b8/5d/bmjopen-2015-009610.PMC4746470.pdf
14. http://publications.nice.org.uk/medicines-adherence-cg76/ guidance#supporting-adherence (accessed 25 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/b8/5d/bmjopen-2015-009610.PMC4746470.pdf
15. http://abcproject.eu/img/ABC%20Project%20Managing%20and% 20Supporting%20Medication%20Adherence.pdf and https://itunes.,Non-OADS,/arxiv_data1/oa_pdf/b8/5d/bmjopen-2015-009610.PMC4746470.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010015).,Non-OADS,/arxiv_data1/oa_pdf/49/3e/bmjopen-2015-010015.PMC4746471.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/49/3e/bmjopen-2015-010015.PMC4746471.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010155).,Non-OADS,/arxiv_data1/oa_pdf/0c/e1/bmjopen-2015-010155.PMC4746474.pdf
"London: Diabetes UK, 2014. https://www.diabetes.org.uk/ Documents/About%20Us/What%20we%20say/diabetes-uk-postition-statement-early-identification-type-2-0914.pdf (accessed 27 Aug2015).",Non-OADS,/arxiv_data1/oa_pdf/0c/e1/bmjopen-2015-010155.PMC4746474.pdf
"London: NICE, 2012. http://guidance.nice.org.uk/PH38 (accessed 27 Aug 2015).",Non-OADS,/arxiv_data1/oa_pdf/0c/e1/bmjopen-2015-010155.PMC4746474.pdf
http://www.hscic.gov.uk/ catalogue/PUB12262/qual-outc-fram-12-13-rep.pdf (accessed 27Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/0c/e1/bmjopen-2015-010155.PMC4746474.pdf
http://www.hqip.org.uk/assets/NCAPOP-Library/ NCAPOP-2014-15/NDA-Care-Processes-report-1-Final.pdf(accessed 27 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/0c/e1/bmjopen-2015-010155.PMC4746474.pdf
http://www.ons.gov.,Non-OADS,/arxiv_data1/oa_pdf/0c/e1/bmjopen-2015-010155.PMC4746474.pdf
https://www.gov.uk/government/ uploads/system/uploads/attachment_data/file/6871/1871208.pdf (accessed 14 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/0c/e1/bmjopen-2015-010155.PMC4746474.pdf
http://www.sciencedirect.com/science/ article/pii/S0140673603152683 (accessed 13 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/0c/e1/bmjopen-2015-010155.PMC4746474.pdf
http://www.nice.,Non-OADS,/arxiv_data1/oa_pdf/0c/e1/bmjopen-2015-010155.PMC4746474.pdf
http://www.healthcheck.nhs.uk/ (accessed 27 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/0c/e1/bmjopen-2015-010155.PMC4746474.pdf
https://riskscore.diabetes.org.uk/ start (accessed 27 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/0c/e1/bmjopen-2015-010155.PMC4746474.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 009857).,Non-OADS,/arxiv_data1/oa_pdf/19/b1/bmjopen-2015-009857.PMC4746481.pdf
"The Cochrane Collaboration, 2011. http://www.cochrane-handbook.org Wang L, et al.BMJ Open 2016; 6:e009857.",OADS,/arxiv_data1/oa_pdf/19/b1/bmjopen-2015-009857.PMC4746481.pdf
Pyrosequencing assays were designed using MethPrimer(http://www.urogene.org/methprimer/index1.html).,OADS,/arxiv_data1/oa_pdf/84/cd/tpj201526a.PMC4746489.pdf
"KARGER: S Karger AG, Basel, 2005 atohttp://www.karger.com.gate2.inist.fr/Article/FullText/85718 4.",Non-OADS,/arxiv_data1/oa_pdf/84/cd/tpj201526a.PMC4746489.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the The Pharmacogenomics Journal website (http://www.nature.com/tpj)IGF1 promoter methylation M Ouni et al 106 The Pharmacogenomics Journal (2016), 102 –106 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/84/cd/tpj201526a.PMC4746489.pdf
"To view please visitthe journal (http://dx.doi.org/ 10.1136/lupus-2015-000127) Received 22 September 2015 Revised 19 November 2015Accepted 8 December 2015 1Cedars Sinai Medical Center, Los Angeles, California, USA 2Wallace Rheumatology Study Center, Los Angeles,California, USA 3Exagen Diagnostics, Vista, California, USA Correspondence to Dr Thierry Dervieux; tdervieux@exagen.comDr Daniel Wallace; danielwallac@gmail.comABSTRACT Objective: We sought to establish the performance of cell-bound complement activation products (CB-CAPs)as a diagnostic tool to distinguish primary fibromyalgia(FM) from systemic lupus erythematosus (SLE).",Non-OADS,/arxiv_data1/oa_pdf/ff/85/lupus-2015-000127.PMC4746498.pdf
"With increasing number of rs3834458 minor alleles,  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
http://dx.doi.org/10.1194/jlr.P032276 .,Non-OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
http://dx.doi.org/10.1093/bioinformatics/bth457 .,Non-OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
http://dx.doi.org/10.1017/S136898000800387X .,Non-OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
http://dx.doi.org/10.1016/j.metabol.,OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
http://dx.doi.org/10.1111/j.1740-8709.2011.00319.x .,Non-OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
Available at:  <http://hapmap.ncbi.nlm.nih.gov/downloads/index.html.en > 13.,Non-OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
http://dx.doi.org/10.3945/ajcn.113.058685 .,Non-OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
http://dx.doi.org/ 10.1194/jlr.P023721 .,Non-OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
2014. http://dx.doi.org/10.1074/ jbc.M114.579557 16.,Non-OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
2014. http://dx.doi.org/ 10.1371/journal.pone.0109896 17.,Non-OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
http://dx.doi.org/10.1016/j.plipres.2013.10.002 .,OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
http://dx.doi.org/10.3945/ajcn.110.006189  ajcn.110.006189  [pii].,Non-OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
http://dx.doi.org/10.1159/000235559 .,Non-OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
http://dx.doi.org/10.1016/j.clnu.,OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
http://dx.doi.org/10.1017/S0007114512003108 .,Non-OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
http://dx.doi.org/10.3945/ajcn.110.004515 .,Non-OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
2000; 66:175– 183. http://dx.doi.org/10.1006/geno.2000.6196 .,Non-OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
http://dx.doi.org/10.1007/ s13668-014-0079-1 .,Non-OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
http://dx.doi.org/10.3945/ajcn.2009.28789 .,Non-OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
http://dx.doi.org/ 10.1371/journal.pone.0017181 .,Non-OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
http://dx.doi.org/10.1016/j.plefa.2012.04.011 .,OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
http://dx.doi.org/10.1289/ehp.1205672 .,Non-OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
http://dx.doi.org/10.1039/c3mt00365e .,Non-OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
http://dx.doi.org/10.1017/S0007114508992564 .,Non-OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
http://dx.doi.org/10.1093/hmg/ddl117 .,Non-OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
2014. http://dx.doi.org/10.1016/j.plefa.2014.10.008 38.,OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
2013; 98:1575– 1582. http://dx.doi.org/10.3945/ajcn.112.051524 .,Non-OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
http://dx.doi.org/10.1016/j.neuro.2008.06.002 .,OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
http://dx.doi.org/10.3945/jn.112.163493 .,Non-OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
2015. http://dx.doi.org/10.3945/ajcn.114.100503 44.,Non-OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
http://dx.doi.org/10.1371/journal.pgen.,Non-OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
http://dx.doi.org/10.1016/j.ntt.2013.06.003 .,OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
http://dx.doi.org/10.1017/S0007114512005934 .,Non-OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
http://dx.doi.org/ 10.3945/jn.108.096156 .,Non-OADS,/arxiv_data1/oa_pdf/e8/0b/nihms730613.PMC4746501.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/openhrt-2015- 000312).,Non-OADS,/arxiv_data1/oa_pdf/7a/23/openhrt-2015-000312.PMC4746526.pdf
"In order to encourage participation, participants were offered the option of receiving the results of their testing in the form of theNEO-PDR Individual Planning Report (NEO-PDR; http://www4.parinc.com/WebUploads/samplerpts/NEO _PDR_Indiv_Rpt.pdf).",Non-OADS,/arxiv_data1/oa_pdf/7a/23/openhrt-2015-000312.PMC4746526.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/4b/3c/openhrt-2015-000365.PMC4746528.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/rmdopen-2015- 000177).,Non-OADS,/arxiv_data1/oa_pdf/1e/64/rmdopen-2015-000177.PMC4746579.pdf
http://www.who.int/ classifications/icf/whodasii/en/index.html 15.,OADS,/arxiv_data1/oa_pdf/1e/64/rmdopen-2015-000177.PMC4746579.pdf
doi:10.1136/ rmdopen-2015-000204 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ rmdopen-2015-000204).,Non-OADS,/arxiv_data1/oa_pdf/5a/73/rmdopen-2015-000204.PMC4746580.pdf
doi:10.1136/rmdopen-2015- 000154 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/rmdopen-2015-000154).,Non-OADS,/arxiv_data1/oa_pdf/66/bb/rmdopen-2015-000154.PMC4746581.pdf
Scientific considerations in demonstrating biosimilarity to a reference product.April 2015. http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm291128.pdf (accessed 26 Mar2015).,Non-OADS,/arxiv_data1/oa_pdf/66/bb/rmdopen-2015-000154.PMC4746581.pdf
December 2014. http://www.ema.europa.eu/ docs/en_GB/document_library/Scientific_guideline/2015/01/WC500180219.pdf (accessed 26 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/66/bb/rmdopen-2015-000154.PMC4746581.pdf
9 December 2014. http://zyduscadila.com/wp-content/uploads/2015/05/PressNote09-12-14.pdf (accessed 29 Oct 2015).,Non-OADS,/arxiv_data1/oa_pdf/66/bb/rmdopen-2015-000154.PMC4746581.pdf
30 January 2015. http://gabionline.net/Biosimilars/News/Adalimumab-similar-biologic-launched-in-India (accessed 29 Oct 2015).,Non-OADS,/arxiv_data1/oa_pdf/66/bb/rmdopen-2015-000154.PMC4746581.pdf
26 June 2015. https://www.clinicaltrials.gov/ct2/show/NCT02134210 (accessed 10Apr 2015).,Non-OADS,/arxiv_data1/oa_pdf/66/bb/rmdopen-2015-000154.PMC4746581.pdf
24 June 2015. https://www.clinicaltrials.gov/ct2/show/NCT01891864 (accessed 10 Apr 2015).,Non-OADS,/arxiv_data1/oa_pdf/66/bb/rmdopen-2015-000154.PMC4746581.pdf
16 June 2015. http://www.hc-sc.gc.ca/dhp-mps/prodpharma/sbd-smd/drug-med/sbd_smd_2014_inflectra_159493-eng.php#a2 (accessed 10 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/66/bb/rmdopen-2015-000154.PMC4746581.pdf
8 October 2014. http://www.amgen.com/media/media_pr_detail.jsp?releaseID=1975377 (accessed 10 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/66/bb/rmdopen-2015-000154.PMC4746581.pdf
http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm444661.pdf (accessed 30 Oct 2015).,Non-OADS,/arxiv_data1/oa_pdf/66/bb/rmdopen-2015-000154.PMC4746581.pdf
14 May 2015. https://clinicaltrials.gov/ct2/show/NCT01970475(accessed 10 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/66/bb/rmdopen-2015-000154.PMC4746581.pdf
https://clinicaltrials.gov/ct2/show/NCT02114931 (accessed 10Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/66/bb/rmdopen-2015-000154.PMC4746581.pdf
https://clinicaltrials.gov/ct2/show/NCT02260791 (accessed 10Jul 2015).59.,Non-OADS,/arxiv_data1/oa_pdf/66/bb/rmdopen-2015-000154.PMC4746581.pdf
25 February 2015. https://clinicaltrials.gov/ct2/show/NCT02016105 (accessed 10 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/66/bb/rmdopen-2015-000154.PMC4746581.pdf
https://www.clinicaltrialsregister.eu/ctr-search/search?query=2014-000352-29 (accessed 10 Jul 2015).,OADS,/arxiv_data1/oa_pdf/66/bb/rmdopen-2015-000154.PMC4746581.pdf
19 May 2015. https://clinicaltrials.gov/ct2/show/NCT01970488 (accessed 10 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/66/bb/rmdopen-2015-000154.PMC4746581.pdf
5 Feb 1997. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E9/Step4/E9_Guideline.pdf (accessed 30 Oct 2015).,Non-OADS,/arxiv_data1/oa_pdf/66/bb/rmdopen-2015-000154.PMC4746581.pdf
20 July 2000. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E10/Step4/E10_Guideline.pdf (accessed 30 Oct 2015).,Non-OADS,/arxiv_data1/oa_pdf/66/bb/rmdopen-2015-000154.PMC4746581.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/6f/dc/jjm-08-12-29491.PMC4746599.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/33/5b/rjw014.PMC4746600.pdf
All of the herein presented networks are ac - cessible online at VisuTranscript (http://www.s-khb.de/visutrans/content/index_eng.html).,OADS,/arxiv_data1/oa_pdf/6c/76/cr20161a.PMC4746609.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/",Non-OADS,/arxiv_data1/oa_pdf/6c/76/cr20161a.PMC4746609.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/",Non-OADS,/arxiv_data1/oa_pdf/ce/2b/cr20163a.PMC4746610.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/f6/b8/jjm-08-12-27896.PMC4746704.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/d3/55/jjm-08-12-27553.PMC4746705.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/7c/4a/jjm-08-12-16217.PMC4746706.pdf
"Reads were mapped, for each sample and biologicalreplicate separately, to the 3 July 2013 frozen gene catalogue of codingsequences ( n= 12 558) (http://genome.jgi-psf.org/Dotse1/) using the Burrows–Wheeler mapping algorithm implemented in Bowtie2 v.2.0.2(Langmead et al., 2009).",OADS,/arxiv_data1/oa_pdf/75/8e/MPP-17-210.PMC4746707.pdf
"Reads that did not map uniquely to a single gene reference were excluded, and the number of reads that mapped to eachgene was determined using custom software (code available at http://mpcox.github.io/mapcount/).",OADS,/arxiv_data1/oa_pdf/75/8e/MPP-17-210.PMC4746707.pdf
Accession numbers shown for D. septosporum genes are Joint Genome Institute (JGI) protein identiﬁcation numbers (http://genome.jgi-psf.org/Dotse1/).,Non-OADS,/arxiv_data1/oa_pdf/75/8e/MPP-17-210.PMC4746707.pdf
"The original GO annotations provided by JGI (http://genome.jgi- psf.org/Dotse1/) were updated using Blast2GO, using standard param-eters and an expect value threshold of 10 −3(Conesa et al., 2005); gene annotation increased from 46% to 61% of gene models with GO terms.Enrichment analysis was performed on DEG sets using the enrichmenttool in Blast2GO (Conesa et al., 2005).",OADS,/arxiv_data1/oa_pdf/75/8e/MPP-17-210.PMC4746707.pdf
Protein ID numbers (http://genome.jgi-psf.org/Dotse1/) are shown for each gene.,OADS,/arxiv_data1/oa_pdf/75/8e/MPP-17-210.PMC4746707.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/22/03/main.PMC4746719.pdf
Contents lists available at ScienceDirect Contemporary Clinical Trials Communications journal homepage: www.elsevier.com/locate/conctc http://dx.doi.org/10.1016/j.conctc.2015.09.001 2451-8654/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/22/03/main.PMC4746719.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Contemporary Clinical Trials Communications 1 (2015) 17 e21,Non-OADS,/arxiv_data1/oa_pdf/22/03/main.PMC4746719.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/f7/18/jjm-08-12-28395.PMC4746793.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/2b/b0/jjm-08-12-27219.PMC4746794.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/00/ba/jjm-08-12-17790.PMC4746795.pdf
Available from:  https://ec.europa.eu/energy/sites/ener/files/documents/109_en.pdf.,OADS,/arxiv_data1/oa_pdf/d9/d8/IJNM-31-31.PMC4746838.pdf
Available  from: http://www.amar.org.ir/Default.aspx?tabid=2031.,Non-OADS,/arxiv_data1/oa_pdf/d9/d8/IJNM-31-31.PMC4746838.pdf
Available from: https://www.ec.europa.eu/ energy/sites/ener/files/documents/RP180%20part  2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d9/d8/IJNM-31-31.PMC4746838.pdf
Available  from: http://www.emedicine.medscape.com/article/411919‑overview#a1.,Non-OADS,/arxiv_data1/oa_pdf/ec/7e/IJNM-31-85.PMC4746857.pdf
"Available from: http://www.Osteogenesis_Imperfecta/overview_oi.pdf,  www.niams.nih.gov/Health./.",Non-OADS,/arxiv_data1/oa_pdf/ec/7e/IJNM-31-85.PMC4746857.pdf
Available  from: http://www.emedicine.medscape.com/article/1256726‑overview.,Non-OADS,/arxiv_data1/oa_pdf/ec/7e/IJNM-31-85.PMC4746857.pdf
Available from: http://www.crunchwear.com/elektex-smart- fabric/.,Non-OADS,/arxiv_data1/oa_pdf/c6/09/JRMS-20-1007.PMC4746860.pdf
Available from: http://www.gizmag.com/map-pressure- mapping-bedsores/28723/.,OADS,/arxiv_data1/oa_pdf/c6/09/JRMS-20-1007.PMC4746860.pdf
Available from:  http://who.int/features/2015/viet-nam-water-sanitation/en/.,Non-OADS,/arxiv_data1/oa_pdf/ca/db/JRMS-20-1016.PMC4746861.pdf
Available  from: http://www.who.int/disabilities/world_report/2011/en/.,Non-OADS,/arxiv_data1/oa_pdf/55/64/JRMS-20-930.PMC4746865.pdf
London:  SAGE Publication; 2004. doi: http://dx.doi.org/10.4135/9780857020123 35.,Non-OADS,/arxiv_data1/oa_pdf/11/f9/JRMS-20-950.PMC4746868.pdf
Available from: http://www.gezondheidsraad.nl/nl/adviezen/bevolkings  onderzoeknaar‑ darmkanker [Last accessed on 2012 Jan 05].,Non-OADS,/arxiv_data1/oa_pdf/28/10/ABR-4-252.PMC4746937.pdf
Headache 2007;47:654-61.33. http://www.yogajournal.com/practice/974.,Non-OADS,/arxiv_data1/oa_pdf/40/38/ABR-4-259.PMC4746941.pdf
Available from: http://www.healthandyoga.com/html/research_ papers/pp.aspx.,Non-OADS,/arxiv_data1/oa_pdf/40/38/ABR-4-259.PMC4746941.pdf
Available from: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/ index.cfm?fuseaction_Search.DrugDetails [Last cited on 2012 Jan 30].,OADS,/arxiv_data1/oa_pdf/80/b4/ABR-4-253.PMC4746945.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/ab/d8/IJCM-41-1.PMC4746946.pdf
Available  at http://www.un.org/ga/search/view_doc.asp?symbol=A/ RES/70/1&Lang=E [Last accessed on 2015 Nov 09].,Non-OADS,/arxiv_data1/oa_pdf/ab/d8/IJCM-41-1.PMC4746946.pdf
Available at http://www.copenhagenconsensus.com/post-2015- consensus/nobel-laureates-guide-smarter-global-targets-2030  [Last accessed on 2015 Nov 09].,Non-OADS,/arxiv_data1/oa_pdf/ab/d8/IJCM-41-1.PMC4746946.pdf
Available from: http://www.worldbank.org/ en/news/speech/2015/09/25/speech-united-nations-general- assembly.,Non-OADS,/arxiv_data1/oa_pdf/ab/d8/IJCM-41-1.PMC4746946.pdf
New York: The Economist;  2015 Available at http://www.economist.com/news/finance-and- economics/21640361-debate-heats-up-about-what-goals-world- should-set-itself-2030 (Last accessed on 2015 Nov 20).,Non-OADS,/arxiv_data1/oa_pdf/ab/d8/IJCM-41-1.PMC4746946.pdf
Available from:  http://censusindia.gov.in/2011-prov-results/paper2/data_files/ india/Rural_Urban_2011.pdf [Last accessed on 2013 Oct 15].,OADS,/arxiv_data1/oa_pdf/28/5e/IJCM-41-16.PMC4746948.pdf
Available from: http://www.who.int/ mediacentre/events/IndicatorsChapter7.pdf.,OADS,/arxiv_data1/oa_pdf/28/5e/IJCM-41-16.PMC4746948.pdf
Available from: http://www.seas.,Non-OADS,/arxiv_data1/oa_pdf/28/5e/IJCM-41-16.PMC4746948.pdf
Available from: http://www.who.int/ mediacentre/factsheets/fs313/en/ [Last accessed on 2013 Oct 15].,Non-OADS,/arxiv_data1/oa_pdf/28/5e/IJCM-41-16.PMC4746948.pdf
Available  from: http://www.envfor.nic.in/sites/default/files/notification/ Recved%20national.pdf.,OADS,/arxiv_data1/oa_pdf/28/5e/IJCM-41-16.PMC4746948.pdf
Available from: http://cpcb.nic.in/Data-2006_air.php [Last  accessed on 2013 Oct 15].,OADS,/arxiv_data1/oa_pdf/28/5e/IJCM-41-16.PMC4746948.pdf
Available  from: http://www.cpcb.nic.in/divisionsofheadoffice/pci2/ noise_rules_2000.pdf.,Non-OADS,/arxiv_data1/oa_pdf/28/5e/IJCM-41-16.PMC4746948.pdf
Available from:http://www.who.int/violence_ injury_prevention/publications/road_traffic/world_report/ summary_en_rev.pdfsummary [Last accessed on 2013 Oct 15].,Non-OADS,/arxiv_data1/oa_pdf/28/5e/IJCM-41-16.PMC4746948.pdf
Available from: http://www.who.int/violence_injury_prevention/ publications/road_traffic/world_report/summary_en_rev.pdf.,Non-OADS,/arxiv_data1/oa_pdf/28/5e/IJCM-41-16.PMC4746948.pdf
Available from: http://www.un.org/ apps/news/story.asp?NewsID=45308&Cr=millennium%20 development%20goals%20&Cr1=#.UkCALrzFbTX [Last  accessed on 2014 Jan 26].,Non-OADS,/arxiv_data1/oa_pdf/ae/6d/IJCM-41-34.PMC4746951.pdf
Available from: http://www.maternalmortalitydata.org/inner.,Non-OADS,/arxiv_data1/oa_pdf/ae/6d/IJCM-41-34.PMC4746951.pdf
Available from:  http://www.censusindia.gov.in/vital_statistics/AHSBulletins/ AHS_Factsheets_2011_12/OdishaFactsheet_2011-12.pdf [Last  accessed on 2014 Jan 25].,OADS,/arxiv_data1/oa_pdf/ae/6d/IJCM-41-34.PMC4746951.pdf
Available from: http://www.un.org/ popin/icpd/conference/offeng/poa.html [Last accessed on 2014  Jan 25].,Non-OADS,/arxiv_data1/oa_pdf/ae/6d/IJCM-41-34.PMC4746951.pdf
Available from: http://www.rchiips.org/pdf/ india_report_dlhs-3.pdf [Last accessed on 2014 Jan 25].,Non-OADS,/arxiv_data1/oa_pdf/ae/6d/IJCM-41-34.PMC4746951.pdf
Available from:  http://www.unfpa.org/gender/men.htm [Last accessed on 2014  Jan 25].,Non-OADS,/arxiv_data1/oa_pdf/ae/6d/IJCM-41-34.PMC4746951.pdf
"UNICEF State of Worlds Children-2011 Adolescence: An age  of opportunity, p1 Available from: http://www.unicef.org/ sowc2011/pdfs/India.pdf [Last accessed on 2011 Aug 23].",Non-OADS,/arxiv_data1/oa_pdf/12/3a/IJCM-41-39.PMC4746952.pdf
Available from: http://www.med.cmb.ac.lk/SMJ/.,Non-OADS,/arxiv_data1/oa_pdf/ea/59/IJCM-41-50.PMC4746955.pdf
Available from: http://www.nhp.gov.in/jssk.,Non-OADS,/arxiv_data1/oa_pdf/96/ea/IJCM-41-65.PMC4746958.pdf
Available from: http://www.tnmsc.com/tnmsc/new/html/ services.php.,OADS,/arxiv_data1/oa_pdf/96/ea/IJCM-41-65.PMC4746958.pdf
Available from: http://dx.doi.org/10.1016/j.arcmed.2012.09.005 [Last accessed 2013 Dec 10].,OADS,/arxiv_data1/oa_pdf/9f/a7/IJCM-41-69.PMC4746959.pdf
Available from: http://apa.org/about/policy/guidelines- supervision.pdf.,Non-OADS,/arxiv_data1/oa_pdf/86/f4/IJCM-41-74.PMC4746961.pdf
Available  from: https://www.theaca.net.au/documents/ACA%20 -Supervision%-20Policy%202013.pdf.,Non-OADS,/arxiv_data1/oa_pdf/86/f4/IJCM-41-74.PMC4746961.pdf
"This is an open-access article distributed under the terms  of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redis - tribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/83/b8/cardiovascmed-05-01-30549.PMC4746995.pdf
"This is an open-access article distributed under the terms  of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redis - tribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/e8/fd/cardiovascmed-05-01-27839.PMC4746996.pdf
(Cell Mol Gastroenterol Hepatol 2015;1:311 –324; http://dx.doi.org/ 10.1016/j.jcmgh.2015.02.003 ) Keywords: Engulfment Pathway; Enteric Infection; Host Cellular Responses; Intestinal In ﬂammation; Salmonella .,Non-OADS,/arxiv_data1/oa_pdf/68/da/main.PMC4747049.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/68/da/main.PMC4747049.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2015.02.003,OADS,/arxiv_data1/oa_pdf/68/da/main.PMC4747049.pdf
"Copyright © 2016  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/34/fb/jos-2015-01417.PMC4747062.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 http://j-stroke.org  73Susceptibility-Weighted Imaging for Detection of  Thrombus in Acute Cardioembolic Stroke Min-Gyu Park,a Se-Jin Oh,a Seung Kug Baik,b Dae Soo Jung,c Kyung-Pil Parka a Department of Neurology, Pusan National University Y angsan Hospital, Pusan National University School of Medicine, Research Institute for  Convergence of Biomedical Science and T echnology, Y angsan, Korea bDepartment of Radiology, Pusan National University Y angsan Hospital, Pusan National University School of Medicine, Y angsan, Korea cDepartment of Neurology, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea Correspondence:  Kyung-Pil Park Department of Neurology, Pusan  National University Yangsan Hospital,  Pusan National University School of  Medicine, Research Institute for  Convergence of Biomedical Science and  Technology, 20 Geumo-ro, Mulgeum-eup,  Yangsan 50612, Korea Tel: +82-55-360-2451 Fax: +82-55-360-2152 E-mail: kppark@pusan.ac.kr Received: August 25, 2015 Revised: November 4, 2015 Accepted: November 5, 2015 The authors have no financial conflicts of  interest.Background and Purpose Susceptibility-weighted imaging (SWI) can show an intravascu - lar thrombus as a hypointense susceptibility vessel sign (SVS).",Non-OADS,/arxiv_data1/oa_pdf/34/fb/jos-2015-01417.PMC4747062.pdf
"Keywords Acute stroke; Diagnosis; Magnetic resonance imaging; Magnetic resonance angi - ographyOriginal ArticleJournal of Stroke  201 6;18(1):73- 79 http://dx.doi.org/10.5853/jos.2015.01417   Introduction In acute cardioembolic stroke, successful recanalization is  crucial because a failure of recanalization is closely associated  with poor outcomes after thrombolysis.1 Recanalization by in - travenous thrombolysis (IVT) can be influenced by the bur - den, composition, and location of a thrombus.2-7 It would be  useful to identify the location and burden of a thrombus before IVT in the planning of the strategy of recanalization therapy.",Non-OADS,/arxiv_data1/oa_pdf/34/fb/jos-2015-01417.PMC4747062.pdf
"Susceptibility Vessel Sign in Cardioembolic Stroke http://dx.doi.org/10.5853/jos.2015.01417  74 http://j-stroke.orgmore, SWI has been known to have similar sensitivity for the  thrombus in proximal intracranial arteries and superior sensi - tivity for the thrombus in distal intracranial arteries to time- of-flight magnetic resonance angiography (MRA).10 These re - sults can be attributed to the characteristics of the SWI se - quence, such as the amplification of the T2* signal drop by the  deoxyhemoglobin of trapped red blood cells (RBCs) in the  thrombus.11 A thrombus in cardioembolic stroke is known to  be composed mainly of RBCs, and therefore, it can be well  characterized by SWI.",Non-OADS,/arxiv_data1/oa_pdf/34/fb/jos-2015-01417.PMC4747062.pdf
1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01417  http://j-stroke.org  75Table 1.,Non-OADS,/arxiv_data1/oa_pdf/34/fb/jos-2015-01417.PMC4747062.pdf
"Susceptibility Vessel Sign in Cardioembolic Stroke http://dx.doi.org/10.5853/jos.2015.01417  76 http://j-stroke.orgwas detected in 81.3% (74/91) and 20.2% (18/31) in each  group (Figure 3, P= 0.009).",Non-OADS,/arxiv_data1/oa_pdf/34/fb/jos-2015-01417.PMC4747062.pdf
1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01417  http://j-stroke.org  77al.,Non-OADS,/arxiv_data1/oa_pdf/34/fb/jos-2015-01417.PMC4747062.pdf
"Susceptibility Vessel Sign in Cardioembolic Stroke http://dx.doi.org/10.5853/jos.2015.01417  78 http://j-stroke.orgConclusions SWI is highly useful in defining the location of a thrombus,  especially of a single thrombus or of multiple thrombi in distal  intracranial arteries, in acute cardioembolic stroke.",Non-OADS,/arxiv_data1/oa_pdf/34/fb/jos-2015-01417.PMC4747062.pdf
1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01417  http://j-stroke.org  7920.,Non-OADS,/arxiv_data1/oa_pdf/34/fb/jos-2015-01417.PMC4747062.pdf
"Copyright © 2016  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9b/ff/jos-2016-00038.PMC4747063.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 http://j-stroke.org  1Moyamoya Disease, Still a Mysterious Disorder Jong S. Kim Editor-in-Chief, Journal of StrokeEditorialJournal of Stroke  201 6;18(1):1-1 http://dx.doi.org/10.5853/jos.2016.00038 Moyamoya disease (MMD) is a chronic occlusive cerebro - vascular disease characterized by progressive stenosis at the  terminal portion of the internal carotid artery and an abnor - mal vascular network at the base of the brain.",Non-OADS,/arxiv_data1/oa_pdf/9b/ff/jos-2016-00038.PMC4747063.pdf
"Copyright © 2016  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b0/5c/jos-2015-01739.PMC4747064.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 http://j-stroke.org  21Moyamoya Disease: Treatment and Outcomes T ackeun Kim,a,b Chang Wan Oh,a,b Jae Seung Bang,a,b Jeong Eun Kim,b,c Won-Sang Chob,c  aDepartment of Neurosurgery, Seoul National University Bundang Hospital, Seongnam, Korea bDepartment of Neurosurgery, Seoul National University College of Medicine, Seoul, Korea cDepartment of Neurosurgery, Seoul National University Hospital, Seoul, Korea Correspondence:  Chang Wan Oh Department of Neurosurgery, Seoul  National University Bundang Hospital,   82 Gumi-ro 173 Beon-gil, Bundang-gu,  Seongnam 13620, Korea Tel: +82-31-787-7162 Fax: +82-31-787-4059 E-mail: wanoh@snu.ac.kr Received: December 7, 2015 Revised: January 17, 2016 Accepted: January 17, 2016 The authors have no financial conflicts of  interest.Although the pathogenesis of moyamoya disease (MMD) has not been fully elucidated, the  effectiveness of surgical revascularization in preventing stroke has been addressed by many  studies.",Non-OADS,/arxiv_data1/oa_pdf/b0/5c/jos-2015-01739.PMC4747064.pdf
"Keywords Moyamoya disease; Cerebral revascularization; Treatment outcomeSpecial ReviewJournal of Stroke  201 6;18(1):21- 30 http://dx.doi.org/10.5853/jos.2015.01739 Introduction Moyamoya disease (MMD) is an idiopathic disease with a  progressive nature leading to recurrent stroke due to occlu - sion of the terminal internal carotid arteries.1 Although a re - cent genetic study identified a possible susceptibility gene,2  the pathogenesis of MMD has not been fully defined.",Non-OADS,/arxiv_data1/oa_pdf/b0/5c/jos-2015-01739.PMC4747064.pdf
Moyamoya Disease - Treatment and Outcomes http://dx.doi.org/10.5853/jos.2015.01739 22 http://j-stroke.orgConservative treatment of MMD Long-term prognosis for patients with non-surgically treat - ed MMD is not fully understood.,Non-OADS,/arxiv_data1/oa_pdf/b0/5c/jos-2015-01739.PMC4747064.pdf
1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01739 http://j-stroke.org  23ment for MMD have not been published.,Non-OADS,/arxiv_data1/oa_pdf/b0/5c/jos-2015-01739.PMC4747064.pdf
Moyamoya Disease - Treatment and Outcomes http://dx.doi.org/10.5853/jos.2015.01739 24 http://j-stroke.orgthe disease in promoting spontaneous leptomeningeal collat - eral formation.32 The one of advantage of indirect revascular - ization is that it is relatively easier to perform than direct sur - gery.,Non-OADS,/arxiv_data1/oa_pdf/b0/5c/jos-2015-01739.PMC4747064.pdf
1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01739 http://j-stroke.org  25periosteum are important sources for indirect revasculariza - tion in this area.,OADS,/arxiv_data1/oa_pdf/b0/5c/jos-2015-01739.PMC4747064.pdf
Moyamoya Disease - Treatment and Outcomes http://dx.doi.org/10.5853/jos.2015.01739 26 http://j-stroke.orgTable 1.,Non-OADS,/arxiv_data1/oa_pdf/b0/5c/jos-2015-01739.PMC4747064.pdf
1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01739 http://j-stroke.org  27revascularization were reviewed.,Non-OADS,/arxiv_data1/oa_pdf/b0/5c/jos-2015-01739.PMC4747064.pdf
Moyamoya Disease - Treatment and Outcomes http://dx.doi.org/10.5853/jos.2015.01739 28 http://j-stroke.orgprogression of cerebrovascular lesions.,Non-OADS,/arxiv_data1/oa_pdf/b0/5c/jos-2015-01739.PMC4747064.pdf
1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01739 http://j-stroke.org  29the success of extracranial-intracranial bypass for occlusive  cerebrovascular disease.,Non-OADS,/arxiv_data1/oa_pdf/b0/5c/jos-2015-01739.PMC4747064.pdf
Moyamoya Disease - Treatment and Outcomes http://dx.doi.org/10.5853/jos.2015.01739 30 http://j-stroke.orgphy study.,Non-OADS,/arxiv_data1/oa_pdf/b0/5c/jos-2015-01739.PMC4747064.pdf
"Copyright © 2016  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ef/41/jos-2015-01326.PMC4747065.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 60 http://j-stroke.orgTrends in Incident and Recurrent Rates of First-Ever  Ischemic Stroke in Taiwan between 2000 and 2011 Meng Lee,a Yi-Ling Wu,a Bruce Ovbiageleb aDepartment of Neurology, Chang Gung University College of Medicine, Chang Gung Memorial Hospital, Chiayi branch, T aiwan   bDepartment of Neurosciences, Medical University of South Carolina, Charleston, South Carolina, USA Correspondence:  Meng Lee Department of Neurology, Chang Gung  University College of Medicine,   Chang Gung Memorial Hospital,   Chiayi branch, 6 West Section,   Chiapu Road, Puzi, Taiwan Email: bluccc@adm.cgmh.org.tw Received: July 20, 2015 Revised: October 23, 2015 Accepted: October 25, 2015 The authors have no financial conflicts of  interest.Background and Purpose The burden of stroke is comparatively greater in Asian countries  than in the Western world.",Non-OADS,/arxiv_data1/oa_pdf/ef/41/jos-2015-01326.PMC4747065.pdf
"The objective of  this study was to explore risk factors, medication use, inci - dence, and one-year recurrence of stroke using the entire pop - ulation in T aiwan by National Health Insurance Research Da - tabase (NHIRD).Journal of Stroke  201 6;18(1):60- 65 http://dx.doi.org/10.5853/jos.2015.01326",Non-OADS,/arxiv_data1/oa_pdf/ef/41/jos-2015-01326.PMC4747065.pdf
"1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01326 http://j-stroke.org  61Methods Study design and dataset We retrospectively assessed data collected 2000 through  2012, from T aiwan NHIRD.",OADS,/arxiv_data1/oa_pdf/ef/41/jos-2015-01326.PMC4747065.pdf
"Trend of Incident and Recurrent Stroke in Taiwan http://dx.doi.org/10.5853/jos.2015.01326 62 http://j-stroke.org100,000 persons) to 2011 (129.5 per 100,000 persons) except  there was an obvious drop in 2003 then increased in 2004    (Figure 1).",Non-OADS,/arxiv_data1/oa_pdf/ef/41/jos-2015-01326.PMC4747065.pdf
"1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01326 http://j-stroke.org  63Discussion This study provided an overview of baseline characteristics,  risk factors, medication use during hospitalization, incidence,  and one-year recurrence of first-ever ischemic stroke using the  entire population of T aiwan from 2000 to 2011.",Non-OADS,/arxiv_data1/oa_pdf/ef/41/jos-2015-01326.PMC4747065.pdf
"Trend of Incident and Recurrent Stroke in Taiwan http://dx.doi.org/10.5853/jos.2015.01326 64 http://j-stroke.orgAs compared to a prior study based on the control arms of  clinical trials for secondary stroke prevention, the current  study had higher recurrent rate of stroke (8% vs. 5%10).",Non-OADS,/arxiv_data1/oa_pdf/ef/41/jos-2015-01326.PMC4747065.pdf
1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01326 http://j-stroke.org  651993-2002.,Non-OADS,/arxiv_data1/oa_pdf/ef/41/jos-2015-01326.PMC4747065.pdf
"Copyright © 2016  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/d1/jos-2015-01102.PMC4747066.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 http://j-stroke.org  31Chronic Management of Hypertension after Stroke:  The Role of Ambulatory Blood Pressure Monitoring  Luis Castilla-Guerra,a,b Maria del Carmen Fernandez-Morenoa aDepartment of Neurology, Hospital de Valme, University of Seville, 41014 Seville, Spain bDepartment of Internal Medicine, Hospital Universitario Virgen Macarena, 41071 Seville, Spain Correspondence:  Luis Castilla-Guerra Department of Neurology, Hospital de  Valme, University of Seville, 41014  Seville, Spain Tel: +44-955077261  Fax: +44-955077260  E-mail: castillafernandez@hotmail.com Received: March 26, 2015 Revised: November 12, 2015 Accepted: November 13, 2015 The authors have no financial conflicts of  interest.Hypertension is the most important potentially reversible risk factor for stroke in all age  groups; high blood pressure (BP) is also associated with increased risk of recurrent stroke in  patients who have already had an ischemic or hemorrhagic event.",Non-OADS,/arxiv_data1/oa_pdf/93/d1/jos-2015-01102.PMC4747066.pdf
"Keywords Ambulatory blood pressure monitoring; Blood pressure; Hypertension; Stroke;  Secondary preventionReview Introduction High blood pressure (BP) is the most important potentially  reversible risk factor for stroke in all age groups, with a contin - uous association between both systolic and diastolic BPs  (SBPs and DBPs, respectively) and risk of stroke, particularly  for intracerebral hemorrhage.1 SBP > 115 mmHg explains 60%  of the population-attributable risk of stroke.2 High BP is also  associated with increased risk of recurrent stroke in patients who have already had an ischemic or hemorrhagic event.3  A recent meta-analysis of 16 randomized controlled trials  and 40,292 patients with history of stroke (ischemic, transient  ischemic attack [TIA], or hemorrhagic), with and without  hypertension, demonstrated that BP-lowering treatment re - duced the risk of recurrent stroke (relative risk reduction,  18%; 95% confidence interval [CI], 9%-26%).4 The meta-re - gression analysis also revealed that each 10-mmHg reduction  in SBP is associated with 33% (95% CI, 9%-51%) reduction Journal of Stroke  201 6;18(1):31- 37 http://dx.doi.org/10.5853/jos.2015.01102",Non-OADS,/arxiv_data1/oa_pdf/93/d1/jos-2015-01102.PMC4747066.pdf
"Ambulatory Blood Pressure Monitoring after Stroke http://dx.doi.org/10.5853/jos.2015.01102 32 http://j-stroke.orgin the risks of recurrent stroke.4  Twenty-four hour ambulatory BP monitoring (ABPM) has  become an important tool for improving the diagnosis and  management of hypertension, and it is increasingly used to as - sess patients with hypertension.",Non-OADS,/arxiv_data1/oa_pdf/93/d1/jos-2015-01102.PMC4747066.pdf
http://dx.doi.org/10.5853/jos.2015.01102 http://j-stroke.org  33Vol.,OADS,/arxiv_data1/oa_pdf/93/d1/jos-2015-01102.PMC4747066.pdf
Ambulatory Blood Pressure Monitoring after Stroke http://dx.doi.org/10.5853/jos.2015.01102 34 http://j-stroke.orgcebo group reduced the difference in BP between the treat - ment groups (SBP differed by 5.4 mmHg at 1 month and 4.0  mmHg at one year) and may have reduced the impact of treat - ment on stroke recurrence.,Non-OADS,/arxiv_data1/oa_pdf/93/d1/jos-2015-01102.PMC4747066.pdf
http://dx.doi.org/10.5853/jos.2015.01102 http://j-stroke.org  35Vol.,OADS,/arxiv_data1/oa_pdf/93/d1/jos-2015-01102.PMC4747066.pdf
"Ambulatory Blood Pressure Monitoring after Stroke http://dx.doi.org/10.5853/jos.2015.01102 36 http://j-stroke.orgPrognosis value of ABPM after stroke As previously discussed, since the introduction of ABPM  devices, target organ damage and cardiovascular morbidity  and mortality are reportedly more closely correlated with ABP  than casual BP .",Non-OADS,/arxiv_data1/oa_pdf/93/d1/jos-2015-01102.PMC4747066.pdf
http://dx.doi.org/10.5853/jos.2015.01102 http://j-stroke.org  37Vol.,OADS,/arxiv_data1/oa_pdf/93/d1/jos-2015-01102.PMC4747066.pdf
"Copyright © 2016  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/49/jos-2015-01410.PMC4747067.pdf
pISSN: 2287-6391 • eISSN: 2287-6405 38 http://j-stroke.orgSilent New Brain Lesions: Innocent Bystander or  Guilty Party?,Non-OADS,/arxiv_data1/oa_pdf/95/49/jos-2015-01410.PMC4747067.pdf
"T o identify these patients in the early phase of the  index stroke, DWI, which is the most sensitive imaging method  for detecting hyperacute ischemic stroke,4,5 has been rigorously Journal of Stroke  201 6;18(1):38- 49 http://dx.doi.org/10.5853/jos.2015.01410",Non-OADS,/arxiv_data1/oa_pdf/95/49/jos-2015-01410.PMC4747067.pdf
http://dx.doi.org/10.5853/jos.2015.01410Vol.,OADS,/arxiv_data1/oa_pdf/95/49/jos-2015-01410.PMC4747067.pdf
1 / January 2016 http://j-stroke.org  39used to detect early recurrent ischemic lesions.,Non-OADS,/arxiv_data1/oa_pdf/95/49/jos-2015-01410.PMC4747067.pdf
"Silent New Brain Lesions http://dx.doi.org/10.5853/jos.2015.01410 40 http://j-stroke.orgMoreover, the lesion size of most SNILs is small,12,13 with the  reported lesion volumes ranging between 0.3 and 0.7 mL,13 and  the majority of SNILs (70.6%) being 10 mm or less in diame - ter.12 These findings are consistent with the fact that most recur - rent ischemic lesions do not cause any evident symptoms in the  patients.",Non-OADS,/arxiv_data1/oa_pdf/95/49/jos-2015-01410.PMC4747067.pdf
http://dx.doi.org/10.5853/jos.2015.01410Vol.,OADS,/arxiv_data1/oa_pdf/95/49/jos-2015-01410.PMC4747067.pdf
"1 / January 2016 http://j-stroke.org  41verse (Figure 3), and they can be categorized according to the  locational distribution of SNILs.",OADS,/arxiv_data1/oa_pdf/95/49/jos-2015-01410.PMC4747067.pdf
Silent New Brain Lesions http://dx.doi.org/10.5853/jos.2015.01410 42 http://j-stroke.orgcompared to those with other primary ICHs.38 The main loca - tions of SNILs have been reported to vary.,Non-OADS,/arxiv_data1/oa_pdf/95/49/jos-2015-01410.PMC4747067.pdf
http://dx.doi.org/10.5853/jos.2015.01410Vol.,OADS,/arxiv_data1/oa_pdf/95/49/jos-2015-01410.PMC4747067.pdf
"1 / January 2016 http://j-stroke.org  43lower limits of cerebral autoregulation might induce cerebral  ischemia in ICH patients with chronic hypertension.37 However,  of note, the perihematoma region is known to be unaccompanied  by hypoperfusion or ischemia, and rather shows benign olige - mia.49-53 Moreover, the relationship between reduction of blood  pressure and the advent of SNILs was not reproduced in some  studies.41,43 Thus, it remains controversial whether decreased  blood pressure is the culprit behind the occurrence of SNILs.",Non-OADS,/arxiv_data1/oa_pdf/95/49/jos-2015-01410.PMC4747067.pdf
"Silent New Brain Lesions http://dx.doi.org/10.5853/jos.2015.01410 44 http://j-stroke.orgSNMs after acute ischemic stroke Microbleeds are frequently found in ischemic stroke patients,  at varying rates (35%-71%).82-84 In addition, they are more com - mon in patients with recurrent strokes than in those experienc - ing a first-ever stroke,85 whereas they are rarely found in TIA pa - tients.86 These findings suggest that ischemic stroke may trigger  the occurrence of microbleeds.",Non-OADS,/arxiv_data1/oa_pdf/95/49/jos-2015-01410.PMC4747067.pdf
http://dx.doi.org/10.5853/jos.2015.01410Vol.,OADS,/arxiv_data1/oa_pdf/95/49/jos-2015-01410.PMC4747067.pdf
"1 / January 2016 http://j-stroke.org  45vere white matter ischemic lesions.90,103,104 In addition, micro - bleeds have been associated with larger volume of ICH105,106 and  hemorrhagic transformation after ischemic stroke,107-109 al- though the latter has been denied by other studies.110-114 Recur - rent ischemic stroke also has been linked to the presence of mi - crobleeds,115 while the association turned out to be only modest  when compared to that of hemorrhagic stroke in a systematic  review.103 Lastly, microbleeds are associated with cognitive dys - function, especially frontal-executive impairment.116,117  Based on the above-mentioned data, SNMs appearing after  acute cerebrovascular events may be suggestive of future risk of  hemorrhagic stroke and cognitive dysfunction, similar to SNILs.",Non-OADS,/arxiv_data1/oa_pdf/95/49/jos-2015-01410.PMC4747067.pdf
"Silent New Brain Lesions http://dx.doi.org/10.5853/jos.2015.01410 46 http://j-stroke.orgSanchez MA, Alvarez-Sabin J.",Non-OADS,/arxiv_data1/oa_pdf/95/49/jos-2015-01410.PMC4747067.pdf
http://dx.doi.org/10.5853/jos.2015.01410Vol.,OADS,/arxiv_data1/oa_pdf/95/49/jos-2015-01410.PMC4747067.pdf
1 / January 2016 http://j-stroke.org  472001;57:18-24.,Non-OADS,/arxiv_data1/oa_pdf/95/49/jos-2015-01410.PMC4747067.pdf
Silent New Brain Lesions http://dx.doi.org/10.5853/jos.2015.01410 48 http://j-stroke.orgpopulation-based Rotterdam Scan Study.,Non-OADS,/arxiv_data1/oa_pdf/95/49/jos-2015-01410.PMC4747067.pdf
http://dx.doi.org/10.5853/jos.2015.01410Vol.,OADS,/arxiv_data1/oa_pdf/95/49/jos-2015-01410.PMC4747067.pdf
1 / January 2016 http://j-stroke.org  49detection of new hemorrhages: potential marker of progression  in cerebral amyloid angiopathy.,Non-OADS,/arxiv_data1/oa_pdf/95/49/jos-2015-01410.PMC4747067.pdf
"102 http://j-stroke.orgCopyright © 2016  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/27/24/jos-2015-01655.PMC4747068.pdf
Keywords Guidelines; Acute ischemic stroke; Large cerebral artery occlusion; Thrombolysis;  Reperfusion; Endovascular recanalization therapyGuidelineJournal of Stroke  201 6;18(1):102- 113 http://dx.doi.org/10.5853/jos.2015.01655,Non-OADS,/arxiv_data1/oa_pdf/27/24/jos-2015-01655.PMC4747068.pdf
"1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01655  http://j-stroke.org  103Introduction Previously, intravenous tissue plasminogen activator (IV- TPA) within 4.5 hours after stroke onset was the only therapy  with proven efficacy from randomized clinical trials (RCT s)  for acute ischemic stroke.1-3 However, patients with severe  stroke due to acute large cerebral artery occlusion are less re - sponsive to IV-TPA alone and are likely to be severely disabled  or dead.",Non-OADS,/arxiv_data1/oa_pdf/27/24/jos-2015-01655.PMC4747068.pdf
"Endovascular Recanalization Therapy Guideline http://dx.doi.org/10.5853/jos.2015.01655  104 http://j-stroke.orgkinase in one trial14),4,14-18 and 9 trials provided IV-TPA to  29.6%8 to 100%6,11,12 of patients randomized to control arms.6- 13,19 In 5 RCT s, patients randomized to ERT were mainly treat - ed with stent-retriever thrombectomy (77.1% to 95.1%).9-13  We assessed and summarized the quality of each RCT using  the Cochrane risk of-bias algorithm (www.cochrane.org/train - ing/cochrane-handbook)20 and reported it in another article.21  Data from eligible trials were independently abstracted by the  two investigators (Ko SB and Hong KS), and discrepancies  were resolved by consensus or discussion with other investiga - tors (Yu KH and Rha JH).",Non-OADS,/arxiv_data1/oa_pdf/27/24/jos-2015-01655.PMC4747068.pdf
1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01655  http://j-stroke.org  105Table 2.,Non-OADS,/arxiv_data1/oa_pdf/27/24/jos-2015-01655.PMC4747068.pdf
"Endovascular Recanalization Therapy Guideline http://dx.doi.org/10.5853/jos.2015.01655  106 http://j-stroke.org Trial SYNTHESIS pilotSynthesis: A Randomized  Controlled Trial on Intra- Arterial Versus Intravenous  Thrombolysis in Acute  Ischemic Stroke (SYNTHE - SIS EXPANSION)MR RESCUEInterventional  Management  of Stroke (IMS) IIIMulticenter Randomized   Clinical trial of Endovascular  treatment for Acute ischemic  stroke in the Netherlands  (MR CLEAN)Endovascular Treatment  for Small Core (ESCAPE) Baseline NIHSS (active/control) 17/16 13/13 17.4/17.7 17/16 17/18 16/17 Time window (hour) 3.0 4.5 8.0 5.0 6.0 12.0 Large artery occlusion confirmation (%) NA NA 100.0 43.0 100.0 100.0 Internal carotid artery/M1 occlusion (%) NA/NA NA/NA 16.9/66.1 22.1/41.1 (active arm only) 27.6/63.8 26.7/68.6 Onset to randomization/groin puncture/    first reperfusion (minute)125/NA/195 146/NA/225 330/381/NA 146/208/244 200/260/NA 170/185/241 Active arm ERT only ERT only ERT with standard care ERT with IV-TPA ERT with standard care ERT with standard care Control arm IV-TPA IV-TPA Standard care IV-TPA Standard care Standard care IV-TPA (active/control) (%) 0/96.6 0/98.3 43.8/29.6 100/100 87.1/90.6 72.7/78.7 ERT performed in active arm (%) 76.0 91.2 95.3 77.0 83.7 91.5 Stent-Retriever in active arm (%) 4.0 12.7 0.0 0.9 81.5 78.8 modified Thrombolysis in Cerebral     Infarction 2b-3 in active arm (%)NA NA 25.0 41.0 58.7 72.4 Outcome assessment (day) 90 90 90 90 90 90 mRS 0-2: active vs. control (%)    OR (95% CI) or P value56.0 vs. 31.0 NA42.0 vs. 46.4 NA18.8 vs. 20.4 NA42.7 vs. 40.2 Absolute difference,     1.5% (-6.1 to 9.1)32.6 vs. 19.1 2.16 (1.39, 3.38)53.0 vs. 29.3 1.7 (1.3, 2.2), P< 0.001 mRS 0-1: active vs. control (%)    OR (95% CI) or P value48.0 vs. 27.6 3.2 (0.9, 11.4), P= 0.06730.4 vs. 34.8 0.71 (0.44, 1.14), P= 0.1614.1 vs. 13.0 NA29.4 vs. 27.1 NA11.6 vs. 6.0 2.07 (1.07, 4.02)35.4 vs. 17.7 NA Shift analysis, OR (95% CI) or P value NA NA P= 0.99 P= 0.25 1.67 (1.21, 2.30) 3.1 (2.0, 4.7), P< 0.001 Mortality: active vs. control (%)    OR (95% CI) or P value24.0 vs. 17.2 No difference,     P value not provided14.4 vs. 9.9 P= 0.2218.8 vs. 24.1 No difference, P value not     provided20.0 vs. 22.4 P= 0.5221.0 vs. 22.1 No difference, P value not     provided10.4 vs. 19.0 0.5 (0.3, 0.8), P= 0.04 mRS 5-6: active vs. control (%)    OR (95% CI) or P value24.0 vs. 17.2 NA19.9 vs. 17.1 NA42.2 vs. 35.2 NA24.8 vs. 29.4 NA27.0 vs. 34.1 NA17.1 vs. 31.3 NA SICH: active vs. control (%)    OR (95% CI) or P value8.0 vs. 13.8 0.5 (0.1, 3.3), P= 0.6755.5 vs. 5.5 P= 0.994.7 vs. 3.7 No difference, P value not     provided6.2 vs. 5.9 P= 0.837.7 vs. 6.4 No difference, P value not     provided3.6 vs. 2.7 1.2 (0.3 to 4.6), P= non-significantTable 2.",Non-OADS,/arxiv_data1/oa_pdf/27/24/jos-2015-01655.PMC4747068.pdf
1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01655  http://j-stroke.org  107TrialExtending the Time for Thrombolysis  in Emergency Neurological Deficits— Intra-Arterial (EXTEND-IA)Solitaire with the Intention for  Thrombectomy as Primary  Endovascular Treatment  (SWIFT PRIME)Revascularization with Solitaire FR  Device versus Best Medical Therapy in  the Treatment of Acute Stroke Due to  Anterior Circulation Large Vessel  Occlusion Presenting within Eight Hours  of Symptom Onset (REVASCAT)Meta-analysis Lee et al.Meta-analysis Hong et al.,Non-OADS,/arxiv_data1/oa_pdf/27/24/jos-2015-01655.PMC4747068.pdf
Endovascular Recanalization Therapy Guideline http://dx.doi.org/10.5853/jos.2015.01655  108 http://j-stroke.orgbe less responsive to and at high risk of SICH with ERT .,Non-OADS,/arxiv_data1/oa_pdf/27/24/jos-2015-01655.PMC4747068.pdf
"1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01655  http://j-stroke.org  109RCTs comparing stent-retriever thrombectomy versus  standard IV-TPA The 5 stent-retriever RCT s enrolled 1,278 patients: 633 in  the ERT group and 645 in the control group.",Non-OADS,/arxiv_data1/oa_pdf/27/24/jos-2015-01655.PMC4747068.pdf
"Endovascular Recanalization Therapy Guideline http://dx.doi.org/10.5853/jos.2015.01655  110 http://j-stroke.orgcooperated and sometimes seriously agitated, which might in - crease the risk of endovascular procedure complication.",Non-OADS,/arxiv_data1/oa_pdf/27/24/jos-2015-01655.PMC4747068.pdf
"1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01655  http://j-stroke.org  111Recommendations Recommendations for ERT , neuroimaging evaluation, and  system organization are summarized in T able 3.",OADS,/arxiv_data1/oa_pdf/27/24/jos-2015-01655.PMC4747068.pdf
"Endovascular Recanalization Therapy Guideline http://dx.doi.org/10.5853/jos.2015.01655  112 http://j-stroke.orgreperfusion, and thereby we need to set up an organized stroke  care system for ERT at regional or national level.",Non-OADS,/arxiv_data1/oa_pdf/27/24/jos-2015-01655.PMC4747068.pdf
1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01655  http://j-stroke.org  113g y. AJNR Am J Neuroradiol 2013;34:E0.,Non-OADS,/arxiv_data1/oa_pdf/27/24/jos-2015-01655.PMC4747068.pdf
ESO-Karolinska Stroke  Update Conference 2014. http://2014.strokeupdate.org/con - sensus-statement-mechanical-thrombectomy-acute-ischemic- stroke.,Non-OADS,/arxiv_data1/oa_pdf/27/24/jos-2015-01655.PMC4747068.pdf
Endovascular Recanalization Therapy Guideline http://dx.doi.org/10.5853/jos.2015.01655  http://j-stroke.orgSupplemental Table 1.,Non-OADS,/arxiv_data1/oa_pdf/27/24/jos-2015-01655.PMC4747068.pdf
1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01655  http://j-stroke.orgSupplemental Table 2.,Non-OADS,/arxiv_data1/oa_pdf/27/24/jos-2015-01655.PMC4747068.pdf
"2 http://j-stroke.orgCopyright © 2016  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/d2/jos-2015-01627.PMC4747069.pdf
"Keywords Moyamoya disease; Epidemiology; Clinical features; DiagnosisSpecial ReviewJournal of Stroke  201 6;18(1):2-11 http://dx.doi.org/10.5853/jos.2015.01627 Introduction Moyamoya disease (MMD), also called spontaneous occlu - sion of the circle of Willis, is a chronic, occlusive cerebrovas - cular disease of unknown etiology characterized by steno-oc - clusive changes at the terminal portion of the internal carotid  artery (ICA) and an abnormal vascular network at the base of  the brain.1 In light of the increasing number of patients with  unilateral involvement2 as well as evidence that a substantial number of unilateral cases progress to bilateral presentation  ,3,4 the diagnostic criteria for definitive MMD were revised to  include patients with both bilateral and unilateral presenta - tion of terminal ICA stenosis with an abnormal vascular net - work at the base of the brain (statement by the Research  Committee of MMD of the Japanese Ministry of Health, La - bour, and Welfare in 2015).",Non-OADS,/arxiv_data1/oa_pdf/d6/d2/jos-2015-01627.PMC4747069.pdf
1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01627 http://j-stroke.org  3nosed by either catheter angiography or magnetic resonance  imaging/angiography (MRI/MRA).,Non-OADS,/arxiv_data1/oa_pdf/d6/d2/jos-2015-01627.PMC4747069.pdf
Kim Moyamoya Epidemiology and Clinical Features http://dx.doi.org/10.5853/jos.2015.01627 4 http://j-stroke.orgTable 1.,Non-OADS,/arxiv_data1/oa_pdf/d6/d2/jos-2015-01627.PMC4747069.pdf
1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01627 http://j-stroke.org  5conclusion should be cautiously drawn.,Non-OADS,/arxiv_data1/oa_pdf/d6/d2/jos-2015-01627.PMC4747069.pdf
"Kim Moyamoya Epidemiology and Clinical Features http://dx.doi.org/10.5853/jos.2015.01627 6 http://j-stroke.orgfrequent ischemic symptom is hemiparesis, followed by speech  disturbances and hemisensory abnormalities.24 In one study  that examined 410 pediatric MMD cases, ischemic symptoms  were attributed to MCA territory in 92, ACA territory in 52,  and PCA territory in 10.25 Although posterior circulation  stroke has been considered uncommon, developing in the late  stage of MMD,26 a more recent study reported that PCA in - volvement was present in 29% of patients, with 17% demon - strating PCA territory infarction.27 Unexpectedly, the preva - lence of PCA involvement was not much different (26% vs.  33%) between pediatric and adult patients.",Non-OADS,/arxiv_data1/oa_pdf/d6/d2/jos-2015-01627.PMC4747069.pdf
"1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01627 http://j-stroke.org  7tients, whereas a honeycomb pattern was more common in  adult patients with advanced vascular stages, which may be as - sociated with age-specific vulnerability of the brain to isch - emia, stage of arteriopathy, or changes of abnormal collateral  pathways.",Non-OADS,/arxiv_data1/oa_pdf/d6/d2/jos-2015-01627.PMC4747069.pdf
Kim Moyamoya Epidemiology and Clinical Features http://dx.doi.org/10.5853/jos.2015.01627 8 http://j-stroke.orgrupture of focal microaneurysms in the abnormally dilated an - terior choroidal artery branches may produce intraventricular  hemorrhages.,Non-OADS,/arxiv_data1/oa_pdf/d6/d2/jos-2015-01627.PMC4747069.pdf
"1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01627 http://j-stroke.org  9patients, and occurred more frequently in pediatric (12%)  than adult (7.8%) patients.",Non-OADS,/arxiv_data1/oa_pdf/d6/d2/jos-2015-01627.PMC4747069.pdf
"Kim Moyamoya Epidemiology and Clinical Features http://dx.doi.org/10.5853/jos.2015.01627 10 http://j-stroke.orgdence, at around 10 years and at 30-40 years, with different  clinical presentations.",Non-OADS,/arxiv_data1/oa_pdf/d6/d2/jos-2015-01627.PMC4747069.pdf
1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01627 http://j-stroke.org  1180:36-40.,Non-OADS,/arxiv_data1/oa_pdf/d6/d2/jos-2015-01627.PMC4747069.pdf
"12 http://j-stroke.orgCopyright © 2016  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c2/ae/jos-2015-01760.PMC4747070.pdf
Keywords Angiogenesis; Caveolin; Endothelial progenitor cells; Growth factors; Moyamoya  diseaseSpecial ReviewJournal of Stroke  201 6;18(1):12- 20 http://dx.doi.org/10.5853/jos.2015.01760 Introduction  Moyamoya disease (MMD) is a unique cerebrovascular  disease characterized by the progressive stenosis of the distal  internal carotid artery (ICA) and the resulting hazy network  of basal collaterals called moyamoya vessels.,Non-OADS,/arxiv_data1/oa_pdf/c2/ae/jos-2015-01760.PMC4747070.pdf
"1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01760 http://j-stroke.org  13the brain by the Research Committee of MMD of the Japa - nese Ministry of Health, Labour, and Welfare in 2015.",Non-OADS,/arxiv_data1/oa_pdf/c2/ae/jos-2015-01760.PMC4747070.pdf
"Pathophysiology of Moyamoya Disease http://dx.doi.org/10.5853/jos.2015.01760 14 http://j-stroke.orgRNF213  in non-p.R4810K (i.e., rs148731719, rs397514563)  were recently found in Caucasian and East and South Asian  patients with MMD.24,29-31 In addition, the clinical manifesta - tions and possibly angiographic findings may differ between  Westerners and East Asians.32 The p.R4810K RNF213  variant  was reportedly related to the ischemic type of MMD, while  the non-p.R4810K RNF213  variants, particularly A4399T ,  were associated with the hemorrhagic-type of MMD.30  Function of RNF213  on MMD pathophysiology  The exact function of RNF213  is unknown.",Non-OADS,/arxiv_data1/oa_pdf/c2/ae/jos-2015-01760.PMC4747070.pdf
"1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01760 http://j-stroke.org  15culating endothelial progenitor cells (EPCs), cytokines, and  caveolin.",Non-OADS,/arxiv_data1/oa_pdf/c2/ae/jos-2015-01760.PMC4747070.pdf
"Pathophysiology of Moyamoya Disease http://dx.doi.org/10.5853/jos.2015.01760 16 http://j-stroke.orgEndothelial function and nitric oxide metabolites Endothelial dysfunction is responsible for the dysregulation  of vascular tone, cellular adhesion, thrombus formation, smooth  muscle cell proliferation, and vessel wall inflammation.",OADS,/arxiv_data1/oa_pdf/c2/ae/jos-2015-01760.PMC4747070.pdf
1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01760 http://j-stroke.org  17tion and decreased stabilization/tube formation in patients  with MMD suggests that the nature of neo-vascularization is  an aberrant rather than a compensatory process.,Non-OADS,/arxiv_data1/oa_pdf/c2/ae/jos-2015-01760.PMC4747070.pdf
Pathophysiology of Moyamoya Disease http://dx.doi.org/10.5853/jos.2015.01760 18 http://j-stroke.orgconstrictive remodeling a major pathogenesis?,Non-OADS,/arxiv_data1/oa_pdf/c2/ae/jos-2015-01760.PMC4747070.pdf
1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01760 http://j-stroke.org  19duced pluripotent stem cell-derived vascular endothelial cells  from moyamoya patients.,OADS,/arxiv_data1/oa_pdf/c2/ae/jos-2015-01760.PMC4747070.pdf
Pathophysiology of Moyamoya Disease http://dx.doi.org/10.5853/jos.2015.01760 20 http://j-stroke.org63.,Non-OADS,/arxiv_data1/oa_pdf/c2/ae/jos-2015-01760.PMC4747070.pdf
"Copyright © 2016  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/f8/jos-2015-01578.PMC4747071.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 http://j-stroke.org  87Effect and Safety of Rosuvastatin in Acute  Ischemic Stroke Ji Hoe Heo,a Dongbeom Song,a Hyo Suk Nam,a Eung Y eop Kim,b Y oung Dae Kim,a Kyung-Yul Lee,c  Ki-Jeong Lee,a Joonsang Y oo,a Y oun Nam Kim,d Byung Chul Lee,e Byung-Woo Y oon,f Jong S. Kim,g  for the EUREKA Investigators  aDepartment of Neurology, Y onsei University College of Medicine, Seoul, Korea bDepartment of Radiology, Gachon University, Gil Medical Center, Incheon, Korea cDepartment of Neurology, Gangnam Severance Hospital, Y onsei University College of Medicine, Seoul, Korea dClinical T rials Center, Severance Hospital, Y onsei University Health System, Seoul, Korea eDepartment of Neurology, Hallym University Sacred Heart Hospital, Pyeongchon, Korea fDepartment of Neurology, Seoul National University College of Medicine, Seoul, Korea gDepartment of Neurology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea Correspondence:  Ji Hoe Heo Department of Neurology, Yonsei  University College of Medicine 50-1 Yonsei-ro, Seodaemoon-gu,   Seoul 03722, Korea Tel: +82-2-2228-1605 Fax: +82-2-393-0705 E-mail: jhheo@yuhs.ac  Received: October 26, 2015 Revised: January 6, 2016 Accepted: January 6, 2016 This trial was supported by a research grant  from AstraZeneca and the Korea Healthcare  Technology R&D Project, Ministry of Health  and Welfare, Republic of Korea (HI08C2149,  HI10C2020).",Non-OADS,/arxiv_data1/oa_pdf/6a/f8/jos-2015-01578.PMC4747071.pdf
Keywords Stroke; Rosuvastatin; Statin; Diffusion-weighted imagingOriginal ArticleJournal of Stroke  201 6;18(1):87- 95 http://dx.doi.org/10.5853/jos.2015.01578 Introduction Statins are effective in primary and secondary prevention of stroke.1-3 Their long-term beneficial effects may be primarily  mediated by their lipid-lowering effects.,Non-OADS,/arxiv_data1/oa_pdf/6a/f8/jos-2015-01578.PMC4747071.pdf
"Rosuvastatin in Acute Stroke http://dx.doi.org/10.5853/jos.2015.01578 88 http://j-stroke.orgacute stage of stroke because they have antithrombotic, anti- inflammatory, and anti-oxidative effects.4-7  Several observational studies have suggested that statin use  before or during the acute stage of stroke was associated with  better functional outcome and reduced mortality.7-9 By con - trast, intracerebral hemorrhage (ICH) developed more fre - quently in patients treated with high-dose statins during the  subacute or chronic stage of ischemic stroke in large random - ized trials.2,10 Since the risk of hemorrhagic transformation is  greater during the acute stage of stroke, statin treatment in  acute stroke raises the concern of increased ICH risk.",Non-OADS,/arxiv_data1/oa_pdf/6a/f8/jos-2015-01578.PMC4747071.pdf
"1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01578 http://j-stroke.org  89artery based on methods used in the North American Symp - tomatic Carotid Endarterectomy T rial for extracranial arteries  and the Warfarin and Aspirin for Symptomatic Intracranial  Arterial Stenosis trial for intracranial arteries15,16 and catego - rized stenosis as ≥ 50% or < 50%.",Non-OADS,/arxiv_data1/oa_pdf/6a/f8/jos-2015-01578.PMC4747071.pdf
"Rosuvastatin in Acute Stroke http://dx.doi.org/10.5853/jos.2015.01578 90 http://j-stroke.orgcluded hemorrhagic infarction (HI) and parenchymal hemor - rhage based on European Cooperative Acute Stroke Study  definitions.17 In case of a discrepancy in the presence of new  lesions or hemorrhagic transformation, conclusions were  reached by consensus.",Non-OADS,/arxiv_data1/oa_pdf/6a/f8/jos-2015-01578.PMC4747071.pdf
1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01578 http://j-stroke.org  91population (137 patients in the rosuvastatin group and 152  patients in the placebo group).,Non-OADS,/arxiv_data1/oa_pdf/6a/f8/jos-2015-01578.PMC4747071.pdf
"Rosuvastatin in Acute Stroke http://dx.doi.org/10.5853/jos.2015.01578 92 http://j-stroke.orgischemic lesions were found in 19 of 83 patients (22.9%) in  the rosuvastatin group and 25 of 87 patients (28.7%) in the  placebo group (RR, 0.80; 95% CI, 0.48-1.33; P= 0.387).",Non-OADS,/arxiv_data1/oa_pdf/6a/f8/jos-2015-01578.PMC4747071.pdf
"1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01578 http://j-stroke.org  93DWI during the acute stage of stroke are clinically silent, but  they are direct surrogate markers of recurrence.",Non-OADS,/arxiv_data1/oa_pdf/6a/f8/jos-2015-01578.PMC4747071.pdf
Rosuvastatin in Acute Stroke http://dx.doi.org/10.5853/jos.2015.01578 94 http://j-stroke.orgJoung-Ho Rha; Seoul National University Hospital: Byung- Woo Y oon; Pusan Paik Hospital: Eung Gyu Kim; Hangang  Sacred Heart Hospital: Yang Ki Minn; Gangnam Severance  Hospital: Kyung-Yul Lee; Asan Medical Center: Jong S. Kim;  Chosun University Hospital: Seong Hwan Ahn; National  Medical Center: Jong Yun Lee; Konyang University Hospital:  Kee Ook Lee; Korea University Hospital: Woo-Keun Seo;  Y eouido St. Mary’s Hospital: A-Hyun Cho; Pusan National  University Hospital: Han-Jin Cho.,Non-OADS,/arxiv_data1/oa_pdf/6a/f8/jos-2015-01578.PMC4747071.pdf
"1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01578 http://j-stroke.org  95CA, et al.",OADS,/arxiv_data1/oa_pdf/6a/f8/jos-2015-01578.PMC4747071.pdf
"Rosuvastatin in Acute Stroke http://dx.doi.org/10.5853/jos.2015.01578 http://j-stroke.orgSUPPLEMENTARY DATA Exclusion criteria The main exclusion criteria were hemorrhagic stroke or history of symptomatic hemorrhagic stroke; presence of high-risk po - tential cardiac sources of embolism or other determined etiology of stroke based on the T rial of Org 10,172 in Acute Stroke T reat - ment classification at the time of enrollment; known major hematologic, neoplastic, metabolic, gastrointestinal, or endocrine dys - function; history of malignancy, except in subjects who had been disease-free > 5 years or whose only malignancy has been basal  or squamous cell skin carcinoma; life-threatening illness indicating that the subject is not expected to survive for at least 2 years;  secondary causes of nephrotic syndrome and/or renal dysfunction (serum creatinine > 2.0 mg/dL); uncontrolled hypertension  defined as either a resting systolic blood pressure > 185 mmHg or resting diastolic blood pressure > 110 mmHg despite blood  pressure lowering therapy; clinically significant heart disease likely to require coronary artery bypass surgery, cardiac transplanta - tion, surgical repair, and/or valve replacement during the course of the study (within 14 days after enrollment); moderate or  greater severity of congestive heart failure (New Y ork Heart Association Class III or IV) or whose most recent determination of  left ventricular ejection fraction was < 0.35; triglyceride level > 500 mg/dL; low-density lipoprotein (LDL) cholesterol level  > 190 mg/dL; creatine kinase > 3 times the upper limit of normal range (ULN); aspartate aminotransferase, alanine aminotrans - ferase, or bilirubin levels > 3 times the ULN; thyroid stimulating hormone > 1.5 times the ULN; modified Rankin scale score 4-6  before stroke; possible need for conventional angiography, intervention, or carotid artery surgery during the course of the study;  known serious hypersensitivity reactions to HMG-CoA reductase inhibitors; and history of myopathy.",Non-OADS,/arxiv_data1/oa_pdf/6a/f8/jos-2015-01578.PMC4747071.pdf
1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01578 http://j-stroke.orgSupplemental Table 2.,Non-OADS,/arxiv_data1/oa_pdf/6a/f8/jos-2015-01578.PMC4747071.pdf
"114 http://j-stroke.orgCopyright © 2016  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/97/23/jos-2014-01228.PMC4747072.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405Petroclival Meningioma Accompanying Posterior  Cerebral Artery Infarction Bum Joon Kim,a Deok Hee Lee,b Dong-Wha Kanga Departments of aNeurology and bRadiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, KoreaLetter to the EditorJournal of Stroke  201 6;18(1):114- 116 http://dx.doi.org/10.5853/jos.2014.01228    Dear Sir: Meningiomas are one of the most common brain tumors.",Non-OADS,/arxiv_data1/oa_pdf/97/23/jos-2014-01228.PMC4747072.pdf
1 / January 2016 http://dx.doi.org/10.5853/jos.2014.01228   http://j-stroke.org  115sibility of a cerebral infarction may be high.,Non-OADS,/arxiv_data1/oa_pdf/97/23/jos-2014-01228.PMC4747072.pdf
"PCA Infarction Caused by Meningioma http://dx.doi.org/10.5853/jos.2014.01228   116 http://j-stroke.orgCorrespondence: Dong-Wha Kang Department of Neurology, Asan Medical Center, University of Ulsan College  of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea Tel: +82-2-3010-3440, Fax: +82-2-474-4691  E-mail: dwkang@amc.seoul.kr Received: May 14, 2015 Revised: November 16, 2015 Accepted: November 24, 2015 This work was supported by a grant from the National Research Foundation  of Korea (NRF), funded by the Korean government (MEST; NRF-2014R1A2A1  A11051280) the Korea Healthcare Technology R &D Project, Ministry for  Healthcare & Welfare, Republic of Korea (HI12C1847 and HI14C1983).",Non-OADS,/arxiv_data1/oa_pdf/97/23/jos-2014-01228.PMC4747072.pdf
"Copyright © 2016  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/39/bb/jos-2015-01347.PMC4747073.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 96 http://j-stroke.orgPrimary Stent Retrieval for Acute Intracranial Large  Artery Occlusion Due to Atherosclerotic Disease Jin Soo Lee,a Ji Man Hong,a Kyu Sun Lee,a Hong Il Suh,a Jin Wook Choi,b Sun Y ong Kimb Departments of aNeurology, bRadiology, School of Medicine, Ajou University Medical Center, Suwon, Korea Correspondence:  Jin Soo Lee Department of Neurology, Ajou   University School of Medicine, Ajou   University Hospital, 164 Worldcup-ro,  Yeongtong-gu, Suwon 16499, Korea Tel: +82-31-219-5175 Fax: +82-31-219-5178 E-mail: jinsoo22@gmail.com Received: July 27, 2015 Revised: August 28, 2015 Accepted: September 7, 2015 This research was partly supported by Basic  Science Research Program through the  National Research Foundation of Korea  (NRF) funded by the Ministry of Education  (NRF-2014R1A1A1008249).",Non-OADS,/arxiv_data1/oa_pdf/39/bb/jos-2015-01347.PMC4747073.pdf
"Stent retrievers were designed for thrombus, which Journal of Stroke  201 6;18(1):96- 101 http://dx.doi.org/10.5853/jos.2015.01347",Non-OADS,/arxiv_data1/oa_pdf/39/bb/jos-2015-01347.PMC4747073.pdf
http://dx.doi.org/10.5853/jos.2015.01347Vol.,OADS,/arxiv_data1/oa_pdf/39/bb/jos-2015-01347.PMC4747073.pdf
1 / January 2016 http://j-stroke.org  97can incorporate into the inner space of the stent.,Non-OADS,/arxiv_data1/oa_pdf/39/bb/jos-2015-01347.PMC4747073.pdf
"Occlusion on Intracranial Atherosclerotic Disease  http://dx.doi.org/10.5853/jos.2015.01347 98 http://j-stroke.orgImmediate effects of stent retrieval and rescue  treatments Median number of stent retriever passes was 2 (range, 1-3).",Non-OADS,/arxiv_data1/oa_pdf/39/bb/jos-2015-01347.PMC4747073.pdf
http://dx.doi.org/10.5853/jos.2015.01347Vol.,OADS,/arxiv_data1/oa_pdf/39/bb/jos-2015-01347.PMC4747073.pdf
"1 / January 2016 http://j-stroke.org  99Discussion In this study, we found that the effectiveness of stent retriev - ers for treating acute IAD-related occlusion was somewhat lim - ited because of hidden stenosis.",Non-OADS,/arxiv_data1/oa_pdf/39/bb/jos-2015-01347.PMC4747073.pdf
Occlusion on Intracranial Atherosclerotic Disease  http://dx.doi.org/10.5853/jos.2015.01347 100 http://j-stroke.orgsomewhat among studies.,Non-OADS,/arxiv_data1/oa_pdf/39/bb/jos-2015-01347.PMC4747073.pdf
http://dx.doi.org/10.5853/jos.2015.01347Vol.,OADS,/arxiv_data1/oa_pdf/39/bb/jos-2015-01347.PMC4747073.pdf
"1 / January 2016 http://j-stroke.org  101Lingsma HF, Y oo AJ, et al.",OADS,/arxiv_data1/oa_pdf/39/bb/jos-2015-01347.PMC4747073.pdf
"Copyright © 2016  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f0/e9/jos-2015-01298.PMC4747074.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 80 http://j-stroke.orgGray-Matter Volume Estimate Score: A Novel  Semi-Automatic Method Measuring Early Ischemic  Change on CT  Dongbeom Song,a Kijeong Lee,a Eun Hye Kim,a Y oung Dae Kim,a Hye Sun Lee,b Jinkwon Kim,a,c   T ae-Jin Song,a,d Sung Soo Ahn,e Hyo Suk Nam,a Ji Hoe Heoa aDepartment of Neurology, Y onsei University College of Medicine, Seoul, Korea bDepartment of Biostatistics, Y onsei University College of Medicine, Seoul, Korea cDepartment of Neurology, CHA Bundang Medical Center, CHA University, Seongnam, Korea dDepartment of Neurology, Ewha women’s University School of Medicine, Seoul, Korea eDepartment of Radiology, Y onsei University College of Medicine, Seoul, Korea Correspondence:  Ji Hoe Heo Department of Neurology, Yonsei  University College of Medicine, 50-1 Yonsei-ro, Seodaemoon-gu,   Seoul 03722, Korea Tel: +82-2-2228-1605 Fax: +82-2-393-0705 E-mail: jhheo@yuhs.ac Received: June 30, 2015 Revised: August 14, 2015 Accepted: August 31, 2015 This study was supported by a grant of the  Korea Healthcare technology R &D Project,  Ministry for Health & Welfare Affairs,  Republic of Korea (HI08C2149).",Non-OADS,/arxiv_data1/oa_pdf/f0/e9/jos-2015-01298.PMC4747074.pdf
Keywords Acute ischemic stroke; Acute stroke imaging; Computed tomography; ASPECTS;  Prediction of outcomeOriginal ArticleJournal of Stroke  201 6;18(1):80- 86 http://dx.doi.org/10.5853/jos.2015.01298,Non-OADS,/arxiv_data1/oa_pdf/f0/e9/jos-2015-01298.PMC4747074.pdf
http://dx.doi.org/10.5853/jos.2015.01298Vol.,OADS,/arxiv_data1/oa_pdf/f0/e9/jos-2015-01298.PMC4747074.pdf
"1 / January 2016 http://j-stroke.org  81Introduction Early ischemic changes (EIC) on Computed T omography  (CT) represent early cytotoxic edema and possible develop - ment of irreversible tissue injury.1,2 As reperfusion to irreversibly  injured tissue is not beneficial and can even be harmful if it leads  to hemorrhage, European Cooperative Acute Stroke Study trials  have excluded patients with EIC involving more than a third of  the middle cerebral artery territory on CT .3-5 However, this  method is not reliable even by experienced clinicians.6 There - fore, to improve the reliability of EIC measurement, the Alberta  Stroke Program Early CT Score (ASPECTS), a systematic  method quantifying EIC, was devised.7 ASPECTS has proved  its worth in predicting outcomes of reperfusion therapy in acute  ischemic stroke,7-12 and was used to exclude patients with large  infarct core in the recently published trials which showed clear  benefit of intra-arterial therapy (IAT).",Non-OADS,/arxiv_data1/oa_pdf/f0/e9/jos-2015-01298.PMC4747074.pdf
Gray-Matter Volume Estimate Score http://dx.doi.org/10.5853/jos.2015.01298 82 http://j-stroke.org A  B C  D E  F Figure 1.,OADS,/arxiv_data1/oa_pdf/f0/e9/jos-2015-01298.PMC4747074.pdf
http://dx.doi.org/10.5853/jos.2015.01298Vol.,OADS,/arxiv_data1/oa_pdf/f0/e9/jos-2015-01298.PMC4747074.pdf
"1 / January 2016 http://j-stroke.org  83tients with unavailable baseline CT and 23 with unreadable CT  (12 with old territorial infarction, 10 with motion artifact, and 1  with brain tumor).",Non-OADS,/arxiv_data1/oa_pdf/f0/e9/jos-2015-01298.PMC4747074.pdf
"Gray-Matter Volume Estimate Score http://dx.doi.org/10.5853/jos.2015.01298 84 http://j-stroke.orgcessful reperfusion, not only ASPECTS (Odds Ratio [OR],  1.401; 95% Confidence Interval [CI], 1.070-1.833; P= 0.014),  but also GRAVES (OR, 0.878; 95% CI, 0.795-0.970; P= 0.011)  were independently associated with a favorable outcome.",Non-OADS,/arxiv_data1/oa_pdf/f0/e9/jos-2015-01298.PMC4747074.pdf
http://dx.doi.org/10.5853/jos.2015.01298Vol.,OADS,/arxiv_data1/oa_pdf/f0/e9/jos-2015-01298.PMC4747074.pdf
"1 / January 2016 http://j-stroke.org  85Discussion A rapid, easy, and reliable determination of irreversibly dam - aged brain tissue is critical in selecting candidates for reperfusion  therapy in acute stroke patients.",Non-OADS,/arxiv_data1/oa_pdf/f0/e9/jos-2015-01298.PMC4747074.pdf
"Gray-Matter Volume Estimate Score http://dx.doi.org/10.5853/jos.2015.01298 86 http://j-stroke.orgReferences 1. del Zoppo GJ, von Kummer R, Hamann GF.",OADS,/arxiv_data1/oa_pdf/f0/e9/jos-2015-01298.PMC4747074.pdf
"Copyright © 2016  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/85/jos-2015-01445.PMC4747075.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 66 http://j-stroke.orgPost-Stenotic Recirculating Flow May Cause  Hemodynamic Perforator Infarction Bum Joon Kim,a Hojin Ha,b Hyung Kyu Huh,b Guk Bae Kim,c Jong S. Kim,a Namkug Kim,d,e   Sang-Joon Lee,b Dong-Wha Kang,a Sun U. Kwona aDepartment of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea bCenter for Biofluid and Biomimic Research, Department of Mechanical Engineering, Pohang University of Science and T echnology, Pohang, Korea cAsan Institute of Life Science, Asan Medical Center, Seoul, Korea dDepartment of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea eDepartment of Convergence Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Correspondence:  Sun U. Kwon Stroke Center and Department of  Neurology, Asan Medical Center,  University of Ulsan College of Medicine,  88 Olympic-ro 43-gil, Songpa-gu,   Seoul 05505, Korea Tel: +82-2-3010-3960 Fax: +82-2-474-4691 E-mail: sukwon@amc.seoul.kr Received: August 30, 2015 Revised: October 5, 2015 Accepted: October 17, 2015 This work was supported by the Korea  Health Technology R &D Project, Ministry  for Health & Welfare, Republic of Korea  (HI12C1847), the National Research  Foundation of Korea under a grant funded  by the Korean government (MSIP)   (No.",Non-OADS,/arxiv_data1/oa_pdf/25/85/jos-2015-01445.PMC4747075.pdf
"Keywords Cerebral blood flow; Hemodynamics; Perforator infarcts; ExperimentalOriginal Article Introduction The pathomechanisms of pontine infarction are diverse, as  shown by the lesion patterns and the patency of the involved  arteries.1 Paramedian pontine infarction (PPI), which extends to the basal surface of the pons, is often associated with the oc - clusion of perforating arteries by atherosclerotic plaques in the  basilar artery (BA), which can be detected by high-resolution  magnetic resonance imaging (HR-MRI).2 Usually, these BA  plaques obliterate the perforator at the most stenotic portion.3Journal of Stroke  201 6;18(1):66- 72 http://dx.doi.org/10.5853/jos.2015.01445",Non-OADS,/arxiv_data1/oa_pdf/25/85/jos-2015-01445.PMC4747075.pdf
http://dx.doi.org/10.5853/jos.2015.01445Vol.,OADS,/arxiv_data1/oa_pdf/25/85/jos-2015-01445.PMC4747075.pdf
"1 / January 2016 http://j-stroke.org  67However, perforator infarctions which occur at the area in - consistent to the area with parental artery stenosis are notice - able and the recirculating flow in the post-stenotic area was  conceptually thought to influence the occurrence of perfora - tor infarction.4 We recently encountered a patient without a  plaque in the region of the PPI, but with a severe stenosis of  the BA immediately proximal to the PPI, as confirmed by  HR-MRI.",Non-OADS,/arxiv_data1/oa_pdf/25/85/jos-2015-01445.PMC4747075.pdf
Post-stenotic Hemodynamic Perforator Infarction http://dx.doi.org/10.5853/jos.2015.01445 68 http://j-stroke.org A  B C  D E  F Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/25/85/jos-2015-01445.PMC4747075.pdf
http://dx.doi.org/10.5853/jos.2015.01445Vol.,OADS,/arxiv_data1/oa_pdf/25/85/jos-2015-01445.PMC4747075.pdf
"1 / January 2016 http://j-stroke.org  69SA1.1, Photron, USA) at different positions were used to mea - sure velocity fields in the horizontal and vertical planes.",OADS,/arxiv_data1/oa_pdf/25/85/jos-2015-01445.PMC4747075.pdf
Post-stenotic Hemodynamic Perforator Infarction http://dx.doi.org/10.5853/jos.2015.01445 70 http://j-stroke.orgTable 1.,Non-OADS,/arxiv_data1/oa_pdf/25/85/jos-2015-01445.PMC4747075.pdf
http://dx.doi.org/10.5853/jos.2015.01445Vol.,OADS,/arxiv_data1/oa_pdf/25/85/jos-2015-01445.PMC4747075.pdf
"1 / January 2016 http://j-stroke.org  71ing using advanced brain imaging techniques.13 Some studies  focused on the small atherosclerotic plaques causing perfora - tor infarctions which were observed from HR-MRI, but not  by conventional MRIs.14 However, those highly advanced im - aging techniques still cannot demonstrate the hemodynamics  of intracranial artery directly.",Non-OADS,/arxiv_data1/oa_pdf/25/85/jos-2015-01445.PMC4747075.pdf
Post-stenotic Hemodynamic Perforator Infarction http://dx.doi.org/10.5853/jos.2015.01445 72 http://j-stroke.orgshape of middle cerebral artery and plaque location: high-reso - lution MRI finding.,Non-OADS,/arxiv_data1/oa_pdf/25/85/jos-2015-01445.PMC4747075.pdf
"50 http://j-stroke.orgCopyright © 2016  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/27/fc/jos-2015-01186.PMC4747076.pdf
"Keywords Ischemic stroke; Diffusion tensor imaging; Hemiparesis; Diffusion tensor tractog - raphy; Upper limb recovery; PredictionSystematic ReviewJournal of Stroke  201 6;18(1):50- 59 http://dx.doi.org/10.5853/jos.2015.01186 Introduction Stroke is a major leading cause of death and disability world - wide especially in the elderly population.1 Upper limb motor  weakness is one of the most frequent complications after  stroke with over 50% of stroke patients experiencing residual  motor deficit.2 Despite advances in treatment of acute isch - emic stroke (IS) and post- stroke rehabilitation, the depen -dency rate after stroke still reaches 20%-30%.3 Prognostication  of upper limb motor outcomes after stroke is an important for  specific rehabilitation strategies and final motor outcomes but,  considered a difficult task.",Non-OADS,/arxiv_data1/oa_pdf/27/fc/jos-2015-01186.PMC4747076.pdf
"1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01186 http://j-stroke.org  51tract (CST), the most important structure for motor control,  especially for fine motor control of the hand in humans.10 Diffusion tensor imaging (DTI) is an advance non-invasive  magnetic resonance imaging technique used to characterize  the orientation properties of diffusion process of water mole - cules.",OADS,/arxiv_data1/oa_pdf/27/fc/jos-2015-01186.PMC4747076.pdf
"Prediction of Motor Recovery after Ischemic Stroke http://dx.doi.org/10.5853/jos.2015.01186 52 http://j-stroke.orgsent, participation in each wave, and attrition.",Non-OADS,/arxiv_data1/oa_pdf/27/fc/jos-2015-01186.PMC4747076.pdf
1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01186 http://j-stroke.org  53Table 1.,Non-OADS,/arxiv_data1/oa_pdf/27/fc/jos-2015-01186.PMC4747076.pdf
Prediction of Motor Recovery after Ischemic Stroke http://dx.doi.org/10.5853/jos.2015.01186 54 http://j-stroke.org Authors & Year CountryNo.,Non-OADS,/arxiv_data1/oa_pdf/27/fc/jos-2015-01186.PMC4747076.pdf
1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01186 http://j-stroke.org  55Table 3.,Non-OADS,/arxiv_data1/oa_pdf/27/fc/jos-2015-01186.PMC4747076.pdf
Prediction of Motor Recovery after Ischemic Stroke http://dx.doi.org/10.5853/jos.2015.01186 56 http://j-stroke.orgthors.,Non-OADS,/arxiv_data1/oa_pdf/27/fc/jos-2015-01186.PMC4747076.pdf
"1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01186 http://j-stroke.org  57recovery of upper limb function.21 The degree of impairment  in FA during the early stages of stroke appears to have the po - tential to predict motor outcome.29,35,36  The studies included in the meta-analysis reported heteroge - neous data, which could be a major limitation to our results.",Non-OADS,/arxiv_data1/oa_pdf/27/fc/jos-2015-01186.PMC4747076.pdf
Prediction of Motor Recovery after Ischemic Stroke http://dx.doi.org/10.5853/jos.2015.01186 58 http://j-stroke.orgJW.,Non-OADS,/arxiv_data1/oa_pdf/27/fc/jos-2015-01186.PMC4747076.pdf
1 / January 2016 http://dx.doi.org/10.5853/jos.2015.01186 http://j-stroke.org  59nal capsule on diffusion tensor tractography as an early imag - ing predictor of motor outcome after stroke.,Non-OADS,/arxiv_data1/oa_pdf/27/fc/jos-2015-01186.PMC4747076.pdf
"Copyright © 2016  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fb/bd/jos-2015-01389.PMC4747077.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 http://j-stroke.org  117Changes in Painting Style by Poststroke Mania Eunjoo Rhee, Connie Hong, Y oung Eun Kim, Byung-Chul Lee Department of Neurology, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, KoreaLetter to the Editor Dear Sir: Post stroke neuropsychiatric syndrome is common.1 Many  patients after stroke experience depression, cognitive impair - ment, personality change, psychosis, apathy, and anxiety.",Non-OADS,/arxiv_data1/oa_pdf/fb/bd/jos-2015-01389.PMC4747077.pdf
"Nevertheless, an in - triguing point of this case is that his mood was clearly reflected Journal of Stroke  201 6;18(1):117- 119 http://dx.doi.org/10.5853/jos.2015.01389",Non-OADS,/arxiv_data1/oa_pdf/fb/bd/jos-2015-01389.PMC4747077.pdf
"Changes in Painting Style by Poststroke Mania http://dx.doi.org/10.5853/jos.2015.01389 118 http://j-stroke.orgin his artistic work, although his neurologic deficit was mini - mal.",Non-OADS,/arxiv_data1/oa_pdf/fb/bd/jos-2015-01389.PMC4747077.pdf
http://dx.doi.org/10.5853/jos.2015.01389Vol.,Non-OADS,/arxiv_data1/oa_pdf/fb/bd/jos-2015-01389.PMC4747077.pdf
1 / January 2016 http://j-stroke.org  119J.,Non-OADS,/arxiv_data1/oa_pdf/fb/bd/jos-2015-01389.PMC4747077.pdf
"This is an open-access article distributed under the terms  of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redis - tribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/c6/9f/cardiovascmed-05-01-28952.PMC4747083.pdf
1 http://repository.edm-forum.org/egems/vol4/iss1/1 DOI: 10.13063/2327-9214.1182,Non-OADS,/arxiv_data1/oa_pdf/09/aa/egems1182.PMC4747120.pdf
1 http://repository.edm-forum.org/egems/vol4/iss1/1 DOI: 10.13063/2327-9214.1182,Non-OADS,/arxiv_data1/oa_pdf/09/aa/egems1182.PMC4747120.pdf
1 http://repository.edm-forum.org/egems/vol4/iss1/1 DOI: 10.13063/2327-9214.1182,Non-OADS,/arxiv_data1/oa_pdf/09/aa/egems1182.PMC4747120.pdf
1 http://repository.edm-forum.org/egems/vol4/iss1/1 DOI: 10.13063/2327-9214.1182,Non-OADS,/arxiv_data1/oa_pdf/09/aa/egems1182.PMC4747120.pdf
1 http://repository.edm-forum.org/egems/vol4/iss1/1 DOI: 10.13063/2327-9214.1182,Non-OADS,/arxiv_data1/oa_pdf/09/aa/egems1182.PMC4747120.pdf
1 http://repository.edm-forum.org/egems/vol4/iss1/1 DOI: 10.13063/2327-9214.1182,Non-OADS,/arxiv_data1/oa_pdf/09/aa/egems1182.PMC4747120.pdf
1 http://repository.edm-forum.org/egems/vol4/iss1/1 DOI: 10.13063/2327-9214.1182,Non-OADS,/arxiv_data1/oa_pdf/09/aa/egems1182.PMC4747120.pdf
1 http://repository.edm-forum.org/egems/vol4/iss1/1 DOI: 10.13063/2327-9214.1182,Non-OADS,/arxiv_data1/oa_pdf/09/aa/egems1182.PMC4747120.pdf
1 http://repository.edm-forum.org/egems/vol4/iss1/1 DOI: 10.13063/2327-9214.1182,Non-OADS,/arxiv_data1/oa_pdf/09/aa/egems1182.PMC4747120.pdf
1 http://repository.edm-forum.org/egems/vol4/iss1/1 DOI: 10.13063/2327-9214.1182,Non-OADS,/arxiv_data1/oa_pdf/09/aa/egems1182.PMC4747120.pdf
1 http://repository.edm-forum.org/egems/vol4/iss1/1 DOI: 10.13063/2327-9214.1182,Non-OADS,/arxiv_data1/oa_pdf/09/aa/egems1182.PMC4747120.pdf
"Bromodomain Protein BRD4 Is Required for Estrogen Receptor- Dependent Enhancer Activation and Gene Transcription Sankari Nagarajan1,2,3, Tareq Hossan1,3, Malik Alawi5,7, Zeynab Najafova1,2,3, Daniela  Indenbirken7, Upasana Bedi2,3, Hanna Taipaleenmäki4, Isabel Ben-Batalla3,6, Marina  Scheller3,6, Sonja Loges3,6, Stefan Knapp8,9, Eric Hesse4, Cheng-Ming Chiang10, Adam  Grundhoff7, and Steven A. Johnsen1,2,3,* 1Department of General, Visceral and Pediatric Surgery, University Medical Center Göttingen,  37075 Göttingen, Germany 2Institute for Molecular Oncology, University Medical Center Göttingen, 37077 Göttingen,  Germany 3Institute for Tumor Biology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg,  Germany 4Heisenberg-Group for Molecular Skeletal Biology, University Medical Center Hamburg- Eppendorf, 20246 Hamburg, Germany 5Bioinformatics Service Facility, University Medical Center Hamburg-Eppendorf, 20246 Hamburg,  Germany 6Department of Hematology and Oncology, University Medical Center Hamburg-Eppendorf,  20246 Hamburg, Germany 7Heinrich Pette Institute, Leibniz Institute for Experimental Virology, 20251 Hamburg, Germany 8Structural Genomics Consortium, University of Oxford, Oxford OX3 7DQ, UK 9Target Discovery Institute, University of Oxford, Oxford OX3 7DQ, UK 10University of Texas Southwestern Medical Center, Dallas, TX 75390-8807, USA SUMMARY This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/96/72/nihms756893.PMC4747248.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four figures, and four tables and can be found with this  article online at http://dx.doi.org/10.1016/j.celrep.2014.06.016 .",OADS,/arxiv_data1/oa_pdf/96/72/nihms756893.PMC4747248.pdf
Available at: http://www.R-project.org.,Non-OADS,/arxiv_data1/oa_pdf/a0/b6/NEURIMMINFL2015007492.PMC4747477.pdf
"In thediscovery set, we obtained normalized compartment-specific global brain volumes as surrogates of atrophy, including GM fraction (GMF), WM fraction (WMF), and total brainparenchymal fraction (BPF), using statistical parametric mapping version 8 (Wellcome Department of Cognitive Neurology, London, UK, http://www.fil.ion.ucl.ac.uk/spm), after manual correction of(1) misclassifications of tissue compartments due to MS lesion, and(2) ineffective contouring of the deep GM structures.",Non-OADS,/arxiv_data1/oa_pdf/dd/9d/NEURIMMINFL2015007229.PMC4747479.pdf
"This is an Open Access article distributed under the terms of the Creative CommonsAttribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/31/f5/jiv508.PMC4747625.pdf
"Peer review under responsibility of Beijing Institute of Genomics, Chinese Academy of Sciences and Genetics Society of China.Genomics Proteomics Bioinformatics 13(2015) 383 HOSTED BY Genomics Proteomics Bioinformatics www.elsevier.com/locate/gpb www.sciencedirect.com http://dx.doi.org/10.1016/j.gpb.2016.01.001 1672-0229 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/23/0f/main.PMC4747661.pdf
"Production and hosting by Elsevier B.V. on behalf of Beijing Institute of Genomics, Chinese Academy of Sciences and Genetics Society of China.This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/23/0f/main.PMC4747661.pdf
"The frequency of HWL talk gradually decreased in Canada (48%–36%) after  new HWLs were implemented; an increase (30%–58%) in Australia corresponded with  implementation of new HWLs, after which talking stabilized; and the frequency of HWL talk in  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/cd/f8/nihms705020.PMC4747859.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/ j.socscimed.2015.05.042 .Thrasher et al.,OADS,/arxiv_data1/oa_pdf/cd/f8/nihms705020.PMC4747859.pdf
It is now reproduced correctly above.journal homepage: http://www.krcp-ksn.comKidney Research and Clinical Practice Contents lists available at ScienceDirect 2211-9132/$ - see front matter &2013.,Non-OADS,/arxiv_data1/oa_pdf/0a/e1/main.PMC4747868.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0a/e1/main.PMC4747868.pdf
http://dx.doi.org/10.1016/j.krcp.2013.04.010DOI of original article: http://dx.doi.org/10.1016/j.krcp.2012.06.006 nCorresponding author.,OADS,/arxiv_data1/oa_pdf/0a/e1/main.PMC4747868.pdf
It is now reproduced correctly above.journal homepage: http://www.krcp-ksn.comKidney Research and Clinical Practice Contents lists available at ScienceDirect 2211-9132/$ - see front matter &2013.,Non-OADS,/arxiv_data1/oa_pdf/74/45/main.PMC4747869.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/45/main.PMC4747869.pdf
http://dx.doi.org/10.1016/j.krcp.2013.07.008DOI of original article: http://dx.doi.org/10.1016/j.krcp.2013.04.006 nCorresponding author.,OADS,/arxiv_data1/oa_pdf/74/45/main.PMC4747869.pdf
"New histopathological classi ﬁcation system for DN The new classi ﬁcation system launched in 2010 distin- guishes between four classes of DN, where essentially onlyjournal homepage: http://www.krcp-ksn.comKidney Research and Clinical Practice Contents lists available at ScienceDirect 2211-9132/$ - see front matter &2013.",Non-OADS,/arxiv_data1/oa_pdf/19/90/main.PMC4747870.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/90/main.PMC4747870.pdf
http://dx.doi.org/10.1016/j.krcp.2013.07.007 Kidney Res Clin Pract 32 (2013) 93 –95,Non-OADS,/arxiv_data1/oa_pdf/19/90/main.PMC4747870.pdf
"The montaging of acquired images was then conducted by applying a matching algorithm in picture editing software (Pho- toshop version 5.5; Adobe, San Jose, CA) according to the manufacture ’s manual (http://www.adobe.com/uk/ aboutadobe/pressroom/p ressmaterials/pdfs/ photoshop55/ps55revg.pdf#search= ’photoshop+5.5 +manual ’).",Non-OADS,/arxiv_data1/oa_pdf/08/38/retina-36-375.PMC4747978.pdf
http://www.nccn.org/professionals/physician_gls/f_guidelines.,Non-OADS,/arxiv_data1/oa_pdf/4c/11/330_2015_Article_3873.PMC4747985.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/67/9f/134_2015_Article_4171.PMC4747987.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s)and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/3d/c1/134_2015_Article_4057.PMC4747996.pdf
Available via http://www.myesr.org/cms/website.php?id=/30447/ en/eu_affairs/esr_subcommittee_on_radiation_protection/ec_tender_project_europ ean_diagnostic_reference_levels_for_ paediatric_imaging/pidrl_-_european_diagnostic_reference_levels_for_paediatric_imaging.htm .,Non-OADS,/arxiv_data1/oa_pdf/18/5d/330_2015_Article_3870.PMC4747997.pdf
"This work was supported by the Center for Translational Molecular Medicine ( http://www.ctmm.nl ), project MARS (Grant 04I-201).",Non-OADS,/arxiv_data1/oa_pdf/63/1a/134_2015_Article_4071.PMC4747999.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/63/1a/134_2015_Article_4071.PMC4747999.pdf
: http://www.fda.gov/Drugs/DrugSafety/ ucm223966.htm692 Eur Radiol (2016) 26:683 –692,Non-OADS,/arxiv_data1/oa_pdf/12/3f/330_2015_Article_3877.PMC4748006.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Infection Ecology and Epidemiology 2016, 6: 30237 - http://dx.doi.org/10.3402/iee.v6.30237 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c5/e1/IEE-6-30237.PMC4748086.pdf
"theguardian.com/world/2015/sep/30/ebola-inquest-un-united- nations-world-health-organisation [cited 25 January 2016].John Jack Woodall 2 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 30237 - http://dx.doi.org/10.3402/iee.v6.30237",Non-OADS,/arxiv_data1/oa_pdf/c5/e1/IEE-6-30237.PMC4748086.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Infection Ecology and Epidemiology 2016, 6: 30139 - http://dx.doi.org/10.3402/iee.v6.30139 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/96/d0/IEE-6-30139.PMC4748089.pdf
doi: http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/96/d0/IEE-6-30139.PMC4748089.pdf
"1590/S0100-879X2006005000082John (Jack) Woodall 2 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 30139 - http://dx.doi.org/10.3402/iee.v6.30139",Non-OADS,/arxiv_data1/oa_pdf/96/d0/IEE-6-30139.PMC4748089.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Oral Microbiology 2016, 8: 29849 - http://dx.doi.org/10.3402/jom.v8.29849 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/66/45/JOM-8-29849.PMC4748091.pdf
"2 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 29849 - http://dx.doi.org/10.3402/jom.v8.29849",Non-OADS,/arxiv_data1/oa_pdf/66/45/JOM-8-29849.PMC4748091.pdf
"Number of resistant isolates in parentheses.Phenotypic characterization of C. glabrata Citation: Journal of Oral Microbiology 2016, 8: 29849 - http://dx.doi.org/10.3402/jom.v8.29849 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/66/45/JOM-8-29849.PMC4748091.pdf
"4 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 29849 - http://dx.doi.org/10.3402/jom.v8.29849",Non-OADS,/arxiv_data1/oa_pdf/66/45/JOM-8-29849.PMC4748091.pdf
"*Due to insufficient evidence that C. glabrata is a good target for therapy with voriconazole, no EUCAST breakpoints were available in 2014, and BPs made for C. albicans ,C. tropicalis , and C. parapsilosis were used.Phenotypic characterization of C. glabrata Citation: Journal of Oral Microbiology 2016, 8: 29849 - http://dx.doi.org/10.3402/jom.v8.29849 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/66/45/JOM-8-29849.PMC4748091.pdf
"6 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 29849 - http://dx.doi.org/10.3402/jom.v8.29849",Non-OADS,/arxiv_data1/oa_pdf/66/45/JOM-8-29849.PMC4748091.pdf
"Considering the BPs for C. albicans ,Phenotypic characterization of C. glabrata Citation: Journal of Oral Microbiology 2016, 8: 29849 - http://dx.doi.org/10.3402/jom.v8.29849 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/66/45/JOM-8-29849.PMC4748091.pdf
"8 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 29849 - http://dx.doi.org/10.3402/jom.v8.29849",Non-OADS,/arxiv_data1/oa_pdf/66/45/JOM-8-29849.PMC4748091.pdf
doi: http://dx.doi.org/10.1016/j.diagmicrobio.,OADS,/arxiv_data1/oa_pdf/66/45/JOM-8-29849.PMC4748091.pdf
doi: http://dx.doi.org/10.1128/JCM.00029-06.,Non-OADS,/arxiv_data1/oa_pdf/66/45/JOM-8-29849.PMC4748091.pdf
doi: http://dx.doi.org/10.1016/j.cmi.2015.,OADS,/arxiv_data1/oa_pdf/66/45/JOM-8-29849.PMC4748091.pdf
doi: http://dx.doi.org/10.1128/JCM.06112-11 12.,Non-OADS,/arxiv_data1/oa_pdf/66/45/JOM-8-29849.PMC4748091.pdf
doi: http://dx.doi.org/10.1097/QCO.0000000000000111 14.,OADS,/arxiv_data1/oa_pdf/66/45/JOM-8-29849.PMC4748091.pdf
BMCMicrobiol 2015; 15: 106. doi: http://dx.doi.org/10.1186/s12866- 015-0442-4 15.,Non-OADS,/arxiv_data1/oa_pdf/66/45/JOM-8-29849.PMC4748091.pdf
doi: http://dx.doi.org/10.1128/JCM.02445-09 18.,Non-OADS,/arxiv_data1/oa_pdf/66/45/JOM-8-29849.PMC4748091.pdf
doi: http://dx.doi.org/10.1128/JCM.40.10.3602-3605.2002 19.,Non-OADS,/arxiv_data1/oa_pdf/66/45/JOM-8-29849.PMC4748091.pdf
J BacteriolParasitol 2013; S5: 002. doi: http://dx.doi.org/10.4172/2155- 9597.S5-002 22.,Non-OADS,/arxiv_data1/oa_pdf/66/45/JOM-8-29849.PMC4748091.pdf
doi: http://dx.doi.org/10.1007/ s10096-015-2322-0 23.,Non-OADS,/arxiv_data1/oa_pdf/66/45/JOM-8-29849.PMC4748091.pdf
"ISSN: 1502-2307 (print)/1890 /C19965 (electronic).Phenotypic characterization of C. glabrata Citation: Journal of Oral Microbiology 2016, 8: 29849 - http://dx.doi.org/10.3402/jom.v8.29849 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/66/45/JOM-8-29849.PMC4748091.pdf
doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/66/45/JOM-8-29849.PMC4748091.pdf
"10 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 29849 - http://dx.doi.org/10.3402/jom.v8.29849",Non-OADS,/arxiv_data1/oa_pdf/66/45/JOM-8-29849.PMC4748091.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b4/f9/czv041.PMC4748128.pdf
"University of Minnesota MIS Research Center Working Paper series, WP 96-04, http://misrc.umn.edu/wpaper/WorkingPapers/9604.pdf.",Non-OADS,/arxiv_data1/oa_pdf/b4/f9/czv041.PMC4748128.pdf
"http://www.who.int/entity/healthsystems/strategy/everybodys_ business.pdf, accessed 23 July 2013.",OADS,/arxiv_data1/oa_pdf/b4/f9/czv041.PMC4748128.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6f/ac/czv042.PMC4748129.pdf
"http://www.who.int/hrh/documents/community_ health_workers_brief.pdf, accessed 20 May 2015.",Non-OADS,/arxiv_data1/oa_pdf/6f/ac/czv042.PMC4748129.pdf
"Kampala, Uganda: Malaria Consortium, http://www.malariaconsortium.org/resources/publications/ 379/improving-access-for-under-ﬁves-to-life-saving-treatment-through- integrated-community-case-management-for-malaria-pneumonia-and- diarrhoea, accessed 6 May 2015.",Non-OADS,/arxiv_data1/oa_pdf/6f/ac/czv042.PMC4748129.pdf
http://www.malariaconsortium.,Non-OADS,/arxiv_data1/oa_pdf/6f/ac/czv042.PMC4748129.pdf
"http://www.ubos.org/UNHS0910/unhs200910.pdf, accessed 6 May 2015.",Non-OADS,/arxiv_data1/oa_pdf/6f/ac/czv042.PMC4748129.pdf
"http://nadic.uac.go.ug/nadic/node/142, accessed 6 May 2015.",Non-OADS,/arxiv_data1/oa_pdf/6f/ac/czv042.PMC4748129.pdf
"http://www.unv.org/en/news-resources/resources/on-volunteer- ism/doc/measuring-volunteering-toolkit.html, accessed 6 May 2015. van den Berg B, Brouwer W, van Exel J et al.",Non-OADS,/arxiv_data1/oa_pdf/6f/ac/czv042.PMC4748129.pdf
"http://www.who.int/whr/2006/whr06_en.pdf, accessed 6 May 2015.Health Policy and Planning , 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/6f/ac/czv042.PMC4748129.pdf
"http://www.who.int/healthsystems/TTR-TaskShifting.pdf, accessed 6 May 2015.",Non-OADS,/arxiv_data1/oa_pdf/6f/ac/czv042.PMC4748129.pdf
"http://www.who.int/ maternal_child_adolescent/documents/statement_child_services_access_ whounicef.pdf, accessed 6 May 2015.",Non-OADS,/arxiv_data1/oa_pdf/6f/ac/czv042.PMC4748129.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/04/czv045.PMC4748130.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/f5/5c/10.1177_2325967115627611.PMC4748157.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4a/98/main.PMC4748167.pdf
"Other reports demonstrated that, following homologous LHR down-regulationContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/bbrepBiochemistry and Biophysics Reports http://dx.doi.org/10.1016/j.bbrep.2016.01.005 2405-5808/ &2016 The Authors.",OADS,/arxiv_data1/oa_pdf/4a/98/main.PMC4748167.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: AP-1, activator protein 1; BSA, bovine serum albumin; CREB, cAMP response element binding protein; db-cAMP, dibutryl cAMP; EGF, epidermalgrowth factor; EGFR, epidermal growth factor receptor; ERG, early response gene;ERK1/2, extracellular signal regulated kinases; EPAC, exchange protein directlyactivated by cAMP; hCG, human chorionic gonadotropin; IBMX, iso-butylmethylxanthine; IP3, 1,4,5-inositol trisphosphate; LHR, luteinizing hormonereceptor (also binds hCG); 4 α-PE, 4 α-phorbol 12,13-didecanoate (inactive phorbol ester); PKA, protein kinase A; PKC, protein kinase C; PMA, phorbol 12-myristate 13- acetate (active phorbol ester); RACK1, receptor for activated C kinase 1; SEM, standard error of the mean; SDS, sodium dodecyl sulfate; SSC, 0.15 M NaCl, 15 mMsodium citrate; TPA, 12-O-tetradecanoyl phorbol 13-acetate (active phorbol ester) nCorresponding author.",Non-OADS,/arxiv_data1/oa_pdf/4a/98/main.PMC4748167.pdf
Appendix A. Transparency Document Transparency Document associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.bbrep.,Non-OADS,/arxiv_data1/oa_pdf/4a/98/main.PMC4748167.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/4c/db/crj-03-074.PMC4748183.pdf
Visit http://acgcasereports.gi.org for  submission guidelines.,Non-OADS,/arxiv_data1/oa_pdf/4c/db/crj-03-074.PMC4748183.pdf
Submit your manuscript online at http://mc.manuscriptcentral.com/acgcr.,Non-OADS,/arxiv_data1/oa_pdf/4c/db/crj-03-074.PMC4748183.pdf
Medscape gastroenterologist compensation report 2015. http://www.medscape.com/features/slideshow/compensa - tion/2015/gastroenterology.,Non-OADS,/arxiv_data1/oa_pdf/4c/db/crj-03-074.PMC4748183.pdf
"Report on medical school faculty salaries, 2013-2014. https://www.aamc.org/data.",Non-OADS,/arxiv_data1/oa_pdf/4c/db/crj-03-074.PMC4748183.pdf
http://www.abim.org/pdf/data-candidates-certified/all-candi - dates.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4c/db/crj-03-074.PMC4748183.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/12/29/crj-03-076.PMC4748184.pdf
"To  view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/cc/ac/crj-03-077.PMC4748185.pdf
Visit http://acgcasereports.gi.org for  submission guidelines.,Non-OADS,/arxiv_data1/oa_pdf/cc/ac/crj-03-077.PMC4748185.pdf
Submit your manuscript online at http://mc.manuscriptcentral.com/acgcr.,Non-OADS,/arxiv_data1/oa_pdf/cc/ac/crj-03-077.PMC4748185.pdf
Watch the video: http://s3.gi.org/media/links/Marques_Video.mp4,Non-OADS,/arxiv_data1/oa_pdf/cc/ac/crj-03-077.PMC4748185.pdf
"To  view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/c5/99/crj-03-079.PMC4748186.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.Figure 2.",Non-OADS,/arxiv_data1/oa_pdf/9a/7a/crj-03-080.PMC4748187.pdf
Visit http://acgcasereports.gi.org for  submission guidelines.,Non-OADS,/arxiv_data1/oa_pdf/9a/7a/crj-03-080.PMC4748187.pdf
Submit your manuscript online at http://mc.manuscriptcentral.com/acgcr.,Non-OADS,/arxiv_data1/oa_pdf/9a/7a/crj-03-080.PMC4748187.pdf
"To  view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/53/2b/crj-03-082.PMC4748188.pdf
Visit http://acgcasereports.gi.org for  submission guidelines.,Non-OADS,/arxiv_data1/oa_pdf/53/2b/crj-03-082.PMC4748188.pdf
Submit your manuscript online at http://mc.manuscriptcentral.com/acgcr.,Non-OADS,/arxiv_data1/oa_pdf/53/2b/crj-03-082.PMC4748188.pdf
"To  view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/9d/9c/crj-03-084.PMC4748189.pdf
Visit http://acgcasereports.gi.org for  submission guidelines.,Non-OADS,/arxiv_data1/oa_pdf/9d/9c/crj-03-084.PMC4748189.pdf
Submit your manuscript online at http://mc.manuscriptcentral.com/acgcr.,Non-OADS,/arxiv_data1/oa_pdf/9d/9c/crj-03-084.PMC4748189.pdf
"To  view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/df/e2/crj-03-086.PMC4748190.pdf
Visit http://acgcasereports.gi.org for  submission guidelines.,Non-OADS,/arxiv_data1/oa_pdf/df/e2/crj-03-086.PMC4748190.pdf
Submit your manuscript online at http://mc.manuscriptcentral.com/acgcr.,Non-OADS,/arxiv_data1/oa_pdf/df/e2/crj-03-086.PMC4748190.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/9c/e4/crj-03-088.PMC4748191.pdf
Watch the video: http://s3.gi.org/ media/links/Dellon_Video.mp4,Non-OADS,/arxiv_data1/oa_pdf/9c/e4/crj-03-088.PMC4748191.pdf
Visit http://acgcasereports.gi.org for  submission guidelines.,Non-OADS,/arxiv_data1/oa_pdf/9c/e4/crj-03-088.PMC4748191.pdf
Submit your manuscript online at http://mc.manuscriptcentral.com/acgcr.,Non-OADS,/arxiv_data1/oa_pdf/9c/e4/crj-03-088.PMC4748191.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/21/76/crj-03-092.PMC4748192.pdf
Visit http://acgcasereports.gi.org for  submission guidelines.,Non-OADS,/arxiv_data1/oa_pdf/21/76/crj-03-092.PMC4748192.pdf
Submit your manuscript online at http://mc.manuscriptcentral.com/acgcr.,Non-OADS,/arxiv_data1/oa_pdf/21/76/crj-03-092.PMC4748192.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/c0/7a/crj-03-095.PMC4748193.pdf
Visit http://acgcasereports.gi.org for  submission guidelines.,Non-OADS,/arxiv_data1/oa_pdf/c0/7a/crj-03-095.PMC4748193.pdf
Submit your manuscript online at http://mc.manuscriptcentral.com/acgcr.,Non-OADS,/arxiv_data1/oa_pdf/c0/7a/crj-03-095.PMC4748193.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/f9/53/crj-03-098.PMC4748194.pdf
Visit http://acgcasereports.gi.org for  submission guidelines.,Non-OADS,/arxiv_data1/oa_pdf/f9/53/crj-03-098.PMC4748194.pdf
Submit your manuscript online at http://mc.manuscriptcentral.com/acgcr.,Non-OADS,/arxiv_data1/oa_pdf/f9/53/crj-03-098.PMC4748194.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/83/1e/crj-03-101.PMC4748195.pdf
Visit http://acgcasereports.gi.org for  submission guidelines.,Non-OADS,/arxiv_data1/oa_pdf/83/1e/crj-03-101.PMC4748195.pdf
Submit your manuscript online at http://mc.manuscriptcentral.com/acgcr.,Non-OADS,/arxiv_data1/oa_pdf/83/1e/crj-03-101.PMC4748195.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/77/b6/crj-03-104.PMC4748196.pdf
Visit http://acgcasereports.gi.org for  submission guidelines.,Non-OADS,/arxiv_data1/oa_pdf/77/b6/crj-03-104.PMC4748196.pdf
Submit your manuscript online at http://mc.manuscriptcentral.com/acgcr.,Non-OADS,/arxiv_data1/oa_pdf/77/b6/crj-03-104.PMC4748196.pdf
"Seattle, WA: Uni - versity of Washington; 1993. http://www.ncbi.nlm.nih.gov/books/ NBK1494/?report=printable.",Non-OADS,/arxiv_data1/oa_pdf/77/b6/crj-03-104.PMC4748196.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/dc/3b/crj-03-107.PMC4748197.pdf
Visit http://acgcasereports.gi.org for  submission guidelines.,Non-OADS,/arxiv_data1/oa_pdf/dc/3b/crj-03-107.PMC4748197.pdf
Submit your manuscript online at http://mc.manuscriptcentral.com/acgcr.,Non-OADS,/arxiv_data1/oa_pdf/dc/3b/crj-03-107.PMC4748197.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/f8/48/crj-03-109.PMC4748198.pdf
Visit http://acgcasereports.gi.org for  submission guidelines.,Non-OADS,/arxiv_data1/oa_pdf/f8/48/crj-03-109.PMC4748198.pdf
Submit your manuscript online at http://mc.manuscriptcentral.com/acgcr.,Non-OADS,/arxiv_data1/oa_pdf/f8/48/crj-03-109.PMC4748198.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/ae/16/crj-03-112.PMC4748199.pdf
Visit http://acgcasereports.gi.org for  submission guidelines.,Non-OADS,/arxiv_data1/oa_pdf/ae/16/crj-03-112.PMC4748199.pdf
Submit your manuscript online at http://mc.manuscriptcentral.com/acgcr.,Non-OADS,/arxiv_data1/oa_pdf/ae/16/crj-03-112.PMC4748199.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/8e/6f/crj-03-115.PMC4748200.pdf
Visit http://acgcasereports.gi.org for  submission guidelines.,Non-OADS,/arxiv_data1/oa_pdf/8e/6f/crj-03-115.PMC4748200.pdf
Submit your manuscript online at http://mc.manuscriptcentral.com/acgcr.,Non-OADS,/arxiv_data1/oa_pdf/8e/6f/crj-03-115.PMC4748200.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/7d/9b/crj-03-118.PMC4748201.pdf
Visit http://acgcasereports.gi.org for  submission guidelines.,Non-OADS,/arxiv_data1/oa_pdf/7d/9b/crj-03-118.PMC4748201.pdf
Submit your manuscript online at http://mc.manuscriptcentral.com/acgcr.,Non-OADS,/arxiv_data1/oa_pdf/7d/9b/crj-03-118.PMC4748201.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/4d/9c/crj-03-121.PMC4748202.pdf
Visit http://acgcasereports.gi.org for  submission guidelines.,Non-OADS,/arxiv_data1/oa_pdf/4d/9c/crj-03-121.PMC4748202.pdf
Submit your manuscript online at http://mc.manuscriptcentral.com/acgcr.,Non-OADS,/arxiv_data1/oa_pdf/4d/9c/crj-03-121.PMC4748202.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/f6/e3/crj-03-124.PMC4748203.pdf
Visit http://acgcasereports.gi.org for  submission guidelines.,Non-OADS,/arxiv_data1/oa_pdf/f6/e3/crj-03-124.PMC4748203.pdf
Submit your manuscript online at http://mc.manuscriptcentral.com/acgcr.,Non-OADS,/arxiv_data1/oa_pdf/f6/e3/crj-03-124.PMC4748203.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/1c/f7/crj-03-127.PMC4748204.pdf
Visit http://acgcasereports.gi.org for  submission guidelines.,Non-OADS,/arxiv_data1/oa_pdf/1c/f7/crj-03-127.PMC4748204.pdf
Submit your manuscript online at http://mc.manuscriptcentral.com/acgcr.,Non-OADS,/arxiv_data1/oa_pdf/1c/f7/crj-03-127.PMC4748204.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/02/8a/crj-03-130.PMC4748205.pdf
Visit http://acgcasereports.gi.org for  submission guidelines.,Non-OADS,/arxiv_data1/oa_pdf/02/8a/crj-03-130.PMC4748205.pdf
Submit your manuscript online at http://mc.manuscriptcentral.com/acgcr.,Non-OADS,/arxiv_data1/oa_pdf/02/8a/crj-03-130.PMC4748205.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/c9/3b/crj-03-133.PMC4748206.pdf
http://livertox.nih.gov.,Non-OADS,/arxiv_data1/oa_pdf/c9/3b/crj-03-133.PMC4748206.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/f0/d5/crj-03-136.PMC4748207.pdf
Visit http://acgcasereports.gi.org for  submission guidelines.,Non-OADS,/arxiv_data1/oa_pdf/f0/d5/crj-03-136.PMC4748207.pdf
Submit your manuscript online at http://mc.manuscriptcentral.com/acgcr.,Non-OADS,/arxiv_data1/oa_pdf/f0/d5/crj-03-136.PMC4748207.pdf
"To  view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/75/8e/crj-03-139.PMC4748208.pdf
Visit http://acgcasereports.gi.org for  submission guidelines.,Non-OADS,/arxiv_data1/oa_pdf/75/8e/crj-03-139.PMC4748208.pdf
Submit your manuscript online at http://mc.manuscriptcentral.com/acgcr.,Non-OADS,/arxiv_data1/oa_pdf/75/8e/crj-03-139.PMC4748208.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.",Non-OADS,/arxiv_data1/oa_pdf/9a/44/crj-03-141.PMC4748209.pdf
Visit http://acgcasereports.gi.org for  submission guidelines.,Non-OADS,/arxiv_data1/oa_pdf/9a/44/crj-03-141.PMC4748209.pdf
Submit your manuscript online at http://mc.manuscriptcentral.com/acgcr.,Non-OADS,/arxiv_data1/oa_pdf/9a/44/crj-03-141.PMC4748209.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f2/3e/rjw013.PMC4748251.pdf
Recurrence in unrelatedpatients and absence from unaffected individuals (http://exac.broadinstitute.org) provides strong evidence that these mutations are pathogenic.,Non-OADS,/arxiv_data1/oa_pdf/f7/a1/ACN3-3-114.PMC4748308.pdf
This  is  an  open  access  article  under the CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/c1/52/main.PMC4748379.pdf
http://dx.doi.org/10.1016/j.toxrep.2014.09.009 2214-7500/©  2014  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/52/main.PMC4748379.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/c1/52/main.PMC4748379.pdf
"Methods— A clinical study was conducted in 15 patients with birch pollen allergy with AD  (group 1), 5 patients with birch pollen allergy without AD (group 2), 5 allergic patients without  birch pollen allergy (group 3), and 5 nonallergic subjects (group 4) by performing skin prick tests  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/51/0c/emss-66295.PMC4748398.pdf
"http://rer.aera.net 79Digital Games, Design, and Learning: A  Systematic Review and Meta-Analysis Douglas B. Clark, Emily E. Tanner-Smith, and   Stephen S. Killingsworth Vanderbilt University In this meta-analysis, we systematically reviewed research on digital games  and learning for K–16 students.",Non-OADS,/arxiv_data1/oa_pdf/e9/aa/10.3102_0034654315582065.PMC4748544.pdf
"Retrieved from http://informalscience.org/images/research/Summit_on_Educational_Games.pdf Feng, J., Spence, I., & Pratt, J.",Non-OADS,/arxiv_data1/oa_pdf/e9/aa/10.3102_0034654315582065.PMC4748544.pdf
Available from: http://www.ginAsthma.org.,Non-OADS,/arxiv_data1/oa_pdf/2d/f3/ATM-11-3.PMC4748613.pdf
Available at: http://www.fda.gov/downloads/ AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ Pulmonary‑AllergyDrugsAdvisoryCommittee/UCM450248.pdf  [accessed on 2015 Jul 12]   281.,Non-OADS,/arxiv_data1/oa_pdf/2d/f3/ATM-11-3.PMC4748613.pdf
Available from: http://search.ancestry.com/search/ db.aspx?dbid=3693.,Non-OADS,/arxiv_data1/oa_pdf/6b/90/ATM-11-49.PMC4748615.pdf
Available  from: http://www.thehindu.com/health/indias‑tuberculosis‑challenge/ article4017246.ece.,Non-OADS,/arxiv_data1/oa_pdf/76/e4/LI-33-27.PMC4748660.pdf
Available from: http://www.who.int/ mediacentre/factsheets/fs104/en/.,Non-OADS,/arxiv_data1/oa_pdf/76/e4/LI-33-27.PMC4748660.pdf
Available from: http://www.apps.who.int/ iris/bitstream/10665/44286/1/9789241599191_eng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/76/e4/LI-33-27.PMC4748660.pdf
Available from: http://www.popline.org/node/254514.,Non-OADS,/arxiv_data1/oa_pdf/76/e4/LI-33-27.PMC4748660.pdf
Available from: http://www.imsear.li.mahidol.ac.th/ handle/123456789/146942.,Non-OADS,/arxiv_data1/oa_pdf/76/e4/LI-33-27.PMC4748660.pdf
Available from:  http://www.medind.nic.in/ibr/t04/i1/ibrt04i1p17.pdf.,Non-OADS,/arxiv_data1/oa_pdf/76/e4/LI-33-27.PMC4748660.pdf
Available from:  http://www.popline.org/node/254455.,Non-OADS,/arxiv_data1/oa_pdf/76/e4/LI-33-27.PMC4748660.pdf
Available from: http://www.lungindia.com/text.,Non-OADS,/arxiv_data1/oa_pdf/76/e4/LI-33-27.PMC4748660.pdf
Available from: http://www.mjafi.net/article/S0377‑1237(06) 80097‑3/ abstract.,Non-OADS,/arxiv_data1/oa_pdf/76/e4/LI-33-27.PMC4748660.pdf
Available from: http://www.goldcopd.org/.,Non-OADS,/arxiv_data1/oa_pdf/7a/92/LI-33-42.PMC4748664.pdf
Available from:  http://www.who.int/nutrition/publications/ micronutrients/anemia.,Non-OADS,/arxiv_data1/oa_pdf/7a/92/LI-33-42.PMC4748664.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/45/46/LI-33-53.PMC4748666.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/32/2a/main.PMC4748737.pdf
E-mail address: seelyea@ohsu.edu http://dx.doi.org/10.1016/j.dadm.2015.09.006 2352-8729/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/32/2a/main.PMC4748737.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/2a/main.PMC4748737.pdf
"Published by Oxford University Press, on behalf of the Society of Systematic Biologists.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f0/40/syv067.PMC4748747.pdf
"Staging Individual limb buds were staged using our publicly available web-based staging system(http://limbstaging.crg.es , last accessed October 1, 2015) ( Boehm et al.",OADS,/arxiv_data1/oa_pdf/f0/40/syv067.PMC4748747.pdf
"Allthe analyses were performed using R ( R Development Core Team 2013 ;http://www.R-project.org , last accessed October 1, 2015); geomorph ( Adams and Otárola-Castillo 2013 ), a package available at CRAN (http://cra n.r-pr oject.org/web/packages/geomorph , last accessed October 1, 2015), and MorphoJ(Klingenberg 2011 ).R ESULTS AND DISCUSSION We here present our results and discuss the genetic and developmental interactions that might beunderlying our morphometric results.",Non-OADS,/arxiv_data1/oa_pdf/f0/40/syv067.PMC4748747.pdf
URL http://www.R-project.org/ .,Non-OADS,/arxiv_data1/oa_pdf/f0/40/syv067.PMC4748747.pdf
"Published by Oxford University Press, on behalf of the Society of Systematic Biologists.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0a/11/syv089.PMC4748752.pdf
" Case Rep Nephrol Dial 201 6;6:1–7  DOI: 10.1159/000443163   Published online: January 8, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   2296‒9705/16/0061‒0001$39.50/0   www.karger.com/cnd   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/84/7a/cnd-0006-0001.PMC4748756.pdf
" Case Rep Oncol 2016;9:45 –50  DOI: 10.1159/000443605   Published online: January 15, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   1662‒6575/16/0091‒0045$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/b8/cb/cro-0009-0045.PMC4748757.pdf
" Case Rep Dermatol  2016;8:1–4  DOI: 10.1159/000443321   Published online: January 8, 2016  © 2016 The Author(s)   Published  by S. Karger AG, Basel   1662‒6567/16/0081‒0001$39.50/0   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/a4/d1/cde-0008-0001.PMC4748758.pdf
" Case Rep Ophthalmol 2016;7:9 –15  DOI: 10.1159/000443324   Published online: January 8, 2016  © 2016 The Author(s)   Published by S. Ka rger AG, Basel   1663‒2699/16/0071‒0009$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/ef/eb/cop-0007-0009.PMC4748760.pdf
The Food and Drug Administration considers autoimmune disease to be a contraindic a- tion to LASIK because of the potential for unpredictable wound healing and keratoly sis  (http://www.amo -inc.com/products/refractive/ilasik/star -s4-ir-excimer -laser)  [13] .,Non-OADS,/arxiv_data1/oa_pdf/ef/eb/cop-0007-0009.PMC4748760.pdf
" Case Rep Ophthalmol 2016;7:1 –8  DOI: 10.1159/000443322   Published online: January 8, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   1663‒2699/16/0071‒0001$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/18/2e/cop-0007-0001.PMC4748766.pdf
" Case Rep Oncol  2016;9:11 –14  DOI: 10.1159/000443327   Published online: January 8, 2016  © 2016 The Author(s)   Published  by S. Karger AG, Basel   1662‒6575/16/0091‒0011$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/4a/db/cro-0009-0011.PMC4748767.pdf
" Case Rep Oncol  2016;9:51 –55  DOI: 10.1159/000443662   Published online: January 15, 2016  © 2016 The Author(s)   Published  by S. Karger AG, Basel   1662‒6575/16/0091‒0051$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/c1/77/cro-0009-0051.PMC4748772.pdf
"Available from:  http://www.ema.euro pa.eu/docs/en_GB/document_library/EPAR_ - _Product_Information/human/002489/WC500134759.pdf (access ed April 23, 2014).",Non-OADS,/arxiv_data1/oa_pdf/c1/77/cro-0009-0051.PMC4748772.pdf
" Case Rep Ophthalmol 2016;7:25 –29  DOI: 10.1159/000443202   Published online: January 8, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   1663‒2699/16/0071‒0025$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/43/55/cop-0007-0025.PMC4748776.pdf
" Case Rep Ophthalmol  2016;7:39 –43  DOI: 10.1159/000442743   Published online: January 12, 2016  © 2016 The Author(s)   Published  by S. Karger AG, Basel   1663‒2699/16/0071‒0039$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/1b/35/cop-0007-0039.PMC4748778.pdf
" Case Rep Neurol 2016;8:16 –19  DOI: 10.1159/000443522   Published online: January 8,  2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   1662‒680X/16/0081‒0016$39.50/0   www.karger.com/crn   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/b8/87/crn-0008-0016.PMC4748781.pdf
" Case Rep Oncol 2016;9:39 –44  DOI: 10.1159/000442875   Published online: January 14, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   1662‒6575/16/0091‒0039$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/a0/0d/cro-0009-0039.PMC4748782.pdf
" Case Rep Ophthalmol  2016;7:21 –24  DOI: 10.1159/000443325   Published online: January 8, 2016  © 2016 The Author(s)   Published  by S. Karger AG, Basel   1663‒2699/16/0071‒0021$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/c6/b0/cop-0007-0021.PMC4748783.pdf
" Case Rep Ophthalmol  2016;7:30 –38  DOI: 10.1159/000443603   Published online: January 8, 2016  © 2016 The Author(s)   Published  by S. Karger AG, Basel   1663‒2699/16/0071‒0030$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/da/9e/cop-0007-0030.PMC4748786.pdf
" Case Rep Nephrol Dial 2016;6:14 –20  DOI: 10.1159/000443727   Published online: January 15, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   2296‒9705/16/0061‒0014$39.50/0   www.karger.com/cnd   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger .com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/58/be/cnd-0006-0014.PMC4748787.pdf
" Case Rep Oncol 2016;9:6 –10  DOI: 10.1159/000443234   Published online: January 8, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   1662‒6575/16/0091‒0006$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/df/fe/cro-0009-0006.PMC4748788.pdf
" Case Rep Oncol 2016;9:33 –38  DOI: 10.1159/000443661   Published online: January 14, 2016  © 2016 The Autho r(s)  Published by S. Karger AG, Basel   1662‒6575/16/0091‒0033$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/6c/4b/cro-0009-0033.PMC4748789.pdf
" Case Rep Ophthalmol  2016;7:16 –20  DOI: 10.1159/000443323   Published online: January 8, 2016  © 2016 The Author(s)   Published  by S. Karger AG, Basel   1663‒2699/16/0071‒0016$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/d3/81/cop-0007-0016.PMC4748790.pdf
" Case Rep Oncol 2016;9:25 –32  DOI: 10.1159/000443682   Published online: January 13, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   1662‒6575/16/0091‒0025$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/4b/e8/cro-0009-0025.PMC4748791.pdf
" Case Rep Oncol 2016;9:15 –24  DOI: 10.1159/000443304   Published online: January 8, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   1662‒6575/16/0091‒0015$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/22/55/cro-0009-0015.PMC4748796.pdf
" Case Rep Oncol 2016;9:1 –5  DOI: 10.1159/000443161   Published online: January 7, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   1662‒6575/16/0091‒0001$39.50/0   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/7c/54/cro-0009-0001.PMC4748798.pdf
" Case Rep Neurol 2016;8:1 –9  DOI: 10.1159/000442196   Published online: January 8, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   1662‒680X/16/0081‒0001$39.50/0   www.karger.com/crn   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/da/bd/crn-0008-0001.PMC4748800.pdf
http://www.accessdata.fda.gov/drugsatfda_docs/la bel/2011/125085s225lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/da/bd/crn-0008-0001.PMC4748800.pdf
" Case Rep Nephrol Dial  2016;6:8–13  DOI: 10.1159/000443328   Published online: January 13, 2016  © 2016 The Author(s)   Published  by S. Karger AG, Basel   2296‒9705/16/0061‒0008$39.50/0   www.karger.com/cnd   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/12/b2/cnd-0006-0008.PMC4748801.pdf
" Case Rep Ophthalmol  2016;7:44 –48  DOI: 10.1159/000443721   Published online: January 14, 2016  © 2016 The Author(s)   Published  by S. Karger AG, Basel   1663‒2699/16/0071‒0044$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/79/f2/cop-0007-0044.PMC4748802.pdf
" Case Rep Neurol 2016;8:10 –15  DOI: 10.1159/000442973   Published online: January 8, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   1662‒680X/16/0081‒0010$39.50/0   www.karger.com/crn   This article is licensed under the Creative Commons Attrib ution -NonCommercial 4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/e7/cf/crn-0008-0010.PMC4748806.pdf
" Case Rep Ophthalmol  2016;7:49 –53  DOI: 10.1159/000443474   Published online: January 14, 2016  © 2016 The Author(s)   Published  by S. Karger AG, Basel   1663‒2699/16/0071‒0049$39.50/0   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial  4.0  International License (CC BY -NC) ( http://www.karger.com/Services/OpenAccessLicense ).",Non-OADS,/arxiv_data1/oa_pdf/30/0b/cop-0007-0049.PMC4748807.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.055590.115.© 2016 Brenner This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http:// rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/ad/5d/317.PMC4748809.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.BOOK REVIEW RNA 22:317; Published by Cold Spring Harbor Laboratory Press for the RNA Society 317",Non-OADS,/arxiv_data1/oa_pdf/ad/5d/317.PMC4748809.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.054353.115.© 2016 Lozano et al.,OADS,/arxiv_data1/oa_pdf/41/60/330.PMC4748811.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/41/60/330.PMC4748811.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.REPORT 330 RNA 22:330 –338; Published by Cold Spring Harbor Laboratory Press for the RNA Society",Non-OADS,/arxiv_data1/oa_pdf/41/60/330.PMC4748811.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.054973.115.© 2016 Foretek et al.,OADS,/arxiv_data1/oa_pdf/1f/98/339.PMC4748812.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/1f/98/339.PMC4748812.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/1f/98/339.PMC4748812.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.053108.115.© 2016 Effenberger et al.,OADS,/arxiv_data1/oa_pdf/56/81/350.PMC4748813.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/56/81/350.PMC4748813.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.054833.115.© 2016 Fu et al.,OADS,/arxiv_data1/oa_pdf/c9/36/373.PMC4748815.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/c9/36/373.PMC4748815.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.055426.115.© 2016 Jakob et al.,OADS,/arxiv_data1/oa_pdf/d8/36/383.PMC4748816.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/d8/36/383.PMC4748816.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.054866.115.,OADS,/arxiv_data1/oa_pdf/30/1d/397.PMC4748817.pdf
"This article, published in RNA , is available under a Creative Commons License (Attribution-NonCommercial 4.0 Internation-al), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/30/1d/397.PMC4748817.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.052928.115.© 2016 Childs et al.,OADS,/arxiv_data1/oa_pdf/d2/4f/408.PMC4748818.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/d2/4f/408.PMC4748818.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/d2/4f/408.PMC4748818.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.055178.115.© 2016 Ruminski et al.,OADS,/arxiv_data1/oa_pdf/e8/35/416.PMC4748819.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/e8/35/416.PMC4748819.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/e8/35/416.PMC4748819.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.053942.115.© 2016 Harnisch et al.,OADS,/arxiv_data1/oa_pdf/45/d7/428.PMC4748820.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/45/d7/428.PMC4748820.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/45/d7/428.PMC4748820.pdf
"Before cRT- PCR analysis, their transcription start sites were mapped toa position 253 nucleotides (nt) upstream of the translation start codon (Supplemental Table I), which differs from the start site listed at http://flybase.org.",Non-OADS,/arxiv_data1/oa_pdf/45/d7/428.PMC4748820.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.054643.115.© 2016 Monachello et al.,OADS,/arxiv_data1/oa_pdf/65/d2/443.PMC4748821.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/65/d2/443.PMC4748821.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.054452.115.,OADS,/arxiv_data1/oa_pdf/23/00/456.PMC4748822.pdf
"This article, published in RNA , is available under a Creative Commons License (Attribution-NonCommercial 4.0 Internation-al), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/23/00/456.PMC4748822.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.054163.115.© 2016 Gomes et al.,OADS,/arxiv_data1/oa_pdf/3d/5c/467.PMC4748823.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/3d/5c/467.PMC4748823.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.METHOD RNA 22:467 –476; Published by Cold Spring Harbor Laboratory Press for the RNA Society 467",Non-OADS,/arxiv_data1/oa_pdf/3d/5c/467.PMC4748823.pdf
"Briefly, a tRNA library was adapted from the tRNAScan-SElibrary by appending CCA to tRNAs from the genomic tRNA data-base (http://gtrnadb.ucsc.edu/Hsapi19/).",OADS,/arxiv_data1/oa_pdf/3d/5c/467.PMC4748823.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.054494.115.© 2016 Gazestani et al.,OADS,/arxiv_data1/oa_pdf/2c/55/477.PMC4748824.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/2c/55/477.PMC4748824.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.METHOD RNA 22:477 –486; Published by Cold Spring Harbor Laboratory Press for the RNA Society 477",Non-OADS,/arxiv_data1/oa_pdf/2c/55/477.PMC4748824.pdf
"We developed a software package written in C#, called circTAIL- seq Analyzer (available at http://trypsNetDB.org/circTAILseqAnalyzer.zip), to systematically extract and analyze tail sequencesfrom the preprocessed reads generated by circTAIL-seq deep se-quencing.",OADS,/arxiv_data1/oa_pdf/2c/55/477.PMC4748824.pdf
We also acknowledge the Minnesota SupercomputingInstitute (MSI) at the University of Minnesota (http://www.msi.umn.edu) for providing resources that contributed to the researchresults reported in this paper.,Non-OADS,/arxiv_data1/oa_pdf/2c/55/477.PMC4748824.pdf
"Park S. et al., Forehead Flaps, available at  http://emedicine.medscape.com/article/880171-overview .",OADS,/arxiv_data1/oa_pdf/14/45/CHSJ-40-4-277.PMC4748831.pdf
"Image Data Processing Imaging data were preprocessed using FSL v5.0 (Func- tional Magnetic Resonance Imaging of the Brain SoftwareLibrary; http://www.fmrib.ox.au.uk/fsl) and SPM8 (statistical parametric mapping, Wellcome Department of Imaging Neuro- science, London, UK; available online at http://www.fil.ion.u-cl.ac.uk/spm) implemented in Matlab 7.3 (MathWorks, Natick, MA).",OADS,/arxiv_data1/oa_pdf/3f/81/medi-95-e2206.PMC4748867.pdf
"To further ensure the accuracy of cross-modality image registration, the unlabeled ASL images and correspondingT1W images of each participant were skull-stripped using theBrain Extraction (BET, part of FSL, http://fsl.fmrib.ox.ac.uk/fsl/ fslwiki/BET) Tool v2.1 (BET and BET2; part of FSL) to remove nonbrain tissues and background noise from the images.",Non-OADS,/arxiv_data1/oa_pdf/3f/81/medi-95-e2206.PMC4748867.pdf
"We used a boundary-based registration algorithm implemented inFMRIB’s Linear Image Registration Tool (FLIRT, part of FSLhttp://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FLIRT) to obtain accurate and robust ASL and T1W image alignment.",OADS,/arxiv_data1/oa_pdf/3f/81/medi-95-e2206.PMC4748867.pdf
"The DARTEL (Diffeomorphic Anatomical Registration Through Exponentiated Lie Algebra) toolbox (part of SPM8,http://www.fil.ion.ucl.ac.uk/spm/software/spm8/)19implemented in SPM8 was used to generate group-specific templates for all the subjects based on their segmented gray matter (GM) and whitematter (WM) probability maps, and each group-specific templatewas registered into the Montreal Neurological Institute (MNI) standard space using affine transformation.",OADS,/arxiv_data1/oa_pdf/3f/81/medi-95-e2206.PMC4748867.pdf
The coordinates of the voxels of each significant cluster were transformed from MNI coordinates into Talairach coordinates using the GingleALE toolbox (The BrainMap Devel-opment Team; http://brainmap.org/ale/index.html).,OADS,/arxiv_data1/oa_pdf/3f/81/medi-95-e2206.PMC4748867.pdf
The Talair-ach and Tournoux atlas (http://www.talairach.org/index.html) was used to identify the anatomic structures of the Talairach coordinates representing significant clusters.,OADS,/arxiv_data1/oa_pdf/3f/81/medi-95-e2206.PMC4748867.pdf
"The PDD group alsoexhibited lower CBF in the parahippocampus (BA 30), anterior cingulate (BA 32), and precuneus (BA 7) (Figure 2A andSupplementary Table 1, http://links.lww.com/MD/A588).",Non-OADS,/arxiv_data1/oa_pdf/3f/81/medi-95-e2206.PMC4748867.pdf
"Parkinson Disease ONVersus Parkinson Disease With Dementia ON A comparison of the PD ONand PDD ONgroups found no significant differences in CBF for the various brain regions (Figure 2B and Supplementary Table 1, http://links.lww.com/MD/A588).TABLE 2.",Non-OADS,/arxiv_data1/oa_pdf/3f/81/medi-95-e2206.PMC4748867.pdf
"Cerebral Blood Flow Comparison Between OFF and ON Status in Patients Parkinson Disease OFFVersus Parkinson Disease ON After the administration of dopaminergic medications, the PD group showed significantly decreased CBF in the leftinferior frontal gyrus (BA 47, 13) (Figure 3A and supple-mentary Table 2, http://links.lww.com/MD/A588).Parkinson Disease With Dementia OFFVersus Parkinson Disease With Dementia ON In patients with PDD, the administration of dopaminergic medications significantly decreased right cerebellar perfusion (inferior semilunar lobule) (Figure 3B and SupplementaryTable 2, http://links.lww.com/MD/A588).",Non-OADS,/arxiv_data1/oa_pdf/3f/81/medi-95-e2206.PMC4748867.pdf
"Combined with the results from VIP (see Figures 1–4, http://links.lww.com/MD/A649, Supplemental Content, whichillustrated variable important for the projection [VIP] following the OPLS-DA model in serum FA pattern), 22:6n-3 and 16:1n-7 were finally indentified as the important individual FAs forcharacteristics of newly diagnosed hypertension and its sub-types.",Non-OADS,/arxiv_data1/oa_pdf/b1/a6/medi-95-e2329.PMC4748868.pdf
"Table S1, http://links.lww.com/ MD/A676 shows a comparison of cases and controls with a 3rdgroup of patients without diabetes admitted for pneumonia: as TABLE 1.",Non-OADS,/arxiv_data1/oa_pdf/4a/9b/medi-95-e2531.PMC4748878.pdf
"Deﬁnition All comorbidities were defined according to ICD-9-CM diagnosis code recorded in adm ission (Supplemental Table 1, http://links.lww.com/MD/A645).",OADS,/arxiv_data1/oa_pdf/68/ad/medi-95-e2587.PMC4748882.pdf
"Male gender,preoperative temporary pacemaker placement and passive fix- ation lead were independent risk factors of CIED infection within 1 year after discharge after multivariable adjustment intotal population (Supplemental Table S2, http://links.lww.com/MD/A645).",Non-OADS,/arxiv_data1/oa_pdf/68/ad/medi-95-e2587.PMC4748882.pdf
"Although subanalysis showed that patients received steroid administration had more comor- bidities, such as diabetes mellitus and COPD, than those withoutreceiving steroid administration (Supplemental Tables S5,http://links.lww.com/MD/A645), no specific purpose of steroid administration could be concluded.",Non-OADS,/arxiv_data1/oa_pdf/68/ad/medi-95-e2587.PMC4748882.pdf
"There was no significant difference in HLA-DR expression on dendritic cells (DCs) in either those who had had mild or those who had hadsevere infection during the 1-year follow-up period (Supple- mentary Figure 1, http://links.lww.com/MD/A651).",Non-OADS,/arxiv_data1/oa_pdf/4e/18/medi-95-e2606.PMC4748887.pdf
"Surprisingly, at 1 month postinfection, there were no significant difference in the expression of HLA-DR on CD14 þcells or IFN- gproduction from CD4þT cells in those who had had mild infection compared with those who had hadsevere infection, after stimulation with inactive H7N9 virus when compared with no stimulation (Supplement Figure S2, http://links.lww.com/MD/A651; P¼0.791 and P¼0.697).",Non-OADS,/arxiv_data1/oa_pdf/4e/18/medi-95-e2606.PMC4748887.pdf
"To evaluate feasibility of HIV RE&IC questionnaire, test- ing staff completed a short questionnaire of feasibility (SQF)while proceeding with 107 participants from HER and 100 fromPCC (207 total) English translated version of SQF (Supple- mental digital content Table 2, http://links.lww.com/MD/ A672).",Non-OADS,/arxiv_data1/oa_pdf/97/d4/medi-95-e2612.PMC4748888.pdf
UNAIDS Strategy 2011-2015. http://www.unaids.org/en/aboutunaids/ unaidsstrategygoalsby2015.,Non-OADS,/arxiv_data1/oa_pdf/97/d4/medi-95-e2612.PMC4748888.pdf
American Family Physician 2014; 89:666AD.http://www.uspreventiveservicestaskforce.org/.,Non-OADS,/arxiv_data1/oa_pdf/97/d4/medi-95-e2612.PMC4748888.pdf
http://www.unaids.org/sites/ default/files/media_asset/20140716_FactSheet_es_0.pdf.,Non-OADS,/arxiv_data1/oa_pdf/97/d4/medi-95-e2612.PMC4748888.pdf
"4 In EAU guidelines, patients with stage pT1 bladder tumor are considered at a high risk for recurrence, whereas patients with stage pTa tumor are classified into the group of low risk forrecurrence (Guidelines on Non muscle-invasive Bladder Can- cer (Ta, T1, and CIS), http://uroweb.org/guideline/non- muscle-invasive-bladder-can cer/, July 21, 2015).",Non-OADS,/arxiv_data1/oa_pdf/ac/43/medi-95-e2625.PMC4748891.pdf
"Pathological stage wasreassigned by a single genitourinary pathologist (JCC) accord- ing to the TNM classification (2002) staging system (TNM Classification of Malignant Tumors, 6th edition, http://www.uicc.org/tnm-classification-malignant-tumours-6th-edi-tion, July 21, 2015), and tumor grading was done according to the 2004 WHO grading system.",Non-OADS,/arxiv_data1/oa_pdf/ac/43/medi-95-e2625.PMC4748891.pdf
"The third domain of the questionnairewas focused on understanding of the concept of translational research (8 items) (Supplemental Digital Content: Questionnaire, http://links.lww.com/MD/A659).",Non-OADS,/arxiv_data1/oa_pdf/3f/6a/medi-95-e2633.PMC4748895.pdf
"Surgical specialties represented 17% (16/96), biological and radiological specialties 7% (7/96), andpublic health disciplines 4% (4/96) (Supplementary Table 1, http://links.lww.com/MD/A659).",Non-OADS,/arxiv_data1/oa_pdf/3f/6a/medi-95-e2633.PMC4748895.pdf
19. http://medine2.com/Public/package_07.html; accessed on September 2015.,Non-OADS,/arxiv_data1/oa_pdf/3f/6a/medi-95-e2633.PMC4748895.pdf
27. http://circulaire.legifrance.gouv.fr/pdf/2013/02/cir_36463.pdf; accessed on September 2015.,Non-OADS,/arxiv_data1/oa_pdf/3f/6a/medi-95-e2633.PMC4748895.pdf
http://optn.transplant.hrsa.gov/converge/resources/allocationcalculators.asp?index=78.,OADS,/arxiv_data1/oa_pdf/c6/6b/medi-95-e2635.PMC4748896.pdf
"The VBM8 tool-box (http://dbm.neuro.uni-jena.de/vbm) with default parameters running in the statistical parametric map- ping-8 (SPM8, http://www.fil.ion.",OADS,/arxiv_data1/oa_pdf/7e/6e/medi-95-e2638.PMC4748897.pdf
"We preprocessed the fMRI imaging data with the toolbox Data Processing Assistant for Resting-State functional MR ima- ging (DPARSF; http://www.restfmri.net/forum/DPARSF) 23 through an rs-fMRI data analysis toolkit (REST1.8; http:// www.restfmri.net) and SPM8 (http://www.fil.ion.ucl.ac.uk/spm/), removing the first 10 volumes of each functional time series for the magnetization equilibrium.",OADS,/arxiv_data1/oa_pdf/7e/6e/medi-95-e2638.PMC4748897.pdf
"The meta-analysis was performed with Review Manager 5 (version: 5.2, Cochrane Informatics and Knowledge Management Department, http://tech.cochrane.org/revman/download).",OADS,/arxiv_data1/oa_pdf/49/18/medi-95-e2641.PMC4748898.pdf
"As shown in Figure 3, increased p-stat3 expression was significantly associ- ated with tumor differentiation (poorly vs well-moderately:OR¼3.70, 95% CI: 1.98–6.93, P<0.0001), and lymph node metastasis (present vs absent: OR ¼2.40, 95% CI: 1.28–4.50, P¼0.007), but not significantly associated with gender (female vs male: OR ¼1.10, 95% CI: 0.92–1.33, P¼0.29), TNM stage (III–IV vs I–II: OR ¼1.63, 95% CI: 0.96–2.76, P¼0.07) and the type of Lauren (diffuse vs intestinal: OR ¼0.86, 95% CI: 0.68–1.11, P¼0.24) (Figure S1, http://links.lww.com/MD/ A667).",Non-OADS,/arxiv_data1/oa_pdf/49/18/medi-95-e2641.PMC4748898.pdf
"The corrected OR regarding the association between p- stat3 expression and tumor differentiation was 2.410 (95% CI:1.28–4.53, P¼0.006), which showed a significantly positive association between p-stat3 expression and tumor differen- tiation (Figure S2 A, http://links.lww.com/MD/A667).",OADS,/arxiv_data1/oa_pdf/49/18/medi-95-e2641.PMC4748898.pdf
"Thecorrected OR regarding the association between p-stat3 expres-sion and lymph node metastasis was 1.545 (95% CI: 0.84–2.83, P¼0.160), which showed that the correction for potential publication bias regarding the association between p-stat3expression and lymph node metastasis had an influence onthe stability of the result (Figure S2 B, http://links.lww.com/ MD/A667).",OADS,/arxiv_data1/oa_pdf/49/18/medi-95-e2641.PMC4748898.pdf
"http://globocan.iarc.fr, Accessed on 18/2/2014.",Non-OADS,/arxiv_data1/oa_pdf/49/18/medi-95-e2641.PMC4748898.pdf
Available at http://seer.cancer.,Non-OADS,/arxiv_data1/oa_pdf/49/18/medi-95-e2641.PMC4748898.pdf
"Retrieved January 21,2015, from Centers for Disease Control and Prevention: http://www.cdc.gov/nchs/nhanes/nh3data.htm.",OADS,/arxiv_data1/oa_pdf/c8/71/medi-95-e2656.PMC4748906.pdf
"Retrieved January 14, 2015, from World Health Organization: http://www.who.int/media-centre/factsheets/fs311/en/.",Non-OADS,/arxiv_data1/oa_pdf/c8/71/medi-95-e2656.PMC4748906.pdf
"Maternal Health and Birth Outcomes The rate of mothers with at least 1 illness consistently increased over time in the study population (SupplementalFigure 1A, http://links.lww.com/MD/A661).",Non-OADS,/arxiv_data1/oa_pdf/f7/8c/medi-95-e2659.PMC4748909.pdf
"The prevalence increased for both GDM (5.41 per 1000 births in 2010, and 8.47 per 1000 births in 2011, Cochran–Armitagetest for trend with Z ¼16.42, P<0.001) and pre-existing DM (1.18 and 1.5 per 1000 births in 2010 and 2011, respectively; Cochran–Armitage test for trend with Z ¼3.49, P<0.001) in Supplemental Figure 1B, http://links.lww.com/MD/A661.",Non-OADS,/arxiv_data1/oa_pdf/f7/8c/medi-95-e2659.PMC4748909.pdf
"Hy-pertension was also prevalent and showed an upward trend overthe study period in both before (0.09 and 0.14 per 1000 births in 2010 and 2011, respectively; Cochran–Armitage test for trend with Z ¼6.44, P<0.001) and during pregnancy (0.57 and 0.71 per 1000 births in 2010 and 2011, respectively; Cochran–Armitage test for trend with Z ¼9.01, P<0.001) (Supple- mental Figure 1C, http://links.lww.com/MD/A661).",Non-OADS,/arxiv_data1/oa_pdf/f7/8c/medi-95-e2659.PMC4748909.pdf
"The upward trend was significant in the incidence of LBW (Z ¼10.81, P<0.001) and gestational age <37 weeks (Z ¼8.87, P<0.001) (see Supple- mental Figure 1D and E, http://links.lww.com/MD/A661).",Non-OADS,/arxiv_data1/oa_pdf/f7/8c/medi-95-e2659.PMC4748909.pdf
"Mother’s behavior risk ( P¼0.08) showed an increased trend over time but not statistical significant (Supplemental Figure1F, http://links.lww.com/MD/A661).",Non-OADS,/arxiv_data1/oa_pdf/f7/8c/medi-95-e2659.PMC4748909.pdf
http://www.hpa.gov.tw/English/ClassPrint.aspx?No ¼201502020008.,Non-OADS,/arxiv_data1/oa_pdf/f7/8c/medi-95-e2659.PMC4748909.pdf
"Similar to logistic models, the multivariate linear regression models demonstrated HBV and HCV coinfections to be associated with higher fibrosis scores in both scoring systems but CD4 T-cell count was not associated (Supple-mentary Table S1, http://links.lww.com/MD/A666).",Non-OADS,/arxiv_data1/oa_pdf/af/fd/medi-95-e2660.PMC4748910.pdf
"All variables between the 2 groups were statistically comparable (see Table1, http://links.lww.com/MD/A658 supplemental content, whichillustrates the baseline characteristics of MVI-positive cohort patients).",Non-OADS,/arxiv_data1/oa_pdf/36/6b/medi-95-e2665.PMC4748913.pdf
"In addition, recurrence situation was also identified as an independent prognostic factor for OS (Table 3).All variables between the 2 groups were statistically compar-able (for age, it was statistically comparable between the 2 groups when divided into 5 consecutive intervals; see Table 2, http://links.lww.com/MD/A658 supplemental content, whichillustrates the baseline characteristics of MVI-negative cohortpatients).",Non-OADS,/arxiv_data1/oa_pdf/36/6b/medi-95-e2665.PMC4748913.pdf
"Hospital admissions for AMIfrom January 1, 2007 to December 31, 2012 among permanentresidents of Beijing were identified according to the principal discharge diagnosis using the International Classification of Diseases 10th revision (ICD-10) codes I21 (AMI) or I22(subsequent AMI), and subtypes of AMI were further classified (STEMI codes I21.0–I21.3, I22.0, I22.1, and I22.8; NSTEMI code I21.4; unspecified AMI I21.9 and I22.9) by referring toprevious reports 3,4and our validation study (see Table 1, supplemental content, http://links.lww.com/MD/A662, Concor- dance of ICD code-based diagnoses/procedures in hospital discharge information system with the clinical diagnoses/pro-cedures in hospital charts).",Non-OADS,/arxiv_data1/oa_pdf/66/79/medi-95-e2677.PMC4748920.pdf
"ICD code-based diagnoses/procedures in the HDIS were validated based on chart reviews (see Table 1and Table 2, supplemental content, http://links.lww.com/MD/A662, which illustrate concordance of ICD code-based diag- noses/procedures in hospital discharge information system with the clinical diagnoses/procedures in hospital charts and pre-dictive value of ICD codes for AMI in hospital dischargeinformation system for clinical diagnosis of AMI defined by MONICA Criteria or Third Universal Definition of Myocardial Infarction respectively).",OADS,/arxiv_data1/oa_pdf/66/79/medi-95-e2677.PMC4748920.pdf
"Length of Hospital Stay and In-Hospital Costs The LOS was longer in women than in men and longer in patients with NSTEMI than STEMI (see Table 3, supplemental content, http://links.lww.com/MD/A662, which illustrates theZhang et al Medicine /C15Volume 95, Number 5, February 2016 2|www.md-journal.com Copyright #2016 Wolters Kluwer Health, Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/66/79/medi-95-e2677.PMC4748920.pdf
"Meanwhile, the in-hospital cost per hospitalizationfor AMI increased by 3.2% after adjusting for inflation (P<0.001), with a significant decrease achieved in PCI for both STEMI and NSTEMI but an increase for CABG (see Table4, supplemental content, http://links.lww.com/MD/A662, which illustrate geometric means of hospital costs per hospi- talization for patients with AMI in Beijing by sex, AMI subtype,and type of intervention from 2007 to 2012).",Non-OADS,/arxiv_data1/oa_pdf/66/79/medi-95-e2677.PMC4748920.pdf
"The baseline characteristics of these patients are shown in Supplementary Table 1, http://links.lww.com/MD/A668.",Non-OADS,/arxiv_data1/oa_pdf/34/80/medi-95-e2692.PMC4748926.pdf
"The ablation success rate parameters of study patients at low- orhigh-dose RAI ablation after surgery are presented in Supple-mentary Table 2, http://links.lww.com/MD/A668.",Non-OADS,/arxiv_data1/oa_pdf/34/80/medi-95-e2692.PMC4748926.pdf
"The mean cLNR andtLNR were 0.20 /C60.27 and 0.31 /C60.17, respectively (Supple- mentary Table 3, http://links.lww.com/MD/A668).",OADS,/arxiv_data1/oa_pdf/34/80/medi-95-e2692.PMC4748926.pdf
"The modelbuilding stopped at step 9 as no additional statistically signifi-cant values of NRI were observed (Supplementary Table 1, http://links.lww.com/MD/A674).",Non-OADS,/arxiv_data1/oa_pdf/63/73/medi-95-e2696.PMC4748928.pdf
"The calibration of the model was good, with close agreement between the observed and predicted risk (Supplementary Figure 1, http://links.lww.com/MD/A674).",Non-OADS,/arxiv_data1/oa_pdf/63/73/medi-95-e2696.PMC4748928.pdf
Clinical Trial Registry: http://www.chictr.org Trial number: ChiCTR-ECH-12002938Financial support: this study is supported by National Natural Science Foundation of China (grant No.,Non-OADS,/arxiv_data1/oa_pdf/0f/35/medi-95-e2734.PMC4748937.pdf
"We filtered out all variants utilized the following information: ##filefor-mat¼VCFv4.0; ##fileDate ¼20120118; ##source ¼dbSNP; ##dbSNP_BUILD_ID ¼135; ##reference ¼GRCh37.p5; ## phasing ¼partial; ##variationPropertyDocumentationUrl ¼ ftp://ftp.ncbi.nlm.nih.gov/ snp/specs/dbSNP_BitField_latest.pdf.After filtering, we identified a mutation in the RECQL5 gene, which was shared by 5 affected members and 1 unknown phe- notype sibling but not by the 4 unaffected members.",OADS,/arxiv_data1/oa_pdf/17/2e/medi-95-e2737.PMC4748938.pdf
injection (“Safety data for caesium chloride”; http://msds.chem.ox.ac.uk/index2.html).,Non-OADS,/arxiv_data1/oa_pdf/3b/9e/mtm201558.PMC4748944.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/3b/9e/mtm201558.PMC4748944.pdf
Available at:  http://esa.un.org/unpd/wpp.,Non-OADS,/arxiv_data1/oa_pdf/82/c6/ejtm-2015-4-5280.PMC4748979.pdf
Available at:  http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/de/e3/ejtm-2015-4-5385.PMC4748982.pdf
Available at:  http://www.ncbi.nlm.nih.gov/pubmed/190 43353.,Non-OADS,/arxiv_data1/oa_pdf/de/e3/ejtm-2015-4-5385.PMC4748982.pdf
"002383°  E - http://www.villaemy.it  Phone  +39 049 9800714 Mobile +39 340 2476527   Organizers: Werner Lindenthaler, Ugo Carraro   This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by -nc 3.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) an d source are credited.",Non-OADS,/arxiv_data1/oa_pdf/1c/bd/ejtm-2015-4-5607.PMC4748986.pdf
"269   Interdepartmental Research Center of Myology   University of Padova, Italy     IRCCS Fondazione Ospedale San Camillo,  Venezia -Lido, Italy               Villa Emy B&B, Stra, Brenta Riviera, Venice         The Dining Ro om, http://www.villaemy.it         Venice Lagoon  from  the San Camillo Hospital   _________________________________________________________________ ___________________ _____________________________________________________________________________________________________________________________ ______ _______________________________________________   Program  Villa Emy B&B, Stra, Brenta Riviera (Venice, Italy ), September 29th - October 1st, 2015  Each time slot will be made of half time  of data presentation followed by  half time  Discussion   Tuesday September 29, 2015   16.3 0  Registration   17.00  Muscle Metrics in Aging, Francesco Piccione, Sandra Zampieri, Chairs   17.00 Functional metrics of human muscles: decay with aging , Paolo Gava, Ugo Carraro, Padova/Venice   17.30  3D Muscle Color Computed Tomography for diagnostics and follow up of mobility impairments , Paolo Gargiulo, Andrea  Marcante, Francesco Piccione, Frances co Gava, Ugo Carraro, Reykjavik/Venice   18.00  Micro morphometry for diagnostics and follow up of mobility impairments , Sandra Zampieri,  et al,  Vienna/ Padova/Venice   18.30  Molecular adaptation of Calcium handling proteins of human skeletal muscle to F ES and Leg-Press Training in aging: an in  situ study , Simone Mosole et al.",Non-OADS,/arxiv_data1/oa_pdf/1c/bd/ejtm-2015-4-5607.PMC4748986.pdf
"002383°  E - http://www.villaemy.it  Phone  +39 049 9800714 Mobile +39 340 2476527   Organizers: Werner Lindenthaler, Ugo Carraro   This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by -nc 3.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) an d source are credited.",Non-OADS,/arxiv_data1/oa_pdf/1c/bd/ejtm-2015-4-5607.PMC4748986.pdf
2010  Nov;14(6):467 -73.   http://www.orpha.net/consor/cgi bin/OC_Exp.php?Expert=2901.,OADS,/arxiv_data1/oa_pdf/1c/bd/ejtm-2015-4-5607.PMC4748986.pdf
"1. http://www.freertos.org   2. http://www.thisisant.com/consumer/ant -101/what -is-ant  *****   Effect of high versus normal intensity acute resistance  exercise on bone metabolism in pre - and postmenopausal  women: rationale and design   Jana Kovárová, Dušan Hamar, Peter Schickhofer, Ján  Cvečka, Veronika Tirpáková, Ľubica Böhmerová, Matej  Vajda, Milan Sedl iak  Department of Sport Kinantropology, Faculty of Physical  Education and Sports, Comenius University in Bratislava,  Slovakia .",Non-OADS,/arxiv_data1/oa_pdf/9c/7f/ejtm-2015-3-5150.PMC4748996.pdf
Available:  http://www.ambu.com/corp/search/product/neuroline_72 0-prod307.aspx?PID=22206.,OADS,/arxiv_data1/oa_pdf/9c/7f/ejtm-2015-3-5150.PMC4748996.pdf
Available: http://kine.is   /Products/MMS/.,Non-OADS,/arxiv_data1/oa_pdf/9c/7f/ejtm-2015-3-5150.PMC4748996.pdf
Available:http://www.ambu.com/corp/search/product /   neuroline_720 -prod307.aspx?PID=22206.,OADS,/arxiv_data1/oa_pdf/9c/7f/ejtm-2015-3-5150.PMC4748996.pdf
Available: http://www.lifematters.com/    emgpads -triode.asp.,OADS,/arxiv_data1/oa_pdf/9c/7f/ejtm-2015-3-5150.PMC4748996.pdf
Available: http://kine.is/  Products/MMS/.,Non-OADS,/arxiv_data1/oa_pdf/9c/7f/ejtm-2015-3-5150.PMC4748996.pdf
PCR primers  for all RYR1 exons were designed with the Primer -3  software (http://frodo.wi.mit.edu/cgibin/primer3/primer3_  www.cgi).,Non-OADS,/arxiv_data1/oa_pdf/9c/7f/ejtm-2015-3-5150.PMC4748996.pdf
http://www.biomedcentral.c om/1471 -2377/11/70 .,Non-OADS,/arxiv_data1/oa_pdf/9c/7f/ejtm-2015-3-5150.PMC4748996.pdf
https://clinicaltrials.gov/ct2/show/NCT01521728 .,Non-OADS,/arxiv_data1/oa_pdf/9c/7f/ejtm-2015-3-5150.PMC4748996.pdf
Available at:  http://www.mater ialise.com.,Non-OADS,/arxiv_data1/oa_pdf/9c/7f/ejtm-2015-3-5150.PMC4748996.pdf
"Publikationsse rver Universität Potsdam, 2014.   http://opus.kobv.de/u bp/volltexte/2014/7244/   19.",Non-OADS,/arxiv_data1/oa_pdf/fb/54/ejtm-2015-3-5183.PMC4748997.pdf
"For a multilingual translation of the  Work Packages, ethical and safety issues link to:  http://www.bio.unipd.it/bam/bam18 -2&3.html   At the beginning of the treatment, biphasic stimulation  impulses of v ery long -duration (120 -150 ms, 60 -75 ms  per phase) at high intensity (up to ±80V and up to ±250  mA) were applied (Training Program 1).",Non-OADS,/arxiv_data1/oa_pdf/c6/d3/ejtm-2014-1-3296.PMC4749003.pdf
"Imaging  of biomaterials and engineered muscle tissue   Eur J Trans l Myol - Basic Appl Myol 2015; 25 (2 ): 63-76  - 66 -   Two -Photon Excited Fluorescence   As previously mentioned, non -invasive imaging  techniques that take advantage of the endogenous  fluorophores of cells have been in development for  decades.31-34  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC384221 2/ - R8.",Non-OADS,/arxiv_data1/oa_pdf/d1/09/ejtm-2015-2-4847.PMC4749010.pdf
"This method has recently been employed in  characterizing the different metabolic and  differentiation states of b oth C. Elegans  and human  endothelial stem cells.21,67  (see in particular  at14  http://www.nature.com/srep/2013/131205/srep  03432/full/srep03432.html   However, for species that are close to each other on  the phasor diagram, phenomena such as photo - bleaching and quenching could account for  significant error in assessing relative species'  concentrations.",Non-OADS,/arxiv_data1/oa_pdf/d1/09/ejtm-2015-2-4847.PMC4749010.pdf
"Imaging  of biomaterials and engineered muscle tissue   Eur J Trans l Myol - Basic Appl Myol 2015; 25 (2 ): 63-76  - 70 -   identify stem cells that were labeled with magnetic  nanoparticles following an intra -arterial  transplant.135http://www.ncbi.nlm.nih.gov/pmc/article s/PMC3799904/ - R180  However, the use of contrast  agents, dyes, or radioactive labels always results in the   destruction of engineered tissu e, so functional  assessment of engineered constructs or post -transplant  engineered tissues is limited to longitudinal studies  assessing multiple timepoints from individual subjects  or constructs .",Non-OADS,/arxiv_data1/oa_pdf/d1/09/ejtm-2015-2-4847.PMC4749010.pdf
Accessed from:  http://repository.tue.nl/posters/738771.pdf   137.,Non-OADS,/arxiv_data1/oa_pdf/d1/09/ejtm-2015-2-4847.PMC4749010.pdf
Accessed  from:  http://www.rcsed.ac.uk/fellows/aaasalem/Rapid _imprint_immunostai ning.htm   139.,Non-OADS,/arxiv_data1/oa_pdf/d1/09/ejtm-2015-2-4847.PMC4749010.pdf
"BioTek Instruments, Inc.,  Winooski, VT. Accessed from:  http://www.biotek.com/resources/articles/quonti fication -cell-viability -epoch.html   140.",OADS,/arxiv_data1/oa_pdf/d1/09/ejtm-2015-2-4847.PMC4749010.pdf
Accessed from:  http://www.uncnephropathology.org/jennette/ch 1.htm   141.,Non-OADS,/arxiv_data1/oa_pdf/d1/09/ejtm-2015-2-4847.PMC4749010.pdf
Accessed from:  http://pinlab.hcuge.ch/research.html   143.,OADS,/arxiv_data1/oa_pdf/d1/09/ejtm-2015-2-4847.PMC4749010.pdf
All signal analyses were per formed with  Matlab software (http://www.mathworks.com).,OADS,/arxiv_data1/oa_pdf/1e/68/ejtm-2015-2-4886.PMC4749011.pdf
"For a multilingual  translation of the work packages, ethical, and safety  issues, visit: http://www.bio.unipd.it/bam/bam18 - 2&3.html.25,26  Muscle tissue segmentation and visua lization  using false -color 3D Computed Tomography   Discrimination of tissue types, densities, a nd volumes   is of particular interest in the medical imaging re search  community.",Non-OADS,/arxiv_data1/oa_pdf/9a/3d/ejtm-2015-2-5133.PMC4749015.pdf
"For the  purposes of this stud y, the imaging software MIMICS  (http://www.materialise.com) was utilized to isolate  and monitor the rectus femoris  within the quadriceps  muscle.",Non-OADS,/arxiv_data1/oa_pdf/9a/3d/ejtm-2015-2-5133.PMC4749015.pdf
The Oklahoma Tobacco Helpline was  established by the Oklahoma Tobacco Settlement Endowment Trust in 2003 to provide free  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d2/11/nihms755667.PMC4749024.pdf
Phoenix AZ: 2009. http://c.ymcdn.com/sites/ www.naquitline.org/resource/resmgr/issue_papers/naqc_issuepaper_increasingre.pdf 14.,Non-OADS,/arxiv_data1/oa_pdf/d2/11/nihms755667.PMC4749024.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/22/70/ijnrd-9-021.PMC4749088.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Nephrology and Renovascular Disease 2016:9 21–33International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  21RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJNRD.S7683 1Strategies to promote adherence to nutritional  advice in patients with chronic kidney disease:   a narrative review and commentary Judith A Beto Katherine A Schury vinod K Bansal Division of Nephrology and  Hypertension, Loyola University  Healthcare System, Loyola University  of Chicago, Maywood, IL, USA Correspondence: Judith A Beto   Division of Nephrology and  Hypertension, Loyola University  Healthcare System, Loyola University  of Chicago,  2160 South First Avenue,  Maywood, IL  60153, USA   Tel +1 708 227 0126  email jbeto@luc.ed uAbstract:  Chronic kidney disease (CKD) requires extensive changes to food and lifestyle.",Non-OADS,/arxiv_data1/oa_pdf/22/70/ijnrd-9-021.PMC4749088.pdf
"Available from: http://www.kidney.org/ professionals/kdoqiguidelines.update s. Accessed June  15, 2015.",Non-OADS,/arxiv_data1/oa_pdf/22/70/ijnrd-9-021.PMC4749088.pdf
"Available  from: http://www.kidney.org/professionals/kdoqiguidelines.update s.  Accessed June  15, 2015.",Non-OADS,/arxiv_data1/oa_pdf/22/70/ijnrd-9-021.PMC4749088.pdf
"Available from: http://www.iom.med/Reports/2013/Sodium-intake-in- populations-assessment-of-evidence.asp x. Accessed June  15, 2015.",OADS,/arxiv_data1/oa_pdf/22/70/ijnrd-9-021.PMC4749088.pdf
"Available from: http://my.americanheart.org/ professional /StatementsGuidelines/ByTopi c. Accessed June  15, 2015.",Non-OADS,/arxiv_data1/oa_pdf/22/70/ijnrd-9-021.PMC4749088.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/22/70/ijnrd-9-021.PMC4749088.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/22/70/ijnrd-9-021.PMC4749088.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/03/9b/ijnrd-9-011.PMC4749089.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/03/9b/ijnrd-9-011.PMC4749089.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nephrology and Renovascular Disease 2016:9 11–19International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  11RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJNRD.S7804 0Phosphate binders for the treatment of chronic  kidney disease: role of iron oxyhydroxide valeria Cernaro Domenico Santoro Antonio Lacquaniti Giuseppe Costantino Luca visconti Antoine Buemi Michele Buemi Department of Clinical and  experimental Medicine, University of  Messina, Messina, Italy Correspondence: valeria Cernaro   Department of Clinical and experimental  Medicine, University of Messina, via  Consolare valeria n 1, 98124 Messina, Italy   T el +39 090 221 2396   Fax +39 090 221 2329   email valecern82@virgilio.i tAbstract:  Chronic kidney disease-mineral bone disorder is frequent in patients with renal  failure.",Non-OADS,/arxiv_data1/oa_pdf/03/9b/ijnrd-9-011.PMC4749089.pdf
Or use: http://youtu.be/zGw9QGlUgs 0,Non-OADS,/arxiv_data1/oa_pdf/03/9b/ijnrd-9-011.PMC4749089.pdf
"Available from: https://www.astellas.com/en/ corporate/news/pdf/150317_1_Eg.pd f. Accessed September 18, 2015.",Non-OADS,/arxiv_data1/oa_pdf/03/9b/ijnrd-9-011.PMC4749089.pdf
46. http://www.velphoro.u s [homepage on the Internet].,Non-OADS,/arxiv_data1/oa_pdf/03/9b/ijnrd-9-011.PMC4749089.pdf
"Available from: http://www.velphoro.u s. Accessed  September 20, 2015.",Non-OADS,/arxiv_data1/oa_pdf/03/9b/ijnrd-9-011.PMC4749089.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/03/9b/ijnrd-9-011.PMC4749089.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/03/9b/ijnrd-9-011.PMC4749089.pdf
Available from: http://dailymed.nlm.nih.gov/dailymed/   drugInfo.cfm?setid =237da26c-f38c-4faa-93ad-735e71c9d0c 1.,Non-OADS,/arxiv_data1/oa_pdf/03/9b/ijnrd-9-011.PMC4749089.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/03/9b/ijnrd-9-011.PMC4749089.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/03/9b/ijnrd-9-011.PMC4749089.pdf
"In two cases, spectral and coherence< @Freely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/06/dd/tre-05-351-7522-1.PMC4749092.pdf
Slow Orthostatic Tremor and Dystonia Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/06/dd/tre-05-351-7522-1.PMC4749092.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/06/dd/tre-05-351-7522-1.PMC4749092.pdf
Slow Orthostatic Tremor and Dystonia Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/06/dd/tre-05-351-7522-1.PMC4749092.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services5,Non-OADS,/arxiv_data1/oa_pdf/06/dd/tre-05-351-7522-1.PMC4749092.pdf
Slow Orthostatic Tremor and Dystonia Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services6,Non-OADS,/arxiv_data1/oa_pdf/06/dd/tre-05-351-7522-1.PMC4749092.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services7,Non-OADS,/arxiv_data1/oa_pdf/06/dd/tre-05-351-7522-1.PMC4749092.pdf
"Mov Disord 2009;24:1550–1553, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/06/dd/tre-05-351-7522-1.PMC4749092.pdf
"Tremor Other Hyperkinet Mov (NY) 2013;3:147, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/06/dd/tre-05-351-7522-1.PMC4749092.pdf
"Mov Disord Clin Pract 2014;1:173–179, doi: http://dx.doi.org/10.1002/mdc3.",Non-OADS,/arxiv_data1/oa_pdf/06/dd/tre-05-351-7522-1.PMC4749092.pdf
"Comput Methods Programs Biomed 1999; 60:65–77, doi: http://dx.doi.org/10.1016/S0169-2607(99)00012-7.",OADS,/arxiv_data1/oa_pdf/06/dd/tre-05-351-7522-1.PMC4749092.pdf
"IJBC 2000;10:2595–2610, doi: http://dx.doi.org/10.1142/ S0218127400001663.",OADS,/arxiv_data1/oa_pdf/06/dd/tre-05-351-7522-1.PMC4749092.pdf
"Comput Stat Data Anal 1999;30:45–55, doi: http://dx.doi.org/10.1016/S0167-9473(98)00106-6.",OADS,/arxiv_data1/oa_pdf/06/dd/tre-05-351-7522-1.PMC4749092.pdf
"Mov Disord 2005;20: 1455–1461, doi: http://dx.doi.org/10.1002/mds.20588.",OADS,/arxiv_data1/oa_pdf/06/dd/tre-05-351-7522-1.PMC4749092.pdf
"Acta Neurol Scand 1990;81:113–117, doi: http://dx.doi.org/10.1111/j.1600-0404.1990.",OADS,/arxiv_data1/oa_pdf/06/dd/tre-05-351-7522-1.PMC4749092.pdf
"Tremor Other Hyperkinet Mov (NY) 2015;5:324, doi: http://dx.doi.org/10.7916/D8S75FHK.",Non-OADS,/arxiv_data1/oa_pdf/06/dd/tre-05-351-7522-1.PMC4749092.pdf
"Neurology 1997;49:1439–1441, doi: http://dx.doi.org/10.1212/WNL.",Non-OADS,/arxiv_data1/oa_pdf/06/dd/tre-05-351-7522-1.PMC4749092.pdf
"Mov Disord 2007;22: 1652–1656, doi: http://dx.doi.org/10.1002/mds.21621.",Non-OADS,/arxiv_data1/oa_pdf/06/dd/tre-05-351-7522-1.PMC4749092.pdf
Slow Orthostatic Tremor and Dystonia Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services8,Non-OADS,/arxiv_data1/oa_pdf/06/dd/tre-05-351-7522-1.PMC4749092.pdf
"Mov Disord 2009;24:144–147, doi: http://dx.doi.org/10.1002/mds.",OADS,/arxiv_data1/oa_pdf/06/dd/tre-05-351-7522-1.PMC4749092.pdf
"Mov Disord 1991;6:230–236, doi: http://dx.doi.org/10.1002/mds.",OADS,/arxiv_data1/oa_pdf/06/dd/tre-05-351-7522-1.PMC4749092.pdf
"Mov Disord 2010;25:560–569, doi: http://dx.doi.org/10.1002/mds.23019.",OADS,/arxiv_data1/oa_pdf/06/dd/tre-05-351-7522-1.PMC4749092.pdf
"J Neurol Neurosurg Psychiatry 2013;84:404–408, doi: http://dx.doi.org/10.1136/jnnp-2012- 303782.",Non-OADS,/arxiv_data1/oa_pdf/06/dd/tre-05-351-7522-1.PMC4749092.pdf
"J Neurol Neurosurg Psychiatry 2014;85:965–968, doi: http://dx.doi.org/10.1136/jnnp-2013-305876.",Non-OADS,/arxiv_data1/oa_pdf/06/dd/tre-05-351-7522-1.PMC4749092.pdf
"Mov Disord 2004;19:758–769, doi: http://dx.doi.",OADS,/arxiv_data1/oa_pdf/06/dd/tre-05-351-7522-1.PMC4749092.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services9,Non-OADS,/arxiv_data1/oa_pdf/06/dd/tre-05-351-7522-1.PMC4749092.pdf
"RotaTeqTMis a trademark of Merck & Co., Inc. Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/bf/f4/40264_2015_Article_376.PMC4749653.pdf
http://vaccine-safety-training.org/tl_ﬁles/vs/pdf/acute- intussusception-infants-children.pdf .,Non-OADS,/arxiv_data1/oa_pdf/bf/f4/40264_2015_Article_376.PMC4749653.pdf
Despite the relative importance of word clusters in the single-featureTable 3 Tenfold cross- validation results showing Fscores for the two classes and the overall accuraciesClassiﬁer Abuse Fscore Non-abuse Fscore Accuracy (%) Naı¨ve Bayes 0.39 0.84 75 Weighted support vector machine (wSVM) 0.45 0.89 81Maximum entropy 0.24 0.85 75J48 0.22 0.92 85Stacking 0.46 0.89 82 3A sample of the ﬁnalized annotations will be made available to the research community at http://diego.asu.edu/Publications/DrugAbuse_ DrugSafety.html .,Non-OADS,/arxiv_data1/oa_pdf/25/ef/40264_2015_Article_379.PMC4749656.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/25/ef/40264_2015_Article_379.PMC4749656.pdf
CNN 2011. http://www.cnn.com/2011/ HEALTH/04/19/drug.abuse/ .,Non-OADS,/arxiv_data1/oa_pdf/25/ef/40264_2015_Article_379.PMC4749656.pdf
2013. http://archive.samhsa.gov/data/2k13/ DAWN127/sr127-DAWN-highlights.htm .,OADS,/arxiv_data1/oa_pdf/25/ef/40264_2015_Article_379.PMC4749656.pdf
2015. http://www.cdc.gov/nchs/ deaths.htm .,Non-OADS,/arxiv_data1/oa_pdf/25/ef/40264_2015_Article_379.PMC4749656.pdf
2015. http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/25/ef/40264_2015_Article_379.PMC4749656.pdf
2015. http://www.cdc.gov/vitalsigns/ painkilleroverdoses/ .,Non-OADS,/arxiv_data1/oa_pdf/25/ef/40264_2015_Article_379.PMC4749656.pdf
https://about.twitter.com/company .,Non-OADS,/arxiv_data1/oa_pdf/25/ef/40264_2015_Article_379.PMC4749656.pdf
July 2015. http://diego.asu.edu/guidelines/ DrugAbuseAnnotationGuideline1.1.pdf .,Non-OADS,/arxiv_data1/oa_pdf/25/ef/40264_2015_Article_379.PMC4749656.pdf
http://www.noslang.com/drugs/dictionary.php .,Non-OADS,/arxiv_data1/oa_pdf/25/ef/40264_2015_Article_379.PMC4749656.pdf
https://wordnet.princeton.edu/ .,Non-OADS,/arxiv_data1/oa_pdf/25/ef/40264_2015_Article_379.PMC4749656.pdf
http://www.aapcc.org/data- system/ .,OADS,/arxiv_data1/oa_pdf/25/ef/40264_2015_Article_379.PMC4749656.pdf
http://www.fda.gov/ .,Non-OADS,/arxiv_data1/oa_pdf/25/ef/40264_2015_Article_379.PMC4749656.pdf
http://www.fda.gov/Safety/MedWatch/ .,Non-OADS,/arxiv_data1/oa_pdf/25/ef/40264_2015_Article_379.PMC4749656.pdf
2013. http://www.samhsa.gov/data/ sites/default/ﬁles/NSDUHresultsPDFWHTML2013/Web/NSDUHresults2013.pdf .,OADS,/arxiv_data1/oa_pdf/25/ef/40264_2015_Article_379.PMC4749656.pdf
"Reprints and permissions:   http://www.sagepub.co.uk/ journalsPermissions.nav 212 http://msj.sagepub.comMULTIPLE SCLEROSIS MSJJOURNAL Introduction Walking impairment is common in MS,1,2 even early in  disease,3 and maintaining mobility is a high priority  among patients with MS.4,5 Prolonged-release (PR)  fampridine tablets (known as sustained/modified-release fampridine in some countries and extended-release dalfampridine in the United States) are approved for improving walking in MS based on results from two pivotal trials 6,7 that demonstrated consistent  improvements in walking speed on the Timed 25-Foot Walk 8 and on patients’ self-assessment of ambulatory  disability on the 12-item MS Walking Scale (MSWS-12).",Non-OADS,/arxiv_data1/oa_pdf/5a/e6/10.1177_1352458515581436.PMC4749757.pdf
"R Hupperts, J Lycke et al.http://msj.sagepub.com 213and TUG, as well as to subjective impression of well- being and patients’ impression of change in walking.",Non-OADS,/arxiv_data1/oa_pdf/5a/e6/10.1177_1352458515581436.PMC4749757.pdf
Multiple Sclerosis Journal 22(2) 214 http://msj.sagepub.com(PHYS)22 and the EuroQoL-5 Dimensions 5-level  (EQ-5D-5L).23 The self-administered MSIS-29 ques- tionnaire contains a 20-item PHYS and a nine-item  psychological subscale.,Non-OADS,/arxiv_data1/oa_pdf/5a/e6/10.1177_1352458515581436.PMC4749757.pdf
"R Hupperts, J Lycke et al.http://msj.sagepub.com 215visit was calculated as the average for trials 1 and 2.",OADS,/arxiv_data1/oa_pdf/5a/e6/10.1177_1352458515581436.PMC4749757.pdf
Multiple Sclerosis Journal 22(2) 216 http://msj.sagepub.com⩾10% (p  = 0.0021) and ⩾ 15% (p  = 0.0262; Figure 3).,Non-OADS,/arxiv_data1/oa_pdf/5a/e6/10.1177_1352458515581436.PMC4749757.pdf
"R Hupperts, J Lycke et al.http://msj.sagepub.com 217Early benefits also were seen in walking ability  measured by MSWS-12, and although MSWS-12 score fluctuated between weeks 4 and 12, it stabi-lised after week 16 and benefits were maintained to the end of the study in patients receiving PR-fampridine therapy.",Non-OADS,/arxiv_data1/oa_pdf/5a/e6/10.1177_1352458515581436.PMC4749757.pdf
Multiple Sclerosis Journal 22(2) 218 http://msj.sagepub.cominsensitivity of generic measures to assess  MS-related changes in QoL.,Non-OADS,/arxiv_data1/oa_pdf/5a/e6/10.1177_1352458515581436.PMC4749757.pdf
"R Hupperts, J Lycke et al.http://msj.sagepub.com 219on input from other authors, and Kristen DeYoung  from Excel Scientific Solutions copy-edited and styled the manuscript per journal requirements.",Non-OADS,/arxiv_data1/oa_pdf/5a/e6/10.1177_1352458515581436.PMC4749757.pdf
"Multiple Sclerosis Journal 22(2) 220 http://msj.sagepub.comM McNeill, Dr Tofil-Kaluza, Dr Mehta and Dr Elkins  are full-time employees of Biogen.",Non-OADS,/arxiv_data1/oa_pdf/5a/e6/10.1177_1352458515581436.PMC4749757.pdf
"R Hupperts, J Lycke et al.http://msj.sagepub.com 221 23.",Non-OADS,/arxiv_data1/oa_pdf/5a/e6/10.1177_1352458515581436.PMC4749757.pdf
"Available at: http://www.euroqol.org/, 2014 (accessed  24 October 2014).",Non-OADS,/arxiv_data1/oa_pdf/5a/e6/10.1177_1352458515581436.PMC4749757.pdf
"Available at: https://clinicaltrials.gov/ct2/show/NCT02219932, 2014 (accessed 24 October 2014).",Non-OADS,/arxiv_data1/oa_pdf/5a/e6/10.1177_1352458515581436.PMC4749757.pdf
Visit SAGE journals online  http://msj.sagepub.com  SAGE journals,Non-OADS,/arxiv_data1/oa_pdf/5a/e6/10.1177_1352458515581436.PMC4749757.pdf
"This is an open-access article distributed under the terms  of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redis - tribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/e7/06/cardiovascmed-05-01-29134.PMC4749848.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1016/j.nicl.2014.07.008 2213-1582/© 2014 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
"Image preprocessing Functional connectivity analyses were completed with a modi ﬁed version of the 1000 Functional Connectomes Project Scripts available athttp://www.nitrc.org/projects/fcon_1000/ ,w h i c hu s eA F N I( Cox, 1996 )a n dF S L( http://www.fmrib.ox.ac.uk ).",OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
"Journal of Comparative Neurology 499, 33 –48.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
"Pain 108, 129 –136.http://dx.doi.org/10.1016/j.pain.2003.12.01515109516 .",Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1016/j.ejpain.2004.,OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1002/hbm.2212422711692 .,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.1984-11.201121957259 .Baliki, M.N., Geha, P.Y., Apkarian, A.V., Chialvo, D.R., 2008.",Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1038/ nn.315322751038 .,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1109/TMI.2003.82282114964560 .,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
"23, 371 –380.http://dx.doi.org/10.1152/physiol.00024.200819074744 .",Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1016/j.jocn.2004.10.00515993077 .,OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1038/npp.2013.,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1111/j.1526-4637.2008.00412.x18298708 .,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
"Annals of the New York Academy of Sci- ences 1124, 1 –38.http://dx.doi.org/10.1196/annals.1440.01118400922 .",Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1136/ jnnp.2009.18863119955113 .,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
"BMC Neuroscience 10, 138. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1016/j.pain.2004.07.,OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1016/j.neuron.2009.07.01419709634 .,OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
"Trends in Cognitive Sciences 15, 85 –93.http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1073/ pnas.081187910619357304 .,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1523/JNEUROSCI.4476-05.,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1097/YCO.,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
"Pain 128, 88 –100.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1002/art.,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
"Frontiers in Human Neuroscience 7, 356. http://dx.doi.org/10.3389/fnhum.2013.",Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1093/ brain/awh09814960499 .,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1002/art.1022512115241 .,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1016/j.pain.2006.05.00516781077 .,OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
"Neuroimage 48, 63 –72.http://dx.doi.org/10.1016/j.neuroimage.",OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
"Archives of Internal Medicine 171, 134–140.http://dx.doi.org/10.1001/archinternmed.2010.51021263103 .",Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.02.06421356318 .,OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1002/art.3768522933378 .,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1016/j.bbr.2010.03.04220347878 .,OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1016/j.pain.2012.07.,OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
"Pain 154, 24 –33.http://dx.doi.org/10.1016/j.pain.2012.07.02923111164 .",Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
"Evidence-Based Complementary and Alternative Medicine: ECAM 2013, 795906. http://dx.doi.org/10.1155/2013/ 79590623843881 .",Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1016/j.pain.2013.06.04424040975 .,OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1177/107385841039622021489967 .,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1016/j.neuroimage.2010.12.01321156210 .,OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1523/JNEUROSCI.2378-09.,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
"Frontiers in Human Neuroscience 7, 571. http://dx.doi.org/10.3389/fnhum.2013.0057124062671 .",Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1001/archpsyc.65.5.,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1523/JNEUROSCI.6709-10.201121389234 .,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1016/j.neuroimage.2008.,OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1016/j.neuroimage.2008.04.23818524629 .,OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1002/art.3441222294427 .,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1002/art.2749720506181 .,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1016/j.pain.2007.11.00118178011 .,OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
"Psychoneuroendocrinology 35, 47 –55.http://dx.doi.org/ 10.1016/j.psyneuen.2009.08.01119758762 .",Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1186/1471-244X-13- 8423497482 .,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
"European Journal of Pain (London, England) 15, 843. http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1093/cercor/bhj08816373457 .,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.10.,OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1016/j.neuroimage.2013.,OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/ 10.1002/da.2201423184639 .,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
"1, 55 –67.http://dx.doi.org/10.1046/j.1526-4637.2000.99101.",Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
"Brain Connectivity 2, 25 –32.http://dx.doi.org/10.1089/brain.2012.",Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
"Gastroenterology 139, 48 –57.http://dx.doi.org/10.1053/j.gastro.2010.03.",Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1523/JNEUROSCI.5280-10.201121593339 .,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1152/ ajpregu.00920.200516484434 .,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1016/j.pain.2010.11.01821196078 .,OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1093/brain/awr11721616963 .,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1007/ s10286-009-0004-719255804 .,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1097/PSY.0b013e31818d1e0219073757 .,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10 .1016/j.pain.2010.11.,OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1016/j.neuroimage.2013.,OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/ 10.1016/j.jocn.2004.11.01816326270 .,OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1016/j.jneumeth.2008.04.,OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
http://dx.doi.org/10.1016/j.neuroimage.2009.09.03719782143 .376 M. Shpaner et al.,OADS,/arxiv_data1/oa_pdf/b9/ef/main.PMC4749849.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1016/j.nicl.2014.06.011 2213-1582/© 2014 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1016/j.drugpo.2013.03.002 .,OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1016/j.neubiorev.2013.06.015 .,OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1093/cercor/bhi062 .,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1016/j.brainres.2010.12.051 .,OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
"Altered white matter microstructure in adolescent substance users.Psychiatry Research 173 (3), 228– 237. http://dx.doi.org/10.1016/j.pscychresns.",Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1016/j.neuroimage.2004.12.053 .,OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1016/0010-0277(94)90018-3 Retrieved from 8039375 .,OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1126/science.275.5304.1293 .,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1038/nn.3177 .,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/ 10.1016/j.neuropsychologia.2009.07.018 .,OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
"Alcohol and Alcoholism (Oxford, Oxfordshire) 40 (3), 194– 200. http://dx.doi.org/10.1093/alcalc/agh134 .",Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1016/j.nicl.2013.06.002 .,OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
"Binge drinking trajectories from adolescence to emerging adulthood in a high-risk sample: predictors and substance abuse outcomes.Journal of Consulting and Clinical Psychology 70, 67 –78.http://dx.doi.org/10.1037/ 0022-006X.70.1.67 .",Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
"2), 5 –22.http://dx.doi.org/10.1111/j.1360-0443.",Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1038/npp.2011.99 .,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
"2), 47 –62.http://dx.doi.org/10.1111/j.1360-0443.2004.00854.x .",Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1038/nrn3313 .,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
"Drug and Alcohol Dependence134, 242– 250. http://dx.doi.org/10.1016/ j.drugalcdep.2013.10.009.",OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1111/j.1530-0277.,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
"http://dx.doi.org/10.1016/j.pscychresns.2007.03.009 .Fein, G., Greenstein, D., Cardenas, V.A., Cuzen, N.L., Fouche, J.-P., Ferrett, H., et al., 2013.",OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1016/j.pscychresns.2013.06.001 .,OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
"Psychology of Addicti ve Behaviors: Journal of the Society of Psy- chologists in Addictive Behaviors 27 (2), 510 –525.http://dx.doi.org/10.1037/a0029767 .",Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1080/ 09638230600998896.,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1038/sj.,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1001/archneur.62.12.1881 .,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1038/13158 .,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1016/j.neurobiolaging.2005.12.013 .,OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1016/j.drugpo.2013.07.008 .,OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1016/j.pscychresns.2012.11.003 .,OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1016/j.pscychresns.2011.05.006 .,OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1146/annurev-clinpsy- 050212-185610.,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1001/archgenpsychiatry.2011.26 .,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1002/jmri.1076 .,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.11.094 .,OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1016/j.neuroimage.2007.12.053 .,OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
"Human Brain Mapping 31 (3), 410 –423.http://dx.doi.org/10.1002/hbm.20875 .",Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
"Frontiers in Psychiatry 4 (July), 53. http://dx.doi.org/10.3389/fpsyt.",Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
"Psychiatry Re-search 211 (1), 17 –23.http://dx.doi.org/10.1016/j.pscychresns.2012.07.009 .",OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.3109/00952990.2013.,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1111/j.1530-0277.2007.00602.x .,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1111/j.1369-1600.2012.00441.x .,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1037/0021-843X.96.2.122 .,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1016/j.neuron.,OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1016/j.pscychresns.,OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1097/01.chi.0000199028.76452.a9 .,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
"Human Brain Mapping 25, 46 –59.http://dx.doi.org/10.1002/hbm.20131 .",Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1093/alcalc/ agt164 .,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1001/ jamapediatrics.2013.2392 .,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
"Progress in Brain Research 186, 13 –28.http://dx.doi.org/10.1016/B978-0-444-53630-3.",Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/ 10.1038/nrn2513 .,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1093/alcalc/agt162 .,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1523/JNEUROSCI.,OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1016/j.neuroscience.2010.12.016 .,OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1098/rstb.2008.0093 .,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
"http://dx.doi.org/10.1002/hbm.20237 .Schmithorst, V.J., Wilke, M., Dard zinski, B.J., Holland, S.K., 2005.",OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1002/hbm.20149 .,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1016/j.alcohol.2009.09.032 .,OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1037/0003-066X.46.,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1162/jocn.2010.21572 .,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1006/nimg.1999.0436 .,OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1038/13154 .,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
"Neurotoxicology and Teratology 41, 51 –59.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1002/dev.20457 .,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
"Brain response to working memory over three years of adolescence: in ﬂuence of initiating heavy drinkingJournal of Studies on Alcohol and Drugs 73 (5), 749 –760 Retrieved from http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3410943&tool= pmcentrez&rendertype=abstract .",Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1111/j.1530-0277.2011.01527.x .,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1007/s00213-011- 2500-4 .,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1037/a0028748 .,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1097/CHI.0b013e3181825b1f .,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1002/nbm.848 .,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
"Neuroimage 68, 63 –74.http://dx.doi.org/10.1016/j.neuroimage.2012.11.039 .",OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1001/archpsyc.,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1097/01.ALC.,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/ 10.1016/j.neuroimage.2010.12.024 .,OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1523/JNEUROSCI.1579-09.2009 .436 S.  W. Feldstein Ewing et al.,OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1038/mp.2011.33 .,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1111/j.1360-0443.2010.03022.x .,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1093/alcalc/agu002 .,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1093/alcalc/agt037 .,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1111/j.1360-0443.2004.00918.x .,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1093/cercor/bhp280 .,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1007/ s00213-013-3198-2 .,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
http://dx.doi.org/10.1037/a0027892 .437 S.W.,Non-OADS,/arxiv_data1/oa_pdf/89/44/main.PMC4749850.pdf
"Cells 2016; 39(1): 1-5  http://dx.doi.org/10.14348/molcells.2016.2368                    Overview on Peroxiredoxin    Sue Goo Rhee*      Peroxiredoxins (Prxs) are a very large and highly con- served family of peroxidases that reduce peroxides, with a conserved cysteine residue, designated the “peroxidatic”  Cys (C P) serving as the site of oxidation by peroxides (Hall  et al., 2011; Rhee et al., 2012).",Non-OADS,/arxiv_data1/oa_pdf/92/cd/molce-39-1-1.PMC4749868.pdf
"EXCEPTIONAL REACTIVITY OF PEROXIDATIC   CYSTEINE    The C P of Prx is oxidized by peroxides like H 2O2, lipid peroxide,  Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",Non-OADS,/arxiv_data1/oa_pdf/92/cd/molce-39-1-1.PMC4749868.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/92/cd/molce-39-1-1.PMC4749868.pdf
"Cells http://molcells.org     or peroxynitrite very rapidly with the second order rate con- stants for the formation of C P-SOH being in the range of 1 × 106  to 108 M–1s–1, which are 5 to 7 orders of magnitude higher than  those for small thiols (Winterbourn, 2013).",Non-OADS,/arxiv_data1/oa_pdf/92/cd/molce-39-1-1.PMC4749868.pdf
Peroxiredoxin  Sue Goo Rhee      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/92/cd/molce-39-1-1.PMC4749868.pdf
"Cells http://molcells.org     Edgar, R.S., Green, E.W., Zhao, Y ., van Ooijen, G., Olmedo, M., Qin,  X., Xu, Y ., Pan, M., Valekunja, U.K., Feeney, K.A.",Non-OADS,/arxiv_data1/oa_pdf/92/cd/molce-39-1-1.PMC4749868.pdf
Peroxiredoxin  Sue Goo Rhee      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/92/cd/molce-39-1-1.PMC4749868.pdf
Cells 2016; 39(1): 20-25  http://dx.doi.org/10.14348/molcells.2016.2324                    Thiol-Based Peroxidases and Ascorbate   Peroxidases: Why Plants Rely on Multiple  Peroxidase Systems in the Photosynthesizing  Chloroplast?,Non-OADS,/arxiv_data1/oa_pdf/cf/f4/molce-39-1-20.PMC4749869.pdf
(2000) observed no  change in light-dependent O 2 uptake in transgenic A. thaliana   Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/cf/f4/molce-39-1-20.PMC4749869.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/cf/f4/molce-39-1-20.PMC4749869.pdf
Peroxide Detoxification in Chloroplasts   Karl-Josef Dietz      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/cf/f4/molce-39-1-20.PMC4749869.pdf
Cells http://molcells.org     THIOL PEROXIDASES    Thiol peroxidases are heme-free enzymes that use a cysteinyl  thiolate to attack the peroxide substrates.,Non-OADS,/arxiv_data1/oa_pdf/cf/f4/molce-39-1-20.PMC4749869.pdf
Peroxide Detoxification in Chloroplasts   Karl-Josef Dietz      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/cf/f4/molce-39-1-20.PMC4749869.pdf
The mutual rank (MR) in the coexpression list was deter- mined using the online tool ATTED-II  (http://atted.jp).,OADS,/arxiv_data1/oa_pdf/cf/f4/molce-39-1-20.PMC4749869.pdf
"Cells http://molcells.org     Liebthal et al., 2016; Muthuramalingam et al., 2009).",Non-OADS,/arxiv_data1/oa_pdf/cf/f4/molce-39-1-20.PMC4749869.pdf
Peroxide Detoxification in Chloroplasts   Karl-Josef Dietz      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/cf/f4/molce-39-1-20.PMC4749869.pdf
"Cells 2016; 39(1): 26-30   http://dx.doi.org/10.14348/molcells.2016.2325                    Kinetic Approaches to Measuring Peroxiredoxin  Reactivity    Christine C. Winterbourn*, and Alexander V. Peskin     Peroxiredoxins are ubiquitous thiol proteins that catalyse  the breakdown of peroxides and regulate redox activity in  the cell.",OADS,/arxiv_data1/oa_pdf/70/08/molce-39-1-26.PMC4749870.pdf
Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/70/08/molce-39-1-26.PMC4749870.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/70/08/molce-39-1-26.PMC4749870.pdf
Peroxiredoxin Kinetics  Christine C. Winterbourn & Alexander V. Peskin      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/70/08/molce-39-1-26.PMC4749870.pdf
"Cells http://molcells.org     tive than with HRP, but gives a good visual representation.",Non-OADS,/arxiv_data1/oa_pdf/70/08/molce-39-1-26.PMC4749870.pdf
Peroxiredoxin Kinetics  Christine C. Winterbourn & Alexander V. Peskin      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/70/08/molce-39-1-26.PMC4749870.pdf
Cells http://molcells.org     ual Prxs to inactivation.,OADS,/arxiv_data1/oa_pdf/70/08/molce-39-1-26.PMC4749870.pdf
"Cells 2016; 39(1): 31-39   http://dx.doi.org/10.14348/molcells.2016.2326                    Microbial 2-Cys Peroxiredoxi ns: Insights into Their  Complex Physiological Roles    Michel B. Toledano*, and Bo Huang     The peroxiredoxins (Prxs) constitute a very large and high- ly conserved family of thiol-based peroxidases that has  been discovered only very recently.",Non-OADS,/arxiv_data1/oa_pdf/3c/cd/molce-39-1-31.PMC4749871.pdf
"Concomitantly in Stadtman’s lab, Rhee and colleagues puri- fied from yeast extracts a 25-kDa polypeptide that protected  glutamine synthase from oxidative inactivation in the presence  of a mixed function oxidation system (MFO)(O 2, iron, and a  reducing agent, dithiothreithol or β-mercaptoethanol) (Kim et al.,  Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",OADS,/arxiv_data1/oa_pdf/3c/cd/molce-39-1-31.PMC4749871.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/3c/cd/molce-39-1-31.PMC4749871.pdf
"Cells http://molcells.org     1988), therefore naming it protector protein.",Non-OADS,/arxiv_data1/oa_pdf/3c/cd/molce-39-1-31.PMC4749871.pdf
The Complex Phenotypes of 2-Cy Peroxiredoxins Gene Mutations   Michel B. Toledano & Bo Huang      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/3c/cd/molce-39-1-31.PMC4749871.pdf
"Cells http://molcells.org     Lee et al., 1999b).",OADS,/arxiv_data1/oa_pdf/3c/cd/molce-39-1-31.PMC4749871.pdf
The Complex Phenotypes of 2-Cy Peroxiredoxins Gene Mutations   Michel B. Toledano & Bo Huang      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/3c/cd/molce-39-1-31.PMC4749871.pdf
Cells http://molcells.org     and a major DNA repair enzyme.,Non-OADS,/arxiv_data1/oa_pdf/3c/cd/molce-39-1-31.PMC4749871.pdf
The Complex Phenotypes of 2-Cy Peroxiredoxins Gene Mutations   Michel B. Toledano & Bo Huang      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/3c/cd/molce-39-1-31.PMC4749871.pdf
Cells http://molcells.org     on transition-state stabilization.,OADS,/arxiv_data1/oa_pdf/3c/cd/molce-39-1-31.PMC4749871.pdf
The Complex Phenotypes of 2-Cy Peroxiredoxins Gene Mutations   Michel B. Toledano & Bo Huang      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/3c/cd/molce-39-1-31.PMC4749871.pdf
"Cells 2016; 39(1): 40-45   http://dx.doi.org/10.14348/molcells.2016.2327                    Peroxiredoxins in Regula tion of MAPK Signalling  Pathways; Sensors and Barriers to Signal  Transduction    Heather R. Latimer, and Elizabeth A. Veal*     Peroxiredoxins are highly conserved and abundant perox- idases.",OADS,/arxiv_data1/oa_pdf/3b/be/molce-39-1-40.PMC4749872.pdf
MAPK signalling  pathways are also important mediators of growth factors and  Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/3b/be/molce-39-1-40.PMC4749872.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/3b/be/molce-39-1-40.PMC4749872.pdf
Peroxiredoxins in Regulation of MAPK Signalling Pathways   Heather R. Latimer & Elizabeth A. Veal      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/3b/be/molce-39-1-40.PMC4749872.pdf
Cells http://molcells.org     ASK1 is critically involved in signal transduction to p38 and JNK  M A P K  i n  r e s p o n s e  t o  a  v a r i e t y  o f  s t i m u l i .,OADS,/arxiv_data1/oa_pdf/3b/be/molce-39-1-40.PMC4749872.pdf
Peroxiredoxins in Regulation of MAPK Signalling Pathways   Heather R. Latimer & Elizabeth A. Veal      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/3b/be/molce-39-1-40.PMC4749872.pdf
"Cells http://molcells.org     activation (Veal et al., 2004).",OADS,/arxiv_data1/oa_pdf/3b/be/molce-39-1-40.PMC4749872.pdf
Peroxiredoxins in Regulation of MAPK Signalling Pathways   Heather R. Latimer & Elizabeth A. Veal      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/3b/be/molce-39-1-40.PMC4749872.pdf
"Cells 2016; 39(1): 46-52   http://dx.doi.org/10.14348/molcells.2016.2328                    Utilizing Natural and Engineered Peroxiredoxins   As Intracellular Pe roxide Reporters    Koen Van Laer, and Tobias P. Dick*     It is increasingly apparent th at nature evolved peroxiredox- ins not only as H 2O2 scavengers but also as highly sensi- tive H2O2 sensors and signal transducers.",OADS,/arxiv_data1/oa_pdf/0f/f1/molce-39-1-46.PMC4749873.pdf
The first moiety is the  Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/0f/f1/molce-39-1-46.PMC4749873.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/0f/f1/molce-39-1-46.PMC4749873.pdf
Peroxiredoxins as Intracellular Peroxide Probes  Koen Van Laer & Tobias P. Dick      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/0f/f1/molce-39-1-46.PMC4749873.pdf
"Cells http://molcells.org     doxins exhibit rather complex biochemical and structural beha- vior (Rhee and Woo, 2011; Perkins  et al., 2015).",Non-OADS,/arxiv_data1/oa_pdf/0f/f1/molce-39-1-46.PMC4749873.pdf
Peroxiredoxins as Intracellular Peroxide Probes  Koen Van Laer & Tobias P. Dick      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/0f/f1/molce-39-1-46.PMC4749873.pdf
"Cells http://molcells.org     The influence of hyperoxidation  The inactivation of peroxiredoxins by hyperoxidation has been  observed under physiological circumstances (Nelson  et al.,  2013; Perkins et al., 2014).",OADS,/arxiv_data1/oa_pdf/0f/f1/molce-39-1-46.PMC4749873.pdf
Peroxiredoxins as Intracellular Peroxide Probes  Koen Van Laer & Tobias P. Dick      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/0f/f1/molce-39-1-46.PMC4749873.pdf
Cells http://molcells.org     dose treatments.,Non-OADS,/arxiv_data1/oa_pdf/0f/f1/molce-39-1-46.PMC4749873.pdf
"Cells 2016; 39(1): 53-59   http://dx.doi.org/10.14348/molcells.2016.2330                    Distribution and Features of the Six Classes of   Peroxiredoxins    Leslie B. Poole1,*, and Kimberly J. Nelson1,2     Peroxiredoxins are cysteine-dependent peroxide reduc- tases that group into 6 different, structurally discernable  classes.",OADS,/arxiv_data1/oa_pdf/f4/5f/molce-39-1-53.PMC4749874.pdf
Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/f4/5f/molce-39-1-53.PMC4749874.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/f4/5f/molce-39-1-53.PMC4749874.pdf
"Cells http://molcells.org     DASP, A BIOINFORMATICS TOOL FOR EXTRACTING  FUNCTIONALLY-RELEVANT SEQUENCE INFORMATION    Pure sequence-based analyses using full sequence, particular-ly when conducted iteratively, provide considerable information  about conserved domains, residues and, in favorable cases,  functions, but this latter extrapolation is often a “leap” in the absence of structural and/or functional characterization of a  very similar orthologous protein.",Non-OADS,/arxiv_data1/oa_pdf/f4/5f/molce-39-1-53.PMC4749874.pdf
Classifying and Analyzing Distribution of Peroxiredoxins  Leslie B. Poole & Kimberly J. Nelson      http://molcells.org  Mol.,OADS,/arxiv_data1/oa_pdf/f4/5f/molce-39-1-53.PMC4749874.pdf
"Cells  55     Recognizing the huge value in providing such subgroup specif- ic information to the community of thiol peroxidase researchers, as well as those not as familiar with the Prxs, we set up a web- accessible, searchable database (http://csb.wfu.edu/PREX) that  allows the user to quickly and easily find the subfamily assign-ment for any Prx protein ident ified utilizing th e methods pre- sented in the associated 2011 paper (Nelson et al., 2011; Soito  et al., 2011).",OADS,/arxiv_data1/oa_pdf/f4/5f/molce-39-1-53.PMC4749874.pdf
"As an example, we searched for “peroxiredoxin” proteins in  “Vitis vinifera ” (grape) using text-based searching in both Uni- prot (http://uniprot.org) and PREX (http://csb.wfu.edu/PREX)  databases (although BLAST analyses using protein se- quences as the query are available at both websites as well).",OADS,/arxiv_data1/oa_pdf/f4/5f/molce-39-1-53.PMC4749874.pdf
(A)  shows the output from a  search for “peroxiredoxin”  and the organism name at http://uniprot.org.,OADS,/arxiv_data1/oa_pdf/f4/5f/molce-39-1-53.PMC4749874.pdf
(B) shows  the output from a parallel  search conducted using the PREX database at  http://csb.wfu.edu/PREX.,OADS,/arxiv_data1/oa_pdf/f4/5f/molce-39-1-53.PMC4749874.pdf
Cells http://molcells.org     region altogether (perhaps due to either the expression of a  splice variant or to one or more mistakes in the sequence  analysis).,Non-OADS,/arxiv_data1/oa_pdf/f4/5f/molce-39-1-53.PMC4749874.pdf
Classifying and Analyzing Distribution of Peroxiredoxins  Leslie B. Poole & Kimberly J. Nelson      http://molcells.org  Mol.,OADS,/arxiv_data1/oa_pdf/f4/5f/molce-39-1-53.PMC4749874.pdf
Cells http://molcells.org     disulfide bond with the C R being located in the C-terminus of a  partner subunit (a “typical 2-Cys” Prx).,Non-OADS,/arxiv_data1/oa_pdf/f4/5f/molce-39-1-53.PMC4749874.pdf
Classifying and Analyzing Distribution of Peroxiredoxins  Leslie B. Poole & Kimberly J. Nelson      http://molcells.org  Mol.,OADS,/arxiv_data1/oa_pdf/f4/5f/molce-39-1-53.PMC4749874.pdf
Cells 2016; 39(1): 6-19  http://dx.doi.org/10.14348/molcells.2016.2323                    Reciprocal Control of the Circadian Clock and   Cellular Redox State - a Critical Appraisal    Marrit Putker* and Jo hn Stuart O’Neill*      Redox signalling comprises the biology of molecular sig- nal transduction mediated by reactive oxygen (or nitrogen) species.,OADS,/arxiv_data1/oa_pdf/3e/16/molce-39-1-6.PMC4749875.pdf
"As a result of aerobic metabolism, superoxide anions are  constantly formed as natural by-products of mitochondrial  respiration; indeed it has been estimated that about 1-2% of  Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",Non-OADS,/arxiv_data1/oa_pdf/3e/16/molce-39-1-6.PMC4749875.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/3e/16/molce-39-1-6.PMC4749875.pdf
Circadian Clock and Cellular Redox State - a Critical Appraisal  Marrit Putker & John Stuart O’Neill      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/3e/16/molce-39-1-6.PMC4749875.pdf
"Cells http://molcells.org     Excepting –SO 3, all cysteine derivatives described above are  reversible.",Non-OADS,/arxiv_data1/oa_pdf/3e/16/molce-39-1-6.PMC4749875.pdf
Circadian Clock and Cellular Redox State - a Critical Appraisal  Marrit Putker & John Stuart O’Neill      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/3e/16/molce-39-1-6.PMC4749875.pdf
Cells http://molcells.org     than a third of protein-coding genes in the mouse genome ex- hibit circadian regulation in one or more tissues.,Non-OADS,/arxiv_data1/oa_pdf/3e/16/molce-39-1-6.PMC4749875.pdf
Circadian Clock and Cellular Redox State - a Critical Appraisal  Marrit Putker & John Stuart O’Neill      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/3e/16/molce-39-1-6.PMC4749875.pdf
Cells http://molcells.org     Thus the erythrocyte cellular clockwork cannot conceivably rely  upon GEFLs.,OADS,/arxiv_data1/oa_pdf/3e/16/molce-39-1-6.PMC4749875.pdf
Circadian Clock and Cellular Redox State - a Critical Appraisal  Marrit Putker & John Stuart O’Neill      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/3e/16/molce-39-1-6.PMC4749875.pdf
Cells http://molcells.org     occur in CRY1 expressed in living cells.,OADS,/arxiv_data1/oa_pdf/3e/16/molce-39-1-6.PMC4749875.pdf
Circadian Clock and Cellular Redox State - a Critical Appraisal  Marrit Putker & John Stuart O’Neill      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/3e/16/molce-39-1-6.PMC4749875.pdf
Cells http://molcells.org     reactivation of hyperoxidized pero xiredoxin through reduction of  cysteine sulfinic acid in the active site to cysteine.,Non-OADS,/arxiv_data1/oa_pdf/3e/16/molce-39-1-6.PMC4749875.pdf
Circadian Clock and Cellular Redox State - a Critical Appraisal  Marrit Putker & John Stuart O’Neill      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/3e/16/molce-39-1-6.PMC4749875.pdf
Cells http://molcells.org     mouse suprachiasmatic nucleus.,Non-OADS,/arxiv_data1/oa_pdf/3e/16/molce-39-1-6.PMC4749875.pdf
Circadian Clock and Cellular Redox State - a Critical Appraisal  Marrit Putker & John Stuart O’Neill      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/3e/16/molce-39-1-6.PMC4749875.pdf
"Cells 2016; 39(1): 60-64   http://dx.doi.org/10.14348/molcells.2016.2341                    Multiple Roles of Peroxire doxins in Inflammation    Bernard Knoops*, Vasiliki Argyropoulou, Sarah Becker, Laura Ferté, and Oksana Kuznetsova     Inflammation is a pathophysiological response to infection  or tissue damage during which high levels of reactive oxy- gen and nitrogen species are produced by phagocytes to kill microorganisms.",Non-OADS,/arxiv_data1/oa_pdf/c2/35/molce-39-1-60.PMC4749876.pdf
"Given that several eukaryotic peroxiredoxins were also shown to be  susceptible to regulation by reversible overoxidative inactivation  or other post-translational modifications, it was proposed that  Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",OADS,/arxiv_data1/oa_pdf/c2/35/molce-39-1-60.PMC4749876.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/c2/35/molce-39-1-60.PMC4749876.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/c2/35/molce-39-1-60.PMC4749876.pdf
"Cells http://molcells.org     augmented ROS generation and JNK-dependent NO produc- tion suggesting that PRDX5 might indeed modulate a ROS- dependent signaling cascade (Sun et al., 2010).",OADS,/arxiv_data1/oa_pdf/c2/35/molce-39-1-60.PMC4749876.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/c2/35/molce-39-1-60.PMC4749876.pdf
Cells http://molcells.org     Biol.,OADS,/arxiv_data1/oa_pdf/c2/35/molce-39-1-60.PMC4749876.pdf
"Cells 2016; 39(1): 65-71   http://dx.doi.org/10.14348/molcells.2016.2349                    The Roles of Peroxiredoxin  and Thioredoxin in   Hydrogen Peroxide Sensing and in Signal  Transduction    Luis E. S. Netto1,*, and Fernando Antunes2,*      A challenge in the redox field is the elucidation of the molecular mechanisms, by which H 2O2 mediates signal  transduction in cells.",OADS,/arxiv_data1/oa_pdf/f1/ff/molce-39-1-65.PMC4749877.pdf
Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/f1/ff/molce-39-1-65.PMC4749877.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/f1/ff/molce-39-1-65.PMC4749877.pdf
"Cells http://molcells.org     MODELS OF H2O2 SENSING AND SIGNALING    Prxs are highly abundant Cys-based peroxidases with crucial  roles in maintaining genome stability, protecting cells against cancer and promoting longevity (Nyström et al., 2012; Rhee  and Woo, 2011).",Non-OADS,/arxiv_data1/oa_pdf/f1/ff/molce-39-1-65.PMC4749877.pdf
"Cys-Based Peroxidase, thioredoxin and H 2O2 Signaling  Luis E. S. Netto & Fernando Antunes      http://molcells.org  Mol.",Non-OADS,/arxiv_data1/oa_pdf/f1/ff/molce-39-1-65.PMC4749877.pdf
"Cells http://molcells.org     2009); (2) apoptosis signaling kinase1 (ASK1) (Jarvis et al.,  2012); and (3) MAPK phosphatases (Turner-Ivey et al., 2013).",Non-OADS,/arxiv_data1/oa_pdf/f1/ff/molce-39-1-65.PMC4749877.pdf
"Cys-Based Peroxidase, thioredoxin and H 2O2 Signaling  Luis E. S. Netto & Fernando Antunes      http://molcells.org  Mol.",Non-OADS,/arxiv_data1/oa_pdf/f1/ff/molce-39-1-65.PMC4749877.pdf
Cells http://molcells.org     chaperone function.,OADS,/arxiv_data1/oa_pdf/f1/ff/molce-39-1-65.PMC4749877.pdf
"Cys-Based Peroxidase, thioredoxin and H 2O2 Signaling  Luis E. S. Netto & Fernando Antunes      http://molcells.org  Mol.",Non-OADS,/arxiv_data1/oa_pdf/f1/ff/molce-39-1-65.PMC4749877.pdf
"Cells 2016; 39(1): 72-76   http://dx.doi.org/10.14348/molcells.2016.2351                    Peroxiredoxins and the Re gulation of Cell Death    Mark B. Hampton*, and Karina M. O’Connor     Cell death pathways such as apoptosis can be activated in  response to oxidative stress, enabling the disposal of  damaged cells.",Non-OADS,/arxiv_data1/oa_pdf/29/4b/molce-39-1-72.PMC4749878.pdf
Pore format ion is controlled by the pro-  and anti-apoptotic members of the Bcl-2 family that initiates  Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,Non-OADS,/arxiv_data1/oa_pdf/29/4b/molce-39-1-72.PMC4749878.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/29/4b/molce-39-1-72.PMC4749878.pdf
Peroxiredoxins and Cell Death  Mark B. Hampton & Karina M. O’Connor      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/29/4b/molce-39-1-72.PMC4749878.pdf
Cells http://molcells.org     overexpression provides protection.,Non-OADS,/arxiv_data1/oa_pdf/29/4b/molce-39-1-72.PMC4749878.pdf
Peroxiredoxins and Cell Death  Mark B. Hampton & Karina M. O’Connor      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/29/4b/molce-39-1-72.PMC4749878.pdf
Cells http://molcells.org     markers of oxidative stress.,OADS,/arxiv_data1/oa_pdf/29/4b/molce-39-1-72.PMC4749878.pdf
"This is an open-access article distributed under the terms  of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redis - tribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/b5/5d/cardiovascmed-05-01-28997.PMC4749892.pdf
"http://dx.doi.org/10.1016/j.jaci.2013.11.008 Mertens-Talcott, S.U., S. Chintharlapalli, X. Li, and S. Safe.",OADS,/arxiv_data1/oa_pdf/76/ff/JEM_20150990.PMC4749926.pdf
"During a comparable 4-year period, no case of Paget’s disease Open AccessC O Aransiola and A IpadeolaPaget’s disease of bone ID: 16-0005; February 2016 DOI: 10.1530/EDM-16-0005 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0Unported License .q2016 The authors http://www.edmcasereports.com Published by Bioscientiﬁca Ltd.",Non-OADS,/arxiv_data1/oa_pdf/eb/78/edmcr-2016-160005.PMC4749932.pdf
C O Aransiola and A IpadeolaPaget’s disease of bone ID: 16-0005; February 2016 DOI: 10.1530/EDM-16-0005 http://www.edmcasereports.com 2,Non-OADS,/arxiv_data1/oa_pdf/eb/78/edmcr-2016-160005.PMC4749932.pdf
C O Aransiola and A IpadeolaPaget’s disease of bone ID: 16-0005; February 2016 DOI: 10.1530/EDM-16-0005 http://www.edmcasereports.com 3,Non-OADS,/arxiv_data1/oa_pdf/eb/78/edmcr-2016-160005.PMC4749932.pdf
C O Aransiola and A IpadeolaPaget’s disease of bone ID: 16-0005; February 2016 DOI: 10.1530/EDM-16-0005 http://www.edmcasereports.com 4,Non-OADS,/arxiv_data1/oa_pdf/eb/78/edmcr-2016-160005.PMC4749932.pdf
( doi:10.1002/jbmr.5650100318 ) Received in ﬁnal form 20 January 2016 Accepted 25 January 2016 C O Aransiola and A IpadeolaPaget’s disease of bone ID: 16-0005; February 2016 DOI: 10.1530/EDM-16-0005 http://www.edmcasereports.com 5,Non-OADS,/arxiv_data1/oa_pdf/eb/78/edmcr-2016-160005.PMC4749932.pdf
"This is an open-access article distributed under the terms  of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redis - tribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/3c/4e/cardiovascmed-05-01-29419.PMC4750008.pdf
"This is an open-access article distributed under the terms  of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redis - tribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/b5/32/cardiovascmed-05-01-29005.PMC4750009.pdf
"In any case, a de ﬁnitive answer regarding the actual contribution of cytoreductive surgery and HIPEC in prognosis of advanced EOC will only be provided by the eagerly awaited results from the ongoing randomized trial on this issue.Gynecologic Oncology Reports 15 (2016) 7 –8 DOI of original article: http://dx.doi.org/10.1016/j.ygyno.2014.11.072 http://dx.doi.org/10.1016/j.gore.2015.11.002 2352-5789/© 2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/43/47/main.PMC4750010.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/43/47/main.PMC4750010.pdf
A CT- Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2015.12.004 2352-5789/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/3c/main.PMC4750011.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/3c/main.PMC4750011.pdf
http://dx.doi.org/10.1016/j.ygyno.2005.01.011 .,OADS,/arxiv_data1/oa_pdf/bf/3c/main.PMC4750011.pdf
http://dx.doi.org/10.1200/JCO.2007.11.,OADS,/arxiv_data1/oa_pdf/bf/3c/main.PMC4750011.pdf
http://dx.doi.org/10.1200/JCO.2007.13.9279 .,Non-OADS,/arxiv_data1/oa_pdf/bf/3c/main.PMC4750011.pdf
http://dx.doi.org/ 10.1016/j.ygyno.2006.06.022 .,OADS,/arxiv_data1/oa_pdf/bf/3c/main.PMC4750011.pdf
1. http://dx.doi.org/10.1097/PGP.,Non-OADS,/arxiv_data1/oa_pdf/bf/3c/main.PMC4750011.pdf
http://dx.doi.org/10.1200/JCO.2013.,OADS,/arxiv_data1/oa_pdf/bf/3c/main.PMC4750011.pdf
http://dx.doi.org/10.1006/gyno.2001.6183 .,Non-OADS,/arxiv_data1/oa_pdf/bf/3c/main.PMC4750011.pdf
http://dx.doi.org/10.1126/science.1241908 .,Non-OADS,/arxiv_data1/oa_pdf/bf/3c/main.PMC4750011.pdf
http://dx.doi.org/10.1056/NEJMoa0902542 .,OADS,/arxiv_data1/oa_pdf/bf/3c/main.PMC4750011.pdf
http://dx.doi.org/10.1016/j.ygyno.2014.03.573 .,OADS,/arxiv_data1/oa_pdf/bf/3c/main.PMC4750011.pdf
"Sobs http://dx.doi.org/ 10.1111/aogs.12720 (n/a –n/a).21 M. Schwartz, G.S.",OADS,/arxiv_data1/oa_pdf/bf/3c/main.PMC4750011.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f6/2f/main.PMC4750012.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gore http://dx.doi.org/10.1016/j.gore.2015.06.002 2352-5789/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f6/2f/main.PMC4750012.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f6/2f/main.PMC4750012.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Sertoli –Leydig Sex-cordCarcinoidHepatoidAlphafetoproteinEndometrioid 1.,Non-OADS,/arxiv_data1/oa_pdf/e8/84/main.PMC4750013.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2015.12.003 2352-5789/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/84/main.PMC4750013.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e8/84/main.PMC4750013.pdf
"Histologically, UTROSCT consists pre- dominantly or exclusively by similar ovarian sex-cord tumor elements Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2015.11.003 2352-5789/© 2015 Published by Elsevier Inc.",Non-OADS,/arxiv_data1/oa_pdf/7f/84/main.PMC4750014.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7f/84/main.PMC4750014.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2015.12.005 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4a/97/main.PMC4750015.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4a/97/main.PMC4750015.pdf
"References American Cancer Society ( http://www.cancer.org/cancer/ovariancancer/ ) Berek, J.S., Hacker, N.F., 2015.",Non-OADS,/arxiv_data1/oa_pdf/4a/97/main.PMC4750015.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/53/eb/main.PMC4750016.pdf
http://dx.doi.org/10.1016/j.gore.2015.07.008 2352-5789/Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/53/eb/main.PMC4750016.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/53/eb/main.PMC4750016.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Endometrial cancerLower-extremity lymphedemaQuality of lifeLymph nodesSurgical approach Medical comorbidities 1.,Non-OADS,/arxiv_data1/oa_pdf/0f/fa/main.PMC4750017.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2015.12.002 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/fa/main.PMC4750017.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0f/fa/main.PMC4750017.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Pilomatrix carcinomaSquamous cell carcinomaVulvaSurgical managementMalignant pilomatrixomaShadow cells 1.,Non-OADS,/arxiv_data1/oa_pdf/5c/37/main.PMC4750018.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2015.12.001 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5c/37/main.PMC4750018.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5c/37/main.PMC4750018.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2016.01.001 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/51/ac/main.PMC4750019.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/ac/main.PMC4750019.pdf
http://dx.doi.org/10.1016/j.gore.2015.07.005 2352-5789/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/cc/5c/main.PMC4750020.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).2.,Non-OADS,/arxiv_data1/oa_pdf/cc/5c/main.PMC4750020.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Obesity and detecting left ventricular hypertrophy JCL Rodrigues et al 203 © 2016 Macmillan Publishers Limited Journal of Human Hypertension (2016) 197 –203",Non-OADS,/arxiv_data1/oa_pdf/e5/c2/jhh201558a.PMC4750022.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a1/41/main.PMC4750048.pdf
E-mail address: katie.gifford@vanderbilt.edu http://dx.doi.org/10.1016/j.dadm.2015.09.004 2352-8729/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a1/41/main.PMC4750048.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/41/main.PMC4750048.pdf
Available at: http://www.R-project.org .,Non-OADS,/arxiv_data1/oa_pdf/a1/41/main.PMC4750048.pdf
We assessed the relationship of resting state functionalReceived: 23 October 2015 Revised: 17 December 2015 Accepted: 22 December 2015 Heliyon (2016) e00058 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
Article No~e00058 2 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
"They reported decreased functional connectivity in the default mode network and the motor sensory network, and Article No~e00058 3 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.",OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
Article No~e00058 4 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
"Additionally, as increased Article No~e00058 5 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
Article No~e00058 6 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
"Because we areinterested in the functional organization of the brain, we defined regions based Article No~e00058 7 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
"To this end, we used Neurosynth ( [167_TD$DIFF]http://neurosynth.org )[88], which identifies functionally related brain regions via meta-analytic methods across more than 11,000 neuroimaging studies.",OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
"The forward inference map defines regional co-activations from apsychological term, whereas the more selective reverse inference map defines a psychological term from regional co-activations ( http://neurosynth.org/faq/#q15 ).",Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
Article No~e00058 8 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
Article No~e00058 9 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
"To reduce noise from non-grey matter activity, we regressed out thefollowing confounders: mean relative motion correction distance [ 111]; mean Article No~e00058 10 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
[344_TD$DIFF] Article No~e00058 11 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
"1 , Path B) To evaluate the relationship between eating behavior and resting state functional connectivity, we computed simple linear regressions between CEBQ scores andeach of the functional connectivity values, [220_TD$DIFF][ IPL:NAC] rsFC, [ FPOLE :NAC] rsFC, and Article No~e00058 12 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
"1 , Path A) Increasing BMI z-scores trended toward significance with decreasing response inhibition-associated [7_TD$DIFF][IPL:NAC]r s F C( p= 0.084; R2= 0.080; r=−0.284; Article No~e00058 13 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
"N=3 8 [14_TD$DIFF]Count (%) Sex Female 17 (44.7) [15_TD$DIFF]Male 21 (55.3) Handedness (N = 36) [16_TD$DIFF]Right 30 (83.3) [17_TD$DIFF]Left 5 (13.9) Ambidextrous 1 (2.8) [18_TD$DIFF]Race American Indian or Native Alaskan 3 (7.89) [19_TD$DIFF]Asian 2 (5.26) Black or African American 16 (42.11) [20_TD$DIFF]Native Hawaiian or Other Pacific Islander 0 (0.00) [21_TD$DIFF]White 17 (44.74) [22_TD$DIFF]Other Race 0 (0.00) [23_TD$DIFF]Mean (std) Min, Max Age (yrs) 11.2 (1.7) 8.4, 13.9 Weight (kg) 44.0 (13.9) 25.9, 81.7 BMI z-score 0.4 (1.1) - [24_TD$DIFF]1.4, 2.4 BMI% 59.9 (30.4) 8.4, 99.2[25_TD$DIFF]Tanner stage (N = 36) [26_TD$DIFF]Girls (N = 17) 2.3 (1.0) 1, 4 [27_TD$DIFF]Boys (N = 19) 2.2 (1.2) 1, 5 Article No~e00058 14 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
Article No~e00058 15 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
Article No~e00058 16 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
Article No~e00058 17 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
Article No~e00058 18 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
Article No~e00058 19 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
Article No~e00058 20 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
Article No~e00058 21 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
Article No~e00058 22 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
Article No~e00058 23 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
Article No~e00058 24 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
Article No~e00058 25 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
Article No~e00058 26 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
Article No~e00058 27 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
Article No~e00058 28 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
Article No~e00058 29 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
"), Global perspectives on childhood obesity: [277_TD$DIFF]Current status, Article No~e00058 30 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
"), The impulsive client, Article No~e00058 31 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
Article No~e00058 32 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
Article No~e00058 33 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
155(5): Article No~e00058 34 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
Article No~e00058 35 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
http://www.cdc.gov/growthcharts/ percentile_data_files.htm.,OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
"Kremers, C. Thijs, The Children's Eating Behaviour Questionnaire: Factorial validity and association with Body Article No~e00058 36 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
Article No~e00058 37 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
Article No~e00058 38 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
Article No~e00058 39 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
Article No~e00058 40 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
Article No~e00058 41 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
Article No~e00058 42 http://dx.doi.org/10.1016/j.heliyon.2015.e00058 2405-8440/Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/b1/main.PMC4750053.pdf
http://dx.doi.org/10.1016/j.stemcr.2015.10.007 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ba/87/main.PMC4750068.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, seven ﬁgures, two tables, and two movies and can be found with this article online at http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/ba/87/main.PMC4750068.pdf
"Funding This work was supported by the Women and Equality Unit, People United (http://www.peopleunited.org.uk), and the United Kingdom Economic and Social Research Council (Grant  ES/J500148/1).",Non-OADS,/arxiv_data1/oa_pdf/0b/ba/10.1177_0956797615615584.PMC4750069.pdf
"Retrieved from http://kar.kent.ac.uk/4106/1/Abrams_KentEquality_Oct_2006.pdf Abrams, D., & Vasiljevic, M. (2014).",Non-OADS,/arxiv_data1/oa_pdf/0b/ba/10.1177_0956797615615584.PMC4750069.pdf
"Retrieved from https://www.ipsos-mori.com/researchpublications/researcharchive/107/Voting-Intention- in-Great-Britain-Recent-Trends.aspx#2005 Jost, J. T., Glaser, J., Kruglanski, A. W., & Sulloway, F. J.",Non-OADS,/arxiv_data1/oa_pdf/0b/ba/10.1177_0956797615615584.PMC4750069.pdf
Retrieved from http://dx.doi.org/10.5255/UKDA-SN-5618-1 National Centre for Social Research.,Non-OADS,/arxiv_data1/oa_pdf/0b/ba/10.1177_0956797615615584.PMC4750069.pdf
"Retrieved from  https://www.europeansocialsurvey.org/docs/methodology/ core_ess_questionnaire/ESS_core_questionnaire_human_ values.pdf Sherif, M. (1966).",Non-OADS,/arxiv_data1/oa_pdf/0b/ba/10.1177_0956797615615584.PMC4750069.pdf
"Stem Cell Reports Perspective Snapshots of Pluripotency Paul J. Tesar1,* 1Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, 10900 Euclid Avenue, Cleveland, OH 44106, USA *Correspondence: paul.tesar@case.edu http://dx.doi.org/10.1016/j.stemcr.2015.12.011 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/58/41/main.PMC4750095.pdf
"), ras.trokovic@helsinki.ﬁ (R.T.) http://dx.doi.org/10.1016/j.stemcr.2015.12.009 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/b7/13/main.PMC4750096.pdf
"The raw expression data of all iPSC clones was analyzed by PluriTest ( http://www.pluritest.org/ ) and only the clones that suc- cessfully passed the test were selected for further analyses ( Muller et al., 2011 ).",OADS,/arxiv_data1/oa_pdf/b7/13/main.PMC4750096.pdf
Data analysis was performed with the R statis- tics package ( http://www.r-project.org/ ).,OADS,/arxiv_data1/oa_pdf/b7/13/main.PMC4750096.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes six ﬁgures and eight tables andcan be found with this article online at http://dx.doi.org/10.1016/ j.stemcr.2015.12.009 .,Non-OADS,/arxiv_data1/oa_pdf/b7/13/main.PMC4750096.pdf
"Stem Cell Reports Article Non-invasive Chamber-Speciﬁc Identiﬁcation of Cardiomyocytes in DifferentiatingPluripotent Stem Cells Eva Brauchle,1,2Anne Knopf,1,2,3Hannah Bauer,2Nian Shen,1,2Sandra Linder,1Michael G. Monaghan,1,2 Kornelia Ellwanger,4Shannon L. Layland,1,2Sara Y. Brucker,2Ali Nsair,3,5and Katja Schenke-Layland1,2,3,5,* 1Department of Cell and Tissue Engineering, Fraunhofer Institute for Interfacial Engineering and Biotechnology (IGB), Nobelstrasse 12, 70569 Stut tgart, Germany 2Department of Women’s Health, Research Institute for Women’s Health, Eberhard Karls University Tu ¨bingen, Silcherstrasse 7/1, 72076 Tu ¨bingen, Germany 3Department of Medicine/Cardiology, Cardiovascular Research Laboratories, David Geffen School of Medicine at UCLA, 675 Charles E. Young Drive Sout h, MRL 3645, Los Angeles, CA 90095, USA 4Institute of Cell Biology and Immunology, University of Stuttgart, Allmandring 31, 70569 Stuttgart, Germany 5Co-senior author *Correspondence: katja.schenke-layland@med.uni-tuebingen.de http://dx.doi.org/10.1016/j.stemcr.2015.12.007 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/14/4d/main.PMC4750099.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, six ﬁgures, ﬁve tables, and three videos and can befound with this article online at http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/14/4d/main.PMC4750099.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 110 e112 http://dx.doi.org/10.1016/j.ipej.2015.07.006 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/a1/92/main.PMC4750115.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/92/main.PMC4750115.pdf
"Narayanan Namboodiri, Editor-in-Chief http://dx.doi.org/10.1016/j.ipej.2015.09.012 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/81/72/main.PMC4750116.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).indian pacing and electrophy siology journal 15 (2015) v evi vi,Non-OADS,/arxiv_data1/oa_pdf/81/72/main.PMC4750116.pdf
":þ351 217805351; fax: þ351 218860151.HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 118 e120 http://dx.doi.org/10.1016/j.ipej.2015.07.008 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/99/dc/main.PMC4750117.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/99/dc/main.PMC4750117.pdf
Available at: http://www.pubmedcentral.,Non-OADS,/arxiv_data1/oa_pdf/99/dc/main.PMC4750117.pdf
J Cardiovasc Electrophysiol 2015 Jun 8. http://dx.doi.org/ 10.1111/jce.12721 [Epub ahead of print].,Non-OADS,/arxiv_data1/oa_pdf/0e/0f/main.PMC4750118.pdf
"E-mail address: dipen.shah@hcuge.ch (D. C. Shah)Available online 3 October 2015 http://dx.doi.org/10.1016/j.ipej.2015.09.010 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/0e/0f/main.PMC4750118.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).indian pacing and electrophy siology journal 15 (2015) 149 e151 151,Non-OADS,/arxiv_data1/oa_pdf/0e/0f/main.PMC4750118.pdf
"1All authors have read the manuscript and contributed to the work.HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 206 e209 http://dx.doi.org/10.1016/j.ipej.2015.10.004 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/be/c5/main.PMC4750119.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/be/c5/main.PMC4750119.pdf
Eur Heart J 2015 Jan 14;36(3):170 e8.http://dx.doi.org/10.1093/ eurheartj/ehu407 [Epub 2014 Oct 29].,Non-OADS,/arxiv_data1/oa_pdf/be/c5/main.PMC4750119.pdf
"E-mail address: ubuckley@mednet.ucla.edu (U. Buckley) Available online 28 July 2015http://dx.doi.org/10.1016/j.ipej.2015.07.002 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/53/11/main.PMC4750120.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).indian pacing and electrophy siology journal 15 (2015) 87 e89 89,Non-OADS,/arxiv_data1/oa_pdf/53/11/main.PMC4750120.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophysiology journal 15 (2015) 96 e102 http://dx.doi.org/10.1016/j.ipej.2015.07.003 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/67/04/main.PMC4750121.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/67/04/main.PMC4750121.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 133 e137 http://dx.doi.org/10.1016/j.ipej.2015.07.012 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/59/39/main.PMC4750122.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/59/39/main.PMC4750122.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 145 e147 http://dx.doi.org/10.1016/j.ipej.2015.09.001 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/a6/a0/main.PMC4750123.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/a0/main.PMC4750123.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 172 e176 http://dx.doi.org/10.1016/j.ipej.2015.09.008 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/76/2c/main.PMC4750124.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/76/2c/main.PMC4750124.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 162 e164 http://dx.doi.org/10.1016/j.ipej.2015.09.002 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/6d/7e/main.PMC4750125.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6d/7e/main.PMC4750125.pdf
"Johnson Francis, Founder and Executive Editor http://dx.doi.org/10.1016/j.ipej.2015.09.011 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/98/21/main.PMC4750126.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/98/21/main.PMC4750126.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 177 e179 http://dx.doi.org/10.1016/j.ipej.2015.10.001 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/86/5d/main.PMC4750127.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/5d/main.PMC4750127.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 213 e215 http://dx.doi.org/10.1016/j.ipej.2015.09.007 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/97/88/main.PMC4750128.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/97/88/main.PMC4750128.pdf
"Peer review under responsibility of Indian Heart Rhythm Society HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 158 e161 http://dx.doi.org/10.1016/j.ipej.2015.10.006 0972-6292/Crown Copyright ©2015, Production and hosting by Elsevier B.V. on behalf of Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/08/a7/main.PMC4750129.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/08/a7/main.PMC4750129.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 165 e167 http://dx.doi.org/10.1016/j.ipej.2015.09.003 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/7b/f3/main.PMC4750130.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/f3/main.PMC4750130.pdf
"E-mail address: drkartikeya@outlook.com Available online 29 October 2015 http://dx.doi.org/10.1016/j.ipej.2015.10.009 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/99/39/main.PMC4750131.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).indian pacing and electrophy siology journal 15 (2015) 189 e192 192,Non-OADS,/arxiv_data1/oa_pdf/99/39/main.PMC4750131.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 180 e183 http://dx.doi.org/10.1016/j.ipej.2015.10.003 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/b6/1b/main.PMC4750132.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b6/1b/main.PMC4750132.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 113 e117 http://dx.doi.org/10.1016/j.ipej.2015.07.007 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/25/63/main.PMC4750133.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/25/63/main.PMC4750133.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 152 e157 http://dx.doi.org/10.1016/j.ipej.2015.07.004 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/71/60/main.PMC4750134.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/60/main.PMC4750134.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 90 e95 http://dx.doi.org/10.1016/j.ipej.2015.07.001 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/6e/64/main.PMC4750135.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6e/64/main.PMC4750135.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 210 e212 http://dx.doi.org/10.1016/j.ipej.2015.10.005 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/3c/f4/main.PMC4750136.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3c/f4/main.PMC4750136.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 141 e142 http://dx.doi.org/10.1016/j.ipej.2015.07.015 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/de/44/main.PMC4750137.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/de/44/main.PMC4750137.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 193 e198 http://dx.doi.org/10.1016/j.ipej.2015.10.007 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/b2/b1/main.PMC4750138.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b2/b1/main.PMC4750138.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 103 e109 http://dx.doi.org/10.1016/j.ipej.2015.07.005 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/00/bd/main.PMC4750139.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/bd/main.PMC4750139.pdf
[5] Ambulatory and Hospital Care Statistics Branch of the Centers for Disease Control and Prevention 's National Center for Health Statistics website http://www.cdc.gov/ nchs/data/ahcd/nhamcs_emergency/2011.ed_web_tables.,OADS,/arxiv_data1/oa_pdf/00/bd/main.PMC4750139.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 224 e225 http://dx.doi.org/10.1016/j.ipej.2015.11.002 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/d4/72/main.PMC4750141.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/72/main.PMC4750141.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 168 e171 http://dx.doi.org/10.1016/j.ipej.2015.09.005 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/eb/24/main.PMC4750142.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/24/main.PMC4750142.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 130 e132 http://dx.doi.org/10.1016/j.ipej.2015.07.011 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/d1/ba/main.PMC4750143.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d1/ba/main.PMC4750143.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 184 e187 http://dx.doi.org/10.1016/j.ipej.2015.10.002 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/a7/3c/main.PMC4750157.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a7/3c/main.PMC4750157.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 199 e201 http://dx.doi.org/10.1016/j.ipej.2015.09.006 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/1a/7f/main.PMC4750158.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1a/7f/main.PMC4750158.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 138 e140 http://dx.doi.org/10.1016/j.ipej.2015.07.013 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/63/27/main.PMC4750159.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/63/27/main.PMC4750159.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 220 e223 http://dx.doi.org/10.1016/j.ipej.2015.11.001 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/fe/e7/main.PMC4750160.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fe/e7/main.PMC4750160.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 125 e129 http://dx.doi.org/10.1016/j.ipej.2015.07.010 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/87/ca/main.PMC4750162.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/87/ca/main.PMC4750162.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 202 e205 http://dx.doi.org/10.1016/j.ipej.2015.09.009 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/82/b0/main.PMC4750163.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/82/b0/main.PMC4750163.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 216 e219 http://dx.doi.org/10.1016/j.ipej.2015.10.008 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/08/c3/main.PMC4750164.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/08/c3/main.PMC4750164.pdf
"HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/IPEJ indian pacing and electrophy siology journal 15 (2015) 121 e124 http://dx.doi.org/10.1016/j.ipej.2015.07.009 0972-6292/Copyright ©2015, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/cd/d2/main.PMC4750165.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cd/d2/main.PMC4750165.pdf
http://dx.doi.org/10.1016/j.stemcr.2016.01.005 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/06/9d/main.PMC4750166.pdf
The data have been deposited in NCBI Gene Expression Omnibus ( http://www.ncbi.nlm.nih.gov/geo/ ) and are accessible through GEO: GSE76371 for gene expression micro- array and GEO: GSE76372 for genome-wide DNA methylation analysis.,OADS,/arxiv_data1/oa_pdf/06/9d/main.PMC4750166.pdf
"Statistics PRISM (GraphPad Software) was used for all statistical analyses.t Tests for paired or unpaired data were used to assess the signiﬁcanceof differences between the means of two experimental groups.SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, six ﬁgures, and two tables and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/06/9d/main.PMC4750166.pdf
"This is an open-access article distributed under the terms  of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redis - tribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/a2/b1/cardiovascmed-05-01-30091.PMC4750222.pdf
@ERSpublications Vaccinating the elderly with 13-valent pneumococcal conjugate vaccine is highly cost-effective http://ow.ly/NVeui Editorial comment in: Eur Respir J 2015; 46: 1265 –1268 [DOI: 10.1183/13993003.01038-2015] This article has supplementary material available from erj.ersjournals.com Received: Feb 26 2015 | Accepted after revision: May 16 2015 | First published online: July 09 2015Copyright ©ERS 2015.,Non-OADS,/arxiv_data1/oa_pdf/8e/0f/ERJ-00325-2015.PMC4750466.pdf
"Heerlen, Statistics Netherlands (CBS), 2014. http://statline.cbs.nl/ Statweb/publication/?DM=SLNL&PA=03759ned&D1=0&D2=0,19-96,118,129&D3=0&D4=24&HDR=T&STB=G2, G3,G1&VW=T Date last accessed: December 4, 2014.",Non-OADS,/arxiv_data1/oa_pdf/8e/0f/ERJ-00325-2015.PMC4750466.pdf
"Abstract 1099. https://idsa.confex.com/idsa/2014/webprogram/Paper47255.html 26 Klugman KP, Madhi SA, Huebner RE, et al.",OADS,/arxiv_data1/oa_pdf/8e/0f/ERJ-00325-2015.PMC4750466.pdf
"2014 http://statline.cbs.nl/ StatWeb/publication/?DM=SLNL&PA=71958ned&D1=0-1,4&D2=0&D3=0,2-11&D4=65&HDR=T&STB=G1,G2,G3&VW=T Date last accessed: August 8, 2014.",OADS,/arxiv_data1/oa_pdf/8e/0f/ERJ-00325-2015.PMC4750466.pdf
"http://stats.oecd.org/index.aspx?queryid=28226 Date last accessed: June 25, 2015.",OADS,/arxiv_data1/oa_pdf/8e/0f/ERJ-00325-2015.PMC4750466.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/c3/41/mtm201556.PMC4750467.pdf
Nature http://dx.doi.org/10.1038/nature15394 (this issue).,Non-OADS,/arxiv_data1/oa_pdf/fb/59/41586_2015_Article_BFnature15393.PMC4750478.pdf
The Haplotype Reference Consortium (http://www.haplotype-reference- consortium.org/).,Non-OADS,/arxiv_data1/oa_pdf/fb/59/41586_2015_Article_BFnature15393.PMC4750478.pdf
Nature http://dx.doi.org/10.1038/nature14962 (2015).,Non-OADS,/arxiv_data1/oa_pdf/fb/59/41586_2015_Article_BFnature15393.PMC4750478.pdf
http://dx.doi.org/10.1038/ng3368 (2015).,Non-OADS,/arxiv_data1/oa_pdf/fb/59/41586_2015_Article_BFnature15393.PMC4750478.pdf
"To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-sa/3.0 74 | NATURE | VOL 526 | 1 OCTOBER 2015RESEARCH ARTICLE G2015 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/fb/59/41586_2015_Article_BFnature15393.PMC4750478.pdf
"To view a copy of this license,  visit http://creativecommons.org/licenses/by-nc-nd/4.0/ *Author for correspondence: danicalcagno@gmail.com.",Non-OADS,/arxiv_data1/oa_pdf/a1/e3/nihms755310.PMC4750480.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7e/71/jev173.PMC4750507.pdf
"Journal of  Preventive Medicine  & Public Health 53 Copyright © 2016  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2016  The Korean Society for Preventive MedicineJ Prev Med Public Health 2016;49:53-60    •  http://dx.doi.org/10.3961/jpmph.15.052 Factors Affecting the Downward Mobility of Psychiatric   Patients: A Korean Study of National Health Insurance  Beneficiaries Un-Na Kim1, Yeon-Yong Kim1, Jin-Seok Lee1,2 1Department of Health Policy and Management, Seoul National University College of Medicine, Seoul; 2Institute of Health Policy and Management,  Seoul National University Medical Research Center, Seoul, KoreaOriginal Article Objectives: The purpose of this study is to examine the magnitude of and the factors associated with the downward mobility of first- episode psychiatric patients.",Non-OADS,/arxiv_data1/oa_pdf/40/0d/jpmph-49-1-53.PMC4750509.pdf
"Key words:  Social mobility, Mental disorders, National Health Insurance, Republic of Korea Received:  August 27, 2015 Accepted:  December 22, 2015 Corresponding author:  Jin-Seok Lee, MD, PhD 103 Daehak-ro, Jongno-gu, Seoul 03080, Korea Tel: +82-2-740-8362, Fax:  +82-2-743-2009 E-mail:  phealth@snu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.pISSN 1975-8375 eISSN 2233-4521  INTRODUCTION The importance of mental disorders is being emphasized  globally.",Non-OADS,/arxiv_data1/oa_pdf/40/0d/jpmph-49-1-53.PMC4750509.pdf
ORCID Un-Na Kim http://orcid.org/0000-0002-6764-2951 Yeon-Yong Kim http://orcid.org/0000-0003-2179-8931  Jin-Seok Lee http://orcid.org/0000-0003-4329-0784  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/40/0d/jpmph-49-1-53.PMC4750509.pdf
Available from:  http://www.mohw.go.kr/front_new/al/sal0301vw.jsp?PAR_ MENU_ID =04&MENU_ID =0403&BOARD_ID =140&BOARD_ FLAG=00&CONT_SEQ =318756&page =1 (Korean).,Non-OADS,/arxiv_data1/oa_pdf/40/0d/jpmph-49-1-53.PMC4750509.pdf
Available from:  http://sticerd.lse.ac.uk/dps/case/CR/CASEreport21.pdf.,Non-OADS,/arxiv_data1/oa_pdf/40/0d/jpmph-49-1-53.PMC4750509.pdf
"Journal of  Preventive Medicine  & Public Health 45 Copyright © 2016  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2016  The Korean Society for Preventive MedicineJ Prev Med Public Health 2016;49:45-52    •  http://dx.doi.org/10.3961/jpmph.15.029 Diabetes Mellitus and Site-specific Colorectal Cancer Risk  in Korea: A Case-control Study Hyeongtaek Woo1, Jeeyoo Lee1,2, Jeonghee Lee3, Ji Won Park4,5, Sungchan Park4, Jeongseon Kim3, Jae Hwan Oh4,   Aesun Shin1,3 1Department of Preventive Medicine, Seoul National University College of Medicine, Seoul; 2Department of Nutritional Science and Food Manage - ment, Ewha Womans University, Seoul; 3Molecular Epidemiology Branch, Division of Cancer Epidemiology and Prevention, Research Institute, Na - tional Cancer Center, Goyang; 4Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang; 5Department of Sur - gery, Seoul National University Hospital, Seoul, KoreaOriginal Article Objectives: Previous large-scale cohort studies conducted in Korea have found a positive association between diabetes mellitus (DM)  and colorectal cancer (CRC) in men only, in contrast to studies of other populations that have found significant associations in both  men and women.",Non-OADS,/arxiv_data1/oa_pdf/96/e8/jpmph-49-1-45.PMC4750510.pdf
"Key words:  Diabetes mellitus, Colorectal neoplasms, Colonic neoplasms Received:  April 30, 2015 Accepted:  December 22, 2015 Corresponding author:  Aesun Shin, MD, PhD 103 Daehak-ro, Jongno-gu, Seoul 03080, Korea  Tel: +82-2-740-8331, Fax:  +82- 2-747-4830 E-mail:  shinaesun@snu.ac.kr  This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.pISSN 1975-8375 eISSN 2233-4521  INTRODUCTION According to the Korean Central Cancer Registry, colorectal  cancer (CRC) is the third most common cancer in Korea, and the  burden of CRC is rapidly increasing [1].",Non-OADS,/arxiv_data1/oa_pdf/96/e8/jpmph-49-1-45.PMC4750510.pdf
ORCID Hyeongtaek Woo http://orcid.org/0000-0003-3020-7400 Jeeyoo Lee http://orcid.org/0000-0002-1470-7504 Ji Won Park https://orcid.org/0000-0003-0046-8175 Jeongseon Kim http://orcid.org/0000-0002-0889-2686 Jae Hwan Oh http://orcid.org/0000-0002-5883-5815 Aesun Shin http://orcid.org/0000-0002-6426-1969 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/96/e8/jpmph-49-1-45.PMC4750510.pdf
"Journal of  Preventive Medicine  & Public Health 1 Copyright © 2016  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2016  The Korean Society for Preventive MedicineJ Prev Med Public Health 2016;49:1-17    •  http://dx.doi.org/10.3961/jpmph.16.009 Legal Issues in Quarantine and Isolation for Control of  Emerging Infectious Diseases Cheonsoo Kim Sungkyunkwan University School of Law, Seoul, Korea Special Article The Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea in 2015 has drawn public attention regarding  the legal regulation of infectious disease control in Korea.",Non-OADS,/arxiv_data1/oa_pdf/35/b8/jpmph-49-1-1.PMC4750511.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.The Middle East respiratory syndrome coronavirus (MERS- CoV) outbreak in South Korea in 2015 has drawn public atten - tion and inspired political debate regarding the regulation of  infectious disease control in Korea.",Non-OADS,/arxiv_data1/oa_pdf/35/b8/jpmph-49-1-1.PMC4750511.pdf
SUPPLEMENTAL MATERIAL Supplemental material (Korean version) is available at  http://www.jpmph.org/.,Non-OADS,/arxiv_data1/oa_pdf/35/b8/jpmph-49-1-1.PMC4750511.pdf
ORCID Cheonsoo Kim https://orcid.org/0000-0002-0588-084X,Non-OADS,/arxiv_data1/oa_pdf/35/b8/jpmph-49-1-1.PMC4750511.pdf
"Journal of  Preventive Medicine  & Public Health 23 Copyright © 2016  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2016  The Korean Society for Preventive MedicineJ Prev Med Public Health 2016;49:23-34    •  http://dx.doi.org/10.3961/jpmph.15.063 The Tobacco Industry’s Abuse of Scientific Evidence and  Activities to Recruit Scientists During Tobacco Litigation Sungkyu Lee National Evidence-based Healthcare Collaborating Agency, Seoul, KoreaSpecial Article South Korea’s state health insurer, the National Health Insurance Service (NHIS), is in the process of a compensation suit against tobac - co industry.",Non-OADS,/arxiv_data1/oa_pdf/66/4e/jpmph-49-1-23.PMC4750512.pdf
"Key words:  Tobacco, Tobacco industry, Tobacco litigation, Tobacco industry litigation tactics Received:  November 12, 2015 Accepted:  January 13, 2016 Corresponding author:  Sungkyu Lee, PhD  173 Toegye-ro, Jung-gu, Seoul 04554, Korea Tel: +82-2-2174-2770, Fax:  +82-2-747-4916 E-mail:  wwwvince77@gmail.com This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.pISSN 1975-8375 eISSN 2233-4521  INTRODUCTION Litigation against tobacco companies plays an important  role in reinforcing and advancing tobacco control policies.",Non-OADS,/arxiv_data1/oa_pdf/66/4e/jpmph-49-1-23.PMC4750512.pdf
SUPPLEMENTAL MATERIAL Supplemental material (Korean version) is available at  http://www.jpmph.org/.,Non-OADS,/arxiv_data1/oa_pdf/66/4e/jpmph-49-1-23.PMC4750512.pdf
ORCID  Sungkyu Lee http://orcid.org/0000-0002-6419-2086,Non-OADS,/arxiv_data1/oa_pdf/66/4e/jpmph-49-1-23.PMC4750512.pdf
Available from: http://news1.kr/arti - cles/?1854787 (Korean).,Non-OADS,/arxiv_data1/oa_pdf/66/4e/jpmph-49-1-23.PMC4750512.pdf
Available from: http://triad-city-beat.com/in-print- cover-story-200000-cigarettes/.,Non-OADS,/arxiv_data1/oa_pdf/66/4e/jpmph-49-1-23.PMC4750512.pdf
Available from: http://news1.kr/arti - cles/?1854787 (Korean).,Non-OADS,/arxiv_data1/oa_pdf/66/4e/jpmph-49-1-23.PMC4750512.pdf
Available from: http://triad-city-beat.com/in-print- cover-story-200000-cigarettes/.,Non-OADS,/arxiv_data1/oa_pdf/66/4e/jpmph-49-1-23.PMC4750512.pdf
"Journal of  Preventive Medicine  & Public Health 35 Copyright © 2016  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2016  The Korean Society for Preventive MedicineJ Prev Med Public Health 2016;49:35-44    •  http://dx.doi.org/10.3961/jpmph.15.055 Associations of Sarcopenia and Sarcopenic Obesity With  Metabolic Syndrome Considering Both Muscle Mass and  Muscle Strength Jihye Lee1, Yeon-pyo Hong1, Hyun Ju Shin2, Weonyoung Lee1 1Department of Preventive Medicine, Chung-Ang University College of Medicine, Seoul; 2Namyangju City Hall, Namyangju, KoreaOriginal Article Objectives: We investigated the associations of sarcopenia-defined both in terms of muscle mass and muscle strength-and sarcope - nic obesity with metabolic syndrome.",Non-OADS,/arxiv_data1/oa_pdf/89/50/jpmph-49-1-35.PMC4750513.pdf
"Key words:  Sarcopenia, Metabolic syndrome X, Association, Muscle strength Received:  September 22, 2015 Accepted:  November 21, 2015 Corresponding author:  Yeon-pyo Hong, MD, PhD 84 Heukseok-ro, Dongjak-gu, Seoul 06974, Korea Tel: +82-2-820-5667, Fax:  +82-2-815-9509 E-mail:  hyp026@cau.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.pISSN 1975-8375 eISSN 2233-4521  INTRODUCTION Community-based health services in Korea include the regis - tration and management of hypertension and diabetes melli - tus patients, maternal and pediatric health care, mental health  care, home visits by health care providers, the management of  infectious diseases, health promotion, and metabolic syndrome  services [1].",Non-OADS,/arxiv_data1/oa_pdf/89/50/jpmph-49-1-35.PMC4750513.pdf
CONFLICT OF INTEREST The authors have no conflicts of interest associated with the  material presented in this paper.ORCID Jihye Lee http://orcid.org/0000-0003-0484-6698 Yeon-pyo Hong http://orcid.org/0000-0001-5332-5739 Hyun Ju Shin http://orcid.org/0000-0001-9974-6731 Weonyoung Lee http://orcid.org/0000-0003-1775-3044 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/89/50/jpmph-49-1-35.PMC4750513.pdf
Available from: http://www.who.int/ageing/en/.,Non-OADS,/arxiv_data1/oa_pdf/89/50/jpmph-49-1-35.PMC4750513.pdf
"Journal of  Preventive Medicine  & Public Health 61 Copyright © 2016  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2016  The Korean Society for Preventive MedicineJ Prev Med Public Health 2016;49:61-68    •  http://dx.doi.org/10.3961/jpmph.15.060 School Violence, Depressive Symptoms, and Help-seeking  Behavior: A Gender-stratified Analysis of Biethnic   Adolescents in South Korea  Ji-Hwan Kim1, Ja Young Kim1, Seung-Sup Kim1,2 1Department of Public Health Sciences, Graduate School of Korea University, Seoul; 2School of Health Policy and Management, Korea University  College of Health Sciences, Seoul, KoreaOriginal Article Objectives: In South Korea (hereafter Korea), the number of adolescent offspring of immigrants has rapidly increased since the early  1990s, mainly due to international marriage.",Non-OADS,/arxiv_data1/oa_pdf/3c/67/jpmph-49-1-61.PMC4750514.pdf
"Key words:  Minority health, Bullying, Depression, Help-seeking behavior, Republic of Korea Received:  November 5, 2015 Accepted:  January 11, 2016 Corresponding author:  Seung-Sup Kim, MD, ScD 145 Anam-ro, Seoungbuk-gu, Seoul 02841, Korea Tel: +82-2-3290-5676, Fax:  +82-2-940-2870   E-mail:  ssk3@korea.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.pISSN 1975-8375 eISSN 2233-4521  INTRODUCTION South Korea (hereafter Korea) has traditionally been regard - ed as a ethnically homogenous society.",Non-OADS,/arxiv_data1/oa_pdf/3c/67/jpmph-49-1-61.PMC4750514.pdf
"The 2012 NSMF is publicly available through the Ko - rea Women’s Development Institute (http://eng.kwdi.re.kr/),  and the data was anonymized and de-identified prior to public  release.",OADS,/arxiv_data1/oa_pdf/3c/67/jpmph-49-1-61.PMC4750514.pdf
ORCID   Ji-Hwan Kim https://orcid.org/0000-0001-9424-5962,Non-OADS,/arxiv_data1/oa_pdf/3c/67/jpmph-49-1-61.PMC4750514.pdf
67School Violence and Depressive Symptoms Ja Young Kim https://orcid.org/0000-0002-8949-1912  Seung-Sup Kim http://orcid.org/0000-0003-1830-0282  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/3c/67/jpmph-49-1-61.PMC4750514.pdf
Available from: http://www.index.,Non-OADS,/arxiv_data1/oa_pdf/3c/67/jpmph-49-1-61.PMC4750514.pdf
Available from: http://kostat.go.kr/portal/korea/kor_nw/2/1/ index.board?bmode =read&aSeq =335384 (Korean).,Non-OADS,/arxiv_data1/oa_pdf/3c/67/jpmph-49-1-61.PMC4750514.pdf
Available from: http://www.worldvalues - survey.org/WVSContents.jsp?CMSID =intinfo.,OADS,/arxiv_data1/oa_pdf/3c/67/jpmph-49-1-61.PMC4750514.pdf
"Journal of  Preventive Medicine  & Public Health 69 Copyright © 2016  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2016  The Korean Society for Preventive MedicineJ Prev Med Public Health 2016;49:69-78    •  http://dx.doi.org/10.3961/jpmph.15.016 Determinants of Mental Health Care Utilization in a Suicide  High-risk Group With Suicidal Ideation Hyun-Soo Kim, Moo-Sik Lee, Jee-Young Hong Department of Preventive Medicine, Konyang University College of Medicine, Daejeon, KoreaOriginal Article Objectives: The suicide rate in Korea is increasing every year, and is the highest among the Organization for Economic Cooperation  and Development countries.",Non-OADS,/arxiv_data1/oa_pdf/8a/0b/jpmph-49-1-69.PMC4750515.pdf
"Key words:  Mental health care, Suicidal ideation, Mental disorders, Republic of Korea Received:  March 18, 2015 Accepted:  January 13, 2016 Corresponding author:  Moo-Sik Lee, MD, PhD 158 Gwanjeodong-ro, Seo-gu, Daejeon 35365, Korea Tel: +82-42-600-6404, Fax:  +82-42-600-6401 E-mail:  mslee@konyang.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Suicide is a significant public health and social problem.",Non-OADS,/arxiv_data1/oa_pdf/8a/0b/jpmph-49-1-69.PMC4750515.pdf
CONFLICT OF INTEREST The authors have no conflicts of interest associated with the  material presented in this paper.ORCID Hyun-Soo Kim http://orcid.org/0000-0001-6024-753X Moo-Sik Lee http://orcid.org/0000-0003-1642-701X Jee-Young Hong http://orcid.org/0000-0003-4540-0780  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/8a/0b/jpmph-49-1-69.PMC4750515.pdf
Avail - able from: http://www.oecd.org/els/health-systems/health- data.htm.,Non-OADS,/arxiv_data1/oa_pdf/8a/0b/jpmph-49-1-69.PMC4750515.pdf
"Journal of  Preventive Medicine  & Public Health 18 Copyright © 2016  The Korean Society for Preventive MedicineJ Prev Med Public Health 2016;49:18-22    •  http://dx.doi.org/10.3961/jpmph.16.013 Ethical Perspectives on the Middle East Respiratory   Syndrome Coronavirus Epidemic in Korea Ock-Joo Kim  Department of the History of Medicine and Medical Humanities, Seoul National University College of Medicine, Seoul, Korea Special Article  Ethical considerations are essential in planning for and responding to outbreaks of infectious diseases.",Non-OADS,/arxiv_data1/oa_pdf/92/37/jpmph-49-1-18.PMC4750516.pdf
"Key words:  Middle East respiratory syndrome coronavirus, Public health, Ethics, Ethical principles, Epidemic, Republic of Korea  Received:  January 3, 2016 Accepted:  January 23, 2016 Corresponding author:  Ock-Joo Kim, MD, PhD 103 Daehak-ro, Jongno-gu, Seoul 03080, Korea Tel: +82-2-740-8061, Fax:  +82-2-765-5110 E-mail:  ockjoo.kim@gmail.com This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Ethical considerations have been embedded in plans made  throughout the world for outbreaks and pandemics [1-4].",Non-OADS,/arxiv_data1/oa_pdf/92/37/jpmph-49-1-18.PMC4750516.pdf
ORCID Ock-Joo Kim https://orcid.org/0000-0003-4095-4768 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/92/37/jpmph-49-1-18.PMC4750516.pdf
Available  from: http://www.nap.edu/read/11917/chapter/1.,Non-OADS,/arxiv_data1/oa_pdf/92/37/jpmph-49-1-18.PMC4750516.pdf
Available from: http://www.cdc.gov/od/science/ integrity/phethics/panFlu_Ethic_Guidelines.pdf.,Non-OADS,/arxiv_data1/oa_pdf/92/37/jpmph-49-1-18.PMC4750516.pdf
Available from: http://jcb.utoronto.,Non-OADS,/arxiv_data1/oa_pdf/92/37/jpmph-49-1-18.PMC4750516.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/f2/MOL2-10-282.PMC4750526.pdf
"2Current address: Northern Institute for Cancer Research, University of Newcastle Upon Tyne, Framlington Place, Newcastle Upon Tyne, UK.available at www.sciencedirect.com ScienceDirect www.elsevier.com /locate/molonc http://dx.doi.org/10.1016/j.molonc.2015.10.004 1574-7891/ ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/11/f2/MOL2-10-282.PMC4750526.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).MOLECULAR ONCOLOGY 10 (2016) 282 e291,Non-OADS,/arxiv_data1/oa_pdf/11/f2/MOL2-10-282.PMC4750526.pdf
Supplementary material Supplementary material related to this article can be found at http://dx.doi.org/10.1016/j.molonc.2015.10.004 .,Non-OADS,/arxiv_data1/oa_pdf/11/f2/MOL2-10-282.PMC4750526.pdf
The mass spectrometry proteomics data and the supplementary data have been deposited to the ProteomeXchange Consortium (24) via the PRIDE partner repository with the dataset identifier PXD002735 (http://www.ebi.ac.uk/pride/archive/projects/PXD002735/files).,OADS,/arxiv_data1/oa_pdf/97/0b/ijo-48-03-1016.PMC4750531.pdf
WmA Declaration of Helsinki - Ethical Principles for m edical  Research Involving Human Subjects: [http://www.wma.net/en/30publications/10policies/b3/index.html.13.,Non-OADS,/arxiv_data1/oa_pdf/ca/2f/ijo-48-03-0998.PMC4750535.pdf
"The study was approved by the Regional  Committee for Medical and Health Research Ethics, South-East Norway (RE k Sør) http://helseforskning.etikkom.no).",Non-OADS,/arxiv_data1/oa_pdf/4a/4a/ijo-48-03-1242.PMC4750536.pdf
"Three micro - grams of total RNA were sent for high-throughput paired-end  RNA-sequencing at the Norwegian Sequencing Centre, Ullevål Hospital (http://www.sequencing.uio.no/).",OADS,/arxiv_data1/oa_pdf/4a/4a/ijo-48-03-1242.PMC4750536.pdf
"The quality of the raw sequence data was assessed using FastQC software (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/).The software TopHat-Fusion was used for the discovery of fusion transcripts (14,15).",OADS,/arxiv_data1/oa_pdf/4a/4a/ijo-48-03-1242.PMC4750536.pdf
"To verify further the fusion gene which was found by TopHat-Fusion, the ‘grep’ command (http://en.wikipedia.org/wiki/Grep) was used to search the fastq files of sequence data (http://en.wikipedia.org/wiki/FASTQ_format).",OADS,/arxiv_data1/oa_pdf/4a/4a/ijo-48-03-1242.PMC4750536.pdf
"The sequences obtained by ‘grep’ were blasted against the human genomic plus transcript database (http://blast.ncbi.nlm.nih.gov/Blast.cgi) as well as the sequences with acces-sion numbers NM_024665.4 ( TBL1XR1 ) and NM_002131.3  (HMGA1 ) and DB051170.1 (TESTI2 Homo sapiens  cDNA  clone TESTI2040990, 5', mRNA sequence).",OADS,/arxiv_data1/oa_pdf/4a/4a/ijo-48-03-1242.PMC4750536.pdf
"PANAGOPOULOS  et al :  FUSION OF THE TBL1XR1  AND HMGA1  GENES IN SPLENIC HEMANGIOMA 1245 (Germany, http://www.gatc-biotech.com/en/home.html).",OADS,/arxiv_data1/oa_pdf/4a/4a/ijo-48-03-1242.PMC4750536.pdf
The  BLAST software (http://blast.ncbi.nlm.nih.gov/Blast.cgi) was used for computer analysis of sequence data.,OADS,/arxiv_data1/oa_pdf/4a/4a/ijo-48-03-1242.PMC4750536.pdf
"BLAT of these sequences on the human genome browser-hg19 assembly (http://genome-euro.ucsc.edu/cgi-bin/hgGateway) showed that they were chimeric cDNA fragments composed of nucleotides which mapped on 3q26 in the coding region of TBL1XR1  and nucleotides mapped on chromosome band 6p21,  circa 700 bp upstream of the HMGA1 sequence with accession  number NM_002131 and within the sequence with accession number DB051170 which is an alternative splicing transcript of HMGA1  found in testis (17).",OADS,/arxiv_data1/oa_pdf/4a/4a/ijo-48-03-1242.PMC4750536.pdf
Six transcript variants were identified encoding two different isoforms (http://www.ncbi.nlm.nih.gov/gene/3159).,Non-OADS,/arxiv_data1/oa_pdf/4a/4a/ijo-48-03-1242.PMC4750536.pdf
Data were analyzed using R statis-tical software (version 2.12.1; http://www.r-project.org/).,OADS,/arxiv_data1/oa_pdf/bc/40/ijo-48-03-0975.PMC4750537.pdf
Statistical analyses of microarray data were normalized using the robust multi-array average method with R statistical soft - ware (version 2.12.1; http://www.r-project.org/) together with the BioConductor package (http://www.bioconductor.org/).,OADS,/arxiv_data1/oa_pdf/bc/40/ijo-48-03-0975.PMC4750537.pdf
"© Maria Giovanna Francipane and Eric Lagasse *Correspondence to: Eric Lagasse; Email: Lagasse@pitt.eduSubmitted: 09/30/2014; Revised: 11/14/2014; Accepted: 11/27/2014 http://dx.doi.org/10.1080/15476278.2014.995509 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/4c/kogg-10-03-995509.PMC4750546.pdf
Gastroenterology 2011; 140:656-66.e2; PMID:21070777; http://dx.doi.org/10.1053/j.gastro.2010.11.006 2.,Non-OADS,/arxiv_data1/oa_pdf/db/4c/kogg-10-03-995509.PMC4750546.pdf
Nat Biotechnol 2012; 30:976- 83; PMID:23000933; http://dx.doi.org/10.1038/ nbt.2379 3.,OADS,/arxiv_data1/oa_pdf/db/4c/kogg-10-03-995509.PMC4750546.pdf
PLoS One 2012; 7:e52659; PMID:23285135; http://dx.doi.org/ 10.1371/journal.pone.0052659 6.,Non-OADS,/arxiv_data1/oa_pdf/db/4c/kogg-10-03-995509.PMC4750546.pdf
Cytokine 1997; 9:717-26; PMID:9344502;http://dx.doi.org/10.1006/cyto.1997.0227 8.,Non-OADS,/arxiv_data1/oa_pdf/db/4c/kogg-10-03-995509.PMC4750546.pdf
Nat Immunol 2004; 5:546-53; PMID:15098031; http://dx.doi.org/10.1038/ni1064 9.,Non-OADS,/arxiv_data1/oa_pdf/db/4c/kogg-10-03-995509.PMC4750546.pdf
Nature 2006; 441:988-91; PMID:16791197; http://dx.doi.org/10.1038/nature04813 10.,Non-OADS,/arxiv_data1/oa_pdf/db/4c/kogg-10-03-995509.PMC4750546.pdf
J Immunol 2009; 182:130-7; PMID:19109143; http://dx.doi.org/ 10.4049/jimmunol.182.1.130 11.,Non-OADS,/arxiv_data1/oa_pdf/db/4c/kogg-10-03-995509.PMC4750546.pdf
"Nat Immunol 2007; 8:304-11; PMID:17277780; http://dx.doi.org/10.1038/ni1438 12 Zuklys S, Balciunaite G, Agarwal A, Fasler-Kan E, Palmer E, Hollander GA. Normal thymic architecture and nega-tive selection are associated with Aire expression, the gene defective in the autoimmune-polyendocrinopathy-candi- diasis-ectodermal dystrophy (APECED).",Non-OADS,/arxiv_data1/oa_pdf/db/4c/kogg-10-03-995509.PMC4750546.pdf
"J Immunol 2000; 165:1976-83; PMID:10925280; http://dx.doi.org/ 10.4049/jimmunol.165.4.1976 13 Baik S, Jenkinson EJ, Lane PJ, Anderson G, Jenkinson WE.",OADS,/arxiv_data1/oa_pdf/db/4c/kogg-10-03-995509.PMC4750546.pdf
Eur J Immunol 2013; 43:589-94; PMID:23299414; http://dx.doi.org/10.1002/eji.201243209 14.,Non-OADS,/arxiv_data1/oa_pdf/db/4c/kogg-10-03-995509.PMC4750546.pdf
J Immunol 2013; 191:1200-9; PMID:23794633; http://dx.doi.org/10.4049/jimmunol.1203042 15.,Non-OADS,/arxiv_data1/oa_pdf/db/4c/kogg-10-03-995509.PMC4750546.pdf
Proc Natl Acad Sci U S A 2013; 110:9885-90; PMID:23720310; http://dx.doi.org/10.1073/ pnas.1301799110 16.,OADS,/arxiv_data1/oa_pdf/db/4c/kogg-10-03-995509.PMC4750546.pdf
Int J Biol Sci 2012; 8:1217-24; PMID:23136549; http://dx.doi.org/10.7150/ijbs.5109 17.,OADS,/arxiv_data1/oa_pdf/db/4c/kogg-10-03-995509.PMC4750546.pdf
Genes Dev 2003; 17:1709-13; PMID:12865297; http://dx.doi.org/10.1101/ gad.267103 18.,OADS,/arxiv_data1/oa_pdf/db/4c/kogg-10-03-995509.PMC4750546.pdf
Nature 2001; 414:98-104; PMID: 11689954; http://dx.doi.org/10.1038/35102160 19.,Non-OADS,/arxiv_data1/oa_pdf/db/4c/kogg-10-03-995509.PMC4750546.pdf
Cell Tissue Res 2012; 347:701-11; PMID:21833761; http://dx.doi.org/10.1007/s00441-011-1215-5 20.,Non-OADS,/arxiv_data1/oa_pdf/db/4c/kogg-10-03-995509.PMC4750546.pdf
Clin Oral Investig 2013;17:9-17; PMID:22695872; http://dx.doi.org/10.1007/ s00784-012-0763-8 21.,Non-OADS,/arxiv_data1/oa_pdf/db/4c/kogg-10-03-995509.PMC4750546.pdf
Haematologica 2012; 97:651-60; PMID:22058199; http://dx.doi.org/10.3324/haematol.2011.050500 22.,Non-OADS,/arxiv_data1/oa_pdf/db/4c/kogg-10-03-995509.PMC4750546.pdf
Biomed Res Int2013; 2013:854917; PMID:24369019; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/db/4c/kogg-10-03-995509.PMC4750546.pdf
Tissue Eng Part B Rev 2011; 17:263-80; PMID:21495897; http://dx.doi.org/10.1089/ten.teb.2010.0612 25.,Non-OADS,/arxiv_data1/oa_pdf/db/4c/kogg-10-03-995509.PMC4750546.pdf
Ann Biomed Eng 2010; 38:3272-9; PMID:20820920; http://dx.doi.org/10.1007/ s10439-010-0148-6 27.,Non-OADS,/arxiv_data1/oa_pdf/db/4c/kogg-10-03-995509.PMC4750546.pdf
Clin DevImmunol 2013; 2013:270301; PMID:23737810; http://dx.doi.org/10.1155/2013/270301 29.,Non-OADS,/arxiv_data1/oa_pdf/db/4c/kogg-10-03-995509.PMC4750546.pdf
Br J Surg 2008; 95:1449-61; PMID:18991254; http://dx.doi.org/10.1002/bjs.6391 31.,Non-OADS,/arxiv_data1/oa_pdf/db/4c/kogg-10-03-995509.PMC4750546.pdf
J Korean Med Sci2010; 25:203-10; PMID:20119571; http://dx.doi.org/ 10.3346/jkms.2010.25.2.203 33.,Non-OADS,/arxiv_data1/oa_pdf/db/4c/kogg-10-03-995509.PMC4750546.pdf
Current opinion in organ transplantation 2014; 19:169-74; PMID:24480968; http://dx.doi.org/10.1097/MOT.0000000000000050 35.,Non-OADS,/arxiv_data1/oa_pdf/db/4c/kogg-10-03-995509.PMC4750546.pdf
Cell Stem Cell 2012; 11:587-8; PMID:23122285; http://dx.doi.org/10.1016/j.stem.2012.10.004 www.landesbioscience.com 331 Organogenesis,OADS,/arxiv_data1/oa_pdf/db/4c/kogg-10-03-995509.PMC4750546.pdf
"In summary, there are concerns that limitations in the study design do not support any conclusion regarding the role of repeated administrations of gadolinium-based con- trast agents in general or a specific contrast agent in thisparticular patient group.Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate cred it to the original author(s) and the source, provide a link to the Crea tive Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/02/0c/330_2015_Article_4019.PMC4750553.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/59/main.PMC4750554.pdf
"Large  radiation  volumes  are  responsible  for  the substantial  risk  of  late  complications,  such  as  radiation  enteritis, http://dx.doi.org/10.1016/j.ejro.2015.07.001 2352-0477/© 2015  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/9b/59/main.PMC4750554.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.,Non-OADS,/arxiv_data1/oa_pdf/9b/59/main.PMC4750554.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3c/61/main.PMC4750556.pdf
http://dx.doi.org/10.1016/j.ejro.2014.12.002 2352-0477/©  2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/3c/61/main.PMC4750556.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3c/61/main.PMC4750556.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/08/main.PMC4750557.pdf
Contents lists available at ScienceDirect Molecular Genetics and Metabolism Reports journal homepage: http://www.journals.e lsevier.com/molecular-genetics-and- metabolism-reports/ http://dx.doi.org/10.1016/j.ymgmr.2015.05.002 2214-4269/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/08/main.PMC4750557.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/08/main.PMC4750557.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9d/d9/main.PMC4750558.pdf
http://dx.doi.org/10.1016/j.ymgmr.2015.03.003 2214-4269/© 2015 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/9d/d9/main.PMC4750558.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9d/d9/main.PMC4750558.pdf
Contents lists available at ScienceDirect Molecular Genetics and Metabolism Reports journal homepage: http://www.journals.elsevier.com/molecular-genetics-and- metabolism-reports/,Non-OADS,/arxiv_data1/oa_pdf/9d/d9/main.PMC4750558.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/37/5f/main.PMC4750559.pdf
http://dx.doi.org/10.1016/j.ymgmr.2015.04.002 2214-4269/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/37/5f/main.PMC4750559.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/37/5f/main.PMC4750559.pdf
Contents lists available at ScienceDirect Molecular Genetics and Metabolism Reports journal homepage: http://www.journals.elsevier.com/molecular-genetics-and- metabolism-reports/,Non-OADS,/arxiv_data1/oa_pdf/37/5f/main.PMC4750559.pdf
"9 (1994) 22 –30,http://dx.doi.org/10.1002/mds.870090105 .",Non-OADS,/arxiv_data1/oa_pdf/37/5f/main.PMC4750559.pdf
"40 (2003) 1797 –1817, http://dx.doi.org/10.1373/clinchem.2003.022178 .",Non-OADS,/arxiv_data1/oa_pdf/37/5f/main.PMC4750559.pdf
doi: http://www.ncbi.nlm.nih.gov/books/NBK1116/accessed on 9/4/15 .,Non-OADS,/arxiv_data1/oa_pdf/37/5f/main.PMC4750559.pdf
"137 (2000) 681 –686, http://dx.doi.org/10.1067/mpd.2000.108954 .",Non-OADS,/arxiv_data1/oa_pdf/37/5f/main.PMC4750559.pdf
"17 (4) (Jul 2013) 383–389, http://dx.doi.org/10.1016/j.ejpn.2013.01.003 (Epub 2013).",OADS,/arxiv_data1/oa_pdf/37/5f/main.PMC4750559.pdf
"142C (2) (May 15, 2006) 86 –94,http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/37/5f/main.PMC4750559.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/34/eb/main.PMC4750561.pdf
"The major indications to perform a videodefecographic examination are constipation, incompleteevacuation or incontinence, perineal pain and as a follow-up http://dx.doi.org/10.1016/j.ejro.2014.09.003 2352-0477/© 2014 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/34/eb/main.PMC4750561.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/34/eb/main.PMC4750561.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5f/ba/main.PMC4750562.pdf
"Moreover, http://dx.doi.org/10.1016/j.ejro.2015.05.003 2352-0477/©  2015  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/5f/ba/main.PMC4750562.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5f/ba/main.PMC4750562.pdf
"For qualitative analyses,  all  image  slices  were  evaluated  using  3D Slicer 4.2  open-source  platform  (http://www.slicer.org ,  Boston, MA) as the  visualization  environment  and  with  ﬂexible  win- dows and  levels  for  ventilation  and  emphysema  extent.",OADS,/arxiv_data1/oa_pdf/5f/ba/main.PMC4750562.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/38/bc/main.PMC4750564.pdf
He  had  a recent (a year  ago)  history  of  surgical  review  of  the  right  hip http://dx.doi.org/10.1016/j.ejro.2014.11.001 2352-0477/©  2014  Published  by  Elsevier  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/38/bc/main.PMC4750564.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/38/bc/main.PMC4750564.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f5/3b/main.PMC4750566.pdf
http://dx.doi.org/10.1016/j.ejro.2014.07.001 2352-0477/©  2014  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/f5/3b/main.PMC4750566.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f5/3b/main.PMC4750566.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ee/20/main.PMC4750569.pdf
:  +81  75  751  3760;  fax:  +81  75  771  9709. http://dx.doi.org/10.1016/j.ejro.2015.05.004 2352-0477/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/ee/20/main.PMC4750569.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.,Non-OADS,/arxiv_data1/oa_pdf/ee/20/main.PMC4750569.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/57/f5/main.PMC4750570.pdf
http://dx.doi.org/10.1016/j.ymgmr.2015.05.007 2214-4269/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/57/f5/main.PMC4750570.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/57/f5/main.PMC4750570.pdf
Contents lists available at ScienceDirect Molecular Genetics and Metabolism Reports journal homepage: http://www.journals.elsevier.com/molecular-genetics-and- metabolism-reports/,Non-OADS,/arxiv_data1/oa_pdf/57/f5/main.PMC4750570.pdf
"Timson, The biochemical basis of hereditary fructose intoler- ance, J Inherit Metab Dis 33 (2010) 105 –112, http://dx.doi.org/10.1007/ s10545-010-9053-2 .",Non-OADS,/arxiv_data1/oa_pdf/57/f5/main.PMC4750570.pdf
"Cox, Neonatal screening for hereditary fructose in- tolerance: frequency of the most common mutant aldolase B allele (A149P) in the British population, J Med Genet 33 (1996) 837 –841, http://dx.doi.org/10.1136/ jmg.33.10.837 .",Non-OADS,/arxiv_data1/oa_pdf/57/f5/main.PMC4750570.pdf
"Tolan, Increased prevalence of mutant null alleles that cause hereditary fructose intolerance in the American population, J Inherit Metab Dis 33 (2010) 33 –42,http://dx.doi.org/10.1007/s10545-010-9192- .",Non-OADS,/arxiv_data1/oa_pdf/57/f5/main.PMC4750570.pdf
"Enzyme de ﬁciencies: essential fructosuria, fructose intolerance, and glycogen-storage disease, Am J Clin Nutr 21 (1968) 693 –698 PubMed: 4875257 http://ajcn.nutrition.org/content/21/6/693.long .",Non-OADS,/arxiv_data1/oa_pdf/57/f5/main.PMC4750570.pdf
"Cox, The genetic consequences of our sweet tooth, Nat Rev Genet 3 (2002) 481 –487, http://dx.doi.org/10.1038/nrg815 .",Non-OADS,/arxiv_data1/oa_pdf/57/f5/main.PMC4750570.pdf
"Diagnosis, management, and course in 55 patients, Am J Dis Child 132 (1978) 605 –608, http://dx.doi.org/10.1001/archpedi.",Non-OADS,/arxiv_data1/oa_pdf/57/f5/main.PMC4750570.pdf
Retrieved from http://hgmdtrial.biobase-international.com/ hgmd/pro/trial.php .,OADS,/arxiv_data1/oa_pdf/57/f5/main.PMC4750570.pdf
"Tolan, C. Gregori, et al., Molec- ular analysis of aldolase B genes in hereditary fructose intolerance, Lancet 335 (1990) 306 –309, http://dx.doi.org/10.1016/0140-6736(90)906033 .",OADS,/arxiv_data1/oa_pdf/57/f5/main.PMC4750570.pdf
"Cox, Catalytic de ﬁciency of human aldolase B in heredi- tary fructose intolerance caused by a common missense mutation, Cell 53 (1988)881 –885, http://dx.doi.org/10.1016/S0092-8674(88)90349-2 .",Non-OADS,/arxiv_data1/oa_pdf/57/f5/main.PMC4750570.pdf
"Tolan, Molecular evidence for compound heterozygosity in hereditary fructose intolerance, Am J Hum Genet 46 (1990) 1194 –1199 http://www.ncbi.nlm.",Non-OADS,/arxiv_data1/oa_pdf/57/f5/main.PMC4750570.pdf
"Tolan, A partially active mutant aldolase B from a patient with he- reditary fructose intolerance, The FASEB J 8 (1994) 107 –113http://www.fasebj.org/ content/8/1/107.full.pdf .",Non-OADS,/arxiv_data1/oa_pdf/57/f5/main.PMC4750570.pdf
"[23] M. Cornblath, I. Rosenthal, R. Sh, W. Sh, C. Rk, Hereditary fructose intolerance, N Engl J Med 269 (1963) 1271 –1278, http://dx.doi.org/10.1056/NEJM196312122692401 .",Non-OADS,/arxiv_data1/oa_pdf/57/f5/main.PMC4750570.pdf
DOI: http://dx.doi.org/10.1016/S0140- 6736 (62)92857-X [25] A.R.,OADS,/arxiv_data1/oa_pdf/57/f5/main.PMC4750570.pdf
"Ryman, High liver glycogen in hereditary fructose intolerance, Gut 12 (1971) 929 –932 PubMed: 5289293 http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC1411945/ .",Non-OADS,/arxiv_data1/oa_pdf/57/f5/main.PMC4750570.pdf
"[28] G. Sebastio, R. de Franchis, P. Strisciuglio, G. Andria, C. Dionisi Vici, G. Sabetta, Aldol- ase B mutations in Italian families affected by hereditary fructose intolerance, J Med Genet 28 (1991) 241 –243, http://dx.doi.org/10.1136/jmg.28.4.241 .",Non-OADS,/arxiv_data1/oa_pdf/57/f5/main.PMC4750570.pdf
"Adão, M.B.A. Glória, Bioactive amines and carbohydrate changes during ripening of‘Prata ’banana ( Musa acuminata × M. balbisiana ), Food Chem 90 (2005) 705 –711, http://dx.doi.org/10.1016/j.foodchem.2004.05.020 .",Non-OADS,/arxiv_data1/oa_pdf/57/f5/main.PMC4750570.pdf
"during ripening, Food Science and Technology 17 (1997) 94–97http://dx.doi.org/10.1590/S0101-20611997000200005 (Campinas).",Non-OADS,/arxiv_data1/oa_pdf/57/f5/main.PMC4750570.pdf
"[33] A. Fiocchi, C. Dionisi-Vici, G. Cotugno, P. Koch, L. Dahdah, Fruit-induced FPIES masquerading as hereditary fructose intolerance, Pediatrics 134 (2014) 602 –605, http://dx.doi.org/10.1542/peds.2013-2623 .",Non-OADS,/arxiv_data1/oa_pdf/57/f5/main.PMC4750570.pdf
"[34] M. Lentze, Congenital diseases of the gastrointestinal tract, Georgian Med News 230 (2014) 46 –53 PubMed: 24940857 http://europepmc.org/abstract/med/24940857 .38 E.R.",Non-OADS,/arxiv_data1/oa_pdf/57/f5/main.PMC4750570.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/10/d9/main.PMC4750572.pdf
http://dx.doi.org/10.1016/j.ymgmr.2015.03.008 2214-4269/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/10/d9/main.PMC4750572.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/10/d9/main.PMC4750572.pdf
Contents lists available at ScienceDirect Molecular Genetics and Metabolism Reports journal homepage: http://www.journals.elsevier.com/molecular-genetics-and- metabolism-reports/,Non-OADS,/arxiv_data1/oa_pdf/10/d9/main.PMC4750572.pdf
4 of these  patients  had  serous  borderline  tumors  of  the  ovaries with low  grade  serous  carcinoma  peritoneal  implants  (three http://dx.doi.org/10.1016/j.ejro.2015.01.001 2352-0477/©  2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/85/05/main.PMC4750573.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/05/main.PMC4750573.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1f/ed/main.PMC4750574.pdf
Contents lists available at ScienceDirect Molecular Genetics and Metabolism Reports journal homepage: http://www.journals.elsevier.com/molecular-genetics-and- metabolism-reports/ http://dx.doi.org/10.1016/j.ymgmr.2015.07.003 2214-4269/Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/1f/ed/main.PMC4750574.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1f/ed/main.PMC4750574.pdf
References [1]http://www.orpha.net/serach: glycogen storage disease0.,Non-OADS,/arxiv_data1/oa_pdf/1f/ed/main.PMC4750574.pdf
[2]http://omim.org/search=glycogen storage disease0 .,Non-OADS,/arxiv_data1/oa_pdf/1f/ed/main.PMC4750574.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/33/main.PMC4750575.pdf
Contents lists available at ScienceDirect Molecular Genetics and Metabolism Reports journal homepage: http://www.journals.elsevier.com/molecular-genetics-and- metabolism-reports/ http://dx.doi.org/10.1016/j.ymgmr.2015.06.003 2214-4269/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a6/33/main.PMC4750575.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a6/33/main.PMC4750575.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ff/78/main.PMC4750576.pdf
http://dx.doi.org/10.1016/j.ymgmr.2015.02.003 2214-4269/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/78/main.PMC4750576.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ff/78/main.PMC4750576.pdf
Contents lists available at ScienceDirect Molecular Genetics and Metabolism Reports journal homepage: http://www.journals.elsevier.com/molecular-genetics-and- metabolism-reports/,Non-OADS,/arxiv_data1/oa_pdf/ff/78/main.PMC4750576.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6e/8c/main.PMC4750577.pdf
http://dx.doi.org/10.1016/j.ymgmr.2015.02.002 2214-4269/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6e/8c/main.PMC4750577.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6e/8c/main.PMC4750577.pdf
Contents lists available at ScienceDirect Molecular Genetics and Metabolism Reports journal homepage: http://www.journals.elsevier.com/molecular-genetics-and- metabolism-reports/,Non-OADS,/arxiv_data1/oa_pdf/6e/8c/main.PMC4750577.pdf
:  +91  9882597988. http://dx.doi.org/10.1016/j.ejro.2015.02.001 2352-0477/©  2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/5e/main.PMC4750578.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/5e/main.PMC4750578.pdf
We analyzed data  using  EpiInfo  version 7.1.4 for  windows  (http://wwwn.cdc.gov/epiinfo/7/ ).,OADS,/arxiv_data1/oa_pdf/dd/5e/main.PMC4750578.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8e/3f/main.PMC4750580.pdf
http://dx.doi.org/10.1016/j.ymgmr.2015.03.004 2214-4269/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8e/3f/main.PMC4750580.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8e/3f/main.PMC4750580.pdf
Contents lists available at ScienceDirect Molecular Genetics and Metabolism Reports journal homepage: http://www.journals.elsevier.com/molecular-genetics-and- metabolism-reports/,Non-OADS,/arxiv_data1/oa_pdf/8e/3f/main.PMC4750580.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/69/f6/main.PMC4750581.pdf
The  ﬁbrotic  stage  is  classiﬁed according  to  histological  criteria  using  the  META VIR  scoring system whereby  stages  F1–F4  predominantly  assess  periportal ﬁbrosis [5]  and  stages  B1–B4  predominantly  assess  pericentral http://dx.doi.org/10.1016/j.ejro.2015.05.002 2352-0477/©  2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/69/f6/main.PMC4750581.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/69/f6/main.PMC4750581.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Molecular Genetics and Metabolism Reports 3 (2015) 65 –74 Abbreviations: 6MWT, Six minute walking test; BAER, Brainstem auditory evoked responses; CNS, Central nervous system; EF, Ejection fraction;ERT, Enzyme replacem ent therapy; ENT, Ear nose and throat; GAGs, Glycosaminoglycans; HAQ, Health Assessment Questionnaire; I2S, Iduronate-2-sulfatase; JROM, Joint range of motion; LV M/LVMI, Left ventricular mass/left- ventricular mass index; MDCT, Multidetector computed tomography; MPS, Mucopolysaccharidosis; MPS II, Mucopolysaccharidosis type II; MRI, Magne tic resonance imaging; QoL, Quality of Life; UAI, Upper airway infections.",Non-OADS,/arxiv_data1/oa_pdf/72/77/main.PMC4750582.pdf
http://dx.doi.org/10.1016/j.ymgmr.2015.03.011 2214-4269/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/72/77/main.PMC4750582.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/72/77/main.PMC4750582.pdf
Contents lists available at ScienceDirect Molecular Genetics and Metabolism Reports journal homepage: http://www.journals.elsevier.com/molecular-genetics-and- metabolism-reports/,Non-OADS,/arxiv_data1/oa_pdf/72/77/main.PMC4750582.pdf
"37 (2014) 1 –12,http://dx.doi.org/10.1007/ s10545-013-9613-3 .",Non-OADS,/arxiv_data1/oa_pdf/72/77/main.PMC4750582.pdf
"[3] R. Martin, M. Beck, C. Eng, R. Giugliani, P. Harmatz, V. Muñoz, et al., Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome), Pediatrics 121 (2008) e377 –e386, http://dx.doi.org/10.1542/peds.2007-1350 .",Non-OADS,/arxiv_data1/oa_pdf/72/77/main.PMC4750582.pdf
"99 (2010) 18 –25,http://dx.doi.org/10.1016/j.ymgme.2009.08.006 .",OADS,/arxiv_data1/oa_pdf/72/77/main.PMC4750582.pdf
"107 (2012) 513 –520, http://dx.doi.org/10.1016/j.ymgme.2012.09.004 .",OADS,/arxiv_data1/oa_pdf/72/77/main.PMC4750582.pdf
"Vlachonikolis, A.M. Tsilimigaki, Spleen length in childhood with US: normal values based on age, sex, and somatometric parameters, Radiology 231 (2004) 129 –134, http://dx.doi.org/10.1148/radiol.2311020963 .",Non-OADS,/arxiv_data1/oa_pdf/72/77/main.PMC4750582.pdf
"91 (2007) 37 –47,http://dx.doi.org/10.1016/j.ymgme.2007.01.011 .",OADS,/arxiv_data1/oa_pdf/72/77/main.PMC4750582.pdf
1 –7 (2014) http://dx.doi.org/10.1007/s10545-014-9686-7 .,Non-OADS,/arxiv_data1/oa_pdf/72/77/main.PMC4750582.pdf
"109 (2013) 41 –48,http://dx.doi.org/ 10.1016/j.ymgme.2013.03.001 .",OADS,/arxiv_data1/oa_pdf/72/77/main.PMC4750582.pdf
"A 158A (2012) 2131 –2138, http://dx.doi.org/10.1002/ajmg.a.35498 .",Non-OADS,/arxiv_data1/oa_pdf/72/77/main.PMC4750582.pdf
"3 (2010) 101 –107, http://dx.doi.org/10.3233/PRM-2010-0112 .",Non-OADS,/arxiv_data1/oa_pdf/72/77/main.PMC4750582.pdf
"77 (2013) 1204 –1208, http://dx.doi.org/10.1016/j.ijporl.2013.05.00 .",OADS,/arxiv_data1/oa_pdf/72/77/main.PMC4750582.pdf
"101 (2012) e42 –e47, http://dx.doi.org/10.1111/ j.1651-2227.2011.02385.x .",Non-OADS,/arxiv_data1/oa_pdf/72/77/main.PMC4750582.pdf
"108 (2013) 172–177, http://dx.doi.org/10.1016/j.ymgme.2012.12.010 .",OADS,/arxiv_data1/oa_pdf/72/77/main.PMC4750582.pdf
"34 (2011) 1183 –1197, http://dx.doi.org/ 10.1007/s10545-011-9359-8 .",Non-OADS,/arxiv_data1/oa_pdf/72/77/main.PMC4750582.pdf
"(2012) 1 –8,http://dx.doi.org/10.1007/s10545-011-9444-z .73 R. Parini et al.",Non-OADS,/arxiv_data1/oa_pdf/72/77/main.PMC4750582.pdf
"98 (2006) 416 –418, http://dx.doi.org/10.1016/j.amjcard.2006.02.047 .",Non-OADS,/arxiv_data1/oa_pdf/72/77/main.PMC4750582.pdf
"Coppa, Enzyme-replacement therapy in a 5-month-old boy with attenuated presymptomatic MPS I: 5-year follow-up, Pediatrics 125 (2010) e183 –e187, http://dx.doi.org/10.1542/peds.2009-1728 .",Non-OADS,/arxiv_data1/oa_pdf/72/77/main.PMC4750582.pdf
"77 (2010) 492 –498, http://dx.doi.org/10.1111/j.1399- 0004.2009.01324.x .",Non-OADS,/arxiv_data1/oa_pdf/72/77/main.PMC4750582.pdf
"34 (2011) 749 –754, http://dx.doi.org/10.1007/s10545-011-9280-1 .",Non-OADS,/arxiv_data1/oa_pdf/72/77/main.PMC4750582.pdf
"[43] A. Pievani, I. Azario, L. Antolini, T. Shimada, P. Patel, C. Remoli, et al., Neonatal bone marrow transplantation prevents bone pathology in a mouse model of mucopolysaccharidosis type I, Blood 125 (2014) 1662 –1671, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/72/77/main.PMC4750582.pdf
"171 (2012) 181 –188, http://dx.doi.org/10.1007/s00431- 011-1606-3 .74 R. Parini et al.",Non-OADS,/arxiv_data1/oa_pdf/72/77/main.PMC4750582.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/66/36/main.PMC4750584.pdf
http://dx.doi.org/10.1016/j.ejro.2014.10.001 2352-0477/©  2014  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/66/36/main.PMC4750584.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/66/36/main.PMC4750584.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/4f/main.PMC4750586.pdf
http://dx.doi.org/10.1016/j.ymgmr.2015.06.002 2214-4269/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/33/4f/main.PMC4750586.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/33/4f/main.PMC4750586.pdf
Contents lists available at ScienceDirect Molecular Genetics and Metabolism Reports journal homepage: http://www.journals.elsevier.com/molecular-genetics-and- metabolism-reports/,Non-OADS,/arxiv_data1/oa_pdf/33/4f/main.PMC4750586.pdf
Multiple sequence alignment of ARSB in a few vertebrate species was carried out using ClustalW server and plotted using ESPript (Easy Se- quencing of Postscript) 3.0 ( http://espript.ibcp.fr )[31].,OADS,/arxiv_data1/oa_pdf/33/4f/main.PMC4750586.pdf
Chapter 41 Available from: http://www.ncbi.nlm.nih.gov/books/NBK1934/.,Non-OADS,/arxiv_data1/oa_pdf/33/4f/main.PMC4750586.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/4b/main.PMC4750587.pdf
http://dx.doi.org/10.1016/j.ymgmr.2015.07.002 2214-4269/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/7b/4b/main.PMC4750587.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/4b/main.PMC4750587.pdf
Contents lists available at ScienceDirect Molecular Genetics and Metabolism Reports journal homepage: http://www.journals.elsevier.com/molecular-genetics-and- metabolism-reports/,Non-OADS,/arxiv_data1/oa_pdf/7b/4b/main.PMC4750587.pdf
"32 (2009) 40 –45,http://dx.doi.org/10.1007/s10545-008-0947- 1.",Non-OADS,/arxiv_data1/oa_pdf/7b/4b/main.PMC4750587.pdf
"35 (2012) 983 –992, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/7b/4b/main.PMC4750587.pdf
"101 (2010) 110 –114, http://dx.doi.org/10.1016/ j.ymgme.2010.06.015 .",OADS,/arxiv_data1/oa_pdf/7b/4b/main.PMC4750587.pdf
"104 (2011) 89 –92,http://dx.doi.org/10.1016/j.ymgme.2011.05.",OADS,/arxiv_data1/oa_pdf/7b/4b/main.PMC4750587.pdf
"95 (2008) 17–20,http://dx.doi.org/10.1016/j.ymgme.2008.06.014 .",OADS,/arxiv_data1/oa_pdf/7b/4b/main.PMC4750587.pdf
"111 (2014) 445 –451, http://dx.doi.org/10.1016/j.ymgme.2014.01.",OADS,/arxiv_data1/oa_pdf/7b/4b/main.PMC4750587.pdf
"68 (2014) 119 –124, http://dx.doi.org/10.1038/ejcn.2013.218 .",Non-OADS,/arxiv_data1/oa_pdf/7b/4b/main.PMC4750587.pdf
(Available from URL: http://www.bls.nvs2.de/ ).,OADS,/arxiv_data1/oa_pdf/7b/4b/main.PMC4750587.pdf
(Available from: URL: http://www.bmelv.de/cae/ servlet/contentblob/378624/publicationFile/25912/EsKiMoStudie.pdf ).,Non-OADS,/arxiv_data1/oa_pdf/7b/4b/main.PMC4750587.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/0a/main.PMC4750588.pdf
http://dx.doi.org/10.1016/j.ymgmr.2015.03.001 2214-4269/Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/3f/0a/main.PMC4750588.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3f/0a/main.PMC4750588.pdf
Contents lists available at ScienceDirect Molecular Genetics and Metabolism Reports journal homepage: http://www.journals.elsevier.com/molecular-genetics-and- metabolism-reports/,Non-OADS,/arxiv_data1/oa_pdf/3f/0a/main.PMC4750588.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4f/57/main.PMC4750589.pdf
http://dx.doi.org/10.1016/j.ymgmr.2015.01.004 2214-4269/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4f/57/main.PMC4750589.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4f/57/main.PMC4750589.pdf
Contents lists available at ScienceDirect Molecular Genetics and Metabolism Reports journal homepage: http://www.journals.elsevier.com/molecular-genetics-and- metabolism-reports/,Non-OADS,/arxiv_data1/oa_pdf/4f/57/main.PMC4750589.pdf
EFG1 consists of 751 amino acids and includes ﬁve Pfam domains (http://pfam.janelia.org )(Fig.,Non-OADS,/arxiv_data1/oa_pdf/4f/57/main.PMC4750589.pdf
EFG1 protein structure with its functional domains ( http://pfam.janelia.org ).,Non-OADS,/arxiv_data1/oa_pdf/4f/57/main.PMC4750589.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-SA  license  (http://creativecommons.org/licenses/ by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/57/06/main.PMC4750607.pdf
However  these  examination  tools  are limited  in  their  ability  to  depict  the  soft  tissue  differences  in http://dx.doi.org/10.1016/j.ejro.2014.09.002 2352-0477/©  2014  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/57/06/main.PMC4750607.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-SA  license  (http://creativecommons.org/licenses/ by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/57/06/main.PMC4750607.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/a6/main.PMC4750608.pdf
http://dx.doi.org/10.1016/j.ejro.2014.12.004 2352-0477/©  2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/32/a6/main.PMC4750608.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/32/a6/main.PMC4750608.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/60/19/main.PMC4750609.pdf
http://dx.doi.org/10.1016/j.ymgmr.2015.04.001 2214-4269/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/60/19/main.PMC4750609.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/60/19/main.PMC4750609.pdf
Contents lists available at ScienceDirect Molecular Genetics and Metabolism Reports journal homepage: http://www.journals.elsevier.com/molecular-genetics-and- metabolism-reports/,Non-OADS,/arxiv_data1/oa_pdf/60/19/main.PMC4750609.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/09/42/main.PMC4750610.pdf
http://dx.doi.org/10.1016/j.ymgmr.2015.07.005 2214-4269/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/09/42/main.PMC4750610.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/09/42/main.PMC4750610.pdf
Contents lists available at ScienceDirect Molecular Genetics and Metabolism Reports journal homepage: http://www.journals.elsevier.com/molecular-genetics-and- metabolism-reports/,Non-OADS,/arxiv_data1/oa_pdf/09/42/main.PMC4750610.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/86/main.PMC4750612.pdf
So http://dx.doi.org/10.1016/j.ejro.2014.08.001 2352-0477/©  2014  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/b8/86/main.PMC4750612.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/86/main.PMC4750612.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/0e/main.PMC4750614.pdf
Contents lists available at ScienceDirect Molecular Genetics and Metabolism Reports journal homepage: http://www.journals.elsevier.com/molecular-genetics-and- metabolism-reports/ http://dx.doi.org/10.1016/j.ymgmr.2015.03.007 2214-4269/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c8/0e/main.PMC4750614.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/0e/main.PMC4750614.pdf
"57 (16) (April 19 2011) 1641 –1649, http://dx.doi.org/10.1016/j.jacc.2011.01.015 .",Non-OADS,/arxiv_data1/oa_pdf/c8/0e/main.PMC4750614.pdf
"5 (4) (August 1 2012) 868 –877, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c8/0e/main.PMC4750614.pdf
"Mansur, A.C. Pereira, C. Friedman, A new duplication in the mitochondrially encoded tRNA proline gene in a patient with dilated cardiomyopa- thy, Mitochondrial DNA 24 (1) (Feb 2013) 46 –49,http://dx.doi.org/10.3109/ 19401736.2012.717933 .",Non-OADS,/arxiv_data1/oa_pdf/c8/0e/main.PMC4750614.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ff/10/main.PMC4750615.pdf
Contents lists available at ScienceDirect Molecular Genetics and Metabolism Reports journal homepage: http://www.journals.elsevier.com/molecular-genetics-and- metabolism-reports/ http://dx.doi.org/10.1016/j.ymgmr.2015.06.001 2214-4269/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/10/main.PMC4750615.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ff/10/main.PMC4750615.pdf
"1793 (2009) 181 –185, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ff/10/main.PMC4750615.pdf
"67 (2000) 1400 –1410, http://dx.doi.org/10.1086/316900 .",Non-OADS,/arxiv_data1/oa_pdf/ff/10/main.PMC4750615.pdf
"35 (2014) 954 –958, http://dx.doi.org/ 10.1002/humu.22596 .",Non-OADS,/arxiv_data1/oa_pdf/ff/10/main.PMC4750615.pdf
"28 (2013) 236 –242, http://dx.doi.org/10.1177/0883073812445787 .",Non-OADS,/arxiv_data1/oa_pdf/ff/10/main.PMC4750615.pdf
"50 (2001) 133 –141, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ff/10/main.PMC4750615.pdf
"341 (1999) 1037 –1044, http://dx.doi.org/10.1056/NEJM199909303411404 .",Non-OADS,/arxiv_data1/oa_pdf/ff/10/main.PMC4750615.pdf
"Tarnopolsky, Beneﬁcial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders, Mus- cle Nerve 35 (2007) 235 –242, http://dx.doi.org/10.1002/mus.20688 .",Non-OADS,/arxiv_data1/oa_pdf/ff/10/main.PMC4750615.pdf
"23 (2000) 27 –44,http://dx.doi.org/10.1023/A:1005694712583 .41 M. Mori et al.",Non-OADS,/arxiv_data1/oa_pdf/ff/10/main.PMC4750615.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/3c/main.PMC4750616.pdf
"Other  intrinsic  factors,  such  as  the  education  and http://dx.doi.org/10.1016/j.ejro.2015.07.002 2352-0477/© 2015  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/b7/3c/main.PMC4750616.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.,Non-OADS,/arxiv_data1/oa_pdf/b7/3c/main.PMC4750616.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the online  version,  at  http://dx.doi.org/10.1016/j.ejro.2015.07.002 References [1]  M.C.",OADS,/arxiv_data1/oa_pdf/b7/3c/main.PMC4750616.pdf
"Part  4:  entrance  doses  achieved  during  the  X-ray  examination  of the chest, RoFo:  Fortschritte  auf  dem  Gebiete  der  Rontgenstrahlen  und  der Nuklearmedizin  180  (2008)  1082–1103,  http://dx.doi.org/10.1055/s-2008- 1027787 [2]  I.I.",Non-OADS,/arxiv_data1/oa_pdf/b7/3c/main.PMC4750616.pdf
"156  (2013)  310–314,  http://dx.doi.org/10.1093/rpd/nct073 [3]  C.E.",Non-OADS,/arxiv_data1/oa_pdf/b7/3c/main.PMC4750616.pdf
"3)  (2004) S196–S200,  http://dx.doi.org/10.1007/s00247-004-1269-6 ,  discussion S234–141.",Non-OADS,/arxiv_data1/oa_pdf/b7/3c/main.PMC4750616.pdf
"Study of  the  course  of  the  disease,  RoFo: Fortschritte  auf  dem  Gebiete  der  Rontgenstrahlen  und  der  Nuklearmedizin 144  (1986)  648–655,  http://dx.doi.org/10.1055/s-2008-1048856 [5]  E.B.",Non-OADS,/arxiv_data1/oa_pdf/b7/3c/main.PMC4750616.pdf
"Annual oration in honor of William  Henry  Neil,  M.D.,  1924–1972, Radiology  140  (1981)  291–300,  http://dx.doi.org/10.1148/radiology.140.2.",Non-OADS,/arxiv_data1/oa_pdf/b7/3c/main.PMC4750616.pdf
"3)  (2004)  S167–S172,  http://dx.doi.org/10.1007/s00247- 004-1266-9 ,  discussion  S234–S141.",Non-OADS,/arxiv_data1/oa_pdf/b7/3c/main.PMC4750616.pdf
"Alt,  D.  Engelmann,  J.P.  Schenk,  J.  Troeger,  Quality  control  of  thoracic X-rays in children in diagnostic centers  with  and  without  pediatric-radiologic competence, RoFo: Fortschritte  auf  dem  Gebiete  der  Rontgenstrahlen  und  der Nuklearmedizin  178  (2006)  191–199,  http://dx.doi.org/10.1055/s-2005- 858965 [8] M.D.",Non-OADS,/arxiv_data1/oa_pdf/b7/3c/main.PMC4750616.pdf
"42  (2012)  668–673, http://dx.doi.org/10.1007/s00247-011-2290-1 [9] K. Schneider, H. Fendel,  C.  Bakawski,  E.  Stein,  M.  Kohn,  M.  Kellner,  K. Schweighofer, G. Cartagena,  R.  Padovani,  W.  Panzer,  C.  Scheurer,  B.",Non-OADS,/arxiv_data1/oa_pdf/b7/3c/main.PMC4750616.pdf
"36  (2006)  22–25,  http://dx.doi.org/10.1007/s00247-005- 0016-y [11]  L.T.",Non-OADS,/arxiv_data1/oa_pdf/b7/3c/main.PMC4750616.pdf
"45  (2015)  158–165,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/b7/3c/main.PMC4750616.pdf
"197  (2011)  217–223,  http://dx.doi.org/10.2214/AJR.10.4979 [14] J.M.",Non-OADS,/arxiv_data1/oa_pdf/b7/3c/main.PMC4750616.pdf
"73  (2000) 843–846,  http://dx.doi.org/10.1259/bjr.73.872.11026859 [15]  J.V.",Non-OADS,/arxiv_data1/oa_pdf/b7/3c/main.PMC4750616.pdf
"41  (2011)  602–610, http://dx.doi.org/10.1007/s00247-010-1904-3 [17]  G.  Benz-Bohm,  Kinderradiologie,  2nd  ed.,  Thieme  Verlag,  Stuttgart,  2005.",Non-OADS,/arxiv_data1/oa_pdf/b7/3c/main.PMC4750616.pdf
23 March 2015Molecular Genetics and Metabolism Reports 3 (2015) 42 http://dx.doi.org/10.1016/j.ymgmr.2015.03.006 2214-4269/© 2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/b1/b9/main.PMC4750617.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/b9/main.PMC4750617.pdf
Contents lists available at ScienceDirect Molecular Genetics and Metabolism Reports journal homepage: http://www.journals.elsevier.com/molecular-genetics-and- metabolism-reports/,Non-OADS,/arxiv_data1/oa_pdf/b1/b9/main.PMC4750617.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/75/53/main.PMC4750618.pdf
Contents lists available at ScienceDirect Molecular Genetics and Metabolism Reports journal homepage: http://www.journals.elsevier.com/molecular-genetics-and- metabolism-reports/ http://dx.doi.org/10.1016/j.ymgmr.2015.04.003 2214-4269/© 2015 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/75/53/main.PMC4750618.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/75/53/main.PMC4750618.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/e7/main.PMC4750620.pdf
http://dx.doi.org/10.1016/j.ejro.2014.09.001 2352-0477/©  2014  Published  by  Elsevier  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/e2/e7/main.PMC4750620.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/e7/main.PMC4750620.pdf
"J  Magn  Reson  Imaging  2013, http://dx.doi.org/10.1002/jmri.24480  [Epub  ahead  of  print].",Non-OADS,/arxiv_data1/oa_pdf/e2/e7/main.PMC4750620.pdf
http://dx.doi.org/10.1016/j.ejro.2015.03.002 2352-0477/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/fa/70/main.PMC4750621.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/9a/main.PMC4750622.pdf
http://dx.doi.org/10.1016/j.ejro.2015.03.001 2352-0477/©  2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/ac/9a/main.PMC4750622.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/9a/main.PMC4750622.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/cd/main.PMC4750624.pdf
These  observations  have  stimulated  efforts  to  ﬁnd  non-invasive http://dx.doi.org/10.1016/j.ejro.2015.04.001 2352-0477/©  2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/cd/main.PMC4750624.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/cd/main.PMC4750624.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/de/main.PMC4750625.pdf
Renal  biopsy  is  an  invasive http://dx.doi.org/10.1016/j.ejro.2015.05.001 2352-0477/©  2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/04/de/main.PMC4750625.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/04/de/main.PMC4750625.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/48/8a/main.PMC4750626.pdf
We  carried  out  this  survey  study to  identify  the  frequency  of  mobile  technology  usage  among  the radiology  residents  in  our  country  and  how  radiology  residents http://dx.doi.org/10.1016/j.ejro.2015.10.001 2352-0477/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/48/8a/main.PMC4750626.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.,Non-OADS,/arxiv_data1/oa_pdf/48/8a/main.PMC4750626.pdf
A  survey  consisting  of  24  questions  was  prepared  using Google  Forms  application  (https://docs.google.com/forms ).,Non-OADS,/arxiv_data1/oa_pdf/48/8a/main.PMC4750626.pdf
The  respondents  were  informed  they  were not  identiﬁable  from  the  data.The  online  version  of  the  survey  can be  accessed  at  http://goo.gl/eWzt0 .,OADS,/arxiv_data1/oa_pdf/48/8a/main.PMC4750626.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.ejro.2015.10.001 .",OADS,/arxiv_data1/oa_pdf/48/8a/main.PMC4750626.pdf
http://www.turkstat.gov.tr/UstMenu.do?metod=temelist (accessed  08.11.2014).,Non-OADS,/arxiv_data1/oa_pdf/48/8a/main.PMC4750626.pdf
http://www.internetworldstats.com/stats4.,Non-OADS,/arxiv_data1/oa_pdf/48/8a/main.PMC4750626.pdf
http://www.internetworldstats.,Non-OADS,/arxiv_data1/oa_pdf/48/8a/main.PMC4750626.pdf
http://www.ntvmsnbc.com/id/25116494/ (accessed  27.04.2014  21.07.2010).,Non-OADS,/arxiv_data1/oa_pdf/48/8a/main.PMC4750626.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/42/1d/main.PMC4750627.pdf
"As  a  consequence,  less  than  300  cases http://dx.doi.org/10.1016/j.ejro.2014.09.004 2352-0477/©  2014  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/42/1d/main.PMC4750627.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/42/1d/main.PMC4750627.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/ by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/58/7d/main.PMC4750628.pdf
"In  most  of  these  disorders,  CSF  dynamics  are  mea- sured in  the  aqueduct  of  Sylvius  and  rarely  in  the  subarachnoid spaces (SAS), although  CSF  ﬂow  through  the  SAS  around  the basilar  artery  is  particularly  important  for  brain  compliance http://dx.doi.org/10.1016/j.ejro.2014.09.005 2352-0477/©  2014  Published  by  Elsevier  Ltd.",Non-OADS,/arxiv_data1/oa_pdf/58/7d/main.PMC4750628.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/ by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/58/7d/main.PMC4750628.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f0/06/main.PMC4750630.pdf
http://dx.doi.org/10.1016/j.ymgmr.2015.05.006 2214-4269/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/06/main.PMC4750630.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f0/06/main.PMC4750630.pdf
Contents lists available at ScienceDirect Molecular Genetics and Metabolism Reports journal homepage: http://www.journals.elsevier.com/molecular-genetics-and- metabolism-reports/,Non-OADS,/arxiv_data1/oa_pdf/f0/06/main.PMC4750630.pdf
"Structural analysis To evaluate the location of an amino acid residue involved in substi- tution, the solvent-accessible surface area (ASA) value of an amino acid in the wild type GLAwas calculated using Stride ( http://webclu.bio.",OADS,/arxiv_data1/oa_pdf/f0/06/main.PMC4750630.pdf
Structural models of mutant AGAL_HUMAN pro- teins with p.(Cys174Gly) and p.(Arg363His) were built using TINKER (http://dasher.wustl.edu/tinker/ ).,OADS,/arxiv_data1/oa_pdf/f0/06/main.PMC4750630.pdf
This mutation is classi ﬁed until present as a single nucleotide polymor- phism at the dbSNP database of the NCBI ( http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/f0/06/main.PMC4750630.pdf
"[23] http://www.ebi.ac.uk/pdbsum/1R46 [24] T. Inoue, K. Hattori, K. Ihara, A. Ishii, K. Nakamura, S. Hirose, Newborn screening for fabry disease in Japan: prevalence and genotypes of fabry disease in a pilot study, J. Hum.",OADS,/arxiv_data1/oa_pdf/f0/06/main.PMC4750630.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/f8/main.PMC4750633.pdf
http://dx.doi.org/10.1016/j.ymgmr.2015.03.010 2214-4269/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/47/f8/main.PMC4750633.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/f8/main.PMC4750633.pdf
Contents lists available at ScienceDirect Molecular Genetics and Metabolism Reports journal homepage: http://www.journals.elsevier.com/molecular-genetics-and- metabolism-reports/,Non-OADS,/arxiv_data1/oa_pdf/47/f8/main.PMC4750633.pdf
"Bashir, Correlation between quantitative whole-body muscle MRI and clinical muscle weakness in Pompe disease, Muscle Nerve (2014), http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/47/f8/main.PMC4750633.pdf
"(2015), http://dx.doi.org/10.1111/nan.12214 (Epub ahead of print).",Non-OADS,/arxiv_data1/oa_pdf/47/f8/main.PMC4750633.pdf
